>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 1; Drug: PCAP2 10 然 Apo 50 然
bRgbLsbRsbRsbRsRsmbRgbRgbRgbRsbRibRgbRgbRsRsRsRsmmmbRgRsmbRgbRgbRsRsmb
RiRsmbRiRsmbRgbRiRsRsmmbRgRsmbRgRsRsmmbRgbRsRgRgbRebRgRsmbRibRgbRgbRgL
sbRsbRsbsbRgbRgbLsRsbRibRibRgbRgbRsRsRsRsmmmbRgbLobLcbLgbLgbRsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 2; Drug: PCAP2 10 然 Apo 50 然
bRcbRsRsmbLgbLsRoLgbRhbRibLsbLsLobLsLobLoLsmbRibRibRibRjbRibRobLibLgbL
gRsbRibRsRsRiRsmmbRibRgbRibLibLibRobRobsbRcbRoLsLibLibLgbLeLsbLeRsbLiL
sbLibLgLsbLgbLibLobRsbRsbLoLsmbRgRsRembRebRgRsmbRebRebRebRcbRgbRibLgLe
bLgbLgbLsbRsbLsbRgbRsbRobLsRhbLebRcbRibRsbRsLsbRgbRsbRsbLeLobRjbRobRsb
RgRgbRsbRcRcRiReRsmbLobLhbLcbRobLsbLobLcbRobRibLsbRebRoLibLibLgbRobRhb
LsbLjbLoLsmbRcbRibRsbRoLsbRsbRobRsbRcbRsRsmbRibLsbRobLgbRcbRebLebLgLsb
LcRsbLhb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 3; Drug: PCAP2 10 然 Apo 50 然
bLgLsbLebLgbRgbRgRsmbRiLsbRibLebLoRgbReRsmbRibRgbRhbRiRsLsmbRgLsbLibLg
bLsbLsbLsbLibLiLsbLgbLebRsbLsLsmbRsbsbLsbsbsbRsRsmbLsLsmbLsbRiRoRsRsmm
bReLsbReReReLsbLgbRsLsbRhbRcRsmbLsRgbRsbRgLsbsbRsLsRsRsLsmbRgRsmbRgRsR
smmbLsLsRsmbRsRsRsRsmmmbRsRgbRgRsLsmbRgbRgRsmbsbRgbRsRsRsRsmmmbRgRsmbR
iRsmbLgbLgRsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 4; Drug: PCAP2 10 然 Apo 50 然
bRgRsmbRsbRgbLsLsRsmbRsbRgRsRgmbRsbRgRsmbRsbRibRcbRibRgbRobLgRsbRgRsLs
mbRsLsbRsbRgbRgRsmbRgbRiRsmbRsbRiRsRimbRsRsmbLsbRsbRgbRcLsLsmbLoRgbRgR
smbRgbRgRsRsmmbRgRgbLsLsmbRsbRsbLsbLsRsbRibRcLsLgbLgbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 5; Drug: PCAP2 10 然 Apo 50 然
bRiRsmbRgbRgbRsRsmbRsRsmbLsbRsbRgbLsbLsbLsbLgbRgbRgbRgbRgRsmbLsbRsbRsb
RsbRgbLsbLsbLgbRsbLsbRsbRsbRgbRoLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 6; Drug: PCAP2 10 然 Apo 50 然
bLibLiLsbLgbRgbLjbLsLsLsmmbLgbLgLsLsmbRsRsmbRgLjbLsbLebLsbRsLsbLsbLsLs
mbLeRsbLeLsbLjbLsLiLsLeLsLebRebLeLsbRgRsmbRhbRiLsbRsLsbLcbLcbRcbLoLsRs
LsmbRsbLgbLgbLsbRsbRebLobRsRgRsLgmbRsbRibRsRsRsmmbLgbLobLsbRjbRebLsbRg
bLsbLcLebLsbRebLoRsbLebLsLjbLeLsbLhLsLsLsLgmmbRsLgbsbLsbRsbsbRsbRsbLsb
RjbsbLsbLsbsbsbsbRsbLsRsbLobLsbLcRsbRgbLsbRibRebLsbRsRsLgmbLcLsLsLsmmm
bRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 7; Drug: PCAP2 3 然 Apo 50 然
bLgbLgbLgbLgLgLhbLobRsbRgbRgbRsLsbRgbRsRsmbRgbLibRjbRiLsbRoRobReRebRhR
gRsmbRgbRsRsLsLsmmbRsRsRsRsRsRsRsRsRsRsmmmmmmmmmbRiRsmbRsbLsRsbRsRsmbL
sRsbRgRsmbLsRsbRsbLsLsRsmbRsbRsbRsbRsRsmbRsRsmbRsLsRsbLcbLoRsLsbLsbRsb
RgbRjRgbRsRsRsmmbRsRsmbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 8; Drug: PCAP2 3 然 Apo 50 然
bRobRcbRoRsmbRobLibReRibRcbRobRibLjbLhbLgbLebsbsbsbLsLsmbLsbsbsbsbRsbR
sbsbsbLsbRsbRsbRsbsbsbsbsbLsbsbsbsbsbsbsbsbsbsbsbsbRsbsbsbLsbsbsbsbLsb
sbLsbsbsbsbsbRsRsmbsbsbLsbLsbRsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 9; Drug: PCAP2 3 然 Apo 50 然
bRibRsRsmbRsbLgbLsbLsLsLsmmbLsbLgbLgbLibLsbLsbLsbRsbLsLsRsmbsbLoLsmbLi
bLiRsbLsLsmbLobLsbLsLsmbLgbLgbLibLgbLgbLoLsLsmmbRsbRsbRsbLhLsbLsbLoRgR
smbRsbRibRgRsmbRsbRsRsmbRgbRibRgbRibRobRiRsLcRsmbRsbRcbLsbRibLsRsbRgbR
gbRsbRsbRsLsbRsbRsbRsRsmbRsRsLsmbRsbRgbRgbLcbRgbRibRiRsRgRgmbRhbLjbLcb
RobRibRebLcbLhbLcbRcbRcbRoLsbRcbRcbLcbLjLsmbLhbLobLibLhbLebLcbRobRibLi
bLcbLhbRibRcbLgLsbRebLibLcbLibLjbLebLgbRibRsbLibLhLsbLibLjbLcbLibRiRcb
RibRjbRhRsmbRcLsbLsbRjbLibLibRobLgLsbLcLsmbLjLsmbLebLjbLgbLsbLibLibRcb
RcbRgbRsbLjbLjbLibLgbLiLsbLibLcbRsbRiLsbLibLsbLgbLebRiRgbRobLiLsLjbRsb
LjbLobRiRsmbRibLsbLhbLibLcbRsbLsbLhbLibLiLsLsmbLibsbLibRibRjbRgbRibRib
RibLhbLgbLcbLjbRgRgRsmbRgReRsmbRobRibRibRebRcRsmbRgbRhbRgbLjbLgLsbLhbL
ibLcbLibLebLcbLebRobRiLsbRhb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 10; Drug: PCAP2 3 然 Apo 50 然
bRhRsmbRhRsmbLsRsbLsRoLgbLgbLibLeRsRgbRgbLgbLgbLibLgbLgLsLsmbLiLsbLgbL
sLsmbLgLsbLgbRoRsmbRiRsmbRcbRcbRcbLgRhbRgbRcRsmbRsbRjRgRcbRgLsbLsLsmbL
sbsbLsbLsLsmbLsLsLsmmbLsbLsLsmbLsLsLsLsLsmmmmbLsLsLsLsLsLsLsLsLsLsLsLg
LsLsLsLsLsLsLsLsLsLsRsmmmmmmmmmmmmmmmmmmmbLsLsLsmmbLgLsbLsbLsLsmbLsLsm
bLsLsmbLsbLsLsLsLsLsmmmmbLsbLsLsLsLsLsmmmmbLsLsLsmmbLsLsLsmmbsbLsbLsbL
sLsLsmmbLsLsLsLsmmmbLsLsLsLsLsmmmmbLgLsLsLsmmbLsLsmbsbLsLsLsmmbLsLsRsm
bLsLsLsLsmmmbLsbLsLsLsmmbLsLsLsLsmmmbLsbLsbLsLsmbLsLsmbLsLsmbLsLsLsRsm
mbLsLsmbLsbLsLsLsmmbLsLsmbLsLsmbLsLsLsmmbLsLsmbLgbLsbLsbLsLsmbLsLsLsmm
bLsLsLsLsLsLgLsLsmmmmmbLgLsLsLsLsmmmbLsLsmbLsbLsLsmbLsRsbLsLsLsRsmmbLs
LsmbLsLoLjbRsLsbRcRobLiLgRsbLibLgbLsLsmbLsLgLsLsLeLcmbLsbRsbRsbLgLsLsm
bLgbRsbRsRsLsLsmmbLsbLibLgLsbLcLsmbLiLjbLibRjRebRgbRgRsmbRsRsmbRsRsRsR
sRsmmmmbRsbRsbRgbRibRibRsbLsLsLsLsmmmbLsLsLgLsLsLsLsLsLsLsLsmmmmmmmmbL
sbLsLsLsLsmmmbLsLsmbLsLsLsLsLsLsLsmmmmmmbLsLsLsmmbsbLsLsLsmmbLgLsLiLsb
LiLibLsbLsbLsbLsLsmbLsLsLsmmbLsbLsLsLsLsmmmbLsLsLsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 11; Drug: PCAP2 3 然 Apo 50 然
bLsbRgbLgRsRsRsLsmmbRsbLcbLibLgbLibLibLgbLgbLcbsbRgbRsRsmbLsbRjRsmbLoL
smbRgbRibRsbLsbRgbLsbLibLhRsbRibLgbLgbLsbLibLobRgbLobLibRjbLhbLibLgbLc
bLobLcbLcbLcbRcbRjbLcbLcbLcbRcbLhbLibLgbLjLsLsmmbRsbLgLsbLjRsRsmbLsbRi
bRsbRgbRgRsmbRgbRsRsmbRgRsmbLgbRgRsRgRsRsRsRsRsmmmmmmbRsbRsbLsRsbRsRsR
sRsmmmbRibRgbRsRgRsRsRsmmmbRsbLsRsRsRsmmbRsRsRgmbRsRsRsRsRsmmmmbRsbRcR
sRsRsRsRsRgmmmmmbLsLsmbRsRsmbRgbLsLsmbRsRsRsRgRsmmmbRsRgRsLsmbRgRgRsRs
mmbLsRsbLsRsbLsbRgRsRgmbRgRsRsmmbRgbLsRsRsmbRsRsRsmmbRsRsRsRsRsRsmmmmm
bRgRsmbRsRsRsRsRsRsRsmmmmmmbRgRsLsmbRsRsLsmbRsRsRsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 12; Drug: PCAP2 3 然 Apo 50 然
bRsbRgbRsbRsbLsbLobRgbRgbRgbRgbRsRsmbRibRsbRobRcbRibRsbRhbRhbRjbRgbRib
RibRgbRibLsbRibLgbLobLibRgbLcbRiRsmbLjbLibRcbReRsmbRsRsRsmmbRibLjbRiRi
bRcbRebRibRiRsmbRebRhbLobLobLsbLobRgbRjbRgbRibRgbRebRibRibRcbRiRsmbReR
sRsmmbLgbLjbLhRsbLobRhbRibLibLhbRibRibRebRibRibRhbRebRibRebRebRibRiRsm
bRgbRjbReRgbRcbRibRhbLebRhbRibRcbRiRsmbLobLgbRcbRebRebRiRsRsRsmmmbLsbL
cbRgbRjbLgbLsbLibRiRsmbLsLsmbLibLibLcLsmbLsLsLsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 13; Drug: PCAP2 1 然 Apo 50 然
bRhbRobRcbRcbLgbRobLsbRobRcbRhbRobLebLgLsbRhbLibLcbLibLgbLobLcbLgbLcbL
cbLcbLcbLcbReRsRsmmbRibRcbRhbRibRibRibRgbLsbRiRsmbRsLsbRibRsRsmbRiRsRs
mmbRibRcbRibRjbRcbLjLsmbRjbRibRiLsLsmbLcbLcLsmbLsbLebLeLsbLsbRiRsmbRgb
RcbRebRsbRsbsbRgbRgLsbRsbRcRiRsmbRcbRsRsmbRgRsRsLsRsmmbRsbLsbRsLsRsLsb
RgbReRsRcmbRcbRsbRcRgRsRsmmbLsRibLjbRibRjbRebRiRcRiLsbRhRhbRhRsmbsbRgR
cRebLcLiLsLhLibRgRsRsmmbReRsRembRhbRsRib

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 14; Drug: PCAP2 1 然 Apo 50 然
bLiLsbLcbLiLsbLgLsbLgbLgLsbLsbLsRsbLgLsbLjLiLsbLeRsLjLsLimbLsbRjbRebRc
bRsbRsLsbRhbLebLjLsmbRsbRhRsRsRhmmbRgRsmbRgRsmbRsRsmbLsRsbLoLsmbLiLsbL
sbLsLsmbLcbLsbLsRsbRsRsRsmmbRsbLcLcbLibLiRsbLcbRsRsmbLsbLhLsbLhbLjbLcb
LcLsmbLsLiLebRoRgbRsbRjbLibLebLsbLhLsbLjLgLgbLibLcRsRsmbLsbLgbLiLeLsbR
gbRibRgbRgRsmbRcbRibRgRsmbRgRsmbRgRsmbRjRsmbRsRgbRsRcbRcbRiRsmbRibLcbR
hbsbRjbRhbRsbLsLsLsmmbRgLsbLhLsbLjLiLsLgbRsLeRsbRsRsmbLhbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 15; Drug: PCAP2 1 然 Apo 50 然
bRcbLibLibLsLsLsLsLsmmmmbLsLsmbLiLsbLgLsbsbLeLsLsmbLjLsmbLsLgbLgLsbLcb
RobRiRsmbRcbRcbRsbRobLcbLebLcbLebRcRsmbRcbRhbRcbLibReRsmbRibRibRcbRjRg
bRibRhRsmbLsLcbLcbLcbLhLsbLobRcbRsbLebLibLcbLcbRiRsmbRhbRhbRgbRgbRcbLs
RoRsmbLebLiLgbLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 16; Drug: PCAP2 1 然 Apo 50 然
bRcbRobLgbLjbRebLibRcbReRsmbRsbLebLeRsbLeLcbLibLebLibLeLsbLsLebRcbRhbL
ebLcbLeLsbLeLsbLibLcbLcbLebRjbRebRcbRebRcbLsbLcbLsbLcbLhbLeRsbRhbRebLg
bLibLibLebLjbLibLebLgbLhbRsbLobLebLjbLcLjbLgbLebLjbRcbLebLgbLebLjbRhbL
gbRebRgRsmbLjbLcbLibRsbLcbLebLhbLibLeLsbLebLiLsLsLsmmbLibLibLebLeLsbLg
bLgbLibRebRibLsbRsbRgbLcbRibLebLhbLiLsbLsbLgbLsbLhbLebLgbLibLibLgLsbLg
bLibLebLebLeLsbLgbLhbLsbLebLebLebLibLibLiLsbLibLsLibLgbLibLibLibLgbLib
RcbRibRgbRgbRgbRhbRibRibRebRibLhbLibRgbLgbLcbLgbLgbLhbLhLhbLsbLebLebLe
bLiLgbLgbRebRgbRgbLebRibRhbRsbRibRibRhbRsbRibRgRsRsmmbRcbRebLgbRibRibR
ibLiLgLsbLibLebLiLgbLibLgbLiLobLebLhLsbLhbRebRibRiLsbLsbRgbRgbRsLsbRsb
RgbRgbRgRsmbRcbRsbRgbRsLsbRebRgLsbLibLsLsLsLsmmmbLsbRebRibRgbRibRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 17; Drug: PCAP2 1 然 Apo 50 然
bRcRsmbRibRebLcbLhbLobLibRsbLobLebLsLcbLobLcbLcbLgbLobRhbLjbLcbRsbLcbL
hbLibLcbRobRibRobRcbLjbRsRsmbLsLobRibLibRsRebRhbLibLobRcbLobLcRsbRsLcL
smbRibRcbRibLibLhRsbLcbLhbLibRcbLibRsRcLsbRobRsRobLgbRcbRebRcbLgbLcbLi
LsbLobRibLcbLibLgbLibRibLcbLhbRibLsbLcbLhbRjbLcbLiRsbLiLsbLibLcbLhbLhb
LobRjbLibLibLcbRsbLcbLcbRibLobLibRsbLcLsmbLgbLjbRhbRgbRjbLjbRjbLsLsLsm
mbRgRsmbRsRsRsRsRsRsRsmmmmmmbRgbRsRsRsmmbRsRsRsmmbRsRgRsmbLeLsbLsLsmbL
cbLhbLgbLhbLgLsbLcbLibLsbLobLibLcbLjbLhbRjbLebLibLhbRebRiRsmbRoLsbRcLs
bRibRcbLjbReRsmbRcLsbLiLsbLcbLhbRgbRibLhbLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 18; Drug: PCAP2 1 然 Apo 50 然
bLibsbRobRobRobLibLobRjbLcbLcbLcbLebRobLibLcLsmbLgbRobLgbRibRiLsbRcbLi
LgbLjbLsbLgbLobLcbLjbLsRsbLsbLsbsbRjbLcbLhLsLsmbLibLobLgbLiLsbRsbLjbLi
bLcbRsLcbLhLsLsmbLcbLiLsbLsbRebLsbRsRebRobLgbLibLcbRcbLcbLibLcbRsbLibR
gbLjbLhLsbLobRibRibLibLgbRoLsbLgbLsRsbLobRhRsLsmbRhbRibLhLsLsmbLibRobR
cbRhLsbLgRsLsbLgLsbRobRcRsRsmmbRsRsmbRjRsmbLobLsbLibLgLsbLibLsbLjbLebL
gLsLsmbLiLsbLibLhLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 19; Drug: Control Apo 50 然
bRcLsbLcbLobLhbLibLiLsbLiLsbLgbLsbRcbLebLeLsbLcLsmbRibLeLsLsmbRcRsmbRh
bRhRsmbRcbLebRcbRsRhbRhbLcbLcbRebRibRhbRibRibRebReRsmbRcbLibRcbRsbRhbR
ibRgbRsRibRibLebRcbRibRgbRgbRibRgbLcbRjbRgRsRsmmbRibRgbRcbRcbLhLsbLhbL
ibRsbRibLhLibLcbLebLgbRibRjbRibRibLebLibLgRsbLibRgbRcbRiLsbRsbRibRibRi
bRibRcbRgLgbLiLsbRjbRebLjbLiLsbLgLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 20; Drug: Control Apo 50 然
bLobLebLgbLobLcbLebLeLsbLebLebLcbLsLgbLcLjLiLsbLjbLcbLobLsbLcbLiLsbLeb
LhbLebLcbLcLsmbLobRcbRcLsbRibRobLsbLibLebLjbLeLsbLebLiLibRcbRibLcLsmbL
cLgbLjLhbLhbLjLsmbLebLebLhLsbLgbLobRibLcbLcbLgbRebRhbLjLgbLibLebLcbLeb
RcbRiLsbLebLebLcbLjLeLsbRcbRhbRiLsbRebRgbLebLibRgbLcbLibRibLcbLebLibLe
bLebRjbLiLebLeLgbLcbLeLibLgbLebLiLsbLeLsbLgbLebLebLjbLibLebLgLebLgbLeb
RjbRebRhbLibRibLebRebLsLsmbRgbRgRsmbRgbRgRsRsRsmmmbLibRhbRgRsmbRibRsRs
mbRjbRiLsbRcbRibRhLsbRhbRgbLcbLebLebLebLcbLhLsbRcbRgRsmbRiRsmbRhRsRsmm
bRibRcLsLsmbRibLebLibLiLsbLibLcbLibRsbRibRiRsmbRcbRibRcbRcbRibRibRhbRi
bLcbLcbLsbLjLebLebRebLsRibRgbLebLebLgbLebLjLebLeLsbLsbLeLebLgLsLgbLebL
cbRhbRhbRhbRibLebLebLebLebLgbRcRsmbRsbLcLib

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 21; Drug: Control Apo 50 然
bLgbLsbRhRiLsRsRsRsmmbLsbRibRebRibLcbLcLsmbLhbLobLcbLobLcbRobRobRhbRcb
RcbRcbRcbRhRsmbLcbRobRibRibRsbRibRcbReRsmbRiRsmbRcbRobRcbRcRsLsRsmbLib
RcbRiRgRsmbRhLsRcLsbRoRsmbRjLsbLjbLcLgLgLsLiLiLsLgbLibLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 22; Drug: Control Apo 50 然
bLobLebLcRsbRsRsmbRcbRobRcbRcbLobLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 23; Drug: Control Apo 50 然
bRobRiLsbRhbRobLhbRobRjbLcbRobRhbRhLsLsmbLcbLhbRibRhbRibRsRhbRgbLcbRob
RhbsbRibRcbRcLsbRibRcbRcRsmbRsRsLsmbRsbsbReLsbLobRgbsbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 24; Drug: Control Apo 50 然
bRjbLcbLsbLebLibLcbLibRsbRsbLhLobLcbLcRsbLsbLcRsbLibLcLsmbLcbRcbRcbRiR
smbRsbRibLcRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 25; Drug: PCAP2 10 然 Apo 50 然
bLsbLobsbLsbLjbLsbRsLsbLsbLsbLsbRjbRsbRcbRjbRjbLibRibLgbRsbLsbLsbsbLsb
RsbRgbRhbRjbRjbRsbRcbRcbRcbRgRsmbRsbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 26; Drug: PCAP2 10 然 Apo 50 然
bLiLsLsmbLsbLsbLsbLsbLsbLsbLsLsRsmbLsLsmbRsbLsbLsbLsRebLcbRsbLsLsmbReb
LsbLsbLibLobRobLoRsRsmbRsbRibsbsbsbsbRgbRgbRobLsbLsLsmbRsbRibRiRsmbRgb
RsbRgbRgLsbRiLsLsmbLsbLsbRibRgbRsbRiRsmbRsbRgbRgbRsbLsbRgbRsbRsbRgbLsb
RgbRgLsbRsbRoLsbRsbsbLsbsbRjbRibRsLsbsbRibRgRsRsmmbRgbRcbLgbRsRsmbRsbR
sbsbsbRsbLsbsbsbsbLsRsbsbsbsbsbsbLsbsbsbsbsbLsbRsbsbsbsbsbsbsbsbsbsbsb
RgbRsRsmbLsRsRsmbRgbRsbRibRsbRiLsbLsLsmbRgbRiRsmbRsbRsbRsbRsbRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 27; Drug: PCAP2 10 然 Apo 50 然
bLibLsLsmbLibRoRsRsLsmmbLsRsLsbLgLsbLeLsbLgLsbLiLsbLiRsbLobLobLgbLiLsb
RoRiRsmbLsLgLsbLobLibLgRsbLgbLgbLgbLgbLgRsbLsRsbLgLsLobLgbLsLsmbLgLsbL
gLsLsmbLsbLsRsLsbLsRsLsbLsbLgRsLcbRgbRsRsmbLsRsbRcRsmbLsRsbLsbLgLsbLeb
RsLsbRsRsmbLsRsLsbRsLsLsmbLsLsmbLebsbLjbRsRsRsmmbLibLibLgbLsbLsbLsRsbL
gLsLsmbLsLsmbLgLsbLgLsbLsLgbLsbLsbRhRoRsmbRiRsmbRcRsRsmmbRsRsmbLsLgbLg
LsbLsbRobRcbRsRsmbRgRsRsmmbRsbRsbRsRsRsmmbLsRsbLsLsLsmmbRsRsmbRhbRiRsm
bRsbLoRsbLibLibLgRsbRsbRsRgbRsRsmbRgRsRsmmbRsRsmbRgbLsbLsbLsRsRsmbLsRs
bRibRsRsLsRsmbRgbRsRsmbRsRsmbRgRsmbRgbRsRsRsmmbRgbRcbRiLsbRiRgbRsbLsLs
RsRgmbRsRsRsmmbRsRsRsLsmmbRsbLsbRsbRsRsmbLsRsRsRsmmbLsbRsbRsRgbRsRsmbR
sRsRsRsmmmbRsRgRsmbRgRsRsRsmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 28; Drug: PCAP2 10 然 Apo 50 然
bRsRsmbLgLsbRjRoRibRoLsLsmbRoRobRobLobLsRsRsmbLsLobRibReRsmbLsLjLcRsbL
gLsbLiLsbLgbLsbLhLobLgbRcReRebRcLsbLsRsbsbLiLsLsmbRsRsmbRjbReLsbLibLib
RsLgbRcbRsbRobRjbRcbRsbRsbRsbLsbsbRsbsbsbRsbLobLcLsLeLsmbRjbRhbsbRibRj
LsLsRsmbRcRgbLgbRobRibReRebRgbRibRhbRsbRibRgRsRsRsmmmbRhRsmbRgRsLsRgmb
RgbRibReRsmbLiRsLcbRsLgbLgLsbRjbRoRsmbRibLjbLjbRsLibLeRsLsbLsLsmbLsbLs
LsLsLsLemmmbLeLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 29; Drug: PCAP2 10 然 Apo 50 然
bRibRibRiRsmbLsbRcbRoRhRsmbRcbRgLsbLsbRgbRhRsmbRgLsbRhbRebLsbLgbRsbLib
LiLsbRsLsbRibLsbRgRsmbLjLsLhmbLjbLibLsbRhbRcbRebRhbLsLsmbLsLsmbsbLsLsm
bRebRcbRcbRsLsbLgRsLsbRcbLobRhLsbLibRgbRibRgbRgbRgbLsbRsbRsbRsRsmbRsLs
bRibRsbRsRsmbLibLebLibRcRsmbReRsRgLsmbLgRsbLgLsbLsbRsbLgRsbRgRsmbLjRgb
LcbRcLsbRhbLibRsLsbRsbLsbLsbRsbLsRsRsmbRsbLcbRhbLgbLibLcbLsbRgbReLjRsb
LgbLgbsbRsbLsLsmbRsLsbLibLhbRsbRsbRgbRhRjRgbRgbRsLsbLsbLibLiLiRgRsRsmm
bRiLsLsmbLibRjbReRibRsbLgbRjbRsbRgRibRebRgbRgRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 30; Drug: PCAP2 10 然 Apo 50 然
bsbLgbLoLsmbLsRsbLcbLsLsLsmmbLeRsRsRsRiRcRgmmbRcbRobRgbRoLsbRcLsbLibRs
bLhbRoRsmbLebLibLgLeLjLiLhbLsbLibLibLibLcbLiLibLebLiLebLgbLgbLhbRibRjb
LcRoRsmbLcLcLsmbLiLsbRgRsmbRgbLjbLiLsbLsbRgbLsbLgLsbLgLsLibLgRsRsmbLsb
LgbsbLobRjbRcbRsbRsbRsbRiRsmbRcbRgbRcbLgbLiLsbLcbRibRgbRiLsbRgRsmbLjLs
mbLcbRsbRgLsLsmbRgbLibsbRgbRgbLgLsbLcbRsRebRsbsbLgbsbRsRsLsmbRjbLhbLcb
RsLsLsmbsbLsRsbsbLsbRsbRibRsbsbRsbsbRgRsRsmmbRsRsLsRembRgbRsRsRgmbLjRc
bRibRgLsbRsbLsRsRsRsRsmmmbLsRsbLeLsLsLsmmbLsLsLsmmbLsbLsLgRsbLibLsLsLs
LcRsmmbRsRsLsRsmbRoLsbLsbLebLhbLebRsbLebLsbRgLsLibLeRsbLibsbsbsbsbsbLs
LibsbLsbLsLcbLiLsbRgbLsReLsRsRsmbRgLsReRsmbRsbRsRoRsRsRsRsmmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 31; Drug: PCAP2 3 然 Apo 50 然
bLobLgbLgbRgLjbLcbLgbRsbLjbLgbLiLsbLgLsbLsbLsbLgbLsLsmbLgbLsbLgbRsbReb
RgRsRsmmbRsRsmbLsRsRsmbRgbRcLsbLsLsmbLsbLsbLsLsmbLsbLgbLsbRcRsmbRgbRsb
RsRsRsmmbRsRsmbRsLsbRsRsRsRsmmmbLsRsbRsLsbRsRsmbRsbRsRsRsRsmmmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 32; Drug: PCAP2 3 然 Apo 50 然
bRsRsmbRiRsmbRgbRsbRgbRgbsbRsbRibRsRsLsmbRiRsRgmbRgbsbRsbRgbRgbRgbRibL
sbRsbRibRsLsbRoRsmbLsLsmbRsRsLsRsmbLgbLgbLsbLgbLsbLgLsbLgLsbLgRsbLgRsb
LoRsLgbRsbRibRgbRgRsmbLsbRgLsbRgbRgRsmbRobLsbLsLsmbLibLgbLsbLgLsbLgbLg
bLgbLgbLgbLgbLsbLsbLgbLgbLgbLgbLgbLgbLgbLgLoRsbLsbRibRoLsLsmbRgLsLsmbL
gbLgbLgbLgbLgLsbLsbLgbLgbLgbLsbLgbLgbLgbLgLsbLgLsbLgbLsLsmbLsbLsbLgLsb
LgbLgbLsbLgRsbLgbLgbLgbLgbLgbLsbLsbLgbLsbLsLsmbLgbLsbLsLsmbLsbLgbLgbLs
LsLsmmbLgLsbLsbLsbLgbLgbLsbLsbLgbLgbLsbLsbLgbLsbLgbLsbLsbLgbLsbLsLsmbL
sbLgLsbLsLsmbLsLsmbLsLsmbLsbLsbLsbLsbLsRsbLsbLsbLsbLsRsbLsbLsbRsbLgbLs
bLsbLsbLsbLsLsmbLsbLsbLsLsmbLsbLgLsbRsLsbRsbRsbLsbLsbRsLsLsmbLsbLsRsbL
sbLsbLsbLsbLsbLsbLsbLsbRsLsLsmbLsbLsbLsbLsbLsbLsbLsLsmbLsbLsbLsbLsbsbR
sbLsbLsbLsLsmbLsbLsbLsbLsbLsLgLsbsbLsbLsLsLsmmbLsbLsbLsbLsbLsLsmbLsbLs
LsLsmmbLsRsbLsLsmbLsbLsLsLsmmbLsbLsbLsbLsbLsbLsbLsbLsLsmbLsbLsbLsbLsbL
sbRsbRsbRibLsbLsbRsbRsbsbsbsbsbsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 33; Drug: PCAP2 3 然 Apo 50 然
bRsbRgRsmbRibLsRcbRoLsbLiLsbLibLsLsmbLiLiLcRsbLiRsbLhLcLsmbRjRibRcRcbL
ibRoLsbRgbLjbRgbRibLeLsbLobLcbLgbLhbLcLgbRebRobRjbLobLcbLcLsmbLgbLibLs
LsmbLgLsbLgbRoRsmbLjLebLcbLsbLjLcbLcbLcLsmbLhLsLcbLeLsbRsLsbLcbLcbLcbL
cLsLgLsLgLgLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 34; Drug: PCAP2 3 然 Apo 50 然
bRsRsmbRgRsRsmmbLsbRoRsRombRiRsmbRsbLebLcbRsbLsRsbLcbRsbRsbRsbLoLsmbLo
bLsbLsRsRsmbLsbRhbRsRsmbRhRsmbRcbLsRsbLsLhbRgbLhLsbRsbRsbRsLsbLcbRsbLs
bLsbLiLsbRsbLsbLsLsmbLsbLsbsbLsLsLsmmbLsLsmbLsLsmbLsbLsLsmbLsLsLsmmbRs
bRsbLsbLsbLsbLgbLgbLsbLsbLsLsLsmmbLsRsbLsLsmbLsbLsbLsLsmbLsLsmbLsbLgbL
gbRsbLsLsmbLsbLsbLsbLsLsmbLsbLsbLsLsmbLsbLsLsmbLsLsLsLsmmmbLsLsRsmbLsL
smbLsLsmbLgbLsbsbLsbRsbLsRsbLsbLsbLsbLsbLsbLsbLsbRsLsbRsLsbLsLsLsmmbLs
LsmbLgbLsLsmbLsLsmbLsbLsbLsbLsbLsLsmbLsLsmbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 35; Drug: PCAP2 3 然 Apo 50 然
bLsbsbLsbRsbLsbLhLsbLhLhbLsbRsRsRsmmbRsRsmbRgRsRsmmbRsRcRsmbRsbLsbRsbR
gbRgRsmbLsRsbLsRsbRsbRsbLsbsbRsbsbsbLhbLiLsbsbRsbLsbLsbLgbLcLsmbLsbLcb
LsRsbRsRsmbLsbLjbsbLsLsLsmmbLsbLsLsmbRsLsRsbLsbLsbRsLsbLsbRsLsbLibLsbR
sbLsbLsLsLsLsmmmbLgbLsbLiLsLsmbLgLsbRgLsbRsbRsLsbLgLsbLsLsmbRsbLsLsmbL
sLsmbRsLgLsbRsRsmbLsLsmbLgbLsbLsbLgLhLoRsbLcRsLhbLiLsbLibLgbLgbLibLiRs
LibLgLoLgbLcbLiLsbLiLsbRsRsmbLsRsLsbsbRgbLhbLsbLcbLjbRjRibRgRgReLsbLcb
LcLsLiLsmbRebRcbRcLsbRcLsLsRsmbRjRgRsmbRibRoRibLibLsbLgbLgbLibLiRsLoRs
bLcbLgbLgbLsbLgLsbLsLsmbLgbLibLcbLhLoLcbLibRsbRsRsmbRgbRiReRiRsmbRsReL
sLsLsmmbRibLibLgbRgbLcbLcbLcLcLsmbLiLsbLhbRcLsbRjbLcbLcbLsLebRsLsRsbLh
bRibRiRsmbRcRoRsmbRoLsbRibRibRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 36; Drug: PCAP2 3 然 Apo 50 然
bRjbRsbRsbRsbRsbRsbRsbsbRgRsmbRgRsmbLsLsmbRsbRsbRsLsbRsbRsbRgbLsRsbRsb
sbRsbRsbRgbRsbLsbsbsbRsbLsbLsRsbRsbRsRsmbRsbRsRsmbRsbRsRsmbRsbRsbRgbRs
bRsbsbsbRsbsbsbRsbRsbRsbRsbRsRsmbRsbRsRsmbRsbRsbRsRsRsmmbRsbLsRsRsmbRs
RsRsmmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 37; Drug: PCAP2 1 然 Apo 50 然
bLobLgLsbLhbLsbRsbLcbLsbRsbLibLsLsmbLgbLgRsbLgbLgbLgbLibLobRiRsmbRgbLs
bLoLsmbLibLgbLcbLcbLhbLhLsbLcbLcbLsbRsLsRsbsbRsbRsRsLsRsmbRsbRsbRsbRsR
smbRsRsRsmmbRsRsRsRsRsmmmmbRsbRsRsmbRsRsmbRsRsRsRsmmmbRsRsRsRsmmmbsbRs
bRsbRsRsRsmmbLsRsRsmbsbRsRsRsRsRsmmmmbRsRsRsmmbRsRsmbRsRsRsRsRsmmmmbRs
Rsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 38; Drug: PCAP2 1 然 Apo 50 然
bsbRgRsRgmbRjbRiLsbLsbRsbRsbRhbRgbRibRgbRiRsmbRibRibLiRsLsbsbLsLsmbLsL
smbLsLsmbLsLsmbLsLsLsmmbLsLsLsmmbRhbRsRibRjLsbRibRsRsmbRsbRsbLcbRsbReb
RiRsmbsbRibLsbRsbRsbRgRsmbRsbRsRsmbRsLsbRsRsRsmmbRsbRgbRgbRsbRsbRgbRsb
RsbRsbRsbRsbsbLcbLhLsbLiLsbLsbRgbLsbLibLgbLiLsbLcLsLsmmbLgbRsRsmbRgLsb
RsbRsRsmbRsRsRsmmbRgbRgbRsRsmbRiRibRsbRsbLsLsmbLjbRhRsmbRgbRcbRcRibRhb
LsbLjbLibLsbLsLsmbRsLsbLgbLsbLgLsbRsbLgbLgbLsbLsLsLsmmbLsbLgbLsLsLsmmb
LsLsmbLsLsmbLsbLgRsbLsLsmbRcbRcbRcbRsbLsbRibRsRsmbRsLsbRhbRgbLcbLiLiLs
bLgbLsbLgbLgLsLsLgLsmbLsbLgbLgLsLsmbLsLsmbLsbLsbLsbLsLsmbLsLsmbLsbRsRs
mbLsbLgRsbLsRsbLsbLgbLsbLsLsmbLgbLsLsmbLsbLsbLgbRsbLsbRcbRiLsbsbRoLsLs
mbRgbRibRgLsbRgbRgbRgRibRibRgbRoRsmbLcLsmbLsbRsbLsbLgLsRsLsbLibLiRsbRs
LsRsbLibLsbLgLsRsLsbLsLsmbLsLsmbLsLsLsmmbLsLgLsbLgbLsLsmbLsLsmbLsbLsbL
sbLgbLsLsLsmmbLsbRjbRobRcbRcbRsbRsbRiRibRibRgRsRsmmbRsbRsbRsbRgRsmbRgR
smbRgbRgbRgRsmbRgRgRsmbRgRsRsmmbRgbRsLsbLjbLibsbsbLgbLsLsLsmmbLsbLsbLs
LgLsLsmbLgbLgLsbLsLsmbLsLsmbLsLsmbLibRsLsbLsbLsbLcbRsbLsLcLsLimbLiRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 39; Drug: PCAP2 1 然 Apo 50 然
bRibRoLsRebRobLcbLibLgLsbRsLsLsmbRobRiRgbRibLsLsmbLsLsmbLgbLiLsbLoLsmb
RsRsmbsbLgLsbLebLgbLgbLsbRsbLibLhLsbLiRsLsLhbLgbLgbRebRhbLhbLibLcbsbLo
bLeLiLiRsbLhbLoLsmbLhbLiRsbRoRgLsbsbLcbRoRibRhbLsbLcbLobLobRsbRjbLcbLo
LsmbLobRsRsmbLibLibLobRjbRcbRibRcbRcbRhbLsbRsLsRsbRsRsmbRsbsbRsRsmbsbs
bsbsbRsRsmbsbRjRsRsmmbLcbLcbLobLobLcLsmbRobRsbRgbLsbRsbRgbRsRebReRsmbR
sbRsRsmbLsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 40; Drug: PCAP2 1 然 Apo 50 然
bLgbRobRoRsmbRobRhbRoRsLsmbLibRoRhbReRsmbLcLgLsbRcbLsLsmbRobRcRsmbRcRs
mbRobRsRsmbRcbRhRsmbRobRcbRibLobRsLibLsbRsLsLgLgbLgLsbLsLsLsLsmmmbLcLs
LsmmbsbRcbLsbLhbLoRsLcRebRiRebRibRcbRcbRibRjLsbRcbsbLgLsbLjLsLsRsmmbLo
bLgLsbLsLsmbLgbLsbLsbLsbLsbsbLgbsbRcbRcbsbLcbLhbLcbRibLcLsmbLobLoRebLc
bRobRhRebRjLsLsmbRhbRgRgbLsbLebRcbLsRsRsmbRcRsmbRhbLgRsLsbRibRgLsbRhbR
sbRgbRiLsRsRsmbRhbLsLsmbRgRsRsRgRsmmmbRibLsRsbRibRsbRcbLibRsbRsRsmbLib
RhbRcbRsbRsRsmbRiLsLsLsmmbRhbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 41; Drug: PCAP2 1 然 Apo 50 然
bRsbLcbLibLsbsbLibLibLcbLsbRhbRcbRibRgRsRsmmbLsbLsLsmbLjLsmbLsLsLsLgmm
bLsLsLsLsLgLsLsmmmmbLsLsmbLsbLsLsLsmmbLsLsLgLsmbLsLsmbLsLsLsLsLsLsLsLs
mmmmmmmbRsRsmbLsLsmbLsbLgbLsLsLsLsmmmbLgLsRsbLsLsLsmmbLsLsLsmmbLsLsLsL
sLsmmmmbLsLsLsLsLsmmmmbLsLsLsmmbLgbLgLsbLsbLsLsLsLsmmmbLsLsmbLsLsLsmmb
LsbLsLsLsmmbLsLsmbLiLoRsbRsLcbReRsRsLsLsmmmbLsbLsbLsRsbRsLsLsmbLsbLsbR
sLsbRsbLsbLsbLsLsRsmbRsbLsbLsbRsbLsbRsbRsRsRsmmbRsbRsRsmbRsbRgRsmbsbLs
bRsRsmbRsLsbsbRiRcRiRsmbRcbRgRsmbRoLsLsmbLsLsRsmbRobRiRsRiRhRsRsmmmbRi
RsmbRsRgbsbsbsbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 42; Drug: PCAP2 1 然 Apo 50 然
bLgbLgLsbLsbLgbLsLsLgmbRoRsmbRgRsmbRsRsmbRgRsmbRoRibRgbLcbLcbLcbLcbLib
LoRsbLcbLcbLcbRcLsbRcbRobRjLsbRcbRcbLhbLjbLcbLcbLobLhbLcbLcbLjbLjb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 43; Drug: Control Apo 50 然
bRsReRsmbRebRoRsRsmmbRibRgbRebRsbLsbLibLsLcbLiRsbLoRsbLeRsbRgbLobLsbsb
RcbRhLsLsLsmmbRsbLcbLibLibLhLsbLsbLcbLcbLcbLcbLibRoRsmbRjbRobLsLsLsLsm
mmbsbLgbRjRjbRcRsmbRcbRsbRsbLsbLsbRoLsLsmbRcbRsbLjbLgLsbLiRsbLcLsmbLsL
sLsmmbLsbRsbRsRsmbRsRsmbRsRsRsmmbRsbRsbRsbLsRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 44; Drug: Control Apo 50 然
bRgbLibLibLgbLsLsmbRsbLgbLgbLjbLhbLjbLibLiLsbLebLibLsLsmbLibLibLibLcbL
hbLiRsbLgLsbLcbLcbLibRebRcbRobRobLgbLgbLgRsbRcbLibLibRobLsRiRgbRgbRcbL
cLsLgLsmbRsbRjRsRsLsRsLsmmbLsLsmbRibLebRsbLgLgLsbLebLiLsLgbLiLsbLibLhb
LiLeLibLebLibLsLsmbLgbLibLibLgbLsLsmbLgbLibLgbLhRsbLhbLebRcbLibRibRcbR
ibLgLsbLiLsbLcbRibRcbRibLibLsbLsbLgLsbLibLebLhbLjRsLsbLgbLgbLibLgbLibL
cbRsLsbLgbLcRsbLgbLcbLibLcbRebRhbLsbLibLibLibLiLsbLgbRgbRhbRibLgbRhbLg
bLjLsmbLebLgbRcRsmbRsbRgLsRsbRsbRgbRcbReRsRsmmbLjLgLsbLhLsbLibLebLgbLi
bLibLibLgbLeLsbRibRibRcbRgbRgbLibLibLibLgbLibLiRsbRjbLcbLibRib

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 45; Drug: Control Apo 50 然
bRcbRebRcbLhbRebRcbReRsmbRsbsbLsRsRsRsRsmmmbRsbRsRsRsmmbRsbRgbLjbLibLo
bLibRobRsRsRsRsRsmmmmbsbRsRsRsRsRsRsRsRsRsmmmmmmmmbRgRsmbRsLcbLhRsLsbL
cbLhbLgbLobRobRiRsmbRoRsmbLsbRobRsbLobLhbLiLsbLgLsLsLsLgLsLsmmmbRjRsmb
RjRgRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 46; Drug: Control Apo 50 然
bRcbLiLsbLhbLsbRsbLebLibLcbLsRsRsRsRsLsmmmbRobLsLibRsbLeLiRsbLhbLsbLeb
LebLsbLhbLibLcbRsbLsLsmbLebLcbLibLibLjbRibRsbLhb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 47; Drug: Control Apo 50 然
bLcbLgLsbLibLobRsbLhbLibLcbLobLsLibLcbLcbLhbLobLgbLibLgbLcbLibLobLcbLc
bLcbLibRcbRobRcbRobRcLsbRcbLcbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 113018; End: 113518;
Recording: 1-1; Individual: 48; Drug: Control Apo 50 然
bsbLcLsmbRjbLjLiRsbLcbRcbRcbRcbRcbRibRjbRcbRhbRibRobRcbRebRcbLcLhbLobL
cbLibLsbLhbLgbLcbLhbRsbLiRsbLebLibRhbLsRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 1; Drug: PCAP2 10 然 Apo 50 然
bLsRsbRsLgbRsbsbLsbLsbLsLsmbLsLsLsmmbLsLsRsLsLsmmbLgbLsRsbLsbLhbRoLsRs
RsRsmmbRgbRsbRoRgbRhbRgRsmbRgbLibRsbRgbRgbRsbRgbRgRsmbRgbRibLsRsRsRsmm
bRgLsbRgbRsRsmbRgRgbRiRsmbRsbRgLsbRiRsmbRsbRhbRgRsmbRiRsmbRgbRgRsmbRgb
RgbRgbRgbRsRibRgRsRsmmbRgbRiRsmbRsbRiLsbRgRsRgmbRgRsmbRgbLhRgRsmbRgbRg
bReReRibLgbRsbRsRsmbRibRiRsLsmbRsbRgbRsRsmbReRsmbRgbRgRsmbRgbRgbRgRsmb
RgbRhb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 2; Drug: PCAP2 10 然 Apo 50 然
bLhbLhbLibLibLhbLibLoLsmbLobRobRsLsbRoRsmbLcbRoRsmbRcbRsRsmbRhbRgbRsRs
mbRgbRcbRcRsmbLoLsmbLgbLoRsbRsbRcbRgRsRsmmbRsbRibRhbLibLobLsbRcbRebRib
RhLsbLgLsbLobLsLsmbRiLsbRobLgbLoRsbRhLsbRcbRgbRsRobRibRcbRcbRgbRcbRcbR
ibRibLobLcbLobLebLobRcbRibRibRsRcbLobLjLsmbLobLoRsRsRsmmbLobLcbLobLcbR
obRcbRcbLsbRcbLsLsmbLcbLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 3; Drug: PCAP2 10 然 Apo 50 然
bLibLibLibLgLsbRsbLgLsRsbLsbLiLobRiRsRsRgmmbLibRgbRgRsmbLiLsbLgLsbLsbR
sbLsRsbRsbLsbLsbLsbLsbRsbLsbLsbLsbLsbLsLsLsmmbLsLgbLgbLsbRsRsmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 4; Drug: PCAP2 10 然 Apo 50 然
bsbLsbRsLsLsmbLsRsRsLsmbRsbRoRsmbRsRsmbLsRsRsmbLsRsRsLsmbRsRsmbRsLsbRo
bLobLsbRsRsmbRsbRsbLsLsLsmmbRoRgbRoLsLsLsmmbLsbRgbLsbsbsbRsbLsLsmbRsLs
LsRsLsRsmbRsRsRsmmbsbRsbLsbsbsbsbRsLsLsmbRsRsmbRsRsRsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 5; Drug: PCAP2 10 然 Apo 50 然
bLgLsbLsLsmbLsbLsbRsbLgbRsRsmbLsbLsbLgbRsbLgbLsbRsbLeLsbRibRgLgLsbRsLg
bLgbLsbLibRsLsLsmbLsLgbLsbLsLsLgmbLsbLsLsLsLsLsmmmmbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 6; Drug: PCAP2 10 然 Apo 50 然
bLsLhLobLeLsbLiLsbLjLgLsLsmbLsbLsRsbLgbLgLsbLsbLcLsmbRsLsbLebLibLeRsbL
ebLsbRhbRsRsmbRhRsmbLjbRsRgRsmbRibLsLjbLibRebRibLebLcLsmbLcbLebLebLcbL
gbLeLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 7; Drug: PCAP2 3 然 Apo 50 然
bLsRsbRsRsRsmmbRsRsmbRsRsRsmmbRsRsRsRsLsmmmbRgRsmbRsbLiRsRibLsbRsbLsbL
gLsLsLsLgLiLgmmbRsRsmbRsLcbLcbLsbRgbLcLsmbLgbLsLsLsmmbLgbLgLgLsbLgLsbL
gRsbLgbLgbLgbLsbLsLsLsmmbLsLsLsmmbLsLsmbLgbLsLsmbLsLsLsLsLsmmmmbLgbLgb
LgLsbLgbLsbLsbsbLsLsmbLgLsbLsLsmbLsLsRsmbLsbLsLsmbLsLsmbLsbLsbLiLoLsmb
LibLsbLsbLsbRsLsbLsbRsbLsbRsLgbLiLsbLgLsbLsLsmbLgbLgRsbLsLsLsmmbLgLsbL
gLsbLgbLgLsbLsbLsbLgbLgbLgRsbLsRsbLsLsmbLsbLgbLsLsmbLsLsmbRsLsbLgbLgLs
LsmbLsLsmbLsbLgbLgLsbLsLsLsRsmmbLgbRsbLsbRsbLsRsLsbsbRsbLgbLgbRsLsbLsL
smbRsbsbLsbsbLsbLsbLsbRsLsbLgbLsbLsLsmbLsbLsbLgbLgLsbLgbLgbLgLsbLsLsmb
LgbLsLsLsmmbLsbLsLsLsRsmmbLsLsLsmmbLsbLsbLsRsbLsbLibLsbLgLgbLsLgbLsLsm
bLsLsLsLsmmmbLgbsbLsLsmbLgLsbLgbLsLsmbLsLsmbLsbLgbLsbLsLsmbLgbLsLsmbLs
LsmbLsLsmbLsLsmbLsRsbLsLsmbLgRsbLgbLsRsbLsLsmbLgbRsLsLsLsLsmmmbLsbLsLs
LsmmbLsLsmbLsbLsbLgbLsRsbRsbLsLsmbLsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 8; Drug: PCAP2 3 然 Apo 50 然
bLsLibLcbLoLsLsLsmmmbLiLsbLcLsmbLcbRsbLcbLcbRsRsmbRobRcRsmbRebRoRgRsmb
LsRgbRobLibLgLcbLcLsLeLsmbLsbLobRsRsmbRcRsmbLgLgbRibRebRcLsbRhRcbRgbLg
LgLsLsLsmmbRcbRiRgbRgRgRsmbRcRsmbRcRsmbRsRiRsmbReRcLsbLeLgLsLhbLobLcLs
mbLgLsbLcLsmbLcRsbLjLeLibRsbLiLgLebLhLcbRgbRjRsmbRhRsRsRsRsmmmmbRsRsRg
RgRsRsmmmbRcbRjbRsRhbRobRsLsbLeLsLsmbLeLsbLeLsbLcLsmbLsLgLebLcbLiLsbLe
LgbLibRebRjbRgRgbRgRsRiRimbRsbRcRsmbRjbRcbRhRsRgmbRgbLiLsRsbLcbLcbLcbL
gbRebRhbLsbRebReRsmbRgbRcLsbRjbRcbRobRiRsmbRcbRsbRcRsmbRcRsRsmmbRcRsmb
RsRsLsLgmbReRsLgLsmbLgLoLibLeLsbLeLoLsmbLgbLiRsbLibRiRcbRibLjbLoLsRsmb
LhbLiLcbLjLgLgbLhLsLsLgLembReRebRcLsbReRcLsRsbRcLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 9; Drug: PCAP2 3 然 Apo 50 然
bRgbLsLsRgmbRibLjbLiLgbLsLsLsLgLsmmbLsLgbLgbRjbLibRsRgRsRgmbRgbRsbRsbR
gbRebLcbRobLiRsbRsRsRsRsRsRsRsRsRsRgmmmmmmmmbRobLsbRjbRcRsmbRcbRiLsbRe
bLsbRebRobRebRsbLeRsbRgbRgReRiRgRebRebRebReLsbRebRebRebRibRsRsmbRgbRjb
LjbLjbLiLsbRsRsmbLjbLjbRsbRcbRiLsbRsRsLsmbRjbLgbLjbLibRebRgRsRsRiRsmmm
bRgbRgbRgbLsRgRsmbRsbLjLibLgbRebRibRcbRhbRcbRhbLjbLgbReRsmbRhbRebRhbLi
bLibLibLcbLgbRcbLcbLhbLhbRjbRibRhbRibLibLibLibLiRsbReRsmbRcRsmbRgbReRs
RimbRibRgRsmbRsRsmbRgReRgRsReRimbRebRgbRgbLobLibLcbLhbLhbLibLibLobLebL
ibLhbRcbRiRsmbRebRcbRibRjbRebRibRcbRgbRibLjbLibLibLcbLcbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 10; Drug: PCAP2 3 然 Apo 50 然
bLsLsLsLsmmmbLsLsmbLsLsmbLsLibRjRcbRibRgRibRsbReLeLiLiLebLgRgRsmbLsLsm
bLsbLsLsmbLgLsLsLsLsLsLsLsmmmmmmbLgLsbLsLsLsmmbLsLsLsLsLsLsLsLgLsLgLsL
sLsmmmmmmmmbLsbLsLsmbLsLsLsLsLsLsLsLsLsLsLsLgLgLsLsLsLsLsLsLsLsLsmmmmm
mmmmmmmmmmmmmbRjbRjbRhbRsbRsRsRsmmbRsbRsbRsRsmbRsbRsbRsbRsbRsbsbRsbRsR
sRsRsRsRsmmmmmbRsbRsbRsbRsbsbsbRsbsbRsRsmbRsRsmbLsRsbsbRsbRsRsmbsbRgbR
gbLsbLsLsRsmbRsRsmbRsbRsbLsRsbRsRsRsRsmmmbRsRsRsmmbRsRsmbRsRsRsmmbRsbR
sRsRsmmbRsRsRsRsmmmbRsRsRsRsmmmbRsRsmbRsRsmbRsbRsRsmbRsbRsbRsbRsbRsbRs
bRsRsmbRsRsmbRsRsmbRsbRsbRsbLsbRibLsbLsLsmbLsbLsLsmbLsbLsLsLsLsmmmbLsL
sRsmbLsbsbsbsbsbRsbLsbRsbRsbsbRsRsmbsbsbRsbLsbRsLsRsbsbLsbLsRsbsbLsRsb
RsbsbsbRsbRsbRsbLsbLsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 11; Drug: PCAP2 3 然 Apo 50 然
bRgbRsRsRsmmbRgRsmbRgbRgbRsbRsRsRsmmbRsRgRsmbRsRsRsmmbRsbRsLsRsbRsbRsR
sRgmbRgbRsLsbRsbRsRsmbRsbRgbRsRsRsmmbRsRsmbRgRsRsmmbRsRebRgbRebRebLcLi
LsLeRebRsbLjbRsRsRsmmbReRsRsRgmmbLsbRsRsmbRsRsRsmmbRsRsmbRsRsRsRsmmmbL
sRsRsmbRsRsRsRsmmmbRsbLsRsRsRsRsRsmmmmbLsbRsbRsbRsRsRsmmbRsRsmbRsRsRsm
mbRsRgRsmbRsRsmbRsRgRsmbRgRsmbRsRsRsRsRsmmmmbRgRsmbLsRsRsmbRsbRsbRsRsm
bRsRsRsmmbRsbRsRsRsRsmmmbLsRsRsRsRsRsRsmmmmmbRsRsRsmmbLsRgRsmbRgbRgbRs
RsRsRsmmmbRgbRsRgbRgRsRsmmbRsRsRsmmbRsRsmbRsRsmbRgbRsRsRsRsRgRsLgmmmmb
RgRsRsmmbLsRsRsmbRgbLsRsRsRsRsmmmbLsRsRsRsRsRsmmmmbRsRsRsRsRsRsmmmmmbR
sRsmbLsRsbRgbLsRsRsRsRsmmmbRsRsmbRsRsRgmbRsbRsbRsRsmbRsbRsRsmbLsRsRsmb
RsRsRsmmbRsRsmbRsRsRgmbLsRsbRsRsmbRsbRsbLsRsRsmbRsRgbRgRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 12; Drug: PCAP2 3 然 Apo 50 然
bRibRibReRsmbRhbRiRsmbRjRibRiLsbRcbRibRhbLjbLiLsbLibLgLsbRjbRhbRhRsmbR
ebLobLibLibLibLibLgbLgbLibLhbRjRgbRibRibRibRiRsmbRebRibRgbRhRsmbLibLsb
ReRsmbRsbRgLsbLgbRhbRebRgbRhbRibRsRibRibRibRcbRibLcbLhbLibLibLcbLibLeL
gLiLgLibLsRsbRebRhbRibRibRsRcbRibRsbLcbLgLgbLibRgbLiLsbLibLoLsmbRebLeR
sLsLebLgbLibLebLsbLsbLgLsbLsRsbRoRsmbRhbLsbRibRebRsRibRcbRhRsmbRobRibR
ebRibRcRsmbRebRibRcbRebLcbLobLibRgRsmbRebRibRebLebLsbLibLcbLsbRjbRibRe
bRobRgRsRsmmbRebRsbLcLsmbLcbLibLobLibRebRebRiRsmbRhbRibRibRhbRebRcbRib
RibRhbLjbRhbRgRsmbLcbLiRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 13; Drug: PCAP2 1 然 Apo 50 然
bRgRsLsRsmbRsbsbLjbRgbRcRsmbRcLsbLiLsbLebLjLgbLiLsbRiLsbRsbRsRsRgRiRsm
mbReRsRsmmbLibRsRsmbRsbRsRsmbRsbRgRsmbRhRsRgmbLsLsLsLsLsLsLsLsLsmmmmmm
mmbLsLsLsLsLsLgRsLsmmmmbLsbRcLsbRiRgRsmbRsRsRsRsmmmbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 14; Drug: PCAP2 1 然 Apo 50 然
bRsbRsbRgbRcbRgRsmbRcLsbRcbRibRsbRgRsLsmbRsbRsRsmbRsbRsbRsRsmbRiRsmbRh
bRsbRsbRsbRsbRibRsbRibRsLsbLsLsmbLsbRsbRiLsLsmbRsRsRsmmbRsLsbRgbRsRsmb
RsRsmbRsbRsbLjbLebLsbRhbRsRsmbRgbRjRgbRsbLsbRsRsmbRgbRsRsmbLsbRsbRjbRs
bRsLsbRgbLeLsLsmbLebLgLsbRobRobRcbRibRsRsmbRsRsmbRgbRgbRgbRgRsmbLsLsRs
mbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 15; Drug: PCAP2 1 然 Apo 50 然
bLsbLebLhbLibRhbRgRsmbRobLsbRebRcbLgLsRsbLebRebRcbRibRhbRsbRcbRibRgbRh
bRibRiRgbRobReRgRsmbRgRsmbLebLcbLsbLcLsmbLibLebLeLsbLcbLibRsbRcbRhbRiR
smbRcbRgbRebRhbRibRiRsmbRibRsbRcbRgbLsLcLsmbLhbLiLgLsLsmbLgbLeRsbLcbLh
bLebLcbLebLibLsbLcbLgbLeLgbLcbLgbLsLgbLsLsmbLebLiLsbLjLgbLibLgLsbRcRib
RhbRhbLsbRcbRgbRebRgbRhbRhRsmbRibRibRoLsbLebLhbLsbRjbRgRsmbRibRgRgbRgR
sRsmmbRsRgRiRibRibLgLsbReRsmbRsRsmbLobLsbLiLsbRsbLhbLcbLiLsbLiRsbLibLi
LsLgLsLsLsLgLgLsLsmmmbLebLebRgbReRibRebRgbLgRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 16; Drug: PCAP2 1 然 Apo 50 然
bRgbRgRibRibRibRgbRjbRiRgbLsbRcbRgbLgbRgRsmbRebRgbRgbRebRsRgbRgbRsLsLs
mbRgbRgbRgbLsbLeRsbLebLiLsbLebLsbLibLeLebRibLebLebRsbRgbRjbRibRgRsmbRg
RgRsmbRiRsmbLgbRebLsbRibRgbRibRgRsRsmmbLgbRcbRhbRiRsRsLsmmbRsRsmbRhbLg
bLcLsmbLgbLibLeLgbLcbLiLsbLibLgbLsLsmbLgbLgbRiRgRsRgRimbRgRgbRgbRgRsmb
RebRiRibRgRsmbRgRsmbRibRgbRsbLgbRsReRsmbRgbLebLhbLhbLiLsbLibLibLebLebL
ibLhRsbLsbLibLibLgLsRsRsmbLibLibLebLjbLebLebLgLsbsbLebLiLsLsLsmmbLibRe
RsmbLsLsmbRebRgbLsbRibReRsRsmmbRiRsmbLcLsLcLsmmbLeLsbLebLiRsbLeLsbLiLs
LsmbRsbLeRsbLebLhLsbLjLibLebLhbRgbLebLibRsbLibLgbLgbRhbLcbRibRsRsmbRgb
RebRhbRebRebRsRsmbLsbLsRsbLiLsbLebRebRib

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 17; Drug: PCAP2 1 然 Apo 50 然
bLibLgbLcbLcbRcRsmbRcbRcbLibRobRibRcLsbRobLhbLhbLibRsbLcLsmbLsbLhLsbLj
bLibLcbRgbLgbLcbLibLebLibLobRjRgRsRsmmbRgbLjbLjLibLibLsLsmbLibLjLgbLeb
RobRgbRebReLsbLgbLiLsbLgbLibRsLibLcbLcbLsbLiLsbLsbLhbRobRcRsmbRcbRibRi
bRcLsbRgbLeLsbLcbLhbLiLsLsmbLebLsLsmbLebRsbLeLgLgbLgbRsLsLsmbLgRsLsbLs
LsLsLsmmmbRjbLhbRoRgbRgRsmbRsbRsRsRsmmbLjbRcbRcbLsbRcbRcbRibRebRcLsbLs
bLsbLsLsRsmbLibLhLsbLebRsbLcbLsLsmbRsbLcbLcbLiLebLsRsLsbLsLsLsmmbLibLi
bLcbLcbLcbLsLsmbLcLebLgbLcbLiLsLebLeLebLgLsbLsbLgbLhbRsbLeLsbLcLsmbRsb
RibRebRhbRcbRgRebLiLsLsmbLgbLebRgbLjbLsLhbRebLebLsbLsbsbLiLsbLsbLiLsLs
LsmmbLcbLebLhbLebLgLsbLibLebLsLeLgbLsbLgbRhbLgbLibLcbLgLeLhbLibLgbLibL
hbLibRobRibRebRibRiRgbLebLiLsLgLebRsbLibLiRsbLibLgLsbLgLeLebLeRsbRjRgb
RcbLcLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 18; Drug: PCAP2 1 然 Apo 50 然
bLhLsbLsLsLsRsLsmmbLsLsmbRsbRsbLsLsmbRebLjLsmbRsbLjbRsRsmbLcLsLsmmbLsL
sRsRsmmbLebLcRsLsLsLsmmbRsbLhbRcbLcbLcRsbLcbRsbLiRsbRsLsbLsLsmbLsbLgbL
sRsRsLsmbRcbLcbLibLcRsLsRsbLcLgbLsbLhLsLsmbLiLsLsmbLobRsRsmbRsbLjbLsLs
LsmmbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 19; Drug: Control Apo 50 然
bRcbRhbRgbRhbRibRibLsLsmbRgbLjbLibLibRibRjbRibRgbRgbRsbLibLibRebRiRsmb
RgbRibRibLcbLibLiLsbLgbLibLgbLibLibLebRsRsmbLgbLgbLibLebLibLeLsbLsbLiL
eLsbRsbLsLsLsmmbLsLgLsLsLsmmbLibLgbRibLibRjbRibRcbLgbRibRsRsRsRgRsmmmb
RsRibLsbRebLgbLsbRibRibRibLiLsbRibRibRsRsmbRsbRgRsmbLsbRcbRibRgbLsbRib
RgbLgbLibLebLibRsbLhbRebRebRibLsRsbLhbLjbLibLgRsbRsLsLgbLgbRgRsmbLsbLs
LsmbLsbLsLsLsmmbLibLgbLsbLsLsmbRsbLsLsmbLiLsbRjbLiLsbLgbLibLibLgRsbLsL
sRsmbLsbLgRsbRsLsbLsbLgbLgbLgLsbLgbRgbLibRsbRibRibRibLgbLsLsmbRsbLsbRg
bRsbRsRgRsmbRgbLgbLjbRebLjbRjbLgbLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 20; Drug: Control Apo 50 然
bLsRcbRgLsbLibLjbLeLsbRibRjbRhbLcbLgbLsRsbLebLjLibLebLebLebLeRsbLhLsbL
ibRjbRjbRibRibRobLibRjbRibRibRgbRgbLsbRgbRgLsbRgbRebRibRjbRjbRcbLiRsbR
iRsmbRcbRhbRebRgbLibRgbLebLebRsRsmbLibLiLsbRsbRcbRebRgbLjbLibRjbLjbLib
LgbLhbRjbRebRebLsbLjbLeRsbLgbLiLsbLgLebRibRgbRcLsbRibLebLebLebRiRiRgbR
ibRobLibLebLsLebLiLebLgbLibLebLhLsbLjLebRjbRiRibRgbRgbRibRsbRgbRibLcbR
sLibRjbRibRibRgRgbRgLsLsmbLjLebLibLeLebLibLcbLhbLebLibLebLjLsLembRhLsb
RcLsbRiRhbRgLsbRgbRjbRiRsmbRibRibLgbLeLsbLsbRgbReRsmbRcbReRsmbRgRsmbRs
bLeLgLsLsmbLgbLsbLgbLgbLebRjbLebLiRsbLhbRjbRcbReRgbLiLgbRcbRhbLsLsmbRi
RibRibLgbLiLebLgbLgbLibLiLibLebLebLjbLiLhbLebLiLebLebLgbLgbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 21; Drug: Control Apo 50 然
bLiRsbLcLcLhLhRsbLiLcLcLeLsbLiLsbLcbLobLcLgLebLcbRcbRcRsRiRhRembRcRiRs
RimbRcbRibRibRibRsLsbLjRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 22; Drug: Control Apo 50 然
b

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 23; Drug: Control Apo 50 然
bRsbsbRsbRebLcbLgLeLsbRcbRobLgbRcbRcbRcbLcbLoLsmbRcbReRgRsRsRsRgLsmmmb
RibRibRiLsbRsbRsbsbRcLsLsmbRcbRcbRcbRiRsmbRiRsmbRsRsRsmmbRgRsmbRsRsmbR
sRsRsRsRsmmmmbRgRsmbRgbRhbReRsmbRcbRiRsRsmmbRiRgbRgbRgbLobLhbLibLgbLib
LiLsbLcbRcRsRsmmbRsRsmbsbRsbRebRcbRcbRebRebRibRsbRgLsbRobRjbReRgbRiRiR
ibRib

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 24; Drug: Control Apo 50 然
bLcbLibRcRsmbRcbLjbLhbLsLsmbRcbRcRsmbRcLsRgRsLsmbRibLoRsLsbLjbLjbRhbRo
bLjbLcbLcbLjbLjLsLsmmbLhbLgbLcbLhbRgbLjbLeLsbRhbRcbLcbRcbRibReRsRsmmbL
hbLibLgbLiLsLsLimbLcbRebRibRcbRsbRjRsmbReRsLgmbRiRsmbLcbLeLsbLhLiLsbLi
LiLsLiLsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 25; Drug: PCAP2 10 然 Apo 50 然
bRibRcRsmbRibRgRsmbRjRsmbRebLsbRcbRsbRsbRjbRobRhbRsRsmbRsRsmbRcbRgbRcb
RibRgbRsbRcLebLjbLsbLobRgbRibRgRsmbRgbRgRsmbRiLsbLsbLgRsRsRembRibsbsbs
bsbsbRsbRsbLsbsbsbsbRsbsbsbRsbRebRebLsbLebLsbRebRgbRcbLsbsbLsbsbRjbRsb
RgbRhbsbRebRjbRgbRibRiRcbLgRibRsbLjbLcbReb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 26; Drug: PCAP2 10 然 Apo 50 然
bRsbLsbRsRsmbRsRsmbRgbRgbRoLsbRgbsbRsbRsbLsLsmbLsbRsbLsbLsLsmbLsbLsbLs
bLsbRjbLsbLsbRsLsRsLsbRsLsbsbRsbsbLsbRsbLsLsmbLsbRsbLobLobsbLgbLsbRsRs
mbLsbRsLsbLsbLsbLsbRobRgLsbRgRsmbRsbRibRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 27; Drug: PCAP2 10 然 Apo 50 然
bRgLsRobRsRsmbRibRgRsmbRsbRsRsRsmmbRsRsRsRsmmmbRsRsRsRsmmmbRsbRsRsRsmm
bRgbRsRsRsRsRsmmmmbRgRsRsRsRsRsRsmmmmmmbRsbRgRsmbRgbRiLsbRsRsRsmmbRsRs
RsmmbRgRsRsmmbLsbRoLsRsbRsbRebRgbRgbRsRsRsRsmmmbRsRsmbRsRsRsmmbRgRsmbL
sRsRsLsmbRgbRgbRgRsmbRsbLsbRsbRsLsbRgbRsRsmbRgRsRsmmbRobRobRibRgbRsbLh
bLibLsLsmbLgLsbLsRsRsmbLsRsLsbRsbRsbRebLcRsbLiRsbRhbRcbRsbsbRgRsmbRsRs
RsmmbRsLsRsbRsRsmbRsRsRsmmbRgbRsRsmbLsRgbRsRsmbRsRsRimbRsRsmbRsRgbRsRs
mbRsRsRsRsmmmbRsRsRsRsmmmbRsRsmbRsRsmbRsRsRsRsmmmbLsRsbRsbLsRsbRgbRgbR
sRsRsmmbRsRsmbRsRsmbRgbRsRsmbRsRsRsmmbRgRsmbRsRsRsRsmmmbRgRsmbRsRsRsRs
mmmbRgRsmbRgRsmbRcLsbLgbLgbLsLsLsmmbLsbRhbRsbRsbRiRsmbRsbRgRsmbRiRobRi
RsmbReLcbLcLsmbLgbLgbLgbLsbLsLsmbRsLsLsLsmmbLsLsmbRgRsmbLgLsLsmbLgRsRs
mbRsbRgRsRgmbRsbRsbLsRsbRgbRsRsmbRsRsmbRsRsmbRiRsLsmbLsbLsRsbsbRsbLsbR
gRsRgmbRsRsLsRsmbRgRsmbRgRsmbRgbRsbRgLsbRgRsRsmmbRsRsRsRsmmmbRgRsmbRgb
RiRsmbRhbRhbRsbRibRiRsRsmmbRsRsmbRgRsmbRsRsRsmmbRgRsmbRgRsRimbRsRsmbRg
RsmbRhRsmbRsRgbRsRsRsmmbRgRsmbRsRsmbRsbLsRsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 28; Drug: PCAP2 10 然 Apo 50 然
bLibsbsbLsLsmbLhLebRgbLibRsRsRsRgmmbRsLsLsmbLsbRsbLgbRjRsmbRhbRgbLjbRg
RsmbsbsbRsbRgRsReLsmbRgRsRembRsLsLeLibLebLsbRhbLsLjLobRiLsbRsRsmbLjbRs
bLoRsbRgbRsRjbLsLsmbRgbRgRebReRebRgbLsLsmbRsReRsmbRgRsRiLsRsmbLsLgLibs
bRgbsbsbsbsbsbLsLsmbRsRsmbLsbLsbRsbLsRsbLcLgbRgRsRsRgmmbRcRibRibRiRsmb
ReRsmbRsRsmbRgReLsRsRsmbRgRobRhbLgbRibRjLgLsbRsRsmbRiRgRsRsmmbRgRsRsRs
RsRsRsmmmmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 29; Drug: PCAP2 10 然 Apo 50 然
bRgLsbRcbLibLobRsbRhbLcLsmbRsbLsbRcbLsRibRgbRebRjLgbLgLsbLsbLsLsmbRibs
bRjbsbLhbLhbLsbRoLsbLsbRibRcRhRsmbRiLsbLhLgbLsbLsLsLsLsLsmmmmbLgbLsbsb
RsLsbLgLsbRcbRcbRiLsRsbRsbRsbRhbLjLsmbLibRcbRcRiLsbLgLsbLsLgLsLsmbLsLs
mbRgbRibRcbRiLgRgLgbLgbLsLsmbsbsbLgbLsLsmbRsRsmbLsRsbRcbRhbLsRsbRsRsmb
RsbRsbRsbLsbsbLjbsbRibRobsbLsbLsbRjbRjRsRsmmbLsbLsbRsbRsbRsLsbLsbLjLsm
bsbLsLsmbRsbRsRsRsmmbRsbRsbRsRsRsmmbRsRsmbRsbRsbRsbsbsbRibLsbLsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 30; Drug: PCAP2 10 然 Apo 50 然
bLsLsmbRsbRsbsbsbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 31; Drug: PCAP2 3 然 Apo 50 然
bRsbRgbRsbRsbRsRsRsRsmmmbRsbRsRsRsmmbRsRsmbRsRsmbRsLsbRsbRsbRsRsRsmmbR
sbRsRsRsmmbRsbRsRsmbRsRsmbRsRsLsmbRsRsRsRsmmmbRsbRsbRsRsLsmbRsRsmbRsbR
sbsbLsbRsRsRsmmbRsbRsLsbRsbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 32; Drug: PCAP2 3 然 Apo 50 然
bRsRjbLebLsbRsbRgbRsbRsbLsbRsbLsbLsbLsbRsbLobRgbLebLgbLsbRgbRebLcbRcbR
iRebRgbLobRcbRibRhbRebRcbRgRsRsmmbRgbLsbRgbRibRiRebRsbLibLiLsbLsLsmbLs
bLsbLgbLgRcbRgRsmbRgLsbRsRsmbRsRsmbLsLsmbRsbLsbLebLibLgbLsLsmbLgbsbLsL
sLsLsmmmbLsLsLsLimmbRsLsLsmbLsbLsLsmbLsbLsbLsbRsLsbLsLsmbLsbRsLsbLsLsm
bLsbRjbRibRgLjbRiLsRsbRsbRsRsmbRsRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 33; Drug: PCAP2 3 然 Apo 50 然
bsbsbsbRsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 34; Drug: PCAP2 3 然 Apo 50 然
bLsLsmbLgbLsbLsbLgLsbsbLsLsmbLsbLsbLsLsmbLsLsmbLsbRsLsLsmbLsbLsLsmbLsb
LsbLsbLsLsLsmmbLsLsLsmmbLsLsLsmmbLsLsLsmmbLsbLsbLsbLsRsbLsbsbLsbRsLsLs
mbLsbLsbLsbLsLsmbLsLsmbLgbLsLsmbLsbLsLsmbLgbLgbLsbRsLsLsmbLsLsLsmmbLsb
LsLsmbLgLsbLsbLgbLgbLsLsmbLsbLsLsLsmmbLgbLsLsLsmmbLsLsmbLgbLgbLgbLgLsR
sbLsbLgLsbLsLgbLgbLsbLgbLsLgbLgLsLsLsmmbRsbLgbLsLsmbLsLsmbLgLsLsmbLgbL
sLsmbLsLsLsmmbLsRsbLgbLgLsbLgbLsbLsLsmbLgbLsbLgbLsLsmbLsLsmbLgbLsbLibL
gbLgbLgbLgbLgbLgbLsbLsbLgbLsbLgbLgbLgLsbLgbLgbLgbLsLgbLgLsbLgbLgbLgbLg
bLgbLgbLgbLgbLgbLgbLgLsbLsLsmbLsbLgLsLsLsmmbLgbLsbLgbLgbLsbLsbLsbLgbLg
bLgbLgbLsbLgbLgbLsRsbLgbLgbLgbLgLsbLgbLgbLgbLiLsbLgbLgbLgLsbLgbLgbLgLs
bLgbLsbLgbLsLsmbLsbLgbLsLsmbLsLsLsmmbLsbLsbLgbLgbLgbLgbLgbLgbLgbLgbLgb
LgbLgLsbLgLsbLgRsbLsLsmbLgbLgbLsLsmbLgbLgbLgbLsLsmbLgbLgbLgbLgbLgbLgRs
bLgbLgbLgbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 35; Drug: PCAP2 3 然 Apo 50 然
bRibRsRsmbRgRgRsRsmmbRiRsmbRgRhRgbRibRgRsmbRgbLsbRgRgbRgbRiRibRjLsbRib
LcbLcbLibLhbLibLjbRjRsmbRjLsbRibRgbRibLsbRsRsRsmmbRgRsmbLsRsRsRsRsLsmm
mbRgRsmbRgRsmbRsRsRsmmbLibLibLibLoRsbLsbLsbRiRebLjLsLsLsLsLsmmmmmbsbRs
bLsbLsRsbRjbRsRsmbRsRsmbRgbRgRsmbRgbRsRsmbRsRsmbRsbRgRsmbRsRsRsmmbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 36; Drug: PCAP2 3 然 Apo 50 然
bRsbRsbRsbRsbRsbRsbRsRsRsmmbLsbLsLsmbRsbRsbRsRsmbRsbLsRsRsmbRsRsRsmmbR
sRsmbRsbRsbRsbRgbRsbsbsbLsbRsRsmbsbLsRsbLsbRsbRsbLsRsRsRsmmbRsbRsbRsbR
sbLsbRsRsmbLsRsRsmbRsbRsbLsRsbRsbRsbRsbRsRsmbRsbRsbRsbRsRsmbRsbRsRsmbs
bRsbRsRsmbLsLsmbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 37; Drug: PCAP2 1 然 Apo 50 然
bRsRsRsRsRsmmmmbRsRsmbRsbRsRsRsRsRsRsRsmmmmmmbRsRsRsmmbRsRsRsRsRsmmmmb
RsRsRsRsmmmbRsRsRsRsmmmbLsbLcbLibLibLgbLcbLgLibLgbLcLsmbLiLsLsmbLgLibL
iLsbLsLsLsmmbLsLsRsmbLsLsLsLsLsmmmmbLgLsLsmbLgbLgbLibLgbLgbLgbLhbLgLsb
LsLgbLgRsLiLsbLibsbRsRsmbRsRsRsRsmmmbRsRsRsRsmmmbRsRsRsmmbRsRsRsRsRsRs
mmmmmbLcbLibLeLgbLeLsbLgbLeLsbLibLiLebLiLiLebLebLibLibLiLgLsLiLgLsbLhb
LhLgLiLsLgLiLgbLsLsLsLsmmmbLgLsLsmbLsLsLsLsLsLsLsmmmmmmbLgbLsLsLgLsmbL
sLsLsmmbLsLsLgLsLiRsmbRgLsbRcbRsRcLsbRsbRgRsmbRiRsmbRcbRiLsRebRiRsmbRs
RsRsRsmmmbRsRsRsmmbRsRsRsRsmmmbRsRsRsRsRsRsRsmmmmmmbRsRsRsRsRsRsmmmmmb
RsRsRsmmbsbLsbRgRsRsRsRsRsmmmmmbRsRsRsRsRsRsRsmmmmmmbRsRsRsmmbRsRsmbRs
RgbRsRsRsRsRsRsRsmmmmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 38; Drug: PCAP2 1 然 Apo 50 然
bRsbRsbRsRsmbLsRsRsmbRsRsmbRgbRsLsbRsLsbLsbRsLsbRgbLsRgbRsLsbRgRsRsRgR
smmmbLcbLibLgLsbLgLsLsmbLsLsmbLsLsmbLsLsmbLgLgLsbLsLsmbLsLsLgmbLgbLsbL
sbLsLsmbLgbRjbRhbRgbRibRsbRibsbRcLsRgRgbLcLsmbLsbRsbLsLsLsLsLgLgLgmmmb
LgLsLgbLgbLsbLsLgLsbLgbLgbLsLsmbLgLsLsLsLgmmbLsbLgbLgbLsbLsbLsbLgbLsbR
cbRhRiRsmbRgbsbRsbRgbRgbRsRsmbRsRsmbLibLcbLiRsbLsbLgLgLsbLgbLgbLgLsbLg
LsbLsLsmbLsLsmbLgbLsbRsRibRibRiRsmbRsbRsbRcLsbRcRiRibRiRsLsmbRsLsbRsbR
gbRsbRgRsmbRsRgRsmbRgRsRsRsRiRsRsmmmmmbRsRgRsmbRgRsmbRgRsRsmmbRsRsmbLj
bLhbLcbRsLsbsbLsRsbLiRsbRsLsbsbLsLsmbLgLsLgLsbLgbLsbLgRsbLgbLgbLsbRsLs
bLiLibRsbRgbLcLsRsmbLsbLsLsmbLgLsbLsLsmbLsbLsbLsLsmbLsLsmbLsLsLsmmbLgb
LcLsmbRcbRsbRhRsmbRiRgbRsbRhRsRgmbLsbLsbRgRcRsmbRibRgRsmbLsRsbRsbRsbRs
RgbRgbRsbRsRsmbRgLsbRgRsmbRgRsmbRsRsmbRsRsRsmmbRgbRsRsmbLjbLcbLcLsmbLs
bLsbLcLgbLiRsLgbLiLsbLibRsbLcLsmbLsbLsbLgbLgbLsbLsLsLsmmbLgLsbLsRsbsbL
sbLiRsRsmbLibLsbLsLsmbLsRsbsbLcLiLhLiRsbLsbLgbLsbLgLsbLgLsbRsbLsbLsbLi
LsbRjbRcbRjbRiLsbLsbLsbRsbRsbRhLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 39; Drug: PCAP2 1 然 Apo 50 然
bsbRsbRsLsRsbRsbRsbRsbsbsbsbsbRsbRhRsmbLsLsmbLsbRsbsbRsLsbRjRsmbLoLhbR
ibRcbRsbRsbRsRsRsmmbRsRsLsmbRsRsRsRsmmmbRsbRsRsRsmmbRsLsRsbRsRsmbRsRsm
bRsbLsbsbsbsbsbLsbLsRsbsbRsbsbsbRsRsmbsbsbRsbsbRsRsmbRsRsmbRsbLsbsbRcR
sRsmmbLobLcbLcRsbRjRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 40; Drug: PCAP2 1 然 Apo 50 然
bsbRsbRsbLsbsbLibRgbRobRcRsmbRobRcRsRsmmbRcbRobRhbRcLsbRobRgbRsbLobRib
ReRsRgmbRsRgbRgbRsbRgRibRsbRiRsmbRsRsRsRgRgmmbRgRsRgRgRgmbRhRsRsRsmmmb
RsRsRsmmbRgLsbRsRsRsRsRsRsRsRsmmmmmmmbRsbRgbRsRsmbRgbRsRgbRgRgRibRiRsm
bRgRsRgRsmmbRsRiRsmbRgbRsbRgbRgLsRibRsRsRsmmbRsRsRsmmbRiRibLsRsRsLsRgR
sRsRgRsRgmmmmbRgRsmbRsRgbsbRgRhLcLgbLsbRsLgLsLiLsLiLeLsLebRsLcbRjbRiRs
RiRembRhbRebLoRsRsmbRgRsRhRgRgRsRsmmmbRsReRsmbRsRiLhbLgLebRjbRcRsmbRgb
RjbLsbLgRsbRsbRgLgbRsRsRombRcbRhRsRgmbLcbLsRsRsRiReRsRimmbRgbRiRibRgRg
bRgRgbRgRsmbRgRib

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 41; Drug: PCAP2 1 然 Apo 50 然
bRgRcbRcRsRsmmbRhbLsbLsbRobRiRiLsRcbRsbRhbRcbsbRiRsRiRhLsLsmmbRoRsLsmb
LsbLjbRgRsRsmmbRjRsLgmbRiRsRhRsRsRsmmmmbLsbLgbRsRsRiRiRiRembRsRsRsRsRs
RsRsRsmmmmmmmbRsRsRgmbRsRsRsmmbLsRsbRsRsRgRgRgmbRsbRsRsmbRsRsRsRsRsRsm
mmmmbRsRsRsRsmmmbRsRsmbRsRsRsmmbRsRsRsRsmmmbRsRsRsRsmmmbRsbLsRsbRsbRsR
sRsmmbLsbRsbRsRsRsmmbRsRsRsmmbRsbRsRsmbRsRsLsmbRsbRsRsRsmmbRsRsmbRsRsR
gmbRsbRsRsRsRsRsRsRsmmmmmmbsbRsbRsbLjLhbLcLsmbLhLsbLgLgLsbLsbLhLsLsmbL
sLsmbLiLsbLsLgbLsLsmbLsbLibLibLobRsbRebsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 42; Drug: PCAP2 1 然 Apo 50 然
bLjbLcbReLsbLsLsLsmmbLsRsRgRsmbLeLsLhLsLsmbRsRsRsLsLimmbRcbsbsbsbRsLsL
smbRcRgRsmbLcLsLsmmbLcbLebLcLsmbRgbRgRgRsmbRsRsRsmmbRcLsbLsbRsbLsbRsRs
RsmmbLsbRiLsbsbsbsbLsLsmbRsbsbsbRsbLjbRgbLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 43; Drug: Control Apo 50 然
bLsbRsbRsLsbLsbRgLsLsmbRcRsmbRcbRcRsmbRsbRsbRsRsRsRsmmmbRsRsRsRsmmmbRs
LsbRsbRsbRsbRsRsLsmbRsbRsRsmbRsbsbLobRsbRsbReRsmbReRgbRcbLoLgbLsLsRsRs
Lsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 44; Drug: Control Apo 50 然
bRgbLsbRibRhbRebRhbLjbLiLsbLgbLiRsbRibLsRsbRhbRibRebRhbRgbLibLibRjRhbR
iRsmbRsbRiRsRsmmbRibRgbRsbRibRibRebRibRsRcbLgbRibRgbRibLsRsbRibRgbLibL
ibLibLibLibLibLibLhbLibRibRhbRibRcbRgbLgbLibLgbLgbRsLgbLcbLibLsbRibRib
RgbRgbRgbLsbRhbRibLsRhbRibRgbRebLobLibLgRsbLgbRebRcbRibLjLhbLsLebLcbLi
LsLsmbLebLgLsbLgbLiRsbLibLiLsbLgbRibLiLsLsLsLimmbLiLsbLsbRcbRiRsmbRgbR
ibRgbLjbLjLsmbRsbLibLibLgbLibLhbRiRsmbLgbRibRgbRibRibRcbRibLhbLgbLgbLg
bLibLiLgbLgbLgLsbRibLebLgLibLibLibLhbLibLiLhbLgbRsbLebRibRibRgRsmbRgLg
bLibLgbLgbLgRsLsbRiRsmbRjbRsRibRibRgRsmbRgbRibRebRebRibRibRcbLgbLjbLiL
sbLibRjbRibRibRibRebRibRcbRibRcbRcbLsbRibLgbLibLibLibLgbLgbLgbRobRibRs
LsbLjLsmbLiLsbLgLsLsLsLsmmmbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 45; Drug: Control Apo 50 然
bRgbRgbRiRsRsRsRsmmmmbRibLobLobLhbLcbLsRsbRobRcbRebLcbLibRcRsmbRgbRcbL
sRsbRcRsmbRhbLcbLiLsbRsLcbLibLibLibLebRjbRhRsRsmmbRgbLcbLibLcbRsLgLsLg
bRgRgbRgRsmbReRsmbRoRsmbRgRhbRiRiRsmbRsbRcLsbLgLibRobRhRsLsmbRibLcbLib
LiLiLsbLebRsRsmbRiRsRsRsRsmmmmbLjbRcbRebRobRgbRcbRcbRgLsbLibLsbLsbRgbR
gRsLsmbRiRsRsmmbLebLcbLibLgbLoLgbRsbRsbLgbLeLebLcbLiLsbLiLhbLgLsbLsLsm
bLsbRjbRhRsRsmmbRsRgRsLsmbLebLgRsbLiRsbLcRsLiLsLgRsbLhLsbLiLgLhLsbLgbL
sbRsbLjbLibLibLibLibLibLibLgbLhbLgLsbLjbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 46; Drug: Control Apo 50 然
bRsbRjbRsbRgbLcLsRsLsmbRcbLcLsmbLcbLhLsbLebLebLsbLsLsmbRibLibLhbLjbLgb
LhbLjbRoRsmbLsLgbRcbRsRgRgRsRsmmbRgbRhbRjbRibRhbRsbRhRiRsRsRemmbRsbLeb
LhbLgbLcLsmbLcbLebRsLibLhbLibLibLsbLibLebRibRibLjbRibRibRibLsbRsbLhLsb
LiLcbLsbRibRibLobRsbRcbLhbLiLsbLcLsmbLgLsbLiRsRgbLibLoLsmbLgbRgbRsbLsR
obRcRebRibRgRsRsRsRsRgmmmmbRgRibRhbRibRsRibRgRsmbLebLhbLgLsbLsbLebLibL
gLsLjLsRsmbLgbLgLgLsbLsLhLsbRgbLibLsRsbRsbLsLibLibLibRhbLibLjLsLsmmbLh
bLgLsLhbLsbLgbRgbLgLsbLgbRcbRibRibLgLgbLibRgbRhbRibRcRgbLjbRebRcbRhbRe
bRiRsmbRiRsmbRgRsmbRsRgRiRib

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 47; Drug: Control Apo 50 然
bLgbLsLgLsLobLobRobRiRcbRebRiRsmbLobLobRobRibRibRcRgRiRhRsRimbRgbLjbLc
bLibLcLsmbLjLhbLhbLhLibLcbLeLsbLibLcLsLsmmbLhLsLsLimbLhbLgLsbLibLibLeL
sLsmbLgbLebLobLeLsLibLcbRhRgbRcbRibLcbLeLsLsmbLibLobLgbLcLsLsLsLsLiLsm
mmmbsbRcbRgbRibLcbLhLsbLcbLgbLcbLiLsLgLibLcbLcbLhbRjbRibLjbLebLcLsmbLo
bLgbRibLhbLhLsbRsbRjbRjbRjbRjbRjbRcRsmbRcbRibRcRsmbRiLsbRgbRhbRcbRgRiR
smbRhbRiLsRsbRobRebRgbLcLsLsmmbLebLiLsLgbLiLsbLiLsLeLsLgbLiLsLgbRcbRhR
cRsRsmmbReRebRiRhbRgLsbRsLjbLhbLobLhbLgbLibLebRsLjLebLcbLebLibLibLibLs
LsmbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 113520; End: 114020;
Recording: 2-1; Individual: 48; Drug: Control Apo 50 然
bRcbLobLobLcbLgbRcRsRsmmbRcbRobRcbRsbRcbRcbRhbRcbRhbRcbRcbRcbRgbsbsbRc
bRibRibRcbRcbRcbRcbRcbRcbRjLsbRcLsbLcbLibLcbLhbLcbLjbLiRsbLibRsbLcbLhb
LhRsbLhbLcbLiRsbLcbRgbLcbLgbLibLcbLibLcbLcbLhbLcbRobRcbRibRcbRgbRobRiR
smbRobRcbRcbRcLsbLcbRcbRcbRhbRcbLsbRcbRgbLcbLibLcbLibLcbRibLibRcbRebRh
bRcbLibRcbRcbRcbRgbRcbRibRcbLsbRcbRhbRcbRcbRcRsmbRebRcRsmbRibRcbRibRcb
RcbRcbRibLibRcbRcbLhbLcbLhbLcbLibRebRebRibRcbLsbLobLgbLibLobLcLsmbLibL
ebRibRibLebLibLoRsbLcbRgbLebLhbLgbLsbLibLcbRibRcLsbRobRsbRhbRibRcbRsbR
cbRcbRibRgbRcbRcbRgbRibRhbRibRibRcbRibRsRcbRobRcbRcbRjbRcLsbRhbLibLcbL
hbRebRebRcbRsbLhbRcbRhbRibLgbRhbLgbLsLibLibLsbLhbLibLibLiRsbLibLibRibR
hbRjbRibRibRhbRcbRcRibRibLcbRcbRibRcbRibRobRhbRcbRebRsbRhbLibLcRsbLcbL
ibLgbLibRcbRcbLibLcbLhbLibLgbLibRgbLgbRjbRobRibRgbRgbRhbRiRsmbRcbRiLsb
RobRgbRjbRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 1; Drug: PCAP2 10 然 Apo 50 然
bRgbRibRgbRgRsmbRibRibRiRsmbRsbRgbReRsmbRgRsmbLsRsRsmbRibRsRibRgbRibRg
bRebRsbRgRcRgLjbLeRsbLgbsbLsbLsbLsbRsbLgLsbLsLsRsmbLsLgbLgRsbLsLsRsmbR
gRsmbRgbRgbRebRibRsRgbRsRsmbRibRibRgbRebRebRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 2; Drug: PCAP2 10 然 Apo 50 然
bLobLibLiLsbLcRsbLcbLsbRsbLibRoRsRsmmbRcbRgRsRsmmbRobLiRsRsmbLiLsRsLsb
LsbLgbLgbLcbLobLibRobLsbsbsbRsbRsbLgbLgRsLcbRsbLgbLsbRobLgbRoRobRibRsR
smbRsbRgbRgRsRgmbRgRsmbRsRsmbRsbRsRiRsRembLoRsbLibLibLhRsbLcRsRsmbRibR
eRsmbRibRoRsmbLgLsbRcbRibRsRgbRsbRsRsRsmmbRgbRhLsLsLsRsmmbRgbRsbLsRsbR
hbRgRsmbRgRsmbRcbLgbRsbRoLgbRcRsRcmbRiRsmbRgbRgRsRsRsRsRgmmmmbRgRsmbRs
RsRsRsRsmmmmbLsLsmbLsRsRsmbRibRsbsbRsLsRsbLsbLsRsbRcRsRombRcRsmbRgRsmb
RebRgbRsbRsRsmbRsbLsbRgbRgRsmbRsbRsRsmbRsRsmbRgbRsRgRebRgRsmbRsRsmbRgb
RsbRsbRsRgRsmbRgbRgbRsRsmbRobRcbLcbLoLibLgbRcRsmbRcRhbLcbLibLibLobLobL
ibLhRsbLibLibLcbRibLsbRcbRcRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 3; Drug: PCAP2 10 然 Apo 50 然
bLoRsLgbLsbLiRcbRebRebRhRebRebLcbRibLcbRibRsbRsbLsbLgRsbRsbLgLsLsRsRsm
mbLiRsbRsbRsbRsbRgbLsbRibLsLsmbRgbsbLobLsbLebLgbLeRsbRiRsmbRibRgbRsRgL
sRcbLsbsbsbsbLsbsbLgRsbLsLsmbLibLgbLibRgRsmbRgbLsbLsbRcbRibRsRsmbRsLsL
sLsmmbRsLsbRgRsRsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 4; Drug: PCAP2 10 然 Apo 50 然
bRsRsmbRsRsmbRsRsmbRgbRsbRsbRsLsbRsbRsRsRsmmbRgRsmbRibRoLgbLoLsLsmmbRg
LsbRgbLsRsbLsbRsLsbRsRsRsmmbLsRsRsmbLsbRsRsRsmmbRsRsRsmmbRsLsLsmbRsRsm
bRsRsmbRsLsLsmbRsbRgbRsbRsRsmbRsbLsbRsRsmbRsRsRsmmbRsRsmbRsRsRsmmbRoLs
bRsbRebRsbRsbLsRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 5; Drug: PCAP2 10 然 Apo 50 然
bLsbLsLsmbRgLsLsmbLgbLgbLsbLibLsbLgbLsbLgbLgbLgbLiRsbLhbLibLibLsLsmbLs
bLsbRsbRsbRebLibLebLgbLibLgbLsLibLsLibLiRsbLgLiLsbLgbLgbLeLsLsmbLibLib
LsLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 6; Drug: PCAP2 10 然 Apo 50 然
bRcbRsbRsbLeLsLsmbLebLoReRsmbLgRsbLobRibLiLsLsmbLsbLsRsbRhbRjbLobRsLsb
RsLsbLsbLgbLgReb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 7; Drug: PCAP2 3 然 Apo 50 然
bRsbLsbLsLsmbLsLsmbRsbLsbRsLsLsmbsbLsbLsbLsLsmbLgLsbLgLsbLsLibLcLsLsmm
bLgLsbLgRsbLgbLgbLsLgbLsbLsbLsLsmbLsLsmbLsLsmbLgRsbLsLsmbLsLsmbLgLsLsm
bLgbLgLsbLsbLgbLgLsbLsLsLsmmbLgbLsbLsbLsbLsbLsLsmbLgbLsbLsbLgbLsbLgbLg
LsbLsbLsbLgbRsLgLsbLgbLgLsbLgRsbLsbLgbLsLsmbLsLsmbLsbLsbLsLsmbLgLsbLgL
sbLsbLsbLgLsRsbLsbLsLsmbLsbLsbLsbLgLsbLgLsbLsbLgbLgbLsbRsLsbLgLsbLsbLs
bLgbLgLsbLgbLgbLsLsmbLsbLsbLsbLsLsmbLsbLsbLsbLsbLsLsLsRsmmbLgLsbLsLsmb
LsLsLsmmbLgbLgbLgLsbLsLsmbLgbLgLsbLsbLgbLsLsLsmmbLsLsLsLgmmbLgLsbLsbLg
bLsbsbsbLsbLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 8; Drug: PCAP2 3 然 Apo 50 然
bRcRibRiRsRcmbRcRibReRcLibLgLgbLebRebRhRsRsRgRsRsRsmmmmmbLebLcLsmbLibL
ibRjbRebLsbRhRsRsRgRsRsRsRsmmmmmmbReLsbRsbRcRiRhLsRhRsRsmmbRhbReReLsbL
hLsbLcbLgbLcbLhbLcbRsbLcbLibRibReRibRcLgbLeRsbLoLgbLeLeLsbRsRobRebLjbL
eLgLebLeLiLgbRsbRobRsRcbRibLsLjLsmbLiLsLsLgmbLhbLibRsbRsRibRcbRjbRcRsm
bRsRcbRcRsmbRiRgbRcbRsRcRebRgRsmbReRsmbRgbRcRsmbRiRgRiRsmbRibRsbRoLsLg
bRcRsmbRiRgbRcbRhRsmbRsbRsRcRsmbLjbLcLsmbLebLgbLiLeLsLeRsbLgRgbReRsmbR
iRcRjbRobLsbRiRsmbRgbRcbRsbRhbReRsmbRibLebLeLsLsmbLhLiLsLsRsmbsbRcRsmb
ReRsRimbRcbRcRsmbLsbLcbLhbLiLsbRjbRoRhRebRcRsLsLsLimmbLeLsbsbRcReRiRoL
sbLebLeRsRsmbLjbLcbLiLgLsLhbLibLibLebLcbLsbLcbLeLgbLcbLsbLcLsmbLibRsRc
RsmbRsRsmbRsRsRsRsRgRsmmmmbRcbRcRiRsmbRsRsRcmbLebRoRhRsRiRsmmbRibReRsm
bRcbRoRsmbRcbRiRsmbRgRcbLiLsbRoRgRibRiLsbLsbLebRebLoRsbRsRcbLibRcRsmbR
jbRcRibLiLsbLebLiReRsRimbRibRsRebRiRsmbRiReRsRgmbRgbRcbRgRsRcmbRibRcbL
sLjbRjbLsbLsbLcbLhbLgRsbLeRsbLhbLgRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 9; Drug: PCAP2 3 然 Apo 50 然
bRsRibRhRebRebRgbLcLsmbLibRobRcbRebLebLibLibLibLhbLgbLcbLibRibRhRsRsmm
bRibRibLsLibLjbLibLibLibRhbRcbRcbRiLsbLibLgbLibLjbLibLsRsbLjLgbLjbRibL
jbReRsRgmbRjbRgbRjRsmbRiRhbRjbRgbLoRsbLgbRiRiRsmbRibRjRsmbRibLsbLjbReR
gRsRsRsRgRsRsmmmmmbReLsbRhbRibRiRsRiRsmmbRsRgRsmbRebRgRgbRiRibRebRgRsm
bRsbLjbLcbRcbRhbRcRsmbRobLjbLhbLibRibLobLibLibLcbRjbRibRibRjbRcbLgbLsb
LgLsLsmbLgbRgRsmbRebRgRsmbRebRsbRiRsmbRsbLjbLibLibRebRibRibRgLsRiRgbRg
bRgbRibRgRebLsLibLjbRjbRcbRjbLibLcbLgbsbLjbLibLibLjbRhbRcbLsbLcbLcbReR
smbRgbRjbsbRgRsmbRiRiRgRgbRebRgbRjbLibRobRhbLibLhbLhbLcbLibRcRsmbRgbLj
bRsbRoLsbRgLsbRcRsmbRcbRsReLsRgRsRsRsRgRgRsmmmmbRibRiRsmbRibRsRgbRgbRi
RsmbRibRsbRibRiRsmbRcRsmbRhRsmbRcbLobLiLsbLgLgbLibRgbRcbLjbLcbLhbLibLi
bLjbLhRsLgRsbLiLsbLsbRgRgbRsRiRsmbRiRsmbRgRsmbRgbRsRebRibRsRsmbRgRhReb
ReRibRhLsbRibLibLjbLcbLhbLgbLhbLcbLcbLibLibLibLgbLcbRibRibRhRsmbRibRib
RhRsmbRhRsmbRgbRibRhbLjbLebLobLgbRibLgbRebRibRhbLjLsmbRibLsRsRgbRebRcb
RsbRiRgRgRsRsmmbRgbRebRebRsbRsRsRsRgRsRiRsRgRgRemmmmbRibRgRib

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 10; Drug: PCAP2 3 然 Apo 50 然
b

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 11; Drug: PCAP2 3 然 Apo 50 然
bRsRsmbRsbLsRsRsmbRsbRsbRsRsmbLsRsbRsRsRsmmbRgRsmbRsRsRsRsRsmmmmbRsbLs
RsbRgbRsbRsRsmbRsbRsbRsbRsLsbLsRsbRsRgRsmbRsRsRsmmbRsRsmbLsRsRsLsmbLsR
sRsRsmmbRsRsLsRsmbRsRsmbLsRsRsRsmmbRsRsmbRsRgbRsRsLsmbRsbRsbRsRsmbRgbR
sRsmbRsbLsRsLsbRsRsmbsbRsRsmbRsRsRsmmbRsRsmbRsbRsRsRsmmbRsbRsbRsbRsbRs
RsmbRsRsmbLsRsRsRsLsmmbRsbRsRsRsRsmmmbLsRsRsmbLsRgbRgbRsRsmbRsLsbRsbRs
RsmbLsRsbRsbRsbRsRsmbRsRsmbLsRsRsmbRsbLsRsRsmbRsRsmbRsRsmbRsRsmbRsbRsR
smbRsRsmbRsRsmbRsRsRsLsRsmmbsbRsRsRsmmbRsRsLsmbRsRsmbLsRgbRsRsRsLsmmbR
sLsbLobRsbRsbLsRsbLsRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 12; Drug: PCAP2 3 然 Apo 50 然
bRebRhbReRgRibRgLsbRcbRgbLobLgbRsRsmbRibRebRgLsRsbLobLibReRibRgbReLsbL
gbLhLsbRgbRjbRcbRgbRebRsbRcRebsbLobLgbRcbRsRsmbRebLcbRibRibRiRsmbRsbLj
bRcbRjbRibRgRsmbLjbRibRgbRibLhbLcbLibLcbRebLsbLiLsbLobRgbRcbRcbRibRsRs
mbLiLsbLibLgbLcRsbLibLobLibLgbLoRsbRhbRibRebRibLhbLibLgbLibLsbLcRsbRib
RhReRsRsmmbRgRsmbRibRibRibRibRgRsmbRibRibRibRsRiRgRsRsmmbRcbLgbLhbLobL
gLsbRjRsRgmbRiRsmbRiRiRsmbRgLsbRiRsRsmmbRgRgRsRgmbRibLcbRibRibRhbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 13; Drug: PCAP2 1 然 Apo 50 然
bRsbLsLsLsmmbLsbLsbRsRsLsmbRhbLsRsbReRhRsLsmbLiLsLsmbLibLgLgbLsbLgbRjb
LsLsmbLsbRoRsRsmmbRibRsbRsRsmbRsbsbRiLsbRibRiLgbRsRgRgRsRsmmbRsbRibRcb
LsbRobReRsRiRsmmbRgLsRsRsRsRsmmmbLjbLibLjbLhbLjbRsbRsLsRsLsbRsLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 14; Drug: PCAP2 1 然 Apo 50 然
bLebLebLebLgLgbLsLgLsLsLgLsmbLgLsLsmbLcLgbLebLiLsbLgLsLsRsmbLsbRsbLsLs
LsLsmmmbLsLsLsLsLsLsLgmmmmmbLgbLgbLgLsbLeRsLsbLgLsLsmbLiLsbLibLsLsLsmm
bLibLiLsbLiLsbLiLgbLgLsbLgLsLsmbLgbLebLhLsbLibLhLsLiLsbLiLsLgbRsLsLsmb
LsLsLgLgmbLsLsmbLsLsLsmmbLsbLsbLsLsmbLsbLsbLsLgbLsLsLsmmbLgbLsLsLsLgmm
bLiLsbLibLgLsLgLsLsmbLgLsbLgLsLsmbLibLibRcbRcRsLsmbLsRsbRsbRsRsmbRsbRg
LsbRsbRgbRsbRsRsmbRsRsmbLjbLebLsLsLsRsRsmmmbLsLsmbLiLsRsbRsLsbLeLsLiLs
LsLsLemmbLebLsbLsbRobLsbLsbLiLsbLsLsmbRsbLsRsbLsLgbLibLiLhLsbLgLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 15; Drug: PCAP2 1 然 Apo 50 然
bLibRsRibLoRsbLoRgbLobLgbRhbLibLobRsbLcRsbLobRsbRhbLoRsRsmbRcRsRcmbRgR
gRibLsRsLsbRsbLsbRsLsbRhbRcbLebLebLcbRiLsRsbRsRsmbLobLibLcbLcbLibLgRsb
RsRibLgbRebRsRhRsRsmmbRiLsbRibRoRsmbLcLsmbLcbLcLsLsmmbLcbRgbRibRhbRiRs
mbRsbRiRsmbRcbLjbLcbLeLsLsLsLsmmmbLcLsmbLibLebLiLsbLcLsmbRcbRibRiRsmbR
obLgLsbRebRgbRibRobLsLsmbLcbLebRcbLebLhLsbRgbRsLsLsmbLeLsLsmbLhbLcLsLg
LsmbRobRsbRibLcbLiLsbLebLebLibLgbRibLcbLeRsbLcbLebLcLsLsLsmmmbRsbRgbLc
bRgbLcbLsbLibLebLhLsbLcLsmbRibLhbRoRsmbRiLsbLibLcbLibLcRgbRsbRcbRhbRob
RibRibRhbRcbLsbLsLhbLgbLjbLibLcbLgbLcbLsbRgbLcbLebLibLcbRgbLcbLebRcbRi
bRgbRibRibLgbLsRibRgbRiRsmbRgbRibRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 16; Drug: PCAP2 1 然 Apo 50 然
bReRsmbRiRsmbRhbRibRgbRebLgbLebLsLsRsmbLobLeRsbLebLibLebLebLibLibLibLc
LsmbRgbLebLcLsmbLgbReRsmbRibRgbLebLebLgbRgbRibRibRibRjbRgbRgbLjLebLeLs
bRsbRjbRoLsbRgLsbRcbRiRsmbRebRibRsbRsbLsbRgbRsbRgbRebLcbLsbLeLhbLibRsb
LebLgbLebLebLebRsbLgbLhbRsbRibRibReRgRsRsmmbRibRibRgbRibRiRsmbRgbRcbRi
RsmbRgbRebRsLibLebLiLsbLhbLcbLcbRgRsmbLibRibRgRsRgmbRgRsmbRgbRsbRiRsRs
mmbRibRgbRebRcbLebReRsmbRgRibRgbRgbRiRsmbRebRgLsbLibRjbRcRsRsmmbRiRgLs
bRiLsbLibRibRibLebLebLiLsbRcbRsRsmbLgbRcbRgbRibRibRsbRibRgbRgbRebRgRsm
bRcRsmbRhbReRsmbRsRsmbRgbRibRibRjbRgbLsbLeLsbLeLebRibRcbRibRgbRgRsmbRg
bLoLhRsbLjbRsRsLsmbRibRgbRibRcbRcLsbRgbRsbLeLsbLhbLgbLhbLgLebLeLsbLhbR
sbLgbRjbRhbRibRhbRgRebRjLsbRebLsbLcbLibLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 17; Drug: PCAP2 1 然 Apo 50 然
bRcbLjbLeLsbLgLsbRgbLibLibLcbLsbLobLebLgbLgLeLsbRjbLcbRgRsmbLibRcbRebR
obRobRiRsmbRibRibRsbRgLsbRcbRobRoRsmbRsRsmbLcbLcLsmbLibLoLsmbRsbRsbLiR
sbRcbRhbLjbLebLeLsbLcbRcRsmbRcbRgbRcRsmbRibRgbRibRcRsRembRgbRcbRcRsRsm
mbRibRcbRcbRcbLcbLiLgbLibLgbLcbLsbLgbLebLcbLsLebLibLcbLsbLcbLgLsRsbRjb
LgbLebRgbRebRsLsbRcbRhbRebRebRebRebRibRcLsbRgbRjbRsRsmbRibRiRsRsmmbRgb
ReRsmbRgRsmbRiRgbRgRsRsLsmmbRgRsmbRgbRiLsbLcbLeLiRsbRcbRgRcbRcRsmbRebR
ibRiRsmbRiRsmbReRsRgmb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 18; Drug: PCAP2 1 然 Apo 50 然
bLcbLcbLeRsbLcLsRsmbRcbRibRgbLibLhbLsLgbLiLgbLgLsbLgLsLsmbRebRcbLcbLhb
LhbLgLsbRcbLgbLsbLiLsLsmbLgLsRsLsbRoRsmbRcbLgbRibRcbRoLsbLibLibLibLeLe
bLebRsbLibLiLsbLiRsbRcbRiRsReRsRgmmbRibRsRsmbLsbLsbsbRsRsRsmmbRsbRebRc
bRcbLcLsmbLibLibLsbLcbLsbLgbLibLcbLobRebRebRebRebsbRebReRsRembLgbRob

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 19; Drug: Control Apo 50 然
bLsLsmbLsbLsLsLembLgbLibLibLibLgbLgRsLsbLsbLsbLiLiRsbLgbLibLsbLgLgbLgb
LibRsRgbLsbLsLsmbLsLgbLsLsLgLgLgLsmbLsLsLsLsLsLsLsLsLsmmmmmmmmbLibLgLs
LsLsLsLsmmmmbLiRsbRgRsmbRsRcbRibLgLsRsbLjbLsbRsLsLsLsLsLsLsmmmmmbLgbLg
bRsLsLsLsLsLsmmmmbLsLsmbLiLsLsLsLsRsmmmbRsLsLsmbRsLsLgLibLgLibLibLibLs
LsmbLsLgLgbLiLsLsLgLimbLebLsLiRsbRjbLsbLsbRjbLjbRobRsbLibRsRsRsmmbRgbL
sLsmbLsbRcRsmbRsLsbRebLgbLsbRibRcbRibRiLsbReRsmbLsbLsbRsLsbLsbLsbLeLsb
LibLsLgbLibLgLsbLibLibLibLcbRjbsbRcbRhbRcbLgbLgRsbLcbLibLgbLibLsbLgbRi
bRiRsmbRgRsmbRibRibRebLsbRsbLsbLebLiLeLsbLsbLiRsbLsbLsbLsbLsLsmbRcRsRs
mmbRgLibLebRsRsmbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 20; Drug: Control Apo 50 然
bLeLgbLebLebLibLibLhbRibRibRgbRebRcbLgbLeLebLebLibLebLebLebLebRibRobLg
bLibLeLsbLcbLgbLcbLiLsbLgbRibRjbRgbLgbLgLsbLebLgbRsLebLhbLcbRcbRibRhbR
ibRgbRgbRibRebLhbLgRsbLiLsLsmbLgbLgbLebLibLebLeLsbRcbRibLobLgbLiLhLsbL
sbLiRsbLebRgbRcbRgbRhbRhbRgbRibRibRibRibReRsmbRiRsmbRgLjLcLcbLebLebLcb
LibLebRibRibRiRsRgmbLhLsLsLiRsmbLibLsbLcbLibLgbLgbLcbRsbLsbLebLgbLibLg
LsbLebLhbLibLebLsbRgbRcbLsbRibRgbLiLebRsbLebLebLebLeLsbLgbLsLebReRsRsm
mbRgbRiRiLsbRiLsbRcbRibRcRsmbRibRgRsmbRiRibRgbRibRibRcbLibLcLsmbLebLib
LibLiLibLebLebRobRhbRibRgRsRsmmbRibRibLjbLibLiLgLhbLebLgbLebLgbRhbRibR
ibRibRgbRibRibRgbRgbRgRgRsmbRsLsbRgbRibRgRgRsmbLgbRebRibRsbRiRsmbRsRsm
bLjbLibLebLgbLgbLgbLebLeLgLebLgLiLgRsbRsbRsbLgbRjbLibLebRjbRjbLsbRiRsm
bRgbRgbRgRgLsbRgbRiRsmbRibRgbRebRgbRsbRgRsmbRgbRibRibLjbLjbLhLsbLsLibL
gbLebLsLiLsbLibLsbLibLsRibLib

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 21; Drug: Control Apo 50 然
bRcbLcbLcLsLiLiLsmbLsLsLsLsLsmmmmbLcLsmbLeLsbLcLsLgLsLiRsLsLsmmbLoRsbL
eRsbLhLsbLcbRibRibRgbRsbLsbRiRsmbRcbRoRsmbRgRsmbRcRhRgbRoRsmbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 22; Drug: Control Apo 50 然
bRsbRcbRoLsbRcbRcRsmbLsbRsbLcRsbLgbLebLsbLibLcbLsLsmbLeRsbLiLsbLgLibLh
bRgbLsbLcLsmbLsbLjbLcbLcLsmbLcbLcbLiLsbLgRsbLiLsbLgbLhLsbLsLsmbLcLsmbL
cbLiLsLsLsmmbLibLsbLjbLsRsbLobLebLcbLebLcbLebLhLhbLcbLcbLobLcLsmbLeRsb
LhbRsLgbLgbLjbLiLsbLibLiLgLsbLiLgLsbLebLcLgbLiRsbLibLjbLsbLiLsLsLsmmbL
iLsLsmbLiLeLsbLiLsbLiLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 23; Drug: Control Apo 50 然
bLsbLeRsbRcbReRgbRgRsRimbLsRsbRiRhRsmbRcbRibRcbRebRgbRcbRebRibRibRsbLe
bLobLgLsLgLsbLsbLibLoRsRgbRhbRsRsRsmmbRibLeLsbLgbLeLebRobRibLcbRebRibR
sLsbRiRebRebRhbRgRsmbRibLgbLjbLgbLjbLhbLcLsmbLgLsbLgbLcbRebRibRiRhbLib
LiLsbLgbLjbLsbLeLsbLebLgbRgbRibRcbRjbLobLgbLsbRibRebRebRgbRgbRebLibReb
LgbRjbLibLgbLibLibRoLsbRgbRibLgbRebRebRebLsLsmbLhbRjRgbRibRsbRiLsRsbLc
bLcbLcbLhbLsLsLsmmbLhbLcbLobLibRjRgRsmbRiRsmbRibRibRgbRcRsmbRiRsLsmbRg
bRgLsbLsbLsbLsbRsRsmbRgbLgbRibLcbLhbLiLsbLibsbLsLsmbLgbRcbRcRsRsmmbRob
RcbRcbRibRibRobRcbRebRsRgbRibRoRsmbLhbLobLcbLibRobRebRhbRibRcRgbRhRsmb
RobRhbRhbRiRsmbRibRiRsmbRibRobRcbRebLebLibRsbsbRjbLsbRsbLgbLsRebLjbRhb
LcbLgLsbLjbLiLeLgbLcbLibRibRjbLebRcRsmbLhRsbRcRsmbRiRsRiRsRgRimmbRebRe
bLobRebLjbLeLsbLgbLibLcbLgbLhLebLiLsLsLgmbLebLhb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 24; Drug: Control Apo 50 然
bLiLsbRcbRebRibLgbLsLhbLiLsbLiLibLhbLiLsbLhLeLsRoLibLeLsLebRjbRebLsRsb
RsLsbRibRibRebRgbRcbRgRiRsRsmmbRibRebRhbRhRebRebLibLsbLcbLibLiLsLsmbLi
bRsLsLsmbLcRsbLhbLsLsRgmbRhbRcbRhbLgbLjbRebsbRiRsmbRsbsbLhbLjbRoRsRsmm
bRjbLebRsRhbRsRsmbRhbRsbRsRjbRhbRcLsbRebLcbLhbLcbLsbLibLhbLcbLgbLebLeb
RjbRhRebRebRsbRebRcLcRsbRjbRgbLhbRsLiLsbLebLebLebLcbLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 25; Drug: PCAP2 10 然 Apo 50 然
bLsbLsbRgbLgLsbLcRsLobLgbRsbRsbLsbLoLsmbLcbRibRsbRgbRsRsRsmmbRcbRsbRoR
smbLcLsmbLsRsRsRsRsmmmbRobRjbLgbsbRebRobRobLjbLgbRebLsRsRsmbRcRgbRgbRj
bLobRibRcbLsbRsRsmbRebRjbLgRjbLgbReRsmbRibRsRsRsmmbRibLgRsbLhRsbRcRsmb
RjRebRebLsbLsbsbLebRgbLiRsbLsbLgRsbLsbRjbLsbRgbRsbRibRgbRibLsbLsbRgbRe
bLcbLobRebRgbLibLsbLjbLobRgbLibReRsmbLjLeLsbLiLsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 26; Drug: PCAP2 10 然 Apo 50 然
bRsbRsbRsbRsbRgRsmbRgbRgLsbRgbRsbRgbRgbRsRsmbRgbRsbRgbRgbRgbRsbRgbRiLs
bLsbLhbLsLsLsmmbRsLsRsbRsbRsLsbLgbLsbLsbLsbLsbsbLsbLsLsmbLsLgbLsbLgbLs
bLsbLsLsLsmmbLsLsmbRcbRsbRsRgbRgbRgbRsbRsRsmbRgbRsbRgbRsRsmbRsRsmbRgRs
mbRsbRsRsmbRgLsbRgbRsbRiRsmbRgbRgbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 27; Drug: PCAP2 10 然 Apo 50 然
bRsRsRsRsLsmmmbRsRsRsmmbRsbRsRgLsbRsbRgLsRsbRsbRiRsmbRsRsmbLsLsmbLsRsL
sbRsbRsbRsRsmbRgRsmbRgRsmbRsRsmbRgbRsbRsRibRiLsbsbRsbRiRibsbLsbRsRsmbR
sRsmbRsRsmbRibRgRsRsmmbRsLsbRgRsRsmmbRgbRsRsRsmmbRsRsmbRsRsmbRgbRsbRgb
LsbRsbRsbRjbRsRsmbLjbLobRsRsRsRsmmmbRgLsRsbRgRsmbLsRsRsLsmbRsbRgRsmbRg
RsRsRsmmmbRsRsRsRsLsmmmbRgRsRsmmbRsRsRsmmbRjRsRsRsRsRsmmmmmbRsRgRsmbRg
RgbRsbRsRsmbRgRsmbRsRsRgRsRsRsRsmmmmmbRsRsRsmmbRiRsmbRjRgRgRsmbRsbRhbR
sRgRsRgRsmmbRsRsRsmmbRsRgRsmbRiRsRsRsmmmbRsRsmbRiRsmbRsRsmbRgRsRsRsRsm
mmmbRiRsmbRiRsRsmmbRhbLsbRibRgbRsbRsbRsRsmbRgRsRsRsmmmbRiRsRsmmbRgRsRs
mmbRgbRsRsmbRgRsmbRsRsRsmmbRgRsRsRsmmmbRsRsRsmmbRsRsRsmmbRsRsRsmmbRgRs
mbRibRsRgRsmbRgLsRsLsbRsRsmbRibRsRsRsmmbRsbRsRgbRgRsRsRsmmmbRibsbRgRgR
sRsmmbRgbRibRsRsRsmmbRgbRsbRsRgRsRsmmbRebLsbRiRcbLiLgbRoRsmbLsLsmbLgbL
jbLibLgLsRsbLsLsmbLsLsmbRsbsbLsbLgbRsLsLsRsLsLsmmbRsLsbRsbRhbRsRsmbRsR
smbRsbRsRsmbRgRsRsmmbRsRsmbRsRsmbRsbRsRsmbRsbRgRsmbRsRsmbRsbRsRsRsmmbR
gRsmbRsLsRsbsbRsRsmbRsbRgbRibRjRgRsmbRsbLsLsLsLsmmmbRibLsbRsRsLsmbRsRs
RsRsmmmbRgRsRsRsmmmbRobRsbRgRsmbRibRsRsmbRgbRgRsmbRsbRgbRgRsmbRgRsmbRs
RsRsmmbRiRsmbRsbRiRsmbRsRsmbRiRsmbLgbLgbsbRsRsmbsbRsbsbRsbRgRsLsmbRsbR
sRsmbRsRsmbRsbRsLsRsbRsRsRsmmbRgbRsbRsRgLsRsbRgbRsRsmbRsbRsbRsRsmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 28; Drug: PCAP2 10 然 Apo 50 然
bRjLsLsLsmmbsbRiLsbRjRsRimbRgRsRgRsRsRsRsRsRsmmmmmmmbRgRiRsRsRsRsRsRgR
smmmmmmbRgbRgRsmbRiRsRsmmbRsbRgRgRgRiRsmbRiRsRsRsRsRsmmmmmbRgRsRiRsRsR
gmmmbRsRsRsRsmmmbRsRsRsRgRsRgReRsmmmmbRiRsmbRiRgRebRgbRhLsbRhRiRsmbRgR
gRsmbRhRgRsLsmbRsRgRsmbRcRsmbRgRsRsmmbRsRsmbRgLsbsbRgbRgbRgRsLsRgLsmbR
gLsbRgRgRsRsRsRgRsRsRiRgRgmmmmmbRibRgbLsbRsbRsbRjbLsbRsbRsbRgbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 29; Drug: PCAP2 10 然 Apo 50 然
bRcbRsLsLgbRsLsbRsbRjbRibRsLsRgbsbLsbRibRsbRsbLsbRiRsRsRcmmbRsbLsbLsLs
mbRsbLsRsbRibRsbLsRsbRsbRsLsbRsbLsbsbRsLsbsbLsRsbRhbRgbLsLsmbLsRsbRiRg
RsmbRsRsmbRsbLsbRsRsmbRsbLsbRsbsbRsbRsbRsRsmbRsbRibRsLsbLsLsmbRsRsmbRs
bRsbRsbRgLsRsbLsRsbRsbRsRsRsmmbRsbsbLsbRsbRgLsLsmbLsRsbLsRsbsbRsRsRsmm
bRsbRgRsmbRsRsmbRsRsRsmmbRsbRsRsmbRsRgbRsRsmbRsbRsbRsbRsbLsRsbRsbRsRsm
bsbRsRsmbRsRsmbLgRsbRsbRgRsmbRsbRsRsmbRsbRgRsRsmmbRsbRsRsmbRsRsmbRsLsb
RgRsLsmbLsbRsRsmbRsbLsRsbRsLsbsbRsbRsRsRsmmbRsRsLsmbRsRsmbsbRsbRsRsRsR
sLsmmmbRsbRsRsmbRsRsmbsbRsbLobRgbRsbRsbRiRsmbLsbLgLgbLsbRgbRgRibRsLsRs
bRsbLsRsbsbRsRsmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 30; Drug: PCAP2 10 然 Apo 50 然
bRsbRsRsmbRsbRcRobRibLgLsbRsbRsbRgbLsLcbLhbsbsbRiRsmbRsLibLcRsRsRsmmbR
gRsmbRsRsmbRebRiRsLsmbRsRsmbLsbRsbLcbRsbLibRsRsmbRgLsLsmbRjRgbLsbRiLsb
sbsbLsbsbsbLibsbRsLsbRsbLsbLgLsLsLsmmbRsbLsbsbLgLobLsLsLsmmbLsbRsbRgbL
sbRjRob

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 31; Drug: PCAP2 3 然 Apo 50 然
bRsRsmbRsbRsbRsLsRsbRsRsLsmbRsbRsbLsRsLsbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 32; Drug: PCAP2 3 然 Apo 50 然
bLsbRsbRhRobLsRibRibLsRgbLsbRsRsLsmbLsLsLsmmbLsLsLsRsmmbLsbRiLsbRgReLs
bRjRiRsRiRsmmbRsRsmbRsbRsbRsbRsbRsbRgRsmbRsRsRsmmbLsRsbRsRsLsmbRsbRsRs
mbRsbRsLsbRsRsmbRsRsmbRsbRsRsRsmmbRsbRjRgRcLsbRgbLgLsLsmbLgLsbLsbLgbRs
bLgbLgbLgLgRsbLsbLsLsmbLgbLgbLgbLgLsbLsLsmbRsLgbLsLsLgmbLsLsmbLsbLsLsm
bLsbLsbLgLsbRgRsRjmbRibRibRibLsRgbLsRsbRsRsRsmmbRsbRsbRsRsLsmbRsRsmbRs
RsmbRsRsmbRsbRsbsbRsbRsbLjbLsbRoRsLsmbLsbLsLoLiLsbLibLgbLgbLsbLgbLsbLs
bLgbLsLsmbLsLsmbRsbLsLsmbLgbLsbLgbsbLsbRsLsbLsbLsbLgbLcRsRgbRgbRgRsRsm
mbRsRsRsmmbRsbRsRsmbRsLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 33; Drug: PCAP2 3 然 Apo 50 然
bLsbsbLsbsbRsbsbLsbLsLsmbLsbsbRsRsmbRsRsLsmbLsbsbRsbsbsbsbLsLsmbLsLsmb
LsbRsbRsbsbsbRsLsbRobRcRcRiLsbRhbRibsbLsLsmbLsbLcLgLiLsbLcbLgLsbLsLgbL
sLsmbLgRsbLsbLsLsmbLsLsmbRsLsbLsbLjLsLcLgmbLjbLgLcLiLsRsbLgLgLsbLgLgLi
LgLsbLsLsmbRcbRcbRcbRhbRebRebRhbRsLsbRsbRgRsmbRsLsbRsbRsLsbLsbRgbLsLsm
bRiRcReRcbRiRsmbRgbRsRsRsRgmmbsbLibRjbLoLsmbRjbRcbLcLsLsLemmbLgbRibRgb
RsbRsRsRsmmbRsRsRsRsmmmbRgLsbRsRsmbRsRsmbRsbRgLsbRgRiLsbLcbRjRsmbRsLhL
sbLcbLsbLcbLibLiRsLsbRjRsmbLob

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 34; Drug: PCAP2 3 然 Apo 50 然
bLgbLgbLgbLgLsbLgbLgbLgbLsLsmbLgbLgbLgbLgLsbLgbLgbLgbLsLsmbLgbLgbLgbLg
bLgLsbLgbLgbLgbLgLsbLgbLgLsbLgbLgbLgLsbLgLsbLgbLgbLgbLgbLgbLgbLgbLgbLg
LsbLgLsbLgbLgbLgbLgLsbLgbLgbLgbLsbRsbLsbRsLsbLsLsLsmmbLgbLsLsmbLsLsmbL
sbLgbLgbLsbLgbLsLsmbLgbLgbLgLsbLgLsbLgbLgbLgbLibLgbLgbLgbLsLsmbLgbLgbL
gbLgbLsLsmbLgbLgRsbLgbLibLgbLgbLgbLgbLgbLgbLgbLgbLgbLgbLgbLibRsLgbLgbL
gbLibLebRhRsmbRoRsmbRcbRoLgbLibLibLgLjRgbLsLiRsRsmbLeLgRgRsmbRgLsRsbLs
bLgbsbsbsbsbsbLebLgRsbLiRsLsbLebsbLjbRsLcbLibLiRsbLsLsmbRcbRiRsmbRiRsR
smmbLsbLcbLcbLcbLsbRgRgRcLsLibLgLsbLeLeRsLibLibLhbRcbRsRsRsmmbLsRsbLsR
sbRsRsmbRsbRsbRsRsmbRsRsRsmmbsbRiLoLibRsbRobRiRgRsmbRsRsmbRgRsmbRgRsmb
RsRsRsRgRsRiRgmmmbLsbRsLsRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 35; Drug: PCAP2 3 然 Apo 50 然
bRsRsRsRsRsRsmmmmmbRsRsRgmbRsRsmbRsRsRsRsRsmmmmbRsRsmbRgRsmbRsRsRsmmbR
sRsRsRsRsmmmmbRsbRsRsRsmmbRgbRgbRgRsmbRgbRgRsmbRsLsbRsRsmbRsbRsRsmbRgR
smbRgRgbRsRsRsmmbRsRsRsmmbRgRsRsmmbRgbRgbRgRsmbRsRgbRgbRsRsmbRgRsmbRgb
RsRsmbRgRsmbRsRsmbRsRsmbRgLsbRsRsRsmmbRsRsRsRsRsmmmmbRgbRgbRgbRgbRgRsR
smmbRgbRgbRgbRsbRgbRsRsRsmmbRgbRgRsRsmmbRgbRjbLsRsbRsbRgRsRsmmbRsRgbRs
bRsRsRsmmbLeLsLsmbLcbRgbRsbsbsbsbRsRsmbRgbRgbRsRsRsmmbRsRsRsmmbRsRsmbR
sRsRsLsmmbRsRgRsmbRsRsmbRgRsmbRsRgRsRsmmbRsRsRsRsmmmbRsRsRsRsmmmbRgRsR
smmbRgbRgRsmbRsRsmbRsRsRsmmbRsbRsbRsbRgRsRsmmbRgbRsRsRsmmbRgbRsRsRsmmb
RgbRsbRgbRsRgbRgbRgbRsRsRsRsLsmmmbRsbRsRsmbRgbRgbRsbRgbRgbRgbRgbRsRsRs
RsRsmmmmbRsbRsbRsbRgbRgbRgbRgRsmbRgLsbRgbRgbRsRsmbRsRsmbRgRsmbRgbRsbRg
bRsRsmbRgbRsRsmbRsbRsbRsLsbsbRgbLsRsbRsRsmbRgbRsRsRsmmbRgRsmbRgbRsRsLs
mbRgbRsbRsRsmbRsbRsRsmbRsbRgLsbRgRsmbRsLsLsmbRgbRsbsbRsLsbRsbRsbRgbRgR
sRsmmbRgbRsbRgRsRsmmbRsRgbRsRsmbRsRsmbRsRsRsRsmmmbRsbRsLsbRsRsmbLsbLsb
RsbsbRsbRgbRsbRsRsmbRsbRgbRgbRsRsmbRsRsmbRgbRsRgRsmbRsRsmbRgRsmbRgbRgR
smbRsbRsRsmbRgbRgbRgRsmbRgbRgRsmbRgbRgbRgLsbRsRsmbRgbRsRsmbRsRsmbRgRsm
bRgbRgbRsRsRsmmbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 36; Drug: PCAP2 3 然 Apo 50 然
bLibRhLoLcLsmbLhLsLsLsLsmmmbRebLibLsbLsbLsbLsLsmbsbLsbLsbLsbLsLsmbLsLs
mbLsRsbLsLsmbsbLsbRsbLsbLsbLsLsmbLsbLsbLsbLsbRsbLsbLsbLsLsmbLsLsLsmmbL
sLsmbLgbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 37; Drug: PCAP2 1 然 Apo 50 然
bRsRsRsRsmmmbRsRsmbRsRsRsRsRsRsRsmmmmmmbRsRsmbRsRsRsRsRsmmmmbRgRsmbRsR
sRsRsRsRsmmmmmbRsRsmbRsRsRsRsRsRsRsmmmmmmbRsRsRsRsRsRgmmmmbRsRsRsRsRsm
mmmbRsRsRsmmbRgRsmbRgbRgbRgbRsRsRsmmbRgbRsRsRsRsRsmmmmbRgRsRsRsRsRsRsR
smmmmmmmbRsRsmbRsRsRsmmbRsRsRsRsmmmbRgbRsRsRsRsRsRsmmmmmbRsRsRsRsRsRsR
smmmmmmbRsbRgbRgRsmbLsbRibRoRhLsbRcbRiRsmbRsRsRsRsmmmbRgRsmbRsRsRsmmbR
sRsRsRsmmmbRsRsRsRsmmmbRgbRsRsRsRsmmmbLsRsRsmbRsRsRsRsRsmmmmbRsRgbLsLs
RsmbRsbLsRsRsRsRsmmmbRsRsRgmbRsRgRsRsmmbRsRsmbRgRsRsmmbRsRsRsRsRsRsRsR
gRsmmmmmmmbRgbRgRsRsmmbRsRsRsmmbRsRsRsLsmmbRsRsRsmmbRgbLsRsRsRsRsRsRsR
sRsmmmmmmmbLsRsRsRsmmbRsRsRsRsmmmbRsRsRsRsRsmmmmbRsRsRgmbRsRgRsRsmmbRi
RsRgRsmmbRgRgRgbRgRsmbRgRsRsmmbRsRsmbRsRsRsRsRsRgRsmmmmmbRgRsmbRgbRsRs
mbRgbRsRsmbRsRsmbRsRsRsRsmmmbRiRgbReRsmbRobRoRsmbRibRebRsRsRsRsmmmbRsR
sRsmmbRsRsRsmmbRsbRsRsRsRsmmmbRsRsRsRsmmmbRgRsmbRsRsmbRsRsRsmmbRsbRsRg
bRsRsRsRsmmmbRsRgbRsRsRsmmbRsRsRsmmbRsRsRsmmbRsRsmbRsRsmbRgRsRsRsmmmbR
sRsRsmmbRgbRsRgbRgbRgbRsRsRsLsmmbRsRsRsmmbRgRsmbRgbRgRsmbRgRsRimbRgRsm
bRgRsRsmmbRgRsRsRgmmbRgRsmbsbRgRsRsRsmmmbRgRsmbRgRsRsRsmmmbRgRibRgbRiR
smbRgRsmbRgbRgRsRsmmbRgRsmbRgRsRsmmbRgRsmbRgRsRsRsmmmbRsRgbRgRsmbRgbRg
RsmbRhRsRsmmbRgbRcRcRebRiRsRcRsmmbReReRsRsmmbLsRsbRgbRibRsRgRsmbRgRsmb
RsRsRsRsRiRsmmmmbLjbLiRsbLgbLibLcLsLsmmbLcbLebLibLeLeLebLcLsmbLsbLhLsb
LsLsmbLgbLsLsmbLsLsLsLsmmmbLgbLgbLgbLgLgbLiLgLoLsLsLcmmbLebLsLsLsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 38; Drug: PCAP2 1 然 Apo 50 然
bRibRibRiRhbRcbRiLsbRibRiRibRsbRiRsRimbRiRsmbLsLsmbRsbRiLsbRgRsRimbRsb
LsbLsbRiRsmbLsLsmbRsRsmbRjLsbRjLsRibRsbRibRibRjRsmbRhbRibLsbLsRsbLsbRh
bRjbLjbRibRhRsmbLsLsmbRhbsbLsbLsLsRsmbLsLsmbRibLsbRjbRibRjbRibsbLsLsmb
LsbRjRsRsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 39; Drug: PCAP2 1 然 Apo 50 然
bRsbRgLsbRsRgRsRgmbRsbRsRsRsmmbRsbRsbsbRsRsmbRgbRsRsmbRsRsRsmmbRsRsmbR
gRsmbLcbRgRsRsRsRsRsRsRsmmmmmmmbRsRsRsRsmmmbRsbRcLgbLoRsLsbRjbRsRsLsmb
RgbRsRgLsLsmbsbsbsbLsbRsRsmbRsRsmbLsbRibLsLsLsLsmmmbRgbLibRhbRsRsRsmmb
LjbRgRgLsbLhbRibsbLobLcbRoRsmbRgRebRsRsRsRsmmmbRjbLcbLobRibRcLsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 40; Drug: PCAP2 1 然 Apo 50 然
bRiRsmbRsRsRsmmbRsbRgRcRcRsRsmmbRsbRsRiRsmbRsbRsRsmbRsbRgLsbRgbRgbLebR
hbRobRobRhRsmbRsRsmbRiLsbRhbRgbLcbRhRsRsmmbRsbRgRsRsRsRsRsRsmmmmmmbRgR
smbRjbsbRgbRsbRgbRibLsRsbRsRgRsmbRgbRsRsRsmmbRgbRgLsbRebRebRebRebReRsm
bRibRcbRibReRsmbReReRsRsmmbRsRgRjRgbRibRgbRsRsReRgLsmbRibRsRsmbRsRsRim
bRsRsRsRsmmmbRgbRsRsmbRsRsRsmmbRgRsmbRgbRgRsmbRsRsmbRgRsmbRsRsLsLsmmbR
gRsRsRsRsReRsmmmmmbRgRsLsmbRsRsmbRgLsbRebLsRsRsRgRgRsRgmmbRebRsRsRgmbR
gbRsRibLgbLsbLsbRjbRiRsmbRsRsRsRgRsRgRsmmmmbRgRsmbRsLsbRgbRsbRiRsmbRsR
sRsRsmmmbRsRsRsRsRsRsRsmmmmmmbRgbRgRibRcbRhbRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 41; Drug: PCAP2 1 然 Apo 50 然
bsbLeLsLsmbLsLsLsmmbLiLsbLgbLsLsLsmmbLjLgLsbLgLsbRcbRobRcRsRsmmbLibLjb
LsLsmbLsLsLsmmbLsLsLgLsLsmmbLgLsbLcbLcLcbLgLsRsbLcbLsLsLsmmbLsLsLsmmbL
sbLebRsbLsLsmbLsLsmbLgbLobLsLsmbLcbLsLsmbLcLsLsmmbLsLsLsmmbLsbLebLcbLc
bLhLsbLgbsbsbLsbRsbLsRsbsbsbsbsbLgLsLsLsmmbLsbLsLsmbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 42; Drug: PCAP2 1 然 Apo 50 然
bLsbRhRsmbRcbRibRibLsLsLsLsLsmmmmbRjbRsbRiRgbRsRsRsmmbRsRibLsRsLsbRsRs
RimbRsLsbRcRgRsLoLsLsmmmbLgbRsRjbRcbRiRgRsmbRhbRsbRjRgRsRsmmbRiRgRgRsR
gRgRsRsmmmbRgbRjRgbRebRcRsmbRcbRebRcRgRsRsmmbRsRsmbRgRsRsmmbLsRsRsRsRs
mmmbRsRsRsRgmmbRibRgReLsRsRsmbRcbRiRibRsRsmbRgRiRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 43; Drug: Control Apo 50 然
bLsLsLsmmbLsLsLsLsLsLsmmmmmbRsbLsLsmbLsLsLsLsLsmmmmbLsbLsLsmbLsLsmbLcR
sLsbRcbRcLsbRcRsmbRgRiLsbRsbRgbRgbRiLsbRcRsmbRsLsLsmbLsbLsbsbLsbLsbLsb
LsLsmbsbLsbLoRsRsmbRobLsbsbLcbRcbRcbRebRebRgbRgbRsbRibRcbRebLibLgLsbLs
LsmbLgbLgLsbLibLgRsLsbLsbLgLsLsmbRjbRebRjRsmbRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 44; Drug: Control Apo 50 然
bLibLibLibLebLgbLibLibLgbRsbRibRibLjLhbLgLibLgbRgbLgLsbLgbLiLgLsbRsLgb
LgbRgbLgLsbLhbLsbRibRcbRibLsbRhRsmbRgbRgRgbRibLsRsReRsRsmmbRgbRhbLiLsb
LgbRjbLibLibLgbLgbLgLsbLibLgbLiLsLibLhLsbLgRsbRgbReRsRsmmbRgRebLiLsbRs
RsmbRgbLhbLibLsbLibLibLgbRcbLgbLjbRjbRibRgRsmbLcbLgRsbLebRsbLcbLiLgbLi
bLibLsbRjbRibRsRgRsmbRibRibRibLibRcbRhbLgbLibLibLiRsbLgbRebRibRibRhbRg
bRhbRhRebRgbRobRgbLibLibLgbLibLgbLibRibRgbRibRibLibRgbRsRsRsmmbRsRsmbR
sRsRsRgmmbRgRsmbRgbLsbRibRiRsmbLsbLcbLibLgbLibLibLsbLgLsbLiLsbRsRsmbLi
LsbLiLsbLgbLgbLgbRjbRibRgbLjbLebLhbRgbRgbRgRsRgRimbLgLsbRibRebRebRgbLi
bLjbLibLgbLgbLgbLgbRgbLibLgbLgbLebLgbLgbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 45; Drug: Control Apo 50 然
bLeLebReRsmbRhbRgRcbReRebRiRsmbRibRibLibLgRsbLgbRgbRibRgbRcRsmbLebLcbL
cLeLebRcRebRiRibRibRcbRebRgbRgLsbRibRcbLgbRoRsmbRebRiRebRgbRobRibLcbLi
LgbLhLgbLebLiLcbLebLgbLibRcRsRgmbReRsRsLsmmbRibRiRsmbRgbRgbRsbRgbRcbRg
bRibRobRcRsRgmbRgbLjLsmbRjbLjbRjRsmbRgRgbRibRiRsmbRiRsmbRebRhRsmbRgRsm
bRgRsmbRsRsmbRsRsmbRgbLibLcbLibReRsmbRhbRhRsmbReRsmbRebRibReRsRsmmbRhb
RgbLhbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 46; Drug: Control Apo 50 然
bRhbRgRgRgbRebRsRsmbRsbReRsReRgmbRibRibLsLsmbRhbRiRebLgbLsbRsLsLsLsLsR
smmmbLsLibLiRsbLgbLibLsbRsLsLibLgbLgLsbLgLsLsmbLebRibLcbRhRhbRibRiRgRs
mbRcRgRsmbRibRcbRiRsmbRsbLsLsmbRsRsRsmmbRsRsRsmmbRsRsRsmmbRsRsRsmmbsbR
iRsmbRgbRgbRiRsmbRsbRhbLsbLgbLgLsbLsbLgbLiLibLiLgLsbLiLsLibRibLeLsbLgb
LsRsLsbLgLsbLiRsbRsbRsRsmbRibRjbRiRgRgbRibLjbRgbLgLgbLsbLsbLgLebLobLeL
sbLjbRiRsmbLgLgbLibLsbLsLsLsLsmmmbLsLgLsbLibLgRsbLebsbLiRsbRsbRibLibRs
RsmbLebLebLjLsmbRjbLeLgbLiLgbLibLsbLebLhbRibRhbLibLhRsbLibRebLibLgLibL
hbLebLibLhbsbRibLjLjbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 47; Drug: Control Apo 50 然
bRjbLjbLsbLobLcbRebRhbRebRiRgbRibRgbRcbRiRsmbRcbRiReRsmbRcbRhbLiLsLibL
gLsbLcbLsbLcbLiLsbLibLebLiRsRsmbLibLiLsbLgbRcbRcbRcRsmbRiRsRembRcbRsbR
cRcRsmbRibLjbRcbLcbLeLgbLgbLibLcLibLebLgbRcbRcbRiRsRsRsRsmmmmbRcLsbRcL
sLsmbRjbRebRgbLobLcbRcbRcbRjbLjbLjbRibRhbRsbRcbRcbRjbRibRibLibLcbRjbRc
bRibRobLoLsLimbLibLcbLebLiLeLgbLibLhbRibLoLsmbLibLcbLhbLsLcLeLibLcbRcb
RebRcLsbRibRjLsbRiRsmbRhbLibLebLiLsLsmbRjbRiRsmbRgRsLsmbRcbRgRsmbLcbLi
LibLibLebLebLibLibLiLibLgbLebLobLeLgbLobLeLiLsLibRjbReRsmbLjbRobLsbRib
LibRjbRibLcbRsRjbLcbLibLsLjbRsRsmbLobRibRcbRjbRhbRcbRiRebRcbRhReLeLsbL
sbLcbLibLcbLibLcbLsbLiRsbLibLgLsbLibLsLiLsLgbLgbLgLsLsmbLiLgbLeLsLeLgb
LgbLobLgbRsRibRsRiRsRsRsmmmbRibRgRibRgbRiRibRebRgbRgbRcReRsReRsReRemmb
RibLobLiRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 114021; End: 114521;
Recording: 3-1; Individual: 48; Drug: Control Apo 50 然
bsbLsbRsRsRsmmbLibRebRobRgbLcbLibRjbRcbLcbLgbLibRcRsmbLobRgbRibLobLibL
ibLgbLebLgbLibLibLibLiRsbLgbRibRcbRjbRgbRibRcbRhbRibRibLjbLjbLibLcbLib
LgbLibLhbLcbRcbRcbLcbLjbLobLebRcbRcbRibRiRsmbLhbLcbLibLcbLsbRcbRcbRgbR
cLsbRcbRhbRibRcbLjbRjbRobRibRiRsmbRcLsbRobRsbLcbRibRcbRcbRcbLeRsbLcbLi
bLgbRhbRcbLibRhbLjbLhLsbRsLcRsLsbLgbRhLsbRcbRcLsbLgbLibLcbLcbLhbLibLcb
LgbRcbRibLjbRgbRobLibLiRsbLibLibLibLibLibLibLibLiRsbLiRsbLjbRcbRjbRcbL
ibRjbRcbRcbRibRcbRgbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 1; Drug: PCAP2 10 然 Apo 50 然
bRgbReRsmbsbRgRsmbRsRgRhRsmbReLgbRobRibRebRhbReRsReRsmmbRebRibRgbRsRsm
bRebLsRebRsRsmbRibRiLcbRhbLhbLgRsbLsbLibLsbRebRhLsbLsbRiRcbLgbRebLoLgb
LgbLibLgbLsRsbLgbLcRsLsbLhbRebRobLsbsbsbLsbLeLsbLhbLiLsbLhbLibRebRibRc
bReRsRsmmbRebRebRebReRiLsbLsbLobLobLiLhbRobRoLsbLcbLcbsbLsbLiLsbLeLsLs
mbRsbLsbLgbLibLhbRcbLhLsbLibLibLobLobRcbRhbLsbRebReRsLsmbRsbRebRsbLsbR
sRibRgbRgRsRimbRibRibRjbRibLcRsLsbLebLibLeLsbLibLiRsbLebLibLibRjbRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 2; Drug: PCAP2 10 然 Apo 50 然
bRcRsRsmmbLsRsbRsbRgbRcbRobLoRsRsmbRcbRiRsRsmmbRgRsRgmbRgbRsRsRsRsmmmb
RgRsmbRsbRhbRsbRibRoRsmbRcRsmbRsRsmbRcRsmbRcRsmbRgbRoRsmbRsbRiRsmbRsbR
gRgbLcbLcbRhbRobLcbLibLoRsRsRsmmbRgbRsRsmbRgRsmbRsRcbRibRibRhLsbRobLsb
RsbRsbRoRsmbLobLsLobRoRsRsmmbRoRsmbLcLsmbLoRgRsmbLoLsmbLsRsbRsRobLsRsR
smbLhbRobRsRsmbRsbLjbRgRsmbLobLgbLibRcbRsRoLsRsbLcbLsLsLsRsmmbLibLgbLs
LgbLebLebLebLibLebLebLeLgbLgRsbLibRsbRsbRsbRibRsbRobRgRsmbLsbLcbRcRsmb
LebLjbLsbLobRsRibRebLibRhbRibLjb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 3; Drug: PCAP2 10 然 Apo 50 然
bsbLsRgbLsbLgbRobLgRcbRoLsbRsRobLsbRsbRsbsbsbsbsbRsbRsbLsbLsLsmbRsbsbL
sbLsbLobsbRsLsbRsbsbLgLsbRsRsmbLsbLsbRjbLiRsbLoRsRsmbLcLsLgmbLgbLiLsbL
sRsbRgbLcbRibRgbRgbLsbRobLgbLcLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 4; Drug: PCAP2 10 然 Apo 50 然
bLsLsLsLsmmmbRgbRsbRsRgRsmbRsLsLsmbRsbRsRsmbRsRsmbRsRsmbRsRsmbRoLsbRhR
gbRsRsRsmmbRsbRsbLsLsLsmmbsbRsRsLsmbsbLsbsbRsLsbLsbsbLsLsRsRsmmbRsbsbR
ib

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 5; Drug: PCAP2 10 然 Apo 50 然
bLibLgLsbLgbLgbLhbLibLgLgbLibLibRsLibLgbLgbLsLibLiLsLsmbLibLibLgLsbLgb
LibRsbLgRsbLibLgbLgLgbLgbLgbsbsbsbsbLgbLgLgbLibLsLgbLgbLibLibLhbRsbLsL
iRsbLgbLobRgRsmbLiLiLsbLsLsLsmmbLiLjbLoLeLsbLsbLsLsLoRsmbLsLebRgbLgLoL
cLsmbRgbLcLsmbLsRsLebLgLsbLibLgbRsbLsLsmbRsbLsbLgbLjLobLiRsRibRgbRgRsm
bLsbLeLsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 6; Drug: PCAP2 10 然 Apo 50 然
bLsbRsbRsbRsbsbRsbLsRsbLgbLebLgRsbRcbRgLsLsLiRsmbLibLgbRsLsbLjbLeLsbLi
bLibLibLgbLgLsLeLsbLoLsmbLibLsLsmbLsbLsbRsRgbLcbRsbRsbRgRsRsmmbRsbLebL
ibLobLgbLebRgRebLcbRoLsLsLiLcLcLsmmbLiLsbRsbLjbRebLgbLeLjbRebLoRsRsmbL
sbLgLsbLebLgLsbRibRobRgbRsRgbLgbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 7; Drug: PCAP2 3 然 Apo 50 然
bRsbLsLsmbsbRsbLsbLgbLobLsbLgbLgbLsbLsLsmbLgbLsLsLsmmbLsLsmbLgLsbLsbLs
bRsbLsbRsbLsbLsbRsbLsbLsbLsbLsLsmbLsbLgbLgbLsbLsbRsbRsbRsRjbLjbLcRsbRs
RsmbLibRsbLsbLsbLsbLsLsmbLsbsbLsLsmbLsLsmbLsLsRsmbLgbLsbLsLsmbLsLsmbRs
bsbRsbRsRsmbsbsbsbLebLsLsmbLgbLgbLsbLsbLsbRsbLsbRjbLsRsLsbsbLsbRsbRsRs
RsmmbRsbRjbLiLsbLsbLsLsmbRsbLsbLsbRsbLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 8; Drug: PCAP2 3 然 Apo 50 然
bRcbRcRsmbLsLhLsLsLsmmbLsRsbLibLibLhLsLcbsbLiLsbLcbLsbLebLcbLebLgbReRs
mbRibRsRsRoLgmbLobRhRsmbRcRgbLhbLebLjLcbLgLsLsLsmmbLcLsLsLgLgmmbLcLebR
cRsRiRsRsRsRsRsRommmmmmbRcbRcbRibRsbRcRcLeLhbLcLsmbLcbLebLebLcLsmbLiLi
LsbLibRsbLiRsLsbLibLibLobLcLsmbRoRgbLsbRcbRhbLibRcbRobLoLsmbLsRsbLcbLi
LgbLeLhLcbLgbRcbRibRebLsLsmbLiLsbLgbRhbRcbRiRcbLibLsbRjRcRiRsRembLsbLi
bLebRcbLcLsmbLebLgbLibLobLsLsmbLcLiLsLibLsRcRsLsRcmbRcbRjRsmbReRsmbRcR
smbRcRibLibRsRcRgLsbRibRsRcbRcbRgbLiLhLibLibLgbLoLiRsbLebLiRgbRjRsmbRc
RgbRcRsmbLsLjbRcbRsRsRsRemmbLsbRsRgbRcbReRsmbRobLcLgbLibLsLgbLhLsbLibL
cLsmbLsbLhbLcbLgLsbLiLibLobLcbLiLibReRiRgbRgRiLsbLeLsbLsbRcbRcbRcbRcbR
gbLhbLobRjReRsmbRgRsRsRsmmmbRsbRebRcbLsLsmbRcbLiLsbLgbRoRsRsRsRhmmmbRc
RiReRsReRsmmbRsbRgbRcRebRobReRsRsmmbRjbRgRsmbLebLcbLgbLcbRjbLsLcbRsLgb
LcbLgLsLsmbLiLsbLiLsbLsLhbLsRjRsmbRibLebLcbLiLhbLgLeLsbLcbLeLsLiLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 9; Drug: PCAP2 3 然 Apo 50 然
bRebRcbRibLhLsbLhbLhbLibLibLobLgbLhRsbLobLhLsbLibLhbRhbRgbLjbLibLiLsbR
hbRiRsmbRhbRebRibRjRsmbRsRgRsRsRsmmmbReRsmbReLsbLsRibLsRiRgbReRsReRhmb
RibRgRgLsbRiRebRebRhRibRibLcbLibRcbRcbRhbRhbRobRebRiRsmbRibRhbRcbRibRc
bRhbRhbRcbRjbLgbLibLibLjbLibLgbLibLibLiLsRsbRgbReRsRiRsmmbRgbRiRsRiReR
smmbRebRebRebLgbRjRibLibLibLibLibLibLhbLcbRcbRibRibRgbLiLsbLibLebLgRsb
LgbLjLsLsRsmmbRibReRhbRiRsRsReRsmmmbRibLibRiRsRsmmbRebRibRgRsmbLobLibL
ibRobRibRcbLgbRibLjbRcRsmbRgRsmbRhbRibRjRsmbRsbRiRsmbRsRiRiRgbRebRiReb
RgbRibRjRibLsbRsRsReRsRgmmbRebReRsmbRebRiRebRhbLhbLibLgbLibLibLibLibLi
bLcbLibLhbLibLgbLibLibLibRgbRjbRibRibRebRibRhbRcRsmbRibRcbRibRibRiRsmb
LjbLjbRibRiRsmbLjbRgRiRsReRsReRsReRsmmmmbRebLsbRibLibLgbRjbRjRsmbRgRsm
bRgbRcbRibLibLiLsbLcbLhbRibLhLsLsmbRjRiRsmbRhbRiRsRimbRsbRibReRibRsRcb
LgbLeLsLgLsbRgbRjbRgbRebRobRhbRcbLebLhRsbLibLoRgbLibRobRibRcbRcbRibReb
LhbLibRibRiRsRgRgRgRgmbRibRiRsRgRsmmbRgRsmbLebRjRiRsmbLjbLsbRcRsRsRsmm
mbRibRebRhRsmbRsRgRsLsmbRebRsRibRgbRsRsRsRsRsRgReRimmmmbRsbRibLhbLjLsm
bLhbLgbRcbRcbRcbLibLibLobLgbLibLcbLibLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 10; Drug: PCAP2 3 然 Apo 50 然
bRsbLsbRsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 11; Drug: PCAP2 3 然 Apo 50 然
bRgRsmbRsLsbRsbRsbRsbRsbRsRsRsRsmmmbLsRsRsmbRsRsmbRgbLsRsbRsbLsRsbRsbR
sRsmbRgbLsRsbRgbRsRsmbRsRsRsmmbLsRsRsmbRsbRsRsmbRsbRsbRsbRsRsRsmmbLsRs
bRsbRsRsRsRsRsmmmmbLsRsbRsbRsbRsRsmbRsRsmbRsRsRsmmbRsRsmbLsRsbRgRsmbsb
RsbRsRsmbRsRsRsmmbLsRsRsRsmmbRsRsmbRsbRsRsRsmmbRsRsRsRsmmmbLsRsbRsRsmb
RsbRsbRsRiLsbLiLsbsbRsbLsRsbRsRsmbRsbLsbLsLsmbLsbLsLsRsmbRsbRsRsmbLsRs
bLsRsRsRsmmbLsRsbRsLsbLsLsLsmmbLsbLsRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 12; Drug: PCAP2 3 然 Apo 50 然
bRsbRsRsmbLsbLjbLhbLibRiRgRgRsRgRsRsmmmbRgRsRsRsmmmbRgbRsRsLsRsRsRgRsm
mmbRsbRgRsRimbLsbRoRsmbRgbRebRobRcbRibRcbRebLeLsbLibLhbLobLsbLibRcLsbR
iRgbRebRebRcbRibLsRebLobLibLobRgLsbLsLsmbLibLgbRiRsmbRsbReLsbRjbRgRsRs
RsRsRsRsRsRsRsRsRsRgRiRsmmmmmmmmmmmmbRsRsmbLsbRiRsRimbRsbRibRgbRibLcbR
ebRgbRjbRsbRebRgbRebRgbRibRebLibLibLobRhbRgRsmbRgbRiRsmbRibLcbLgbRsLcb
RgRiRgbRgRibRsRsRsmmbLsbRiRsmbReRsmbRsRgbRhbRsRsRsRiRsmmmbRhbRgLsbRgRs
mbLcbLcbLgbLgbRcbRhbRcbRibLgbRhbLcbLjbRsbLcbLibLibRjRsmbRhbRebRgbLcbLi
bLgbLoLsmbRebLjLcbLibLgRsbLsLsLsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 13; Drug: PCAP2 1 然 Apo 50 然
bLiLsRsbLeLgbRjbRjRsLsRsmbRsRsRsRgmmbRjLsbRiRhRsRgmbLsReRgRsmbLsbRgRsR
smmbRhRsRiLsmbLgLsbRhbRgbLsLsmbRiRsLsRsmbRsRsmbRcRiRibRhRsRsmmbRibRsbR
sRsRsRgmmbRibLsLgbsbLsbRgbRjLsbRgbLgLsbRsbRiRiLsRsRsmbRhRiRgRgbLsRsRsR
sRgmmbLgbRgbRhRsRgLsmbLgbRjbRibReb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 14; Drug: PCAP2 1 然 Apo 50 然
bRsRsLsmbsbLgLsbLeLiLiLsbLibLgLsbLiLsbLgLsbLibLiLsLebLhLsLhLibLibLiLsL
iLgLiLsbLgbLsLsmbRsbLiLgLsbLsbLsLsLsmmbLgRsbLgbLjLiRsbLgbLgbLgLsLsLsLs
LgmmmbLsbLsLgbLeLsLsLsmmbLsLsmbsbLgLgLebLsbLsLsLsmmbLgbLsbLgbLgbLgbRsb
LgbRsbLiLsbLgLsLsRsmbLgbLsbLsLsLsmmbLebLiLsLsmbLeLsLgbLsbLgLsbLiLgLgbL
gLgbLgLgLsbRsbLsbLgbLibLsLsmbLgLsbLsLsLsLsLsmmmmbLgbLibLiLgbLiLsbLiLgL
sLhLsbLgbLeLebLebRsbLsLebLhb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 15; Drug: PCAP2 1 然 Apo 50 然
bLjbLebLcbLhbLgbLebLibLebLebLcLsmbLibLhbLebLebLebRibRcbRsbRgbRjRgRsmbR
hbRgLsbRgbRcbRsbRjbRhbRebRsbRgRsmbRobLeLsbLiLsbLhLcbLebLeLsLgLsbLebLiL
sbLibLibLebLibLebLibLcbRsLsbRiLsbLoLsLsmmbLebLsbLiLsbLebLgLsbLcbLobLeb
LhLsbLhbLibLebLibLoLsmbLeLsLsmbLiLsbLsbLcbLibLeLsbLjbLsLsmbLhbLgLsbLeL
sbLeLgbLebLibRcbRibRcLsbLsbRobRiRsmbRgbRhLsbRibLgLsbRhbRgbRibRgbRgbRgR
sRsLsmmbRgbRgbRibRibRibRgRsmbRiRgRsRsmmbRiRgRgbRibRiRsRsRgRgmmbRibRebL
obLhLsbLcbLhbLiLsbLibsbLcbLibRibRebRiRsmbRiRsRsRsRsmmmmbRiRsmbRgbRgbRg
RsmbRibRsbRibRhRsmbRiLsbRjbRgbRiRsRsRsmmmbRiRgRsmbLgLsbLsRhRcbLgLsbRgb
RobRsbRjRsmbLjbRibRibRcbLibLgbLhbLcbLibLjLibLgbLjbLcLsmbRibLebLhbLebLi
bLgbLeLsbRgbLibLibLhbRsRcbRsbLebLibLcbLjLsmbRcbRibRhbRebRcbLsLsmbRibRg
LsbRgRsmbRibRgbRgbRiRsmbLcbRhLsbLcbLcbLibRobRjRsLsmbLhbLcbRgbLsLibLcbL
hbLcbLcLsmbLcbLcbLibLebLcbLcbLeLsbLiLsbLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 16; Drug: PCAP2 1 然 Apo 50 然
bRiRsRsRsmmmbRibRibReRsmbLjbRhbLobRcbLebLcLsmbLebLeLsbLibLcbLebLebLebL
cbLjLhbLibLgLsLebLsbRibRgbRibRcbLsbLebRibRgbRibRhbRiRgbRebRgRsmbRgRsmb
RgbRibRcbRgbRibRgbLebLcbLebLcbLiLibLebLebLibRcbRiRibRgRsmbRgRsmbRibLsb
RibLsbRgbRgRsmbRibRoLsbRsbLibLibLgLgLibLgLsbRsLsRsbRsbRhbRebRgbRibRobR
sbLebLjbRcbLibRjbRiRsmbRibReRsmbRsRibRgbLsbRebRebRhbReRsmbRsbLiLgbLhbL
jbLibLebLjbLebRgbLjLhbLcbLgbLgbLhbRsbLebLibLgLgbLsbRcbLibRiRebRhbRgbRg
bRgRsRsmmbRsRsmbRibRibRgbLgbLebLebLebLgbLcbLgbRcbLcbLjLgLsLsmbLebLiLsb
LebLgLsLgLsLsmbLibLsRsbLcbLgbLgLhbLebRhRsmbRgbRibRibRibRsbRgRsmbRibRgb
RibRgRebRgbRsRsmbRjbLibLcLsmbLiLsbLiLgbLsLsmbLsbLebLeLsLsLimbLgbReRsmb
LeLsbLcbLebLgbLgLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 17; Drug: PCAP2 1 然 Apo 50 然
bRhbRcRiRiRsRhmbRiRsmbLcbLeLsbLibLsbRibLcbRcbRgRsRembRsbRibRoLsbLhbLcL
sLsmmbLeLcLsmbLiLcbLgLcbRiRsmbRobRibRcbRibRgbRobLcRsbLobLcbLibLibLgLsb
LcbLcbLhLeLhbLgLsLiLgLgbLibRobRobRgbRebRibRgRiRgbRibLcbLibLiLsbLhbLhLs
bLiLcbLcLsLhLeLimbLiLsbLgLebRgLsLsmbRjbLcbRobRiRsmbRibRibRobRobRcRsmbR
ebsbRibRcRcbRcRhbRibRiRsmbRsbRcbRcbRhbRhbRgbLebLcbLebLhLsLhbLhbLibLcbL
cLsmbLebLebRobRcbRhRsmbRgRsmbReRebRhbRibLcbLibRibRibRgbLjbLcbLcbLebLcL
smbLhbLhbLcLsmbLhbLebLibLgbLibLcbLibLibLibLibRhRsmbLibRgbLcLsmbLcbLgbL
cRgbRhbRibLcbRsbRobRiLsRsRibRgLsbLjbLcLsmbLibLeLsbLibRcbRgbRgRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 18; Drug: PCAP2 1 然 Apo 50 然
b

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 19; Drug: Control Apo 50 然
bsbsbsbsbRsbsbsbsbsbsbRsbLjbLsbRibReRsmbRsbRibLsbLcbLiLsbLibRgbRhbRhbR
iLsbRgbRsbRsbRsRsRsRsmmmbRhbLsbLgbRiRsmbRibReLsbRsbRgbRsRsRsmmbRsRsmbR
sLsbsbLsbRcRsRsmmbRibRibRsbRibRhbRgRsmbRibRgbRobRgbRsLjbLcbLibLibLgLsb
LgLsbLjbLsbLibRebRebRsbRibRjbRgbRhbRgbLgLsbLibLjbRsbRebRsbRgbRebRibsbs
bRgRsRgRsmmbRsbRgbLsbRiRsmbsbRsbRsRsmbRcLsbLcbLibLibRjbRiRsmbRhRsmbRgR
smbRsLsbRhbLgbRjRsRsmmbRhbRibLcbLobLhbLhLsbLibLgRsbLcbLgbRsbRebRhbRibR
iLsbRgRsRsRsRsmmmmbRgbRibLgbLjbLiLsLsLsLsLsLsLsLgmmmmmmbLibLibLhbLibRi
bRjbRiRsmbRibRgbRgbLjbRibRhbLsbRibRibRiRsmbRgRsmbRgbRgbRgbRibRcbRgbLhb
LibLgbLgRsRsmbRibRhbRibRgbLsbRhLsbRibRiLsbRgbRgbLsbRibRgbRibRibRgbRgbR
ibRsbLibRebLjbLibLiLsLsmbLiLsLsLsLgmmbLsbLgbLibLgLsLsLsmmbLsLgbLgbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 20; Drug: Control Apo 50 然
bLibLgLsbRibRibLsbReRsmbRsbRgReRsRsRsRemmmbLsbLebRsRsmbRgbRgbRjLgRsRsL
sRsRsRsmmmbLibLibRjbRibLjbLjbRjRsmbLsbLjbLiLgbRsLsLsLgmbLjbLibLibLhbLh
bLsLsLgmbRcbRibRgbRjbRhbRgRsmbRiRsRgRsmmbRiRibRgbRgbRibLgbRibRgLsbRibL
ibLebLiRsbLiRsbLebLebRsbLgbLgLsLebLebLcbLcLsmbRgbLebLgLibLebLebRcbRibR
gbRgbRsbRgRsmbLjbRgbLsbRgRsLsmbLeRsbLibLgLsLsmbLgbLhbLebRibRibRgbRgbRh
bRcbLgLsbLsbRsLsLgLsbRsRsmbRgRsmbRgbRsbRgbRibRgbRgbRgRsmbLgbRibRobRgbR
sbLibLgbLgbLgbRjbRgLsbRgbRgRsmbRgRsLsmbLhLgLsLgbLibLgbLebLgbLcbRibRhLs
bLgRsbRibRjRgbLgLsRsRsmbRgRsmbRibRibRhbRhbRiRsmbRgRsmbRsRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 21; Drug: Control Apo 50 然
bLcbLiLhLsbLhbLhbLiLgLeRsbLgLsbLgLebLgbRsRsmbLibLsbLcLebRcRsRsRsmmmbRi
RsRsRsRsRsRsRsRsRsRsmmmmmmmmmmbRsbLjbLibLsbLibLiLsLsmbLcLsmbLjbLobLhbL
ebLgLsbLcbLebLeLhLsbLibRsRsmbRcbRcbRiRsmbRiRsmbRsRsRsmmbRgRsRsmmbRjbLj
bLsbLcbLibLgbLiLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 22; Drug: Control Apo 50 然
bLibLsRsRsLsRsmbLiLsbLsbLebsbLhbRcRsmbRibReRhReRgRsRiRsRgRsmmmbRiRsmbR
ebLhbsbLcbLgbLgbLgLiLiLsbLebLhbLiLiLsbLiLsLsmbLgbLibLsLsmbLgLsbLcbRebR
eRiRgbRiRsRsmmbRgRebLebLebLeLsbLebLcbLebLebLsLebLebLgbRsbLsLsmbLsbRjbR
sbRibRcRoLgbRcbRcbRiLsbRcbRcbRcbRiRsmbLsRebRebRebRiLsbLiRsbLiLsLsmbLsb
RsbLsbLgLsLsmbLebLebRsRsmbsbRsbLsbRsbLsLsmbRsbLsbRsLsbRsbLsbRsbRsbLsbL
sbLsRsbLsbRjbRibLcLebLsbRjbLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 23; Drug: Control Apo 50 然
bLsbRjbLibRhbRibRibLsbLhbRibRcLsbRsRibRebRibRibRsbRgbLjbLibRjbRjLsbRgR
gRibRibRibRhbRibLsRsbLjbRibRgbsbRgbRsbRhRsmbRhbLhbLebLibLiLsbLgbLgbRjb
ReRsmbRibRgbRgbRebRsbRgRgbRgbRebRgbRoLsbLobLiLibRjbLsbRobReRsmbReRsmbR
ibRhbRcbRibRibRgLsbRcRsmbLjbRcbRgbRibRgbLobLgbRhbLcLiLsbLgLgLibLgbLibL
gLibLgLsbLgRebRhbLjbRiRsmbLcbLobLgbLibLibLibLibLhbLebLibRjbLcbLhbLeLeL
gLsbLiLsbLebLebLgRsbRhbRcbRibLibRhbRibRibRibRcRsRhRsmmbRsLsbLcbLobLibR
gbLibLibLgbRibReRsmbLsbRgLsbLsbRibRebRebRibLsLgbLsbsbRiRsmbRgbRgbRibRi
bRgbRibRgbRibLcbLibLcbLiLsbLibLibRobRibRibRsbRgbRjRgbRgbRgbRjbRsbRjbRi
bLjbLjbRjbRjbRibRjbRcbLhbRjbRcbRgbRjbRgbRgbRsbLgLsbRibLibLcbLibLgbLsRi
bLhbLhbLsbLhbRgbRjRsmbLibLoRsbLhbLgbLibRhbLgbLibLebLibRgRsmbLibRjbRhbL
jbRhbRibRgLsbRcbLibRoLsbRiLsbRsbRiRsmbLjLsmbRjbLjbRsbRgbRcbRibsbLcbRcb
LcbLhbLiLebLgbRjbLgLsbRjbRiLsbRob

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 24; Drug: Control Apo 50 然
bRgRsmbRjbReRsmbRsbRcbRcbRiRsmbRhRsRsmmbRibsbRsbsbsbsbRsbRiRsmbLcbLcRs
bLcLsLimbLsbRjbRebRiRsmbRgRiRibRcbRjLsbRgbLsbRgbRsRjRgRsmbRcRsmbRibRcb
RgbRhbRibRgbRiLgbLjbLjbLcbLibRebRibRiRsmbRibReRsmbRibRibRibRobLiLgbRib
RiLsLgbLhbLgbRcRgbRsbRiRiRsmbRgbRebLcbLcbLhbLcbLsbLsbLeRsbRsbRsRiRsmbL
cbLebLsbLcbLcLsmbLgLjLcLsmbLibLibLcLsLsmmbReRsRsmmbRiRgbRibRhRsmbRiRsR
imbLsbLsLsmbsbLjbRiRsmbReRsmbRjReRsmbRibRgRsmbLjbLgbRibRgRsmbRsRsmbReb
LgLgbLjbLjbRcbLhLsbLhbLibLebLibLibLiLhRgbLcbLiRsRsmbLsRsbLgbLibLcbLhLs
bLhLsbRibRcbRibRibRibRgRiRgRsLsRimbRgLsbRiLsRiRsmbLsbRjbLsbRjbLsbLhbRc
RsmbRcbRibLcbLibLibRcbRibRgLsbRiRhbRiRsmbRiRgbRgbRebLjLsmbRhLsbLibRhbR
iRsmbRebRibRebRebRhbRebLibRsReRsmbRebRjLsbRibRjbLsbRibReRsmbRiRsmbLsLh
bLgbRhbRiRsmbLjbRibRibRgbRsbLibLcbLgLcLsmbLgRsbLiLsbLsbLsRsbsbLsLjRsbL
ebLibLgbRjbLjbLjbLhbLcLsmbRsRibRibRcbRjbRibRiRiLjbRibRhRsmbLjRsbLgbRjb
LjLsmbLgLhbLgbLjbLjbLibLjbLibLsbLibLiLibLibLibLibLiLsbRsbLibLsbLibRjbL
ibRibRjbRcbRsbRibRiLsbLhbLcbLiLibLiRsbLgRsbRibRibRhRgbRibRjbRgbRiRsmbR
ib

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 25; Drug: PCAP2 10 然 Apo 50 然
bRgRsmbLsbRsbRsbRgbRibRsbRsRsRgRsRimmbRsbRgbRcbRsRsmbLsbRjbRobLhLsbLeb
sbsbsbsbRsbLsLsmbLsbsbsbsbLsbLsbLsbRsbRsbRsbLsRsbLsbsbLsbRsbsbLsbLsbsb
LsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 26; Drug: PCAP2 10 然 Apo 50 然
bRsbRsbLsbRsbRsbRsbRsLsbRgbRgbRsRsmbRsbRiLsLsmbRgLsbRibRgbRgbRgbRsbRsR
smbRsRsmbRsRsmbRgLsbRgbRsbRsbRoLsbRgbRsbRgbRgbRsbRsbRgbRgRsmbRgbRgRsmb
RsbRsRsmbRibLsbsbRsbRsbRibRgbRsbRgRsmbRsRsmbRsRsmbRgbRgbRgbRsRsmbRsbRs
bRsbRsRsmbRgbRgbRgbRgRsmbRgLsbRgbRsRsmbRsbRgRsmbLebLsbRibRobLiLsbLsbLs
bLsbLsLsmbLgbLgbLsbLsLsLsmmbLsbLgbLsbLgbLsLsmbLgLsbLsLsmbLgbLsbLsLgbLg
bLsRsbLsbLgbLsbLsLsLsmmbLsLsmbLsbLsbLsLsLsmmbLsLsmbLsLsmbLsbLgRsRsRsmm
bsbLsbLgbLsLsmbLgbLsbLsbLsLsmbLgbLsLsmbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 27; Drug: PCAP2 10 然 Apo 50 然
bRsRsmbRsbRsRsRsRsRsRsmmmmmbRsRsLsmbRsbRsbRgbRgRsRsRsmmmbRgRsmbLgLsbRg
RsRsmmbLgbLsLgLsbLibLgLsbLebLibLgLsbLibLsbLsRsbLsbLsLgbLsbLsbRsbLsLsmb
RibRgbRjbLsbLgbLsLsmbLsLsmbLsbLgbRsbLsbLcbRsbRsbLsbLsLsLsmmbLsLsmbRsLs
RsbLsLsLsmmbLsRsbLiLsbLsLsLsLsmmmbRjbLsbRjbRibLoLsmbLiRsbLibLhbLsLsLsL
smmmbLsRsbLsLsLsmmbsbRsRsmbsbRgLsbRsLsbLsLsLsmmbLsLsmbRsLsbLgbLgbLsRsL
sbRsLsbsbLsbsbRsbLsbsbsbsbsbRjbRsbLjbRjbRcbRiRsmbRsRsmbRsRsLsmbRsbRsbR
sbRsRiRsmbRsRsRsmmbLsbRgbRgRsmbLsbsbRsbRsbRsbRsRsRsRsRsRsmmmmmbRsbLgbs
bRgbRgbRsRsmbLsbRsRsmbRgbRsRsRsmmbLsRsbRgRsRsRsmmmbRsRsRsRsmmmbRsRsRsm
mbLsRsbRsbRsRsRsmmbRgbRgRsmbLsLsRsmbLsRsbRsRsRsmmbRsbRgbRsRsRsRsmmmbRs
bRsbLsbRsRsRsmmbRsbsbRsbRsbRsRsRsRgRsmmmbRsbRsbLsbRsRsmbRsbsbRgRsmbRgR
smbRsbRgRsmbRsbRsbsbLsRgRsmbRsLsbLsRsbRjbRsbRsbRsbRsbRiLsLoRibRibLibLo
bLhbLoRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 28; Drug: PCAP2 10 然 Apo 50 然
bRiRsmbRgLebRjbLibRcbLiLsbLibLgbRsbRsRsRsLsmmbRgbLsbRgbRsbRsLsbRjbLsLg
bRgbLgbRgbRebsbsbLsbRsbRiLsbLgRsRsRsRsmmmbRsLsRsRsRsRsRsmmmmbRsRsLsRgm
bLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 29; Drug: PCAP2 10 然 Apo 50 然
bRsRsmbRgRsmbRsbRsRsRsRsLsmmmbLsbsbRibLsbRiLsLsmbRsbLsbLsbRibLsbLjbLgb
LsbRoLsbLsbRsbRsbsbRhbRcbLjLsLsLsLsmmmmbLsLsmbRgRsmbRsbRsRsmbRgbRsbRsR
sLsRsmbRsbRgbLsRsbLsRsRsmbRsRsRsmmbRsbRsRsRsmmbRsbRsbRgbLsLsmbsbRsbRsR
sRsmmbRibRsbRsLsbRsbRsbsbRsbRgbRsRsmbRsRsmbLsbRsRsLsmbRsbsbsbRiRsmbRsb
LsRsLsbLsLsmbRsbRsbsbRsbRsbRsbRsRsmbRsRsmbsbRsbRsRsmbLsRsbRsbRsbRsRsmb
RsbRgRhLsbLsLsmbLsLsmbRsLsbsbRsbRsbRsLsbRsRsRsmmbLsLsLombRsbRhLsbRsbLs
bRsbRibLsLsmbLsLsLsmmbRsRsmbRsbLsbRsRsmbsbLsbLsbsbsbRsbRsRsmbRsbRsRsLs
mbRsbRsbRsRsmbRsbRsbLsbRsRsmbLsbRsRsmbRsbLsbsbRcbRsbLsLsLsLsLsmmmmbLsL
smbLsLsmbsbsbsbRsLsbsbLsbLsLsmbRsLsbsbLsbLgbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 30; Drug: PCAP2 10 然 Apo 50 然
bLsbRiRsmbReLsbRibRcbLcLsmbRhRsmbRgRsRsmmbRobLhbLcbLsbsbRsLsbRsbsbsbLs
bRsbLsRsbRhbRsbLcbLgbRsRsmbRjbsbRhRsmbRcbRsRsmbRsRsmbRjRsmbRgbRsRsRsmm
bRgRsmbRsbLgbRiLsbRsRsmbRsRsmbRsLsbRcbRcbRsbLjLsmbRcRsRhRsRsmmmbLgbRgb
RsbRsRsLsmbRsRgbsbRgbRiRsmbRgbRebRebLobRiLgRsbRsbLebLoLobRsRsmbRsbLcbR
cbRibRgRsRembRebLibLcbRibRsRsmbRsbRsbRgbRsbLjbLcbRjbRebRgbLsbsbsbsbRgb
LjbLsbRgbLebLgbsbLibLsbsbLoRsbRsRsmbsbsbRsRsRsmmbRsbRjRsmbRobRhRsmbRiR
smbRoRsmbRsbsbLsbRiRsmbRsRsmbRhbLsbLsbsbLcLgbLjbRcRgbRobsbRoRsRsLsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 31; Drug: PCAP2 3 然 Apo 50 然
bRsRsmbRsbRsRsmbRsRsRsmmbRsRsmbRsRsmbLsRsLsbRsbsbLsbRsbsbRsRsmbsbRsRsm
bLsbRsRsRsmmbRsbsbRgbRsLsbRsRsmbRsRsmbRsbLsLsmbRsbRsRsmbRsbRsRsmbRsRsm
bRsbRsbRsRsmbRsRsRsmmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 32; Drug: PCAP2 3 然 Apo 50 然
bRsRsmbRsRsmbRsRsmbRsRsmbRsRsRsmmbLsbsbRsRsRsmmbRsbRjLsbLjbLibLsbLgbLg
bLgbLgbLgbLsbLgbLsLsmbLsLsmbLgbLgbLsbLsbsbLgLcLsmbLjLgbLgbRsbLsbLsbLsb
LsLsLsmmbLsbLsbLgLsbLsbLgLobLiLgRsbLibLibLiLsRsbLgLiLgbLsLiLsLebLcLsLs
mmbsbLsbRsLsbRsbRsRsmbRsbRjRsRsmmbLjbLibLibLgbLgbLsbLsbLsLsmbLsbLsbLsL
smbLsbLjbLgbLgbLibLgbLgbLgRsbRsLsLsmbLsbLsbRsLsbLgLsbLsbLsLsLsLsmmmbRc
bLebLgbLgbLgbLgLgbLsLgbLgLsLsmbLgbLgbLsLsmbLsLsLsmmbLgbLgLsbLsLsmbLsbL
sbRsbLsbRsbLsbLsbLsbLsbLsLsmbLsLsmbLsbRsbLiLsbLsLsLsmmbLsbLsbLgbLsbLsL
sLsmmbLsLgLgbLsLsmbLgbLgbLsbLsbLsbLsLsmbLsbLsLsmbLsbLsbLsbLsbLsbLgbLgb
LsLsmbLsLsmbLsbLsbLsLsmbLsbLsbLsbLsbLgbLsbLsLsLsmmbLgbLsLsLsmmbLsbLgbL
ibRsbLsLsLsmmbLgbLsLsLsLsmmmbLsLsLsRsmmbLsLsmbLibLjLsmbRsLsbLsLsLsmmbL
gbLgLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 33; Drug: PCAP2 3 然 Apo 50 然
bRsbsbLcbRcbRcbLsbRsRsmbLibRcbRhRsmbRgRgbRgRsRsmmbRsbRgRsLsRgmbRsRgLsb
RsRsRgRsLsRgRsmmmbRsbRcLsRsLsbRjbRcLsbRsbRsRsmbRsbLsbRsbRibRjRsmbLsLsm
bLsLhbLiLsbLsRsbLiLsLeLsbRcRsmbLsRsbRsRsRsRsRgRgRsmmmmbRgRsmbRgbRgbRsR
smbRgbRsRgbLsLsmbRhbLgLsbRsLsbRsLsbLhbRgbRgbLcLcbLgbLibLcLsmbRgbsbRsRs
RsRsRsLsmmmmbsbLibLcbLsbLsbRibReRhLsbLibLsLiLsbLsLsLsLeLsLimmbLcLcbLgL
gbLiLsLhLsLsmbLgLsbLgbLsbLjLiLgbRobRibRcLsbRiLsbLgLsLsmbLsLsLsmmbLcLcb
RsLebLibLsLgLsbLiRsbLcLsmbLcLsLsmmbLsLsmbLsbLsbLsLsLsLsLsmmmmbLcLhRsbL
cLiLsLebLhLsLeLiLeLeLsLsLsmmbLcRgRsRsmmbRhbLeLsLsLsmmbLgbLgLsLsLsmmbLs
LsLsmmbLgLsbLsLgLsbLgLgbLsLsmbLgLgLsLgLsbLhRgRgbLibLgRsbRsbLjRsbLibLob
RsRsmbRcLsLsLsLsmmmbLibLibLgLsbLsLgRsbLgLsLsmbLsLsmbLsLsLsLsLsLsmmmmmb
LgbLsbLsbLsLsmbLgbLsLsmbLcbLcbRsLsLsmbRjbRiRsmbRsLsbRiLsbLhbLcLsLsmmbR
sLsLsmbLsbLsbRsbsbsbRcLsbLsbRiLsRsbLsbRsbLjb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 34; Drug: PCAP2 3 然 Apo 50 然
bRsRsmbLeLgbRsbLsbRsLcbLgRsRsmbRgbRsRsRsRsmmmbLsRsbRsbRsRsmbRsbsbRsbRs
RsRsmmbRgbRiRiRsRhRsmmbLsRsRsRsmmbLsbRsRsmbLsbRsRsRsRsmmmbRsRsmbRsRsRs
mmbRsRsLsmbRsbRsRsmbRobRibRcbRsbRgRsRsRsmmmbRsRgRsRsRsRgRsmmmmbRgRgbsb
sbRsbRsRsmbRsRsmbRsRsmbRsbRsbsbRsRsmbsbRsbLsbLsbRsbLsRsRsmbRsRsmbLsRsb
RsRsRsmmbRsbRsRsRsmmbRsbRsbRsRsRgmbRsRsmbRgbRsRsRsmmbRsRsmbRgbRsRsRsmm
bRsRsRsRsmmmbRsRsRsRsRsmmmmbRsRsmbRsbRsRsmbRsLsRsbLsRsRsmbLsRsRsmbRsRs
mbRsbRsRsmbRsbRsbRsbRsRsmbRsRsRsmmbRsRsRsmmbRsbsbRsRsRsmmbLsRsbLsRgRsm
bRsRsRsRsRgRgmmmbRsRsRgmbLsRsRsRsRsmmmbLsRsRsRsRsmmmbRsRsRsmmbRsRsRsmm
bRsRsmbRsbsbRsbRsRsLsmbRsbRgRsmbRsRsRsRsRsmmmmbLsRsRsmbRsbRsbLsRsbRsRs
mbLsbRsRsmbRsRsRsRsmmmbRsbRsRsRsRsRsmmmmbRsbRsRsRsmmbRsbRsbRsbRsbRsbRi
bRcRsRsLsmmbRgRsRsRsmmmbRsRsRsRsRsRsmmmmmbRsRsRgmbRgRsRsmmbRgbRsRsmbRs
RsmbRsRsmbLsRsRsRsmmbRsRsRsRsmmmbLsRsRsRsRsmmmbRsRsRsmmbRgbRsRsmbRgbRs
LsbRsbRgRsRsRsRsRsmmmmmbRsRsmbRsRsmbRsRsRsRsmmmbRgRsmbRsRsRsmmbRsRsmbR
sRsmbRsRsRsRsmmmbRsRsRsmmbLsRsRsmbLcbLibLgbLgRsRsmbLgbLsLsLsmmbLsLsLgL
gmbLsLsLgLsmbLsLsmbLsLgLsLsLsmmbLsLsLsLsmmmbLgLsbLgLsLsmbLsLsLsLsmmmbL
sbLsbLgLsLsLsLsmmmbLsLsmbLsLsLsLsLsmmmmbLsLsmbRsLgLsLsmbRsLsbLsLsLsmmb
LsLgbLgbLsLsLsLsmmmbLsLsLsLsLsmmmmbLiRsbLgbLgLsLsLsLsLsLsLsLsLsmmmmmmm
mbLsLsmbLsLsLsLsLsLsmmmmmbLgbLgbRcRsRimbRsbLsRsRsmbRgbRsbLsRsRsRsRsRsR
smmmmmbRsRsmbRsRgRsmbRsbRsRsmbRsbRsRsRsRsLsmmmbRsRsRsRsRsmmmmbLsRsRsRs
RsmmmbRsRgRsmbRsRsRsRsRsRsRsmmmmmmbRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmbRs
RsRsmmbRsbRgbRsRsRsRsRsRgRsmmmmmbRgRsRsRsmmmbRsRsRsRsRsRsRsRimmmmmmbRg
bRsbRgbRsRsRsmmbRsRsmbRsRsRsmmbLsRsRsRsRsRsmmmmbRgRsmbRsRsRsRsRsmmmmbR
sRgbRsRsmbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 35; Drug: PCAP2 3 然 Apo 50 然
bRgbRgbRgbRgRsmbRgbRsRsmbRgbRgbRgbRgRsmbRgRsmbRsRsmbRsbRgbRgbRgLsbRsbR
sbRsbRgRsmbRgLsbRsbRsbRgbRgbRgbRsRsRsmmbRgbRgLsbRgbRsbRsbRgbRsRsmbRsbR
gbRsbRsbRgbRsbRsRsmbRgbRsbRsRsmbRgRsRsmmbRgbRsRsmbRsRsmbRgbRgRsmbRgbRg
RsmbRgRsRsmmbRgRsmbRgbRsbRgbRsRgRsmbRgbRgRsRsmmbRgRsLsmbRgbRsRsmbRgbRs
bRgbRgbRgbRgbRgbRgbRsbRsRsmbRsRgLsbRgRsmbRsbRsbRgbRgbRgRsmbRgbRsbRgLsb
RgRsmbRgbRgLsbRsbRgbRgbRgRsmbRsbRsbRsbRsRsRsRsmmmbRsbRsRsmbRgbRgbRsbRs
bRgbRgbRgbRgRsmbRsRsRsmmbRsRsmbRgRsmbRgbRsbRgbRsRsRsRsmmmbRgbRsbRgbRgb
RsbRgLsbRsRsRsmmbRgbRgRsmbRsRsRsmmbRsRsmbRsbRgLsbRsbRsRsmbRsRsmbRsRsRs
mmbRsbRgRsmbRgbRsLsRsbRgbRgbRgbRgbRgbRgbRsRsmbRsRsLsmbRgRsmbRgbRsLsbRs
bRsbRsbRgbRgbRsbRgbRsbRsRsLsmbRgbRsRsRsmmbRsRsmbRsRsmbRsRsmbRgRsmbRsbR
gbRgbRsbRgbRsbRgbRsRgbRsbRgbRgbRgbRgbRsbRsbRsbRsRsmbRsLsbRsRsRsmmbRsLs
bRgRsmbRsRsRsRsmmmbRsRsmbRgbRsbRsbRgbRgbRsbRsbRsbRgRsmbRsbRgbRsbRsRsmb
RgRsmbRgbRgRsmbRgbRgbRgRsmbRsRsmbRsLsbRgRsmbRgRsmbRgRsmbRgRsmbRsRsmbRs
bRsRsmbRgbRgbRsbRsRsmbRsRsmbRsRsRsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 36; Drug: PCAP2 3 然 Apo 50 然
bLsbLsbRobRsbsbRsbRsbRsbLsbLsLsmbsbLsbsbsbRsbRsRsLsmbRsRsLsLsRsLsmmbLs
RsbLsbLsbRsbsbsbsbsbsbsbsbsbsbRsbRsbsbLsbsbLsLsmbLsLsmbsbLsbLsLsLsmmbR
sbLsbLsbLsbLsLsmbLgbLsbLsbRsbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 37; Drug: PCAP2 1 然 Apo 50 然
bLsbLgLsbLgLsbLgLsbLibRhRcRsmbLsbLsRsbLsLsLsmmbLsLsRsmbRibLobLhbLebLgb
LhLebRsLeLsbLsbRjbLjLsmbLgbLgbLgLsbLibRjbRcRsLsmbReRsRiReRsmmbRcbRsRcR
ebRcRebRgbRgbLgbRsRsRsRemmbLcbRcRsmbRhbRcRcbRiRsmbRebRgRebLsLgbRsRgLsb
RhRsRsmmbRhbReRsmbReRebRiRsmbRiRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 38; Drug: PCAP2 1 然 Apo 50 然
bRiRsmbLjbLiLsbRsbLiLsbRsLsbRsLsRsbLhbLiLsRsbRsLsLsmbRsLsbLgbLjLsmbLsb
RsbRsLsbLibRsLsbLsbsbLiRsbLsLsmbLsLsmbLjbLiRsbsbLsLsmbLsbLsbLhRsbLsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 39; Drug: PCAP2 1 然 Apo 50 然
bLebLgbLibLsLsmbLsLsRsmbLibLsLgbLgLsbLsLsmbLgbLsbLiLsLsLsLgLsLsmmmbLsL
sLsLsmmmbLsLsLimbLgLsLsmbLhbLcbLcLsmbRcbRcRsmbRibRoRsmbRobRcReRsmbRsRs
mbLsLsmbRcRsmbLhbLobLcRsbLcbLgLsRsbLcbLobLcbLibLiLgLiLsbLhRsbLsLsLsLsL
sLsLgLsLeRsLsmmmmmbLgLsbLibLiLsbLgLsLsLsLsLsmmmmbLsLsLsLsmmmbLgbLgbLgL
sbLsLibLibRsLsbRcbRibRibRibRibRibRibRcbRibRsRsmbRibRebLcbRcbLobLcRsbRi
bLjLsmbLsbLcbLcbLcbLgRsbLeLsRsbLibLgbLibLiLsbLibLobLgbLgbLgLgLsLgLgLeb
LhRibRcRsmbRgbRgbLhbRibRcbRgRsmbRhbRibRhbRibRiRsmbRiRsmbsbRsbLsLsmbLgL
sbLsLsLsmmbLibLgbLsbLhRsbLobLobLobRebRiRgRsRiRemb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 40; Drug: PCAP2 1 然 Apo 50 然
bLibRobLcLsmbLibLcLsRsmbLcbLcRsbLebRhbRoRsmbRgbRibRhbRgbLebLgLsLgLsbLs
LsmbLsLiLgLhbLsLsLsLgLimmbLebLgbLsRsbLgLsbLgLsLsLhLsmbLsLsLembLcRsbLib
LjbLjLsmbLsLsLsLiLiLsmmbLsLsLgLgmbLebLgLeLsRsbLgLsbLgbLgbLsbLgbLsLsLsm
mbLeLsLgbLibLhRsbLobLcLsLgmbLgbLgLsLsLiLiLsmbLgbLgbLgLeRsbLgLsLsLgLemb
LibLgLsLsLsLsLsmmmmbLgLsLsLsLeLsLeLsmmbLibLcbRhRsLsmbRgReRsmbLsbRsbRsR
sRsRsRsRsRsmmmmmmbLgRsRsRsmmbRsbRsbRsbLjbRiRsmbRgRsmbReRsmbRsReRsReRsm
mbRgRsRiRgmbLobLibRsLsbLsbLgLsLsLsmmbLsLsmbLsbLibRibRsRobLeLsLeLsbLgbR
eRsmbRoLsbLgbLgbLgbsbLgLsLeLebLgbLsbLibLsbLsLsLsmmbLgbLgbLiLsbLiLsbLiR
sbLsbLgbLhLsbLibLibLeLsbLgRsbLeLebLibLsbLebLibLibLcRsLsbLeLsbLeLebLgRs
RgLsLsRsRsmmbLebLgbRsbRsbLgLsbRsLsbRcbRiRsmbLibLsLsLgLsmbLgbLsLsLsLsLg
RsmmmbRsLhbLgbLibLgLsLsLgLsmbLiLibLsbLiLsLsmbLgbLgbLibLebLibRibLgLgLgb
LsbLibLsLsmbLebLgLsbLgbLeRsbLiLibLsbLiLibLgbLibLiRsbLgbLgbRsbLibLgbLiR
sbRebLibLgLsLiLsbLibLgLsbLibLeLgLsbLibLgbLhbLsLsmbLeLebLebLebRjbRobLcb
LgLsbRhbRgbRcbRibRebReRsmbRhbRebRgbRebRsLsbRhbRibLgbLjbRjRsRgRsRsRsRsR
sRsRsRemmmmmmmmbRgLsbRgRsRsRsRsRsmmmmmbLsRsRsRgRsRgRsRiRsRsmmmmmbRgbRg
bLsbRiRsRsRemmbRgRsmbRsRsRsmmbLgRsRsRsmmbRsRiRsRsmmbRsRgRgRiRiRsmbRgbR
gRsRgRiRembReRsmbLsReRgbRsRsmbLsRsLsbRgbRgRsmbRgRgbRgRsmbRhbReb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 41; Drug: PCAP2 1 然 Apo 50 然
bLgbLsbLgLsbLgLgLsbLcbLsLsmbLjbLsLsLsmmbLhLsbLgbLcbLebLiLhbLiLsLsLsmmb
LsLsLsmmbLsLsmbLgLgbLgLsbLsbLsbLsLsRsmbRibLgbLsLsmbLgLsLsLsLsmmmbLoRsL
sbRsRsmbLcLsmbLjLsLsmmbLiRsbLhbLhbLcbLgLsRsbLsbLgLsbLgLsbLgLsbLgLsbLgb
LsbLsRsLsbLcLsmbLcLsmbLcbLcRsLsLsLeLsmbLgbLsLsmbLsLsLsLsLsmmmmbLsLsLsL
sLsLsLsLsmmmmmmmbLjLsmbLsLsmbLsbRcLsbRsbRcRsmbLsbLsLsmbRcRsmbRcRibRsRo
bRcbRiRgRibRgbRsbRsRsmbRsLsbLsbRsbRsRsmbRcbLsLsLsmmbRcRsmbRhbRcRsmbRhL
sRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 42; Drug: PCAP2 1 然 Apo 50 然
bRjbRcbRgbRhbLsbRsbRhLsLiLsbLcbRjbsbRgRsLsmbRsLsbRgRgRsLsRgRsRsmmmbRsR
iLgbRiRsmbRgRsRsmmbRsLsbRiLsLsRsRsmmbRsbRgbRgLsbRcRgRcRsRembLcLebLsbLi
bLibLcbLgbRhbRsbRsbRjRsRsmmbRsbReRsmbRgRsRhRiRsmmbReRib

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 43; Drug: Control Apo 50 然
bRibReLsRsbLcbRsbRiRsmbRibRibRcbRcbRcbRebRgRsmbRhLsbRgRsLsmbRsbRcRsmbR
cRsRsmmbLjbLgbLgLsbLebLebLcbLhLiLsbLibLebLgLibRjbLjbLsbLsbLsRjbRibRibR
ebRgLsbLhbLsbLebRjbLgLsbLsLgLsLsLsmmbLgLsbLebLjbRsbLgbRjbRhLsbLcLiLsbR
cbRcbLgRsLsbRcbRcbRcRibRcRsRembLebLgbLsLsmbRjbRsRcbRcbLibRcbRhRsmbRiRg
bRcbRgLsbLgbRibRibRibRsbRibLebLibLsLsLsLsLsmmmmbLsLeLsLsLsLsmmmbRjbRjb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 44; Drug: Control Apo 50 然
bRgbRjbLibLibRsbLgbRsbRibRsbRhRsmbLsbRiRsmbRibRgbRgbRibRibRsRgRsmbRgbR
gbLgbLibLibLgbRjbRgbRiLsbLsbLsLgRsbLibLiLsLsLsmmbLsRsLgbLsbLgLsLsmbLgb
LibLgbLibRjbRibRibRgRsLsRsmbRsbRibRibRcbLgbLgLsbLgbLsRsbLgbLgbRcbRhbRi
bRsbRibLsRebRibRgbRibRcbRgbLgbLgbLgbLgbLgbLiLgbLgbLiLsbLsbLibLiLsbLgLs
bRgLsbLibLgbRjbLiLsbRsLsbLgRsbLibLgbRgbRibRhbRibLgLgbRiRsmbRibRgbRgbRs
bRgRsRsRsRsRsRgRsRsmmmmmmmbRgRsmbRiRsRsmmbRiRsmbRibRibRgbRsRsmbRiRsmbR
gbLsRsRsmbRgbRgRsmbRgbRibLcbLibLgLsbLgbRsbLibLiLgLsbRibRibRiLsbRgRsRsm
mbRsRsRsRsmmmbLebRgLsLsmbLsLsLsLemmbLebLibLcLsmbRebRibLjbLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 45; Drug: Control Apo 50 然
bsbLsbsbsbsbLsbsbsbLsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 46; Drug: Control Apo 50 然
bLsLsLsmmbLsLsLsmmbLsbLsbLiRsRsLsLsRsmmbRhLsbLebLsbLsLeLsbRgbLebLibLgb
LiLebLebLebLibLebLibLibLiRsbLcbLhbLcbRsbLgbLibLgbRgbLibRcbRiRsmbRsRsRg
RsRsRsmmmmbLeLgbLsbLiLsbRsbRsRsRsmmbRsRsmbLiLsbLgbLiLgLibLgbLgLsbLgLgL
sbLebRiRibLebLibLgRsbLsbLsLsmbRsbLiLsbLiLgbLibRiRgbLsbLeLsLsmbLsbRibRe
bRgbLjbLibRsbLsLsLsLsmmmbLsbLsbLiRsbLsLsLsLsLsLgLsLsmmmmmbLeRsbRibRhbL
sbRibRsRgRiRebRgbRebRibRiLsbRgbLibRobLsLsmbLsLsmbLgRsbLgRsLsbLgLgLsbLe
bLhbLsbLibLebRibLibLeLsbLibLcbLebRhRibRibLsRsbRgLsbRibRhbRhbRjRhbRgRiR
smbLsLsRsRsmmbRibRgRgbRcbLgbLgbLgbLebLgbLibLibLgLibLibLgLsbLgbLgbLgRsb
LsLgbLhbLhbRibRibRiRsmbRgbLjbLhbLgbLebRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 47; Drug: Control Apo 50 然
bLjLsmbLibLcbRjbLhbRcbRcbRhbRhRsmbRiRsRimbRibRgbRhbRiRhbReRsmbRiRcbRhR
smbRibRibRcbRgRsmbRebRcRsmbReLsbLcbLiLsbLgRsbLhbLcbLhbLebLiLebLgRsbLib
LibLgbLgbLiLsbLgLiRsbLcbLgbLibLgLsbRcbRibRibRcbLgbLibLhLibLibLcbLiLsbL
gbLiLiLsLsLsmmbRebRhbLjLibLibRjbRibRibRhRsmbRgbRibRjLsbLgbLjbLiLsbLeLe
LsLiLebLiLsbLiRsLsbLiLgLsbLgbLjbLibRjbRhbLjbLibRcbRibRcbRcbRhRebRgbRib
LcbLcRsbLibLgLsLhbLcbLibRjbLcbLgLsbRjbRjbRibLibRcbRcbLobRjbLhRsbRsRjbR
cbRcbRcbRibRsRib

>ZF Recording 2016-04-15; tW: 300s; Start: 114523; End: 115023;
Recording: 4-1; Individual: 48; Drug: Control Apo 50 然
bRcbRgbRhbRibRhbRibRhbLcbLibLibLhbLsbRobRibLjbLcRsbLibLibLcbLibLjbLibL
ibLgbLcbLsRgbRcbRobRhbRcbLibLibLhbLibLibLibLibLhLibLgLsbLibLhbLhbLgbLi
bLibLibLgbLoRsbLgbLhbLgbLibLcbRhLsbRibRhbLcbLcbLibLibLibLgLibLsLsmbLib
RobRibRgbRgRsmbRiRsRsRgmmbRcbRibRhbLibLibRcbRhbLibLhbLhbLcbLhbLibLibLc
bLibLcbLhbLibLibLebLgbLhbLibLibRcbRibRibRcbLibLcbLibLibLibLibLgbLcbLgb
LibLsbLcbLgLgbLiLibLgbLgLsbLgLsbLibLibLhbLgbLibLibLcbRsbLebLibLibRjbRc
bRhbLjbRcbRgbRcbRibLibLibLsbLhbRibRcbRibRgbRcbRebRcbRgbRgbRibRsbRhb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 1; Drug: PCAP2 10 然 Apo 50 然
bRsbRebRsbRibRebRgRsmbRgbRibRgbRsbRiRsRiRembRebRiLsbLsbRibRiRsmbRiRsmb
RoRsmbRibLhbRsbLobLeLsbLiLgbLgbLeLsLsmbLsLibLeLsbLjbLibLsbLiLibLibLgbL
gbLsbLsLgRsbRsRsmbRsbLiLeLebLsbLiLsbLgbLsbLsbLgbLibLsLgLsLsLgmbLsLsLgL
smbLgLsbLebLsbLsLsLsmmbLgLsbRsLsbLsbLsbLsbLsLgLsLgbLsbLsLsmbLsLsLsLsLs
LgLsmmmmbLsLsLsmmbLgLsbLsLsmbLsLsmbLsLsmbRsLsLsmbLsLgLsbLsRsbRsbLgLsbL
sLsmbLgbLgbLgbLgRsbLsLsLgmbLgbLebLsbLoRsbsbLsLsLsRsmmbRsbRsRsmbRgbRgbR
jRsmbRsRsmbRsRsRsmmbRgbRibRsbLsbRibLebRobLsRibLgbLcLebLiLeLsLgRsbLsbRo
RsmbLjbLgbLgbLgbLsbLeLsbRoLhbLsbLsbLsbRiRsmbRibRgbRsRsmbRibLsbRibLobRo
bRsbRgbRgRsmbRsbRgRsRsmmbRsRsmbRsbRsRsmbRgbRsbRsbRsRsRsmmbLgbRcbLobRgb
LsbRibLebLcbLibRhLsbLgRsbLebLobLsRsbLjbRgbRsRsRgmbRcLsbLoLsmbLgLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 2; Drug: PCAP2 10 然 Apo 50 然
bLibLiLiRsbLibRhbRcLsbRoRobRobRibRibLibLobLsLsLsmmbLgbRsbLsLsLsRsmmbLs
LsmbRobRibRsbLgbRoLsbRgbLsbLobRobRcRsmbLjbLoRsbLoRsRsRembRhbLoRsLgbLob
LiRsbLhbLoRsRgbRobLgbRoRibRcRsmbRgbRoLgbLhbLobLgbLibLobLgbLobRgbRcbLgR
sbRgbRibRsbRsRgRsmbRgbRgRiRsRembRgbRgRsRsmmbRgRsmbRgRsmbRhRsRsmmbRsRgR
gRsRsmmbRebRgRsmbReRsRsmmbLsRsRsRgRsRsRsmmmmbRebRebRsbRgRsLsmbRebRiReR
smbRgRsRsmmbRgRsmbRgbRiRsRsRemmbRebRsbRiRsmbRgRsRcmbRobRcbRiRobRsbLeLs
LibRebLsbRobLcbLoRsRsRsmmbRcRsmbLsRsbRebRgRsRiRsmmbReRsRimbRgbReLsbRib
LobLiRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 3; Drug: PCAP2 10 然 Apo 50 然
bLgLsbLsLjbRiRsmbRibRsbsbsbRsbRjRsmbsbRgbRsbRsbLsLsLombRsbRiRobRebRibR
cbLebLebLgbRsbsbsbsbsbLsbsbsbLsbRsbLsbsbLsbRsbsbsbsbRcbRcbRgRsmbRcbRhb
LsbRsRgRsmbsbLsbsbRcbLobLgbRcbLsbRgbRebLsRsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 4; Drug: PCAP2 10 然 Apo 50 然
bLsbLsbLsRsbRsRsmbRsbRsbRsbLgbRsbLsLsmbLoRsbRsbRsRsRsRsRsRsmmmmmbRsLsL
smbLgbLoRsRgbLhbLsbsbRsbRsbsbsbsbRsLsbsbRsbLsbsbsbsbsbLsRsbsbsbRsbLsbs
bsbRcbRcRsRcmbLiLibLgbLgRsbLsRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 5; Drug: PCAP2 10 然 Apo 50 然
bRgbRhbRibRgbRibRibLgbLsbRsbRsRsmbRgRsLsmbsbRsbRsbRsRsmbLsRsRsmbRgbLsb
RsbRgRsmbRsbRsbRsbRgLsLsmbRsbRgLsRsbRiRsmbRgLsbRgRsRsmmbRgLsbRgbRsRsmb
RsbLsbRsbRsRsLsmbLsRsRsRsmmbRgRsmbRibRsbLsLsmbRgRsmbRgLsbRgbRgbRgRsmbR
gLsbRsRsLsmbRgRsmbRsLsbRgbLsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 6; Drug: PCAP2 10 然 Apo 50 然
bRgbLjLsLsLsmmmbRsbsbRcbLsbLgLsbRsbsbRsbLgbLibLobRibLiRjbLeLsbLebRsRsR
sRsmmmbLsbLcbRgbLebLsbRcbRobRsbRcbRiLsLsmbRgbLcbLsLibLjbRcbRsRsmbLobRe
bLgbLsLsmbLgbLgLsRsbLgbLsbRgbLcbLebLgbRhbRibRiRsmbLgbRgbRebLhbLgLsLsmb
LsLibRsbLhbRhbLsbRoLjbLsLsRsmbRgRsmbRsbsbsbRsRsRsLsLsLsmmmmbLsbRsLsbRs
RsLsRsLsRsmbRsLsbRsLsbLsRsbLsRsRsmbLsbLsLsLsmmbLsRsRsLsLsRsLsmmbLsbLsR
sbLsbRsLsbLsbLsbsbLsbLoRobRsbRebRcbLgbLiLsbReRoLsLsLsmmbLeRsbLoLsmbLeb
LiLsLsmbRgLgbRsbRsLsbLjbLsLsmbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 7; Drug: PCAP2 3 然 Apo 50 然
bLsbRsbLsbLsbLsRsbsbLsbLsbLsbLsLsmbRsbLsbLsLsmbLoRsbLgLsbLsbRibRsbLsLs
mbRsbRgRsRsmmbLsLsLsmmbLcbReRsmbLsbLsbsbRsRsmbRsLsbRsRsRsmmbRsbRsRsmbs
bRsLsbLsbRsbRsRsmbLsLsRsmbLsbRsLsbRsRsmbRsRsmbRsbRsbRsbRsbLsbRsbRsbLsR
sbRgbRsRsmbRsbRsbsbRsbRsRsmbLcbLobLibLsbRgbRsbsbRsbRsbRsbLsbLsLsmbRsLs
bRsbRsbLsbLsbRsLsRsbRcRsmbLgbLgLsbLsLsmbLcbRsbRsRsmbLsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 8; Drug: PCAP2 3 然 Apo 50 然
bRjbRjbRjbRcRsmbLcbLcLsmbLsLgLoLsLsLiLsmmbLibLcbReRibReRsmbRobLeLgbLcb
LgbLebRebRebLobRebRiLcLsmbLobLcLsLsLiLsLsmmmbRcRgRsRsmmbRgbRsRebRcbRcb
LcLsLsmmbLibLgbLhbLcbLhLhLiLsLeRsbLobLibRcbRcLsbRhRebRsRcRsmbRsLgbRjRj
RiRcRsRsmmbLoLsmbLibRobRcLibRcbRiRsmbRiRsmbRobRcRgRsRcmbRcbRiRsmbLcLib
LcbLcRsbLcbLcbLobLcLsmbRjbRibRgRgbRgbRcbRcRebRgbRsReRsmbRcRsmbLsbRcRsR
sRemmbRoRsmbRjbRcbRhbRcbRcbLebRjbRcbRebRsbRcRsmbRiRsmbLhLsRsbLcLsLsLsL
smmmmbLsLsLsLgmmbLiLsbRcbRobRcbRsbRhbRebRcbLgbRcRsmbRjRgRhbRebRcRsRemb
LsLcbLibLgbLcbLgbLiLsLgLebLsLcLcbLcbLiLsbLeLsLsLsLsmmmbRcbRcbRcbLebLgL
iLgRobRgLsbLsbLibLcbLhbLibLhbLcbLeLsLsLsLsLsLsLsmmmmmmbLhLsRsbLibRsRsR
gRsRsmmmbRsbRibRcbLiLhLoRsbLcbLebLibLiLsLsmbRibLobRgRebLcbLjbLsLjb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 9; Drug: PCAP2 3 然 Apo 50 然
bRiRgRsRsmmbRgRgbRgbRibRgRsRsmmbRgbLgbRibRibRebRebRcbLibLhbLibLsbRibRe
bLsbRibRobRgbRsbRcbRgbRobRhbRebRibRibRibRibRiLsRsbLiLsRsbLsbLsLsRsLimb
LgbLgbLjbRebRibRibLibLsLjbLcbLibLibLibRjRsRsRsRsRsRsmmmmmmbRhbRhbRgbRj
bLsbLibRjRsmbRibLgbLsLgbRiRiRgRsRgmbRjRgLsbLsRsRsRsRsReRgRiRsmmmmbReRs
RembLebRiRsRsRemmbLgbsbRgRsmbRgbRebRgbRcRsmbRhbRhRsmbLibLibLibLibLcbLg
bLibLgbRibLcbLhbRjbRebRiRsRsLsmmbRiRsRsRsmmmbRiRsRiRembRsRsRsmmbRgbRiR
gRebRebReRsmbLibRibRhRibRibRjbRebRgbRcbRibRibRgbLibLjLsmbLibLcbRiRgbLg
bLibLgbRhbRgbLgbRgRsRsRsRsmmmmbRiRsmbReRgRsmbRebLcbRiRsmbRsRiRsRsRgmmb
ReRibLjbLgbLibRjbRiLsbRiRgRiRhbReRebReRebLsbRhbRebRebLjbRiRsmbLgbLcbRo
bRgbRgbRobRsRsmbLcbLibLobRcRsmbRiRsRsmmbRsRsRsmmbRiRsmbLibRcbRibRebRsb
RiRiRsmbReRsRsmmbRgRsmbLsRibLcbRibRsRiRebRgbRebRsRebRiRsmbRibRebReRsRs
mmbLibRiRsRsRsmmmbRgbRgbReRebRebReReRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 10; Drug: PCAP2 3 然 Apo 50 然
bLsbsbLsbsbsbsbsbLsbsbsbsbRsbRsbsbsbRsbsbsbsbsbLsbsbsbsbsbLsbRsbsbsbLs
bsbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 11; Drug: PCAP2 3 然 Apo 50 然
bLsLsmbRsbLsRsbRsbRsRsmbLgbsbLsRsbLsbLsRsbRsbRsRsmbRsRsRsmmbRsbLsRsRsm
bRsRsmbRsRsmbRsRsRsmmbRsbRsbRsRsmbRsRsLsmbRsRsmbRsbLsRsbLsRsbsbLsRsbRs
RsRsmmbRsbRsRsmbRsRsRsmmbLsLsRsLsmbRsbLsRsbRsbRsbLsRsbLsRsbRsbLsRsLsbL
sRsbRsbLsRsbLsRsRsmbLsRsbRsLsbRsbLsbLsRsbRsRsmbRsbRgbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 12; Drug: PCAP2 3 然 Apo 50 然
bReRsRsmmbReRsmbRcbRibRibLcbRhbRgRsmbRiRsmbRhbRgbRgRsmbRsLsRsRsRsRsmmm
bRgRsmbRgbRgbRgbRgbReRhbRcbRhRsRembReRsmbRgRibReRgbRsRsRsRsRsmmmmbRhRs
RsmmbLsbRgbReLsbRibRhRsmbRjbRibRibRiRgRsRsmmbRgRgbRsRgRgRiRgbRgbRibRib
RibRsbRebLibLcRsbRebLjbLeLsbRsRiRgRsmbRsRibRsRgRsmbRsRibRgRgbRgbRgbLob
RcbLobRsbLeRsLsbLobRgbRibRcbRebRcbRhRsRsmmbRebLhLsbLibLhLsbRsbRhRsmbRe
bRiRsmbRgRsRsLsRsmmbRsRibRiRgbRgbLcbLcbRjbRsbRsbRsRgRsRsRsmmmbRsbRcbRh
bLsLsmbRjbRiRsRsmmbRsReRgRsRsRgmmbRgRsmbRiRgbLsRgbRgbRsbRiRsRgReRembRg
LsbRsRiRgbReReRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 13; Drug: PCAP2 1 然 Apo 50 然
bRebRgRsmbRiRsLsmbRhbRjbLcLsLsmmbLebLhbLebLcbLsLebsbRsbRgbsbRsbRcRsmbR
gbRhbRebRcRibRcbLgbLgbLoLsmbLcbLhbLcLsmbLibLibLsbLsbLgRsbLgbLhLsLebRgb
RibRsRsmbRiLsRsbRibRibRcbRcRsmbRiReRsmbLsLsLsmmbRibLgbRhbLsbRjbRibRebL
ebLebLsbRsbRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 14; Drug: PCAP2 1 然 Apo 50 然
bLsbRiRsmbRgLsLsmbRsbsbLsbsbLsRsLsbLsbLsLsmbLsbRsbLsRsbLsLsmbRsbLsbsbR
sbLsbLsbRsbLsbRsbRsbRsbRsRsmbRsbRsbsbLsbRsLsbLsbLsLsmbLsbLsbLsbLsbLsRs
bLsbRsbRsbLsbRsRsmbLsbLsbLsbLsbLsbRsbLsbLsbRsbRsLsLsmbRsbsbLsbLsbLsbLs
bRsbsbRsLsbRsLsLsmbLsbRsLsbRsbLsRsbLsbRsLsLsmbLsLsmbRsRsmbRsbRsbLsRsLs
bLsbLsbLsbLsbRsbsbLsLsRsmbRsbRsLsbLsRsbLsLsLsmmbRsbsbsbRsLsRsbLsbsbRsR
sLsmbRsbRsbRsbLsRsRsLsRsRsmmbRsbLsbLsRsRsmbRsbRsbLsRsRsLsRsmbRsRsmbLsR
sbsbRsRsLsRsmbLsLsRsmbLsbRsbLsLsmbsbRsRsLsLsmmbsbRsbLsbsbLsbRsbLsbRsbs
bRsbsbLsbLsbRebRgReRsmbRibRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 15; Drug: PCAP2 1 然 Apo 50 然
bLcbLcbLibLeLsbLsLsLsLsmmmbLjLsLsmmbLibRjRsmbRibRibLcbRiLsbRiRsmbRgRsR
sRsRsmmmmbLjbLhbLcbRiRsmbLeLsbLgbLeLsLsmbLcbLjbLibLeLsLsRsmbLhbLcbLcbL
cLsmbLebLebLcbLeLsLsLsLsLsmmmmbLcLsmbLibLcbLebLebRibRjbRgRsRgmbRiRsmbR
gRsLsmbRcbRcRsmbRgbLcLsmbRsbLebLibRcbLibRobRibRcLsbRibRcRsmbRcbLcbLibL
cbLebLibLcLsmbLebLiLsbLcLsmbLsbLhbLgLgLsLsLsLsmmmbLhLsbLibLcbLibLhLsbL
gbLcbLibLcbRsbRcbRcbReRgbRibRibRcbRibRgbRhbRibRibLgLsbRjRebRgRiRebRiRs
mbRibRobRgbRhRsmbLsRsbRgRsmbRgbRgbLcbLcbLcbLcbLibLibLebLcbLsLiLsbLsbLs
bRcbRgRhbRcbRibRgRsRhmbLcLsmbLcLsmbLeLgLgbLebLobLcLsmbLhbRibLcbLeLsLsm
b

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 16; Drug: PCAP2 1 然 Apo 50 然
bLiLsbLsbLgLsLsLsLsLsmmmmbLsbLsLsmbLsLsmbLeLsbLiLsbLiRsbLgbLcbLgbRibRi
bRsbRsRsmbRsRgRsRsRsRsRgRgmmmmbRhbRsRsmbRibRgRsmbRsRsmbRibLsLsmbLsbLeb
LhRsbLiLsbLsbLsLsLsmmbLsLsLgmbLibLeLsbLgLsbRsbLgLsbLsLsLsLsmmmbLgbLsbR
gbLsLsmbLsLsRsmbLsLsmbLsLsLsmmbLsbLgbLsLsLgmbLsLsLsLsLsmmmmbLgbLgbLgLs
LsmbLebLgLsbReRsmbRibRebRebLsbLsbRsbRhbLsbLgbLgLsLsmbLgLsLgbRsbLgbLgLs
LsmbLgLsLsmbLsLgbLsLsLsLsLsLsLsLsmmmmmmmbLgLsRsbLsLgbLgLsLsmbLsLsmbLgb
LibLibRsRsmbLsLsmbLhbLgbLgbLgbLsLsmbLgLsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 17; Drug: PCAP2 1 然 Apo 50 然
bLhLsRsbLcLsLsmmbLgbLibLiLsbLibLibLebLibLcbRoRsmbRgbsbRiRgbRgbRcbRiRib
RgbReRsRsRgmmbRgbRcbLgbLcbLiLsbLobLcLsmbLibLhRsbRcbLibLgbRjbRsbRhbRcbR
iRsmbRcbRiRsmbRibRibRebRiRsmbRiRsRsmmbLhbLebLhLibLsbRibLcbLeLsbLibLobL
sbLcLsmbLhLsbRobRcReRsmbRobRsbRsbLobLibLebLcbLcbLgbLcbLcLsmbLgbLiLsbRh
RsRsmmbLcbLcLsmbLibLibLcLsLsLemmbRhbLcLsmbLhbLgLsbRhbLcbLgbRoRsmbRcRsm
bRibRibRhbRibRcRibRibRibRiRsmbRoLsbRgbRcbLgbRebLibRcRibsbLebLcbLeLsbLc
bRebRhbLobLeLsbLsbLebLebLhLsbLibLobRebRobLcbLgbLobRibRhbRcbRcLsbRiRibR
gbRcbLcbLhbLeLibLebLibLebLgRsbRebRcbLcbLhbLiLsbRcbRcRhbRsRiRsRsmmbLcbL
cbLsbRoLsbRgbRgRebRebRcLsbRebRcbRjLsbRsRobLobLgbLhRsbRsLeLsbLhbLebRsRg
bLcbLibRobRcRsLsmbRobRobLjbLcLsmbRobLeRsbLcLsmbLgbLhbLjRsbRobRsbRiRsmb
RiRebReReRibRibRebLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 18; Drug: PCAP2 1 然 Apo 50 然
bLsLsLsmmbLhLsbLcbLebLsLsmbRsLebLebRsLsLsmbLsLsLsLsmmmbLsbRebReRsmbLsb
LgbLgbRsLsbRgLsbRsLgLsbRjbsbRcRgLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 19; Drug: Control Apo 50 然
bRgbRebReRsmbRgbLsLsmbRgRsmbRgRsmbLibLhbLibLsbRhbRibRgLsRsbRgbRgRsRsmm
bRsbRgLsbLjbLcbLsbLgLsbLgbLcbRgbRiRsmbRibRhbLsbRhbRibRiRsmbRgRgRsmbRgb
RibRjbRsbRhbRgbLgLsbLjbLibLibLsLgLgbLibRsLgbLiLsbLjbLgLsbLgbLgLsbLgbLs
bRhbRibLsbRgbRgLsbRsbLsbRibRsbRiRsRsmmbRsbRsRsRsRsmmmbRgRsRsmmbRsRsRsm
mbRsRsRsRsRsRsmmmmmbRgbRsbRsLsbRsRgbLgLsbRsRsRsRsLsmmmbRgRsRsRgmmbRiRg
RsRgmbRebReRsRhRsmmbRebRsRsRsRsmmmbRsRsRsmmbRsbLsbLsbRsRsRsRsmmmbRsReb
ReRsmbRsRebRsbRibRibRsbRgbRgRsLsmbRsRsRsRiLsmmbRsRsRsRsmmmbRgbLeLsbLib
LsbLgbRsLsbsbsbLgLsLsLsmmbLhLsLsmbRibLgbLgLsbLsbLgLsbLsLgbLgLsbRsRsRsm
mbLsbLiLgbLiLsLsmbLibLgRsbLsLsmbLsbLsbLibLsbLgLsLsLsLsmmmbLgLsbRsLgLsL
sLgmbLibLsLgLsbLgbLiLgbLsLiLsbLgLsbLgbLiLgLebLiLsbLgRsbLibLgbLgbLsbLsL
gbLibLeLsLgbLgbLibLeLeLgbLgLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 20; Drug: Control Apo 50 然
bRgRsRsmmbRiRsmbRiRibLsbLsbLcbLjbLgbLebLgbLiLibLobRjbRiRsmbRebRgRiLsbR
cbLsbLcbLebLibLsLsmbLgbLjLiRsbRibRjbRiLsbRgbRibLjbRibRgbRsbLcbLgLiLsbR
sRsmbRiRsmbRibRhbLsbRibLgbRgRsmbRhbLebRibRibLebLgbLhLsbLibLcbRjRibReRs
mbRjRsRsmmbRsRgbRibRsbLebLibLgbLebLibLibLiLsbLibLebLibLebLobLebLebReRs
LsmbRgLsbRiRsmbRebRgbRebRobLhbLcbRgbRibRiRsmbRgbRjbLebLibLibLgbLebLebL
ebRgLsRsbLgRsbLebLiLsbLibLgbLgbLcbRjbLhLeLgbLibLibLibLgLsbLgbRgbRgbRob
RebLsbLgbLiLsLsLembLebRjbRsbRgbRsbRgRibRibRsbLebLhbLibLibLsLsmbLsLsmbL
sbLhLsbRsbLibLjbRhbRibRcbRcbRcRsmbRgLsbRgLsbRgbRebRcbLsbLebLibLeLsbLiL
hLsLsmbLebLgbLgbRjbLhbLsbLebLgbLebLcbLebLiRsbLsbRobRgbRibRgRsRsRsRimmm
bRebReRibRgbLhbLibLgbLsbRibRgbRgbRgRsRsmmbRgRsmbRgbRsRgbRibLsbLebLgLsb
LeLsbLgLsLgbLibLsLsLsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 21; Drug: Control Apo 50 然
bLiRsbRgbRcRsRiRiRsRsmmmbRibRcbsbRcbRcbRsbRcRiRgRiRsmbRjbLsRiRsmbRhRsR
gmbRobRibLcbLcLgbLiLsbLsbLgbLgLsbLoLsmbLiLhbRcbLcbLgLsbRcbRcRhRsLsmbRc
bRsbLcLcLiLsbRjbLcbRsbRobRcbRcbRcRsmbRsbRgRgRgRebRsRsRcmbLobLcbLiRsbRc
bRgRibRebRgbRsRcbReRsmbRgRsRsRemmbLeRsbLebRjbLcLsmbLsbLiLgLsLeLhbLgbLc
bLiLeLiLeLsbLibLobLcLiLsbLgbLsbLiRsbLiRsRsRsRsmmmbLoLsmbLsLsmbLcbRsRsm
bLcLsmbLibLiLsLgbLgbLgbLcbLgbLcbLeLsbRsbLiRsbLiLgLsbLsLsLsmmbLebLiLsbL
sbLcbLcbLeLsbLgLeLsRsbRob

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 22; Drug: Control Apo 50 然
bsbRsLsLsRsLsRsRsLsRsLsmmbRsRsLsmbRsbLsbsbsbLibRsRgbLcbLcbLcLsmbLobLob
LiLsbRsLibLibLibLsbLcbLobRcbRcbRcRsRsRsmmmbRsRsmbRebLjbLhbLibRjbRcbRcb
RcbRhRsmbRhRsmbsbRgbLcbRcbRcbRcbRebReRsRsRemmbRhbRgRsmbRebRsRibRiRsmbR
cReRiReRcRsmbRhbReRibRcbRgbReRcbRcbRiRsmbRcReRsmbReRsReReRsmmbRibRiRsR
gRiReReRembRebRsbLcbLebRcbLcbLcbLgbLcLsLiLgmbLibLibLgLhbLcbLgbLiLibLjb
RsbLibLiLsbRsLsbLhRsbLobLcLsmbRcbRcRsmbRcbRiRsRsmmbRibRcbRcbRcbRcbRcbR
cRsmbRibLeLsbLiLiLiLsbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 23; Drug: Control Apo 50 然
bLjbRobRgbRibLsRsLsbRibRgbLibLibRibRibRhbRibLgbRcbRebRibRsbRibRibRibRj
RibLibRcbRebRcbRgbRcbLobLibLhbLibLjbRjRsmbLibLgbRgbRhbLsbRjbLsbRhbLgbL
jbLebRcbRjbRibRgbRgbRsbRsbLjbLcbLibLsbLibRhbRibRibLsbRgbRsbRiRsmbRiRsm
bRcbRcbRibRsRsmbLebLibLibLgbRjbRiLsbRjbLsbLsLsmbRgbLgbRibRibRcbLsbLibR
obRhbRgbRgRsRsmmbRgbRgRsmbRsbRgbRibRhRsmbRcbRcbRgbRgRsmbRobLiLsbRcbRjb
RcLsbRibRibRibRibRgbRibRgbRgbRgbLgbLhbRjbRebRcbLcbRcbRibRibRibRibLibRj
bRjRsmbRhbRibRcbRgbRgbRgbRgbRibLibLcLsmbLibLsRibRgbLhbLibLcbRhbLcRsbLi
bRjbRobRoRsmbLsbRibRebRsbLgbLjbRibRjbRibLibLobRcbLsbLgbLhbLhbLibRibReb
RgbRibLsbRjbRhbLsLsLsmmbRibRcRsmbRibRgbRhbRcbRebRgbRibRsRsmbRibRobLjbL
hbLibRibReb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 24; Drug: Control Apo 50 然
bRgbRiRibRcbLsbRcbRgRsRgRsRsRsmmmmbRhbRhbRhbRsbLgbRsbRhbRiLsbLhbLhRsbL
cbLsbLibLiLsbLgLsLgLsbLibLiLibLgbLgbLgbLjbLibLgbLsRsbLiLgbLcLgbRsbLjbL
eRsbRibRebLibLibRjbRibRiRgbRgbRgbRgbRhbRiLsbLjbLiRsbLibLiLsbLjbLjbLcbL
cLsmbLiRsbLibLsbLiLsbLibRibRjbRibRiRgRsmbRiRibRiRsmbRgRsRsLsmmbLsRsLib
sbRsbLjLsmbLjbRgbLhbLjLsmbLibLhbLgbLibLgbLhbRibRsbLgbLcbRjbRhRsmbRgRgb
RiRsmbRcRsmbRibRjRsmbRhbLsbRiRgLsbsbLjbsbRobRhbLsLsmbRsbRsbLjbLcbLebRs
bLobRcRsmbRgbLibLhbLcbLiRsbLibRibLibRibLcbLibLibRiRsmbLhLibRgbLibLiLsb
LgbLjbLgbRsbRsbLsbLsbLsLsmbLibLcbLcLsmbLibLhbLhbLhbLiLsbLjbLebLhbLcbLi
RsbLibLgbRebRcbRibRsbLibLjbLibLgbRsbLgRgbLcbLiRsbLgbLgLcRsbLibLibRcbRi
bRibRibRibRcRsmbRibRcRsmbRgbRgbRibRgRsmbRiRgbRibRgbRcLsbLjLcbRibRebRiR
cbRibRhbRgbRoRsRsmmbReRsmbLibRsLebRcbRebRiRiRsRsmmbRgbLsLibRjRsmbLibLj
LsmbLjbLhbLibLhbLjbLibLjLibsbLcbLibLibLibLibLibLjbLjLsmbLjbLjbLjbLibLj
bLcbLgbLiRsbRjbLhbLhLsbLibLebLjbLibLhbLibLjbLhRsbLgbRsbRjbLibRjbLjbLjb
RcbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 25; Drug: PCAP2 10 然 Apo 50 然
bLsbLsbRsRsmbsbRsbsbsbRsLsbLsbLsbRsbsbsbLsLsmbLsbsbLsbLsbLsLsmbRsbsbRs
LsRsbLgLsbsbsbRsLsLsmbsbRsLsLsmbsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 26; Drug: PCAP2 10 然 Apo 50 然
bLsbLsbLsLgbLgLsbLgRsbLgbLgbLsbLsbLsLsmbLgbLsbLsbLsLsLsRsmmbLgbLgbLsbL
sbLsbLsLsLsLsmmmbLgbLsbLibLsLsmbRsbRsbRsbRsbLsRsbRsRsmbRsRsRsmmbRgbRgb
RhLsLsLsmmbLsbLhbLsbsbsbsbsbLsLsLsLsmmmbLsLsmbLsLsmbLgbLgbLsbLsLsLsmmb
LsbLsbLsbLsbLsbLsRsbLsbLsLsmbRsLsbLsbLgRsbLgLsbLsbLsLsmbLsbLgbLsLsmbLs
bLsLsmbLgbLsbLsRsLsbLsbLsbLsLsmbLsbLgbLsLsmbLsLsLsmmbLsbLsbLsbLsLsmbLg
bLsbLsbLsbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 27; Drug: PCAP2 10 然 Apo 50 然
bLebLsRsbLgLsbLsbLgbRsbLsbLsbLsLsmbRsbRsRsmbLsRsbRsbRsbLsbRsbLsLsmbLsL
smbRcRoLsbLsLsmbLsbsbRibLcLsRsmbLiLiLeRsbLgbLgbLgbLgbRsbLsbLgLsLsmbLsR
sRsmbRsbRjbRcbLsRsRsmbRgRgbLgRsbRgRsmbLsbRsRsRsmmbRsRsLsmbRsRsmbRgbRsL
sRsRsmbRgbRgbRsLsbRgRsmbLsRsbRsbRgRsmbRsbRgRgRsmbRsbRsRsmbRjLsLsmbRsRg
bRgbRgbLgbRsLsbRhLsbRsRgRsmbRsRsmbRsRsmbsbRsbRsbLsLsRsmbRsRsLsRsRsmmbs
bRsbsbsbsbRsRsmbRsbRgLsRsbRsbRiLsRsbLsRsRsmbRiRsmbRsLsbRsRsmbRsRsRsmmb
RsRsRsRsmmmbRsbRgbRsRsmbRgbRgRsmbRiRsRsRsmmmbRsRsRsmmbRgbRcRsmbRiLsLsm
bLgRsbRcbLhbLhbRsbRgRsRsRsmmmbRsRsmbRgRsRsRsmmmbRgbLsRsbRsbLsRsbRsRsmb
RsRsmbLsRsRsmbRsRsRsmmbRsRgbLgRsbLiLsbLsLsLsLsmmmbRsLsbLsLsmbLsbRebsbR
sbRsbRsbRgRsmbRsRsRsRsmmmbLsRsbRgRsmbRsRsmbRgbRsRsRgLsmbRsRsmbRgbLsRsL
sbRgRsmbRsRsmbRsRsRsRsmmmbRsRsmbRsRgLsbRgbRsbLsLsLsmmbRjRgRsmbLsbLibRi
bRsRsmbRsRsRsmmbRsRsRsmmbRsRsRsmmbRsRsmbRsRsmbRsbLsbRsbRsbRsbLsbRsbRiR
smbRsbRsRsmbRgRsmbRgRsRsRsmmmbRgRsRsmmbRjLsRsbRsRsRsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 28; Drug: PCAP2 10 然 Apo 50 然
bRobRsbLsbRiLsbRgbRjRsRsRsmmmbRgRsLsmbRsRsmbRsRsLsLsRgRsmmmbRsRsmbRjRs
RgmbRsRsmbLgRibRgLsbLsLsmbRsRsmbRgLsRsRsLsmbRgLsbRgbRgbRgRsLsmbRhbRsRs
RsRsRsRsRsRsRsRsRsRgRgRsLsmmmmmmmmmmmbRgLgbRsRsRsmmbRsbRsbRiLsbRgRsmbR
sRsRsRsRiRsmmmmbRgRgbRjLsLsRsRsLsRgRsRsLsmmmmbRjbLgbRgLsLsRsRsRsmmmbRs
RiLsbRsbRebsbRgRsRsRsLsmmmbRgRgRsLsmbRsRsmbRjRsmbRgbRiLsbRjbRjbRiRsLsm
bRgRgRsRsRsRsRsmmmmmbRcbRibRibRiRsLsmbRjRgLsbRsRsRsLsRsmmbLsbRjRsmbRgb
RgbRgbRgbRsRibRiRsmbRgbRoLsLsmbRgRgbRgRsmbRgbRgbRsbRoLsLsReLsRoRhmbRiR
ibRgRsLsmbRibRhRsmbRibRhLsbLiRsLsbLiLsbLobRsLsLsmbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 29; Drug: PCAP2 10 然 Apo 50 然
bRcbRiRsmbLsRsLsLsmbLsbRgRsmbRsbRgbLsbRsbRsbRsbLgbRgRsmbsbRsRsmbLsbLsb
RsbRsRsRsmmbRsbRsbRsRsmbLsRsRsRsmmbLsRsbRsbRsRsmbRsbRsRsmbsbRsRsLsmbRs
RsmbRsLsbsbRsbLsRsbRsRsmbRsRsLsmbRsLsbRsRsmbsbRsRsLsmbRsRsRsRsRsRsmmmm
mbRsRsmbLsbRgRsRsLsmmbRgRsmbRsbsbRgbRsRsRsmmbRsbRsbRsbLsbsbRgbRgRsmbRc
LsbRibRcbRiRgbLgLsbRsbsbsbsbsbRiRsmbLsbRsRsRsmmbRgbRsbLsRsbRsRsmbRsRsm
bRsbRibRsbRhRsmbLsLsLsmmbRsbLsbsbsbLsbRobRsRsmbRsRsmbRsbRsbRsRsmbsbRsb
LsbLsLsLsmmbRsbRgbRsbRsRsmbRgRsmbRsRsRsmmbLeLsbLsbLhRsbRsLsLsmbLsLsmbR
sLsLsmbRibLsLsmbsbLgbRsbLsbRsbRsbLsbRcLsbRiRsmbLsLsmbRsbRsRsmbRgRsmbRi
bRibRibRibsbsbRsbsbRsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 30; Drug: PCAP2 10 然 Apo 50 然
bRcbLjbLcbLgbRsRsmbRgRsRsmmbRjbRcRiRebRsRobLiLsRsbRhbRibRgbRsbRgbLeLsb
RcRsmbLjbLobRsbLsbLjbLhbLibLjbLjbRgbLhRsbLibRsbRsbRcbLcLsmbRsbRjRsmbRs
RcbRiRsRsmmbLhbLsLgbLgLsbLibLsLsmbLsbLiLsLiLgLsbRcbsbRgbsbReRgbLgRsbRi
bRcbRiLsbRsbRsbRiRsRsmmbRiLsbRcRsmbRgbRiRsmbRiRiRgRsmbRhRgLgbLibRsbRcb
sbLsbRsbsbLcbLgLsbRgbLiLsbLgbRsLsbLgbRjRobRiRsmbRobLibLeLhRsbRsbRgbRib
RebLebRibRebLsbLsRgbRsRgbLsbRsLsbLsbRgbRsbRsbsbRsRsLsmbRgbRsRsRsRsmmmb
sbLsbRsbLibRgbRsbRiLsbLibLjLgLsbLhbRsRsLsmbRgbRibRibsbRsRsmbReLsbRjbRo
RsRsmmbRhRsRsRsmmmbRcbRobsbRgRsmbRsLsbRcbLoLibRibRsbLibLiLsbLsLcbLgbLo
bLgLsbRibRiLsbRgbRibRiRsRiRsRimmbRhbsbRiLsbRhRsmbRgbRjbLgbRiRsmbRcRsmb
RcLsbLcbRsLibLibLoLibRcbRhbRsbsbRjRsmbRgRsmbRjRsRgRembLgbLiLsLibLgRsbR
sbLibRsLibRcbRibsbRjbRsbLeLsbRsbLsbRcbRcbRibRgRsmbLsLsmbRebReRsmbRhRgb
sbRsRsmbLsbRibLsRgbRsbLsbRsbLsbRibRhLgbLhbLhRsLibLhbLgbRobRibRiLsLsmbL
sbRjbLcbLcbLsbLcbLcRsLsRsbRibRobLgbLcbRobRhRgRsRjmbRibRsbRcbRgbRhRsmbR
gbRcbLgbLcLjbLcbLobLjbRiRiRibLsbRsbLcbLcbLsbLiLgbLcLibLgLsbLsbLhbLhLsb
LiLiRsLgbLibLoRsbLhbRebLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 31; Drug: PCAP2 3 然 Apo 50 然
bRsRsLsmbRsbRsRsRsmmbsbRsRsRsLsmmbRsRgbRgbRsRsmbLsRsRsRsmmbRsRsmbRsbRs
bRsbRsRsmbRsRsRsRsmmmbRsRsLsLsmmbRsRsmbRsbRsRsmbRsRsmbRsbRsRsRsmmbRsbR
sRsmbLsRsbRsRsmbRsRsRsmmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 32; Drug: PCAP2 3 然 Apo 50 然
bLsbLsLsmbLsLsRsmbLsbLsbLsbLsbLsLsLsmmbLibLsbLsbLsLsmbLgbLgRsRsmbLsbLg
bLsLsmbLsbLgLsbLsbLgbLsbLsLsLsmmbLgbLebLeLebLsbLgLgLebLgbLgbLgbRjbLgbL
sLsmbLsLsmbLsbLsbLsbLgbLsbLgbLsbLgRsbLsLsmbLgbLgbLgbLsbLgbLsbLgbLsbLsb
LsbLsbLgbLgbLsLsmbLgbLsbRjbRcbRgbRsbRsRgbLsbRsbRsbRsbRsbRsbRgRsmbRgbLs
bLsbsbLsbRiLsLsmbRsbRgbRibLsbRjRgbLsbLsbRgbRsbRsRsmbRsbRsbLsbRgbLsLsmb
RsbRsRsmbLsRsbLsRsbRjRsmbLsbRebRjbLsbLsbLebRsbRgRiRibLsbLgbLiLsbLgbLgL
gLebLsbsbLcbLobLebLgbLiLgLgLsbLebLibRibRjbRcRsmbRgRsmbRgbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 33; Drug: PCAP2 3 然 Apo 50 然
bRcbRhbRcbRgbRhbRgRsmbRgbRebLsLjbLoLsmbLgLsLgLsLibLgLsbLiRsbLcLsLimbLc
LsLembLgLsLiLsLeLgLsLsmbLsLcLcbLcbLsLgLeLgbLcLsLsLsmmmbLcbLebLiLgLiLgL
sLsmbLgbRsLsbRcbRibRcbLsbRcbLjbRcbRgbRgbRsLsbRsRgbRcLsbRhbRcbRgbRgbRsb
RiLsLsLsmmbLgLsbRiLsbRgRgbRcbRiLsbRcbRibRibRcLsbLsbRcRsmbRcbRhReRsmbRs
LsbLjbLcbLcLgbLgLsLsmbLobLcbLhLibLibRsRgRsRsRsmmmbLcLsmbRsRsLsmbRsRsmb
LibLsLsmbLsbLgbRsLhLeLcbLibLgLiLiLsLsLsLgLsLgLsmmbLeLsLgbLcLsmbLibLgbL
gRsbLgLsLgLgbLcbLcbLibLcbRibLsbLjbRcbRhLsLsmbRcbRgRsRsmmbRcRiRiRsRembR
iReRsmbRsbRiRsLsmbReLsRiRgbRibRsbLibLhLsbLibLcLsLeLsLhLsLsmmbLgLsbLgLs
LsmbLsLgLsbRsRsmbLgLsLsLsLsLsLemmmmbLgbLhLgbLcbLeLsLcbLcbLgbLsbLsbRjbR
hRsmbRoRiRsRsmmbRhbsbLjbRsLsLsmbLhbLiLsLebLcLsmbLcbLhLsLgLsLsmbLibLcRs
bLsLjLhLgLsLiLsLsmbLiLiLsbLgbLhLsbLsbLcbLeLsLsmbLebLgLsLsmbLibLcLsLgLs
mbLcLcbLcLsmbLeLibLibLibLiLiLibLebLebLcLiLebRcbReLsRhbRgbRiRsRimbRgbRc
ReRhRebRiRcbReRsmbRiRgbRiRsRiReRsRgmmbRhbLcLhLcLsmbLeLsLeLgbLcLeLiLeLe
LebLiLcbRibRiRsRsRiReRsRsmmmmbRgLsRgRsmbRgRgRsmbRiRsRgmbLjbRsRgbRibRib
RsbRcbRcLsbRiRsRsRiLsmmbRgbReRsmbRgRsmbLhbLibLgbRsbRsbLgbLsLsLsLsmmmbL
iLsbLgLsbLsbLsLsLgLsLgmbLibLcLsmbRsbLcLhLsLebLcLsLiLsLsRsRsLiLsLgmmmbL
iLhLsLsLeLsmbLiLsbLiLsbLiLibLeLsLiLsLeLsLsmbLiLeLeLsbLebsbRjbRhb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 34; Drug: PCAP2 3 然 Apo 50 然
bLsRsRsmbRsRsRsRsLsRsRsRsRsmmmmmmbRgbRsbRgRsRsRsRsmmmmbRgRsRsRsmmmbRsR
sRsmmbRgRsRgmbRsRsRsRsmmmbRibRsRsLsmbLsRsbLjbLoLsmbLgbRsLsbRgbRgRgRgRs
mbRiRgRsRsRsRsmmmmbRgbRsRsmbRgbRsRsRsRsmmmbRsRgRsmbsbRsRsRsRsRsRsmmmmm
bRsRsRsmmbRgRsRsmmbRgRsmbRgbRgRsRsmmbRiRsRsmmbRgRgbRsbRgRsmbRgRsRsRgRs
mmmbRgRsmbRsRsRsRsmmmbRsbRsRsRsRsmmmbLcbLgbLgLsLsmbLgLsLsLsLsLsLsLsLsL
sLsmmmmmmmmmbLgLsbLsLsLsLsLsLsLgmmmmmbLiLsbLsLgbLgbLgLsLsmbLgbLsLsmbLs
bLsLsLsLsLsLsmmmmmbLsLgbLsbLgbLsLsLgLsLsmmbLsbLgbLsLsLsmmbLgbLgbLgbLgb
LgbLgLsLgLsLsLgLsmbRsLsbLibLgLsLsmbLgRsbRsLgbLgbLsLsLgLsmbLoRsbRgbRsbL
cbLgbLgbLsbLsLibLsLsmbLgbLgLgbLgLsbLsLsmbLsbLsbLsLsmbRoRgRiRgRsRsRgRsm
mmbRsbLsRsbRsRsmbLsRsRsRsRsmmmbRsbRsRsmbLsbRsRsmbRsbRgRgRsRsRsmmmbLcbL
gLgbLsbLgbLsRsbLsbLibLsbLgLsLsmbLgbLgLgLsbRgRgRgbRsRsRsmmbRgRebLgbLiLs
LibLgLsbLgRsbLebLgbLjLgLsbLsbLcbLsbLebLebLibLsLsLsmmbLsLsLgLsLsLsmmmbL
sLsmbLgbLgLsLsmbLsbRcbRcbRebRsbRsLsRsRsRsRsRsRsRsRsRsRemmmmmmmmbRibLib
LhbLsbRsLsbLibLsLsLsmmbLsLgbLsLsLsLsLimmmbsbLsLgbLgbLcbRsbLcLiLgLibRjL
ibRjLsbRcLsbRoRsmbRcbReRsmbRoRsRgRiRsLsmmbLsbLcRsbLsLibRebRsRsmbRcRsRc
mbLsbRsbLjLgbLgbsbRsbsbLsLsmbLsbLsbLgLgLgLiLsLsLsmmbLgbLiLsbRcRsRcRsmm
bRiRsRsmmbRgRhbRgbRsRgRsRsRsRsRsmmmmmbLsRsbRgRgRsRsRgReRsRsmmmmbLsRsRs
RsRsmmmbRgRsRsRsRsRgmmmmbRjRebRibRebReRsmbLjbLgbLobLiRgbRcRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 35; Drug: PCAP2 3 然 Apo 50 然
bRsbRsRsmbRgbRgbRsRsLsmbRgbRsbRsRsmbRsbRsbRsbRsbRsLsbRcLsbRsRsmbRsRsmb
RsRsmbRsbRsbRsbRsRsmbRgbRsbRsbRsRsmbRsRsmbRsbRgRsLsmbRsbRsbRsbRsbRsRsm
bRsbLgbLoLebRgbLsbLsbLiRoLsbLsbRsbRsbRgRgbRgbRgbRsbRsbRsbRsRsmbRsbRsRs
RsmmbRsRsRsmmbRsRsmbRsbRsbRsbRsLsbRsRsmbRsbLsRsRsmbRsRsmbRsbRsbRsRsmbR
sbRsRsmbRsbRsbRsbRsRsmbRsRsRsmmbRsbRsbRgbsbLgLhLsbRjRsRsmmbLebLsbLsbRh
bLiRsLjLhRsRsmbRsbRgRsmbRsbRgbRsRsmbRgbRebRsLsbRsbRsRgRsRsmmbRsbLeLsLh
RsLibLgbLcbLsbsbLsLsRsmbLibLsLsmbLsRsbsbLhbLeLsLibRsLsbLsLsmbRgbRgbRgR
smbRsbRsbRsRsmbRsbRsRsmbRgbRsbRsRsmbRsRsmbRsRsmbRsbsbRsRsmbRsRsmbRgLsb
RsRsmbRsRsmbRsRsmbRsbRsRsmbRsbRsRsmbRsbRsbRsbRsbRsbRsbRsbRsRsmbRsRsmbR
sLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 36; Drug: PCAP2 3 然 Apo 50 然
bLsLsLsmmbLsLsLsmmbsbRsbRsbRsLsbLsbRsbRsbRsRsmbLsbRsbLsLsmbRsbRsLsRsbL
sLsLsmmbRsbLsLsmbLsbLsLsLsmmbLsLsmbLsbsbLsbLsbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 37; Drug: PCAP2 1 然 Apo 50 然
bRhReReRsRsReRemmbRgRsmbRsRsRembRgbRibRcbRcbRibRebRcbLiRsbRjbRgbRsRsRs
RsRsRsRsRgmmmmmmbRsRsRgmbRsRsmbRgRsRsRiRsRimmmbLsRiRsmbRgbLsbLjLgLsRsb
LsLsLsLsmmmbLiLsLsLsLiLsmmbLsLsmbLgLsbLgLsRsRsmbLhbLsRsLsbLsbLsLsmbLob
RcRsmbRibRcReRsmbRiRsmbLjbReRcbRebRiRsRsRiRsmmmbRobRiRsRsmmbRebRgbRgRg
RsmbRiRiRsmbRgRsLsmbRgRgRsRembRiRsmbLobLhLsRsbLgbLcbRhbRebRibRcbRcbRiR
smbRhRsmbRebRgReRibLsbsbLsRsRsmbLsRgRsmbRgRsmbRgRsmbLsbReReRsmbReRsmbR
iReRsmbRsRsmbRhbRiRiRgRsRiRiRsmmbRiRgbRhRsmbRcbRibRcRsmbRiRsmbRibRiRgR
smbRcbRgbRhbRibRhRebRhbRgLsbRsLibLibRjbLiLsbLsbLsLsLiLsLeLsLhLgmbLsLgL
sbLsLgLsRsbLsbLsLsLsLsLsLsmmmmmbLeLebRjbRcbLcLgbLibLobLcLgLibLsbLibLiL
sLhLhbLeLibLgbLobLiRsbLiLsbLibLsLsLsLsLsmmmmbLsLsLsLsLiLsmmmbLiLeLsbLg
bLgLsbLeLebRsbLgLsLsmbLsLsmbLsLgLsbLsLgLsLsLsmmbLgbLgLgbLgbLgLsLsmbLsL
sLsLsmmmbLgLsbLgLsbLgLsLsLgLsmbLoLsmbLcLsmbLgLsLsmbLsLsmbLsLsLsmmbLsLs
LsmmbLsbLebLcbLgLsLsLsRsmmbLgLsbLsLsLsLsLsmmmmbLsLsLsmmbLiRsLsbLgLsbLg
LsbLgLsLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 38; Drug: PCAP2 1 然 Apo 50 然
bLjLsmbRsbLcbLsRsLsRsbRsRsLsRsmbLebLcbLcLebLiLsLsLgLsLsLgRsmmbLsbRcbLs
bRhbRsbRcbRiLsLsmbRibRiRsmbRhbRcbRgbRhbLcbLibLibLibLgLsbLsbLibLsbLsLsm
bLgLsbLsbLcbLsbLsLsmbLjbLhbLcbLsbLibLibLiLgbLgLsLsmbLsbLgbLgbLgLsLsmbL
eLsbLiLsbLcbLhbLhbLhLsLsmbLiLgbLgLgbLsbLgbLsLsLsLsLgLgLsLiLgLsmmmbLgLs
LsLgLgmbLgbLibLgbLiLgbLgbLgLsLsLsLgmmbLgLsLsLgLsLgmbLiLsbRcLsRsbRibRiL
sRsRsmbRsbRgRsRsmmbRobRcbRibRsbRsbRiRsmbRsRsmbsbLjLsmbLjLiLsbLhLsLsmbL
sLsmbRcbRhbRibRiRsmbRibRhbRgRsmbRgbRsbRgRgbRgRsRsRsRgRemmmbRsbRgbRsRsm
bRiRsmbRsRsRsmmbRsbRsbRiLsRsbLcbLhbLibLeLsLsLhmbLiLsbLiLsbLsLsmbLibRgR
smbRhbRcbRgbRibRgbLsbRiRsmbRibRcbRiRsReRsRgmmbRgbRgbLjLsmbLjbLjLgbLsLs
RsmbLcbRsbLhbLeLeLsbLsbLiLibLgLsLeLsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 39; Drug: PCAP2 1 然 Apo 50 然
bRgRsmbRgRsRsmmbsbRgRsmbLcLsmbRoLsbRgRgbRgbRcRsmbLibRobRsRiRsmbRibLobR
cbRgRsLsRsmbsbRgbRgbRibRhbsbRibRibLcbLibLjbLibRjbRcbRjLsbLobLcbLhLgbLc
bLgLsbLcLsmbRjbRgLsLsmbRsbLsRiRsRembsbRgLsbRibRhLsRsbRcbRobRibRiRiRsRg
RcmbRgbRiRsRsmmbRgRsRsRgRsRsmmmmbRsRsRsRsRemmmbRsbRjRsmbLoRsbLcLsmbLeb
LibRhbRibRsbRgLsRsLsRsLsRsbRgRsLsRsRsRsRsRiRsRsmmmmmmbRgbLsRsLsbRibLoL
smbLobLcbLibLhLsbLiRsbLibLiLsLsmbLcbLgbRhbRibRiRsRsmmbRgRsRsmmbRgbRsRs
mbLcbRcbRobRoRsmbRcRsmbLibRgRsmbLjbLsLiRsRsmbRcbRebLcbLebLobRsbLcbLiLs
bLiLsbLcbLhbLibLobLibLibLgLsbLobLibLibLcbLibLibLcbRsRsmbLjbLibLibRjbRc
bLsLsmbRibRobLgbLgLsLsmbLiRsLsbRjRjbLobRcbRcLsRsbLhLsLsmbRjbLgbRibLjbL
hbLhRsRibLcRsbLcLsLsmmbRiRsmbLobRjbRobRcbRibRiRsmbRgbRgbReRsRsRsRimmmb
RebLoRsbLoLsmbLibLgLsbLiLsLsmbRjbRibRibRgRgbRgRsmbRibRjRsmbRjRibRsRsmb
RgbRgbReLsbRibRibRhbRgRsmbRibRcRsmbLsbLiLsbRcbRsbRgbRgbRibLsbLsRsLsbLi
bLhRsbRobRibRhbLibRcbRsbLibRibRiRsRsmmbRgRsRcmbRsRiRgRsRsmmbRibRiRsRiR
sReRimmbLcbRhbRgbRhRsRsRsRgRsRsRemmmmmbRgbLjLsmbRcRsRsmmbRcbRcbRhbRebR
hbRhbRgbLcLsmbLiRsbLibRjbLcbRcbRcbRcRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 40; Drug: PCAP2 1 然 Apo 50 然
bRebRebRibRibRsRsmbRebRebRgbRsRsmbRgbRiRsmbRobRoRsmbRoRsRsLimmbRcRsRgm
bRebRebRgbLcbRgRsRsRsRsRsRsmmmmmmbRsLsRsRsRgRgRsRsRsmmmmbRgRsmbRsbRgbR
gbRsbRibLhLgbLibRobRibRoLsbRcRsmbRcbLebRhbRgRsmbRgRsmbRgRgRsRembRiRsmb
RibRibRobRjbRhRsmbRhbLgbRcbLgbReRsmbReRsmbReRsmbRibRhLsbLibRsRjRsmbRib
RhbRcbLhbRcbRcbLgbRhbRgbRgbRhLsbLgRsbRsRsRsmmbRibLgRsLsbLsRsbRiRsmbRgR
sRembReRgbRibRibRsLsLsmbRibRibLsbRhbRsRibRcbRgRsmbRibRgRsmbRgRsRsRsmmm
bRibLibRibRibLgbRcbRgbRcbLgRsLsbRjbLjLsmbRoRsmbRhRsmbRsLsRsRsmbRsbRsRs
RsmmbRsRibRibRebLcbRcbRcRsmbReRsRsmmbLeLsbRebRsRsRsRsRsmmmmbLcbRcRsmbR
iRsmbRiRsRsRiRsRiRsmmmmbLsbLcbRjbLcbLhbRcbLsRgRgRsRsRsRsmmmmbLsRgRsRsR
immbRibRsbLcbLibRjbRhbLjbRcRsRsmmbReRebRgbLobRhRsmbRsRsRsRgmmbLjbRcbLg
bRibRsRsRsmmbRibRibRsRsRsmmbRgRsRsmmbRsRsRsRsRsRsRhmmmmmbLsbRiRsmbRgRs
RsRsmmmbRibLgRsRsmbLibRebRcbRsbRibRsRgRibRgbLgbRibRsRgbRiRsmbRgRsRsmmb
RsRsmbRgRsmbRgbLgbRcbRsRsRembRgRsmbRgbLibRcbReRsmbRobRjLsbRibRcbRibRib
RjbLcbRhRsmbRgbRibRcbRsbRibRcbLibRibLibRjLsRsbRsbRcRsmbLsRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 41; Drug: PCAP2 1 然 Apo 50 然
bRcbRcRsmbRcRsRgmbRiRsRcRiLsRsmbReRsRsmmbRsRsmbRcRsmbLsbRhbRiRsmbRgbRg
RsRsmmbRcRibRcbRobRcRsmbRibRsbsbLsbLibLsbRsbsbLgLgLebRgbRcbLsLsLjmbLsL
smbLsLsmbLgLsbLhLsbLsLsRsmbLsLsmbLibLsLgbLsLgbLsbLgRsbLgLsbLgLsLsmbLgb
LibLobLebLcRsbLsbLgbLiLsLsmbLeLsLsLsmmbLsbLsLgLsbLsLsmbLsLsmbLsLsmbLgb
LgLsbLgLsbLsbLsLsmbLcbRcRsmbRcRsRsmmbRiRsmbRibsbLcbLsLsmbLsbLgLsbLsLsm
bRcbRoRsRsRsmmmbRobLgbLhbLobLibLgbLobLiLsbLgbLgbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 42; Drug: PCAP2 1 然 Apo 50 然
bRgbRiRsmbRiReRsmbLiLsbRcRsmbRsbRibRsRsRsmmbLsbRsbRgRgRsRgmbRgbRsRsLsm
bRgbRsRsRsRsmmmbRjRsRsRsmmmbRiRsmbRhbRcbRibRiRsmbRibRibRobRgbRcbRgRsmb
RsRgRsRsLsmmbLsbRgRsRsRsRsRsRgRsmmmmmmbRgbRgbRgRsLsRsLsRsRsmmbRsRsRsRs
mmmbRibRiRsLsmbRibRiRsmbRgbRgbRiRsmbRibRgRhRsRgRsRiRsRimmmbRgbRibLsRsb
LsRsRsmbRhRsLsmbRiLsbRgRsmbRibRcRsmbRsbRgReRgbRsbRsRsmbRibRiRibLcLsmbL
hLsLsLeLhmbLcbLiRsbLcbLibLeRsbRibRibRibRsbRsbRgRsmbRsLsRsbRsbRsbsbRibR
gRsmbRsRsmbRcRsmbRibRcRebRiRibLgbLcbLebLeLiLsbLgLsLgLsbLcLsLsLgmmbLeLi
bLiLhLgbLcbLhLsbLibLibRsRsRsmmbRjbRiRgbRibRgRgbReRsmbRgRsmbRgRsmbRgbRc
RgRsRhmbRsbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 43; Drug: Control Apo 50 然
bRcbLsbRiRsmbRobRcbRhbRiRsmbLjLsmbRsRsLsmbRjbRcbRibRibLiLhLsLsmbRsLsbL
cLsmbsbLgRsLsRsLsRsbRsRcRjbRibLibRiLsbRsRhbRcbLsLsmbRjbRcbRiLsLsmbLgbR
oLsbRsbLjbRjbRhbLcbLebLibLcLsmbLgbLibRjbRebRibLsbRhLsbRsLsbRebRcLsbRcR
ibReRsmbRgbLjbRibRiLsbRibRhRsmbLsbRcbRsbRhbRiLsRsbRsbRibRcRgbRcbLjRsbL
hbRhRsmbRibLgLsbRibRhbRhLsbRcbRibRebRcbRhbRsRiLsbLcbLeLsLsLsmmbLibLsbL
jLsmbRjbRcbLcbLhLiLgLsbLgbLsbLiRsbLibRjbRcLsbRiLsbRibRiRebRgbRibRcRsmb
RhbRcbLjbLiRsbLhbRcbRcbRhRgbRgbRebLibLibLcLsmbLcbLobLibLcbLebLeLgbLibL
gbLgbRcbRiRsmbRibRibRgRgRebRebLsRsbRsRsmbLsLobLebRiLsLibLiLsLsmbLsLebL
ebLsbLsbLsLsLsLemmbLjRsbRibLsbRhbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 44; Drug: Control Apo 50 然
bLcbRsbLibLgbLsbLsLibLibLgLsbLibLgLsbLibRibRebRhbRsbRiRsmbRsbRgbRibRsR
smbRibLeLsLsLsmmbRibLsbRsLsbLgbRjbLgLsbLiLgLgbLsbLgbLebRebRibRiLsbRsbR
ibLsbLsbLiLsLsLsmmbLiLsbLgRsbRibRhbRiRsmbRgbLgbRcbRgbLgRsbRgbRgbRsbLsL
smbRibRiLsLsmbLiLsbRibLgRsLsRsLsLsLsLsLsLemmmmbLsLsLsLsmmmbLgbLgbLgbLo
bLibReRsRsmmbRibRgLsbRgbRgbRiRsRgmbRiRsRsRemmbRgbRgbRgbLhbRsbLgLsLsLiL
sLembRsLsbLiLsbLgbRsbLhbRsLsbLiLsLsmbLgbLgLsLsmbLgLsbLsbRsbLgbLsLsmbLs
LsmbRcRsmbRibLiLsbRebRibRgbRgRsRiReRgmbRibLjbRiRsmbRibRgbLibRhbLibRhRs
mbRsbRcbLgbRsbRiRiRsRsmmbRibRiReRgbRibRsbLgbRhb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 45; Drug: Control Apo 50 然
bsbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 46; Drug: Control Apo 50 然
bLhLsbLsbLgLibLgLsbLsbLsbLhbRebRebRibLibLgLsbLgbLiRsbRgLibRobLiLgbRsbL
ibLsLsLsmmbLgLiLsbRibLgbLgLcbRsRsmbLibLeLsLsmbLiLgbLiLsbLgLsbLgbLgLsLs
mbLebLebLibLeRsbLebLiLgbLibLibLebLiLsbLcbLibRsbLgLebLhbLgbLebLibLibLgb
LgbLhLsbLcbLibLibLcbLhRsbLcbLebLgLgLsbLhLebLiLsbLjbLebLcbRiRsRsRsmmmbL
sbLgbLibLgbLgbLiLsbLhLsLsLsLgmmbLiLgbLgLibRsLcLsmbLebLhbLebLibRjbLibLi
bLeLsbLhLgbLsbLgbLibLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 47; Drug: Control Apo 50 然
bRibRibRcbRjbRiRsmbRiRsmbLsLcLsLsmmbRcRsmbRhbRcbRcbRcbRcbLibLcLsmbLibL
iLsbLcbLhbLcLsmbRiRsmbRiRsmbRhbRcRsmbRibLjLsmbLebRebRcbLibRgRsRsmmbLgb
RibRebLiLsbReRsmbRgRsmbLhbRhbLhbRoRsmbRcbRcbRiRsmbLcbLobRcRsmbRcbRgbRh
bRjbRjbRsRsRjmb

>ZF Recording 2016-04-15; tW: 300s; Start: 115025; End: 115525;
Recording: 5-1; Individual: 48; Drug: Control Apo 50 然
bLgLsbLgLsbLhbRcbRcbLjbLcRsbLibLibLcbLobLgbLobLibLcRsbLcbLobLobRjbRcRs
mbRibRibRjbRcLsbRibRoRsmbRgbRibRgbLobRibLibLibLebLgLsbLeLgLsbLobLcbLgR
gbLjbLibLgbLibLibLibLgbLgbLhbLobRcbRsbRhbRibRiRsmbRibLsbLjbLibLibLiRsL
sbLibLcbLgbLgbLgbLhbLgbLobLsLibLibLgbLiLsbLibLibLiRsbLgbLebLeLeLsbLgLs
RsbLsbLcbRsbLsbLgbLgbLgbRgbLibLibLcbRibLebLibLebLobLibLsbLhbLibLjLjbLh
bRcbRibRibRibRibLebLibLibRebLcbLibLcbLibLib

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 1; Drug: PCAP2 10 然 Apo 50 然
bLsbLsbLibRobRgbRsbRsRsmbRsRsmbRgRsRsRsRsmmmmbLsbRsRsRsmmbRsbRsRsRsmmb
RsbRsRsRsmmbRsRsmbRsbRgbRgLsbLobRcbLcbLgbRsbLgLsRgbRgbLsbRgbRgbRsRsmbL
sRsLsbRsbLjbLibRobRgbLsbRsbRsbRgbRsbRsbRsbRgRsmbRgbLoLsmbRgRsmbRgbLsbR
sRsRsRsRsRsRsmmmmmmbRsRgbLsbRgbLobRsbRsbRgbLsbRsbRcbLjLsRsmbRobRibLoLe
LeLsbLsbLsbLsLgLsbLjLsmbLgLgbLsbRebLjbLcRsRsmbRsLsRsbRcbRjbRobRibRjbRh
bRobRgRsRsRsRgRsRgRgmmmmbRcLgbReRsmbRsbRsRsLsmbRsbRsbRsbLgbRhLsbLgLsbR
sbLsbLsbLsbLsbLsbLsLsLsmmbLgLsLgbLsbLsbLsbLsbLobRhbLgbRgLoRsbLsbRobRgb
RsbRsbLsRsbRsbLcLsmbsbLsRjLsLsmbRoLsbRgbRsRsRsmmbRebRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 2; Drug: PCAP2 10 然 Apo 50 然
bLobLgLsbRsbRsbRsbRsbRgbRgbRgRsmbRgRebRobRcbReRebLcbLcbLoRsbRoRsmbLcLs
mbLoRsbLobLhbLcbLoRsbRgbLcbLibLcRsbRhRsRsmmbRsbRgRsRgRsRsRsmmmmbRsRsmb
RsRsRsRemmbRebRgbLsbLsbRsbRobRcRsmbRobRcRsRsmmbRibRcbRebRobLoLhLsbLiLi
LoRsRsmbRoRsmbLgbLebRsbLibsbLeLibLibLobLobRsbRsbRhbRsbRgRsLsmbLgbLgbRs
bRgbRgRsmbRibRibRobLobsbRiRsmbLebLiRsbLiRebRoRsmbLcbRgbLhRsbLcLgbRjbRc
RsRsmmbRgbLcbLibLibRsbLobRcRsmbRgRgRsmbRcRsmbLsbRibRibRgbRgRsRsReRsRsR
gmmmmbRgbRibRgRsmbRgbRgbRibRiRsmbRgRsmbRcbRhbRcRsmbRibRoRsRsRsmmmbLgbR
ebRobRibLobLibLsLhbRsbLibRsbRgRsRsmmbsbRgRsmbRgbRgbLobLsbRcRsRsmmbLoLs
LsmmbLgbLgLgbLibLsLiRsLsbLgbRcbRgbRibLsLsLsmmbLsRsRsmbRcRsLsmbRgbRgbRs
LsbRgbRgRibLgbRsRgbsbRsRsRsRgRsLsLsRsmmmmbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 3; Drug: PCAP2 10 然 Apo 50 然
bRoRsmbReRobLoRsbLebLsbRsRgbRsbRsRsmbRjbRiRgRsRsmmbLibLsRsbReRsmbLibRo
RcbRhRsRcmbRebRoLibRsbLhbLgRsbRibRebRibLjbRobLebLsbLsRsbLibLobLobLibRj
bRjbLsbRibLjbRibRiRgRsRjmbRebRobRibRsbRsRsmbLsbRjLgRsbRgRsmbLibLgbRgbL
obLibRhbRhLsbRsRsmbLgbLibLgbLgbRsLsbLsbsbsbRsRsmbRcRsmbRsbRsbLsRsRsmbR
sLsbRsRsLombRsbRsLsbRsbLsbRsbLsRsbsbsbRsbsbRgbLobLsbRcbLobLibLoRsbLibR
gbRibRsbRsbRsbLsbRsbLsbRsbRsbLsbLsbRsbLjbsbRsbRcbReRsmbRobRobRibsbRjbR
cRsLsmbRgbRibRsRsmbsbLjbLsbLjbRcbLhbsbLsbRsbRsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 4; Drug: PCAP2 10 然 Apo 50 然
bRsLsbLsRsLsbLsbLsLsRsmbLoRgRsmbRsbRsbRsbRobLsbRsLsRsbLsRsbLsbLsbLsbsb
sbsbsbsbLobLobLiRsbLsbRsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 5; Drug: PCAP2 10 然 Apo 50 然
bRsbRgRsmbLsbLsbLsbRsbRsbRgRsmbRgbRgbLsRsRsRsmmbsbsbsbLsbRsbRsRsmbRgLs
bRsbRsbRsbRiLsRsbRsbRsbRsbRsRsLsmbRsRsRsmmbRgRsmbRgLsbRsbRsbsbsbRsRsRs
LsmmbRgbRgbRsRsmbRgbRsbRgbRsRsmbRsRsmbRsbLsbRsRsmbRibsbRsRsmbRsRsmbRgb
RiRgRsmbRsLsRsbRsRsmbLsRsbRsRsmbRsRsRsmmbRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 6; Drug: PCAP2 10 然 Apo 50 然
bLobRsbLebsbLeRoRjbRhbRiLsLeLibLebLsbRobLobRgRsmbLhLobLcbRobLsRjbRibRo
bRebRobLiLsbLsbLcbLcbRiLsbRcRsLsmbRibLsLsmbRgbLgbRcbRiLsbLgbLgbLeLsbRs
LsbLeLsbLcLsLcLsmmbLobRoLsbLgbsbLjRsbsbLiLsbRjLeRsbLebRcbRoRsmbRoRsRsm
mbRsRsmbLsbRgRsRsmmbLebRcLsRgbRiRsRsmmbLgbLebLgbLgRsbRobRibRibRgbLobLc
bLsRgbLgbRjbRsbLjbLibLsbRsRsmbLobRsRsRsmmbLgbRjbRobLcLsmbLgbRcbRjbLgRs
RsmbLibLebRebLsbLibRobRhbRgRsRimbRsRgbRcbLob

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 7; Drug: PCAP2 3 然 Apo 50 然
bRgbsbRsbLsbRsbRsRsmbRgbRsbRsbRsbRsRsmbRsbRsbRsRsmbRsbRsRsmbRgbLsbRsbR
sRsmbRsbRgbRsbRjbRgbLsLsLsmmbLsbRgRsmbRsRsmbRsbRsbRibLgbRsbRsbsbRsbRsb
RgbRhbLobLcbLgbLibLibLibLgLsbLsbLgbLsbLsbLsbLsLsmbLsLsRsmbLsLsmbLsLsmb
LsbLsbLsbRsbLsbLsbLsLsLsmmbLsbLsbLcbsbLsRsbLsRsbLobLsbRsLsLsmbLgbLsLsm
bsbLsLsmbRsbRsbLibLcLeLsLsmbLcbLsLsLsLsmmmbRsLsbLsLsLsRsmmbLsbLsbLgLsb
LsRsbLsLsmbLsLsmbLsbLgbRob

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 8; Drug: PCAP2 3 然 Apo 50 然
bLsLsmbLjbLcbLebLhLsbRibRebLcLsLcmbRebRgbLcbLgbLobLiLsbLibRcRsReLgmbLe
bRobRcbRcbLsbLcLsmbLiLgbLcLsmbLcbRjbRsRjbRibRjbRsRebReRsmbRcbLebRsbLcL
smbRsbLcLsLcmbLgbLeLsLsmbLebLcLgbLcbRjbRjbLcbLebLsLibLcbLibLebLiRsbRsb
RcbRebLibRcRsmbReRsmbLebReLsbLgbLebRjLsbRjbLcbLcLsLsmmbLcRsbRebRebLcbL
obRcbLsLhLsbLcLsmbLebLhLsbRebRsbRebRcbRsRsmbLsRhRgbRibReRsmbRsRebRsRcb
RiRgRsmbReRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 9; Drug: PCAP2 3 然 Apo 50 然
bRjbRibRibReRsRsReRsRsRhmmmmbRiRsRembRibLjbReRsRiRsRsRsLsmmmmbLsLsReRg
RgmbReRsmbRiRsRsRsLsmmmbRgRsmbRibRiRsRsRsRsRsRgmmmmmbRsRcbRjbLcbLcbRib
RjRsRsRsmmmbRgRsmbRiRsRsmmbRiRgRsRsRgmmbRgRiRgRsmbRhRsmbRiRsRembRgRsmb
ReRgbReRsLsmbRsRsmbRibRiReRsmbRebRgbRhbRcRsRsRsmmmbLgRebRibRcbRobRcRsm
bLibLibRibLcbLsbLibRcbRcbRgRsRsmmbRiRsRsmmbRgRsRgRsRimmbRgbRsRiRsRsmmb
RgRgbRgRebRibLibRibLibRebRgRgbRgbRjbReRsmbLjbRebLcbsbLsbLsRsbRcRsmbRgR
sRiRsmmbsbRsRsRsmmbRsbRsbRsbRgRsRsRsRimmmbRiRsRsRgLsmmbRgRgbRgbRgRsRsR
sRsRsmmmmmbRebRsRibRebRibRibRebReRsmbRibRsbRebLsRsRgRsRgRsmmbLsbRcbLeb
LibRiRsmbRhbRcbLebLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 10; Drug: PCAP2 3 然 Apo 50 然
b

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 11; Drug: PCAP2 3 然 Apo 50 然
bRsbRsRsRsmmbLsRsbRsRsmbRsRsmbRsbRsbRsbRsbsbRsbRsbLsRsRsRsmmbsbsbRsRsL
smbRsbRsbRsRsmbRsbRsRsRsmmbRsbRsbRsbRsbRsbLsRsRsmbRsRsmbRsbRsbRsbLsRsb
RsbLsbRsRsmbLsRsRsmbLsRsbLsbLsbLsRsRsmbLsRsbLsbRsRsmbRsbRsbsbRsRsmbsbs
bRsbRsRsmbRsRsmbRsbLsRsbRsbRsbRsbRsbRsRsmbRsbRsbRsRsRsmmbRsRsmbRsbLsRs
bRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 12; Drug: PCAP2 3 然 Apo 50 然
bRsRhbsbLsbRiRsRgRgmbLibRcbRsRsRsRsRsmmmmbLibRcbRsRgRibRebRgbRebRibReb
LcbLcbLiRsbRhRsRsRsRsRsRgRsRsRsRsReRhRsRgmmmmmmmmmmbRsRsRsRsmmmbRsRsRs
RgRsmmmbLcLsmbLibLgLsLsLsmmbLgLsbLibRgbRcbRebReRsmbRebRibRgbRcbRebRiRg
bRsRgbLibLsbLhbLgbLsbRsRgbRgRsRsRsRsRsRsRsRsRimmmmmmmmbRsbRgRsmbRgRsRs
RsRgRsRsRsmmmmmmbRebReRsmbLobRsLsbLibRiRsRiRsRsRsmmmmbRiRsRsmmbRgbRsRi
bRgRsRimbRsRgRebRsRsmbRgbLgbRcbRhbRebRcbRebLobRsRsRsRsmmmbRsRsRsRgRsmm
mbReLsbRgRsRsRemmbLcbsbsbRsbRsRsRsRiRgRsRsRsmmmmmbRgRsmbRiRsRsRsmmmbRs
RsRsRsRsRsmmmmmbLsRsbRgRgbLsRsbRsRsRsmmbRgbRgRsmbLsbLobRsbRsRsmbRjRsRg
mbRsRgRsRsRsRgmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 13; Drug: PCAP2 1 然 Apo 50 然
bLjRsbLjLsmbLebLsbLcbLcbLiLiLebLibReRsmbLjLsmbLjbLibLcbLhbLebLgRsLeLsb
LgLsLsLsmmbLsLebLgbLibLhbRcbRcbRcbRcRsReLembLgLsLsmbLiRsbRjbLjLsmbLjLg
bLibLhLsbLoRsbRibRcRsRsmmbRibLgbRjRsmbRcbRcbRcbRcbsbsbRhRsRsmmbRgLsbRs
bLibLobLhLsbLcLsLsmmbRgRsmbLiLsLsLsLsLemmmbLeLsLsmbRsLgLiLgbRgbLebRgRs
mbRsbRsRsRsRsmmmbRsRgRcbLhLsLsmbLjbRibRcbRhbRsbRsRsRsRsmmmbRgRsmbsbRsb
RibRobRcRebLsRsbRgbRsbRiLsLgLsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 14; Drug: PCAP2 1 然 Apo 50 然
bRebRsbRsRsReRsmmbRgbRibsbsbsbsbsbsbsbsbsbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 15; Drug: PCAP2 1 然 Apo 50 然
bLcbLgbLebLhbLcLsmbRibRgbRibLgLsLsmbLsbLobRhbRiRsmbRibRsbRebRibRiRgbRo
bRsRhRsRgmbRsRhbLsbRcbLjLjLsmbRsRgRsRsmmbLiLsbLibLibRibLcbLiLsbLiLsbLg
bRiRsmbLeLsLgLibLibLibLibLiLibLebRgbRibRhbRobLgbLibLcLsmbRhLgbLsbRjbLi
bRsRsmbLgLsbLjLsLsmmbLgbLcbLibLcbRgRgRsRsmmbLgLsbsbRcbRsRcbRjRsmbRebLi
bRjbRcRsRsRsRimmmbRgRsmbRgbRibRsLsbRhbRgbRcbRjbRcbRhbRiRsmbRcbLcbRcbLj
LsmbRibRgbLebRsbRibLcLsmbLgLgLsbRsRsRsRsRsmmmmbLcbRiRsmbLjLsLsmmbRibLe
bLsbsbRgRsmbRibRsRsmbLcbLiLsbLiLsbLcbLgbLhbLibRsbLcbRgLsbLobLiLsbLebLe
bRibLibLjb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 16; Drug: PCAP2 1 然 Apo 50 然
bLgLsbRsbLsLsmbLgLsLsRsmbLsLsmbLsLsmbLgLsbLsbRsbLgLsbLsLsLsLsLsLsmmmmm
bLibLiLsLsmbLsbLsLsmbLsLsLgLsLsLsmmmbLsLsRsmbLsRsbLibLsbLsbLsLsmbLsbLs
bLsLsLsmmbLsbLgLsbLsLgbLgRsLsLsLsLgmmbLgbLgbLsLsmbLsbLgbLgbLgbLgLsbLsL
sLsmmbLsLgLsbLsLgbLgLsbLgLsbLgLsbLgbRsbLsbLgLgLsLgLsbRcbRhbRibLsbRebLe
LsbLebLebLibLgLsbLsLgLsbLsbLsbLgbLgbLsbLgbLsbLgLsLgbLsLgbRibLebLiLsbRg
bRgbRgbRsbRiLsbRsbRsRgRsRsmmbRgRsRsmmbLsbRsRsmbRgbRgbRibRsRsmbLsLsLsRs
mmbRsLsbLgLsLsmbLgLsbLgbsbRgbLgLsbLsbLgbLibRcbsbsbRgbRhbRgbLsRsbRibRgb
RsRgRsmbRgbRsRsmbRgbRgbRsRsmbRgbRgLsbRibRgRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 17; Drug: PCAP2 1 然 Apo 50 然
bLsbRgbLobLsbLeLsbRcRsRsRsRgmmmbRiLsbReRsLgmbLcbLoLsmbLibLcbLgbLibLcbL
sbRcbRgRsmbLibRibRcbRobLebRgbRibRhbLeLsbLiLsbLibLcbLgLsbLebLhbLcbLebLi
bLcLsmbRjbLcLsmbLjbRibRsbRhbRibReRsmbRhbLsLebLeLsbLsbLebLgbLibLcLgbLeb
LcLsRsRgmbLhbLibLebRobRibRibRibRiRsmbRcbRiRibRhbLebLjLgbLebLeLibLibRib
LcbLjbLcLgLsbLibRcLsbRibRobLsLsmbLcbLhLibLgbRjRibLcbLebLcbLeLibLhbLhbL
ibRibLsbRobRibRgbRhbRgbLsbLsbLhbLgRsbRsbLjbRcbRjRsmbRjbRibRjbRebLcbRgb
RhRsmbRjbLiLsbLcbLobLobRhRsmbRcbLobLibLhbLgLgbRoRsmbLcbLcbLhbLgbLsbLcb
LhbLsLebLibLsbLobLcbLobRgLsbLsbsbsbRebRjbRgLsbLebLcbLgLsbLcbRgbRobRgRg
bRibRcbLobLibLcbLobLcLcLsmbLeLsbLebLcbLibLibLiRsRsmbLjbLcbLjLcbLjbLibL
jLsmbLjbLjLjbLcbRibLjRsbRibRjbRcbLjbLcbLsbLsLsLsmmbLcbLcbLiLsbLgbLebLc
bLibLebLcbLhRsLibRjbRhbRibRibRsLsbRibRjbRjbRgbLgbLebLibLiLsbLjLhbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 18; Drug: PCAP2 1 然 Apo 50 然
bLjLsRsRsRsmmmbRiRsmbRoLsbRcRiRsmbRsbRjRsRgRsmmbRsbRibRoLsbRjRcbRgbRsR
sRsLsmmbRgRgRsRsLsmmbRgRsmbLcbRsLhbLcLsmbLsbRoLsbRobRhbRiRsmbLcbRsRsRs
mmbRjbRiLsLsmbRgbRibRoRsmbReRsRsmmbRcbRcbRcbRsbLgbRsRsmbRcRsRsmmbRcbRc
RsRsmmbRcRsmbRcbRcbRebRsRsmbLcbLibLsbReRiRsRsRsmmmbLsRsRsRgRsmmbRibRcb
LsbsbRsbLgLsRsbRjbRgRsmbLgbLsLibLoRhbLibRcbLsbRcRsRsmmbReRsmbsbRcRsmbR
obRiRibsbRgbRsbRcLsbRhbRobRsRsRembRebRjRsmbRebRebRjRgbLsbLjbLhLgbRjbRh
bRjRgRiRsmbLibReRsmbLjRebLjbLibRjbRsbRhbRsRsRsRsmmmbRsRgbLcbLcbLsRsbLc
RsbLibLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 19; Drug: Control Apo 50 然
bLsLgbLebLgbLebLgbLiLeLgbLiLsLgbLgLgbLeLebLibLgLsLsmbLgbLiLsbLsLgLsLsm
bLsLsLembsbRsbLsLsmbLeLsbLgbLibLsLsmbLebLeLsbLgbLgbLebLcLsmbLoLsmbRebR
sLsLsmbRsbLebRgLsLgbLsLsLembLebLgLsbRsbLsLsLeLsLhLsmbRsbRsbRsbRsbLsLsm
bsbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 20; Drug: Control Apo 50 然
bLsLebLgLsLebLgbLebRcbRibLsbRsbLhLsbLebLibLebRgbRibRgRsmbRsLsbRgRsRsmm
bRgbRgRsRsmmbLjbRebLgbLcLgbLibLiLgLsLsLsLsLsmmmmbRsLsbLgLsRsbRsbRjbRib
RgbRgRsmbRgbRsRsmbRiRgRsmbRiRibRibRgbLhbLcbLibLebRebLsbRhbRjbRsbLsbLib
LgbLebLebRibRibRsbRcbLgbLsRsbLsRsbRcbLgbLcbLibLgbLhLsLsLgmbLebReRsmbRh
bRcRsmbLgbLgbLebLcbLgbLsbRebLgbLgLebRibLsbLhbLebLgLsRsbLiLsbLgbLibLibL
gbLhbLcbLcbRobsbRsRsmbLsbRiLsbRsbLsbRibRgbRgRsmbRcbRiRgbLjLsmbLibLcbRh
bRgRsLsmbRebRobRibRsbRgRsRsmmbRsRgbRibRgbLsRgbRcLgLsbLeRsbLsLsmbRgRsmb
RsRsRsRsRsRsmmmmmbRsRsmbRsRsRgRsRsmmmbRibRgRsmbRgRgRsRsRsmmmbRibLsbRib
RgRgRsRsRsRsRsmmmmmbRsRsRsRsRsRsRsRgmmmmmmbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 21; Drug: Control Apo 50 然
bRsRsRsRsRgReRsmmmmbRhbRcRhRebRiReRebRgbRebRiRsRsmmbLhbsbRcbLsbRibLjbL
eLhbLcRiRsmbRgbLhbLiLsLsLoLgRsRsLsmmbRcLibRsbRebRgbRobRgbRcbRibLcbRjbR
ibRibLsbLsbLjbRibRsRgRgRsRsRiRsmmmbRsRsReRgmbRiRsLsRsLsmbRoRsmbRsbRibR
sbLgbLsbRsbLsbRsbRsbLsbRsbLjLsmbRhRsRembRiRgbRgRebRsRebRcbRcbRiRsmbRgb
RgbRobRibRgbRcbRgbRhbRobRgbRiRsmbRsbRiRsmbRibLsbRsbRiRsmbRgbRgRsmbRgRs
mbRgbLhbLibLibLgRsbRsRsmbLhbRcRsmbRgRsRsRsmmmbsbsbRsbRsbLsLsLsmmbLsLsm
bRsbsbsbsbLsbLsLsRsmbLsbLsbsbRsRsmbRsbsbsbsbLsbRsLsLsmbLsbsbsbsbRsbsbs
bLsbLsLsRsmbRsRibRsLsbLcLsLgmbLsbLiLsbLsLgLsLeLsbLoRsRjbRiRcbRcRgbRgbL
sbLoLibLgLsbLgLsRsLsbLgRsbLiLsbLgLgLobLobLeLhbLebLgLibLgLsbLiLsbLhLsLs
LgmbLgbLhbLiLsLsLgmbLgLsLsLsLimmbLibsbRsRsLgmbRcbLcbLibRibRcRibRgbRgLs
bRgbLjbLebLgLsLsmbLsLsLgLsLsmmbRcRsmbLcbLobLibLcbLeLgLsbLgbLiLsLibLibR
ebRhRebRsLsbRobRibRcbRibRibRgRsmbRiRsRsRsmmmbRgRsRsmmbRgRsmbReRsRsRiRs
mmmbRsbRgbRsLsbLsbRsbLsbRiRsmbRgRsRsmmbRsbRibLibLcLiLiLgbLgbLsLsmbLibR
cbRhRebRcbRgbRsbRhbRebRiLsbRgRsmbRsbRsbLsbRsLsbRsRsmbLjb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 22; Drug: Control Apo 50 然
bRcbLcLsmbLhbRcbRibRgbRibRcbRcRgRibRcbRhRibRhRsmbRibRibRcbRcRsmbRcbRcb
RiRsmbRibRcRsmbRcbRcbRcbRcbRebRcbRcbRibReRebReRsmbRebReRsmbRiRsmbRiRsR
eRsRsmmmbRgbLcbRcbLobLcbLobRcbRobRcbRibRhbRiRcRsmbRcbRcbRjbLobRebRcbRi
bRebRhbRebReRsmbRebRebRibRcRsmbRhbRcbRcbRebRebLiLsbRhbRebLsRcRsmbRhRsm
bLhbRcRsmbRcbRebRcbLcbRcbRhLsbRibRiRsmbRhbReRsmbRcbRcbRibRibRcbRhRiRsm
bRsbLcbLcbRcbRhbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 23; Drug: Control Apo 50 然
bRcbRgbRibRjRsmbRjRgbRjbRhbLgbLgbLibLsbLhbLibRgbLeLgLgbLgbLgbLibLibLib
LibLibLibLibLgbRjbLgbLobLgbRibRibRiRsRsmmbReRebRgbsbRebRsRgbReLsbReRgb
RhbRgbRcRsmbRiRsRgmbRebRiRsmbLibLibLiLsbRjbLibLibLgbRsRsmbRcbLcbLjbRcb
RhbLibRjbLjbRcbRgbLibRjbRsRsmbRibLcbRgbRgbLsbRjbLhbLcbRcbRibRgbRibRiRh
bRiRsRembRiRsmbRcLsbRoLsLsmbRibRsRsRsmmbLebLgbRsbLgbLgbLibLgbLibLibLgb
LibLgbLgbLgLsbLgbLhbLhbLgbLgbLgbLgbLgLsbLgbLiRsbLgbRibLhLibLgbLjbRjbLi
bRgbLiLsLgbLcbLgbRhLsbLiLsbLgRgLsbLibRibLgLsbLibRjbRhbRibRgRgbRibRcbRh
bRgbRibRgLsbRjbRibLgbLhbRcbRgbRobRibLibRibRibLjbLcbLibRcbRgbRibRsbRgbR
sbRsRhbLibsbLjbLibLsbLibLibRibRibRobRcbLoRsbLibLibLibRebRiRsmbLcbRcbLc
LgLgLsbLibLibRibLiRsbLibLibRgbLibLgRsbLibLgbRhbRibRhbRsbRibRgRgLsbRsRc
bRsRoLsbLebLebLobLibLhbLgbLsLiLsbLgbLgLsbLgbRhbLjbLibLibRcbLcLgLsbLgbL
gLgbRgbRcbLebLibLibLgbLibLgbLgRsbLsRsbLibLgbRgbLibRhbLhbRcbRiRsmbRiRgR
smbRhbRgRsmbRgbRgbRgbRebRibLcbRcbRibRgbRgbRgbRgbRgbRsbRsbRgbRsbLjbLibR
jbLcbLebRjbRcbLsbLcRsbRhb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 24; Drug: Control Apo 50 然
bLiLjLsLsmmbLjbLiLsLsmbLibLibLibLiLgbLibLcbLiLsbLgLsbRjbLgRsbLhLsbLjLs
mbLibLhLsbLibLiLsLsmbRjbLibLcbLibLjLsmbLgLsbLiLsLsmbLjLsmbLcbLibLjLsmb
LibRebLhbLgbRjbLgbRcbLcLsmbReLsbRiRsmbRcRsmbLobLcbLcLsmbLcLibLibRsLsbL
sRsbLsRcbLibLcbLgbRsbLiRsbRibLibRiRsmbLsbLibsbsbLhLsbLcbLcbLcbLcbLebLi
RsbLsRsbRiRsmbRcbLjbLsbLcbLhLsbLjLsmbLcbLiLsbLibLiLsbLhLsbLibLgbLcbRjR
smbLiLsbLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 25; Drug: PCAP2 10 然 Apo 50 然
bLsLsmbRgbLcbRsbRgbLsbRebRhbLcLsmbRebRgbRsRibRibRebRebRhbRcbRjRebsbRsL
sbLsbLsbRsbsbLsbRcbRgbRiRebRsbRiRsmbLsLsLsLsLsmmmmbRhbRjbLgbRcRsmbRsLs
bRiRgbRgRsmbRsRsRsmmbRsRsmbLebLibLcLsmbLjbLsbRhbRsRibLibLcbRsbLoLsmbLc
LsmbLsLgbLsLsLgLsLsmmbRsbLsRsLsbsbRsbsbRebRebLsbRgbRgbLobRsbLsLsmbReRs
mbLibLcbRibRcbLsRsbLgbLgLsbLcRsbLcRsbLgbLhbRjbRibLgbsbRsbRgbLsLsmbRebR
ebLibRcbRjbRibRiRsmbsbRsRibRiRsmbRsbRgbReLibLsLsmbsbsbLsRsbLebRhLsbLgb
LcbReRsmbRjbRibLsLibLsbLjbLsbLsLsmbLsbsbRcbRgbLgbRjbLcbLsbsbRebLsbLcRs
bRsbRsRsRsRsmmmbRcbRobLcbLebRsRsLsmbRgRsmbLsbReRsmbReRiRsmbReRsRsRgmmb
RgbRsRsmbRsbRebRhRsRsmmbRiRsmbRebLob

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 26; Drug: PCAP2 10 然 Apo 50 然
bLsbLgbLsLsmbLsLsmbLgbLsbLsbsbLsbRsLsbLsLsLsmmbLsLsmbLsLsmbLsbLgLsRsbL
sbLgbLsLsmbLsbLsRsbLsLsmbLsbLgbLsLsmbLgRsRsRsLgmmbsbsbRsbsbsbsbsbLsbLs
LsmbLsLsmbsbRsLsbLsLsmbsbsbLgLsbLgbLgLsbLgbLsbLgbLsLsmbLsLsmbLsbLgbLgb
LsLgbLsbLsLsRsmbLsbLsRsbLgbLsbsbLsbLsbsbsbLsLsLsLsLsmmmmbLgLsbLgbLgbLs
bLsbLsbLsLsmbLsLsmbLsRsLsbLsLsmbLgbLgLsbLsLsmbLsLsLsmmbLsLsLsmmbLsLsLs
mmbRsbRsLsLsRsmbLgbsbsbsbLsLsmbsbLsbLgbLgbLgbLsbLsLsmbLsLsLsmmbLgbLsLs
RsRsmmbLsbLsLsmbLgbLsbLsbLsbLgbsbsbsbsbLsbLsbsbLsbLsbsbLgbLgLsLsmbLgbL
sLsmbLiLsbLobRibRsbsbRsbLsRsbRsRsmbRsRsmbRsRsmbRgbRibRsbRibLeRgRsLoLhm
bLsLsmbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 27; Drug: PCAP2 10 然 Apo 50 然
bRsLsLsmbRiLsRsbRsbRsRsmbLsbRsRsmbLsRsbRgRsmbRgbRsLsbRsbLsRsbRgRsmbRsR
smbRgRsmbRsRsRsRsmmmbRsLsbRgRsmbRsRsRsRsmmmbRgbRgRsmbLsRsbLgbsbsbLsRob
RgLsbsbRgbRsRsmbRgRsmbRgRsmbRsbRsRsmbRsbRiRsRsmmbRsbRiRsmbRsRsRsmmbLsb
LiLsLsmbRsRgbLibLoLibLobLiLsbLiLsbLeRsbLsLsRsmbsbLsbsbsbLsRsLsbRsbsbsb
LsbRsbLsLsLsLsLsLsmmmmmbLsLsmbLsLsmbLcLobRcbLjLobLsbRibLgbLebLebLiLcbL
eLsRsbLgLebLiLsbLiLsbLsLsLsmmbLsLsLsLgmmbLgLsbRsRsmbRsbRsRsmbsbsbsbLgb
LgLsRsbLgLsbLgbLgbRsbLsLgLsbLsLsLsLsmmmbsbsbLsLsmbRgbLsbLgbLiLgbRsbLsb
sbsbRsRsmbLsbRjRsmbRsRsRjmbRgbRibRgbRobLeLsbLhbsbLgbLsbLgLsRsRsRsmmbsb
LgLsbLsbRsRsLsmbLibLibLsbLibRhLsRsbRhRsRsRsmmmbRgRsmbsbRgRobLiLibLsbRo
bRgbLsbRsbRsbRgbRgbRibRcbRcbLcbLsbLgRsbRsbLsbLebLgLsbLsRsbRsRsLsmbLibR
sRsmbLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 28; Drug: PCAP2 10 然 Apo 50 然
bRcLsLsmbRiRiRhbLjbLgLsbRgbLsbRgbLsLcRsbLiLsLsLgmbLiRsbLibLiLiRsRsLiLs
mbLgRgbRhRsmbRcRsmbRgbLibRhbLsbLhbLibLiLiRsbRjRiRibRiLsbRcbRibsbsbRebL
hLsbLsLsmbLjRsbLcRsbLhLsbLiLsLibLiRsLgLibRobRiRsRsRsmmmbRibReRsmbReRsR
smmbRebLgLsbLsLsmbLsbLoRsRsmbRgbLsLsmbRiLsLsRgLsmbRoLiLiLgbLiLebLgbLgL
ibLcLeRsbLgLsbLgLgbRjbLgbRiLsbRcbRsbRjRgLsbLsLsLsmmbsbRsbRsbRsbRiRsRsm
mbLobLibLgRsRibLeLsbLgRsLgLsbLiLsLsLsmmbLebLgbLgbLsRibLsbRjbLhLsbLcLsm
bRiRsRimbRebRcbRhRebLgRsbRhRhbRobRibRcRsRsRsmmmbRobRibRibRhbRiRhbRsReb
RhbRgbLebRsbLcbLgLsbLiLsbLiLsbLhbLoRsbLobLiLsRsbLcRsRsmbRsbLiLsbRjbLsb
RebLsbRibRoLsbRgRsmbRibRcRsmbRhbRgbsbsbRiRsmbRcRsmbRhRsmbReRgRebRoLsbR
cbLsLsmbLcRsbRibLsRsLsLsRsmbRjbRgbLsbsbsbLhbLibRjbRsbLjbLsLsLsmmbLoRsR
smbLgRsRsRsmmbLobsbRjbRgbRcRsmbRiRsmbsbRhRibLjbLgLgbLsbLiRsbLiLgLsRsbL
ibsbLgLsLsLsmmbLibsbsbsbLiLsLibRjbRhbRcbRebRobRhRsmbRsbReRsmbReb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 29; Drug: PCAP2 10 然 Apo 50 然
bRsbRgbRhbRsLsbLgbLgbsbRgbRsbRibRsbRibRiRsmbLhbRjbRsbRsLsbRsbRsbRgRsmb
RhRgbLsLsmbRjbRibRiRsRsmmbLsLgbRsbRiRsmbsbRsbsbRsbsbRhbRebRsbRoLsRiRsm
bRcRhRhRsmbLibLsbLsbLsbRsbLsLsRsmbRoRsRsmmbsbsbRsbRsbsbsbRsbRsRsmbsbsb
sbRiLsbsbRsbLsbRiRsmbRhbRsbRsbRoRsLsmbRsRsmbRsRsmbRsbRsRsmbRsbLsbRsbRs
bRhbLjLgLsbRsbRobRiRsmbRsbRsRsLsmbRobLhLsbLiLsLsmbRsRsLsmbsbRsbLgbLiLs
bLgbLiLsLsmbRibRiRsmbRsbRsRgRsmbRgRsRsLsmmbRgbRgbRgRsLsmbRgRsmbRcbRgbR
cRsmbRibLsbLhbLibRcbRibLsbRsbRgRgLsbRgbRgbsbLsLsmbRgRsRsmmbRgbRsRsmbLo
bLiLsbLsbsbRjbLsbLsLobsbRcRgRsmbRhRsmbRgbRsRsmbRsbRgLsRsbRgbLsLjLjbRgR
smbRsRsmbRsRsRsmmbRgLsLsRsmbRsLsbLobLibsbLibRiRsRgmbLjLjbRiRsmbRhbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 30; Drug: PCAP2 10 然 Apo 50 然
bLsbRhbRibRgRsRsmmbRhRhbRibRgLsLsRsmbRcRsmbRsbRibRsbRiRsmbRgbRgRsLsRim
bRiRsLsRiRsRiRsLsmmmbRiRsmbRgbRsbLebLibLgbLiLsbLobLgbRebRiRsmbRsbRiRib
LobLiLsbLsRsRgbRobRibRgbRhbRgbRcbRibRibRibRgRsmbLsbRgbRgbRsbRibRjRsRcm
bRobRhRobLoRsbLcbLiLsLgbLiRsLhbLgbRgbRjbLjbLibRgRsmbLsbLsbsbLjbLiLsbLc
bRsbLiLsbLobLgbLoRsLcbLsbLsbLibRjbRebRoLsbRcbLjLjbRcbRhLsbRsbRibLsbLcb
LgRsRsRsRsmmmbLgbsbsbsbLjbLsLhbLgbLjbLgbRhbRebRiRsmbRsRsmbRiRsmbRsRhbL
iLcLsmbLhLjLebReRsmbRgbRibRsRgRsRsRsRsmmmmbLsbRiRsmbRibLobLgbRsbLcRsbR
iRsRimbLobLibLcbLcbLcbRibLhbLsbLsbLcbLgbRgbRsRgbRhbRhbLhLsLsmbRiRsmbRe
bRoRsmbRiRsmbRsRgRsmbRebLsbLiRebRgbRgbRhbRebLiRsbRsRsRsmmbLsbRebRiRsRs
mmbRgRsmbLgLsbLcbLibLjbRcbRsbLsLjbLibLgbRiRsmbLsbLcbLcbLsbLcRsLsbLgbLo
bsbLcbRibRgbRebRhRibRebRsbRgRsRgRsmmbRebLhLcbLcbLibLsbsbLebRcbRebLsbLs
bLhbLiRsbLgbLcbRobRsRebLsbLhbLgbLgbLcbLsbsbLsbLgbRjbLsbLiLsLgbLgbsbLjb
sbLsbLsLsmbLcbLsRsbRcbRobRebLcbRhbRgRsmbsbRiRjbLsbLcRsRsLsmbRsbRcbLjbL
cLhbLcbLiLsbRsbRobRebRsRibRgRsmbLhRsRsmbRgbRjbLcLsmbLcbRsbLgbLcbReRsmb
RebLcbLcLsmbLgbLsbLcbLcbLcbRjRsmbRsRsRsmmbRiLgbLibRsLgbRobsbsbRcbRhRsR
smmbRsbRsRsmbLgbRibRgbLhLcbRhb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 31; Drug: PCAP2 3 然 Apo 50 然
bRsRsmbLsLsmbRsbRsRsmbLsbRsRsmbsbRsLsbLsRsRsmbRsbRsbsbRsbRsbRsRsRsmmbR
sbRsRsRsmmbRsRsRsLsmmbLsbsbsbsbsbsbRibRsRsLsmbRsbRsRsmbRsbRsRsRsmmbRsR
sRsmmbRsRsmbLsbLsbRsbLsbLsbLsbsbRsbRsbsbsbRsRsmbRsRsRsmmbRsRsRsmmbRsbR
gbRsRsmbRsRsmbRsbRsRsRsmmbRsbRsLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 32; Drug: PCAP2 3 然 Apo 50 然
bLibLsbRsbRsbRsRsmbLsbLsbRgLsLsmbRibLsLsmbRgbRgbRgbLsRsbLgbRiRsmbRgLsR
sbRsbRsRsmbRjRgRsmbRibLsbLhbLobLiLsbLgLsbLgbLsbLsbLsLgbRsLsbRjbLsbRcbR
hLsbRsbRhbLgbsbRibRiRsmbRiRiRgbRebRgbRsRsmbRgbRibLsbLcbLsbLsbLgbRgLsbL
gbLsbLgbLgbLhbLcbLeLsbLgbLgbLsbLsbLsRsbLsbLsbLsLgbLsbLsbLsbLsbLsLsLsmm
bLsLsmbLsLsmbLsbLsbLsbLsbsbsbsbLsbLcLsmbRjbLhbLjLsmbLcLeLsbLiLsbLsbRjb
RjbLsRiRsmbLsRsbRsbRgLsbsbRhbRgbRibRiLsbRibRiRiRebRibRsbLsbRibRibRsbRs
bRgbLsbRgbRgbLsbLsbRgbRgbLsbRsRsLsmbRsRsmbRgbRsRsRsmmbRibRgRsmbRiRhbLs
bsbLgbLsbRgbLsbRsbLsbRsbRgRsmbRibRgRsmbRsbRibRsRsmbRibRcRiRsmbRgRsmbRg
bRsRsRsmmbRgRebRhLsbRsbRgbLsLsmbRibRibLsRsLsbRiLsbRsbsbRsRsmbRgbLsRsbR
sRsmbRsbLebLiLgLgLsbLiLgbLjLsmbRsLsbLgLobLebLcbLebLibLgbLgbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 33; Drug: PCAP2 3 然 Apo 50 然
bRiRiRibRiReRgbRcRsmbRgbRebRiRgRgbRgRiRibRibRiRgRsmbRibRibRiRibRebRhRg
bReRsLsmbRcRiRgbRgReRibRsRsmbLjbLjLsLsmmbLhbLcLcbLcLsLgLsLsmmbLgLibLjb
RsLsLsmbLgLsbLcLgbLcLsLsLeLiLsLsmmmbLebLiLjbLcLeLsbLcbLcLiLsLsmbLebLcb
RiRsmbRiLsbRgRsRembLcLsmbLhLsLsmbLsbLcLhLsLiLsbLiLsLiLsLsLimbLjRsbRsLs
bLsbsbRebRibRibRiRgRsRsRsmmmbLjbLiLsbLcbLsbsbsbLsLsmbLibLgbReLsRsbRgbR
gLsLsRsRgmbRsbLcLsmbLgbLsLsLiLiLiLsmbLsbLgbLiLsbRsbLcLsLsRsmmbLiLoLsLc
mbLgbLeLiRsbLgLgLiLibLgLsbLgLsbLeLsbLiLsbLebLcLiLeLsLsLcLiLsmbLgLsLsLs
LsmmmbLeLcLsmbLebRgbRgLsbsbLiLsLgbLiLgLsbRsLgLsbLgRsLsbLgLsbLjLcLgbRsb
LiLsbLjLgbLgbLiLsLsmbLcbLhLsbLjbLgLiLsLhLsLgLgbLhLiRibReRsRgmbRgbRibLs
bLgbsbLsLsLsmmbLsbLgLsLgLsbLsbLsbLgLsbLjLsLsLsmmmbLibLgbLhbLgbLiLsbLib
LobLeLsLsmbLcLibLcLgbLcbLibLiLsLgLiLsLsmbLgLgLsbLibLgRsLgbLgLsbLiLgbLi
bRcbRhbRcbRibRgRsmbLsLjLcbLsLsmbLcbLibRgLsbLjbRsRsmbLjbsbLjbLjLsLsLgLs
LsLsLsLhLsmmmmmbRsLsRsbLgLsLsLsLsmmmbLsLsLsmmbLsLsmbLgLsbLebRgRgRsRsmm
bRgLgbLcLsRsmbLsLsLsLimmbLiRsbLcbLjRsbLiLsbLgLsbLcLsmbLeLsbLhbLibLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 34; Drug: PCAP2 3 然 Apo 50 然
bRebRcbLibLiLgbLhbLgLsbLgbLgLgLgbLgbRsbLibLgLsbLhbLcRsbLsbLcbLiRsbLgbL
cbRcRsRsRcRcmmbRhRsmbRsRgRgRsRsRhRimmbRhbReRsRembRsRsmbRhRsLsmbRgRsRgR
iReRsmmbRgbRgRsmbRibRgRgRsRgRsmmbRgRiRgbRgRsRsRsReRhmmmbRiRsRsmmbRgbRs
RgbRoRgbRcbRiRebRgRsRiRiRsRsmmmbRgRebRsbRiRsLsRsmbLjbLcLsmbLiLgbLiRsbL
iLsbRsbsbRsbLibLgLsLgLsLgRsbLgbLgLsLgbLiLibLibLgLsbLsLsLgmbLsLgLgLsLsL
sLsmmmbLgLsbsbLiLgbLgLsbLsLsLgmbLgLsLsLsmmbLgLsLgLsLsLsLsLsLsLsLsLgmmm
mmmmbLsbLgLsLsLsLhLgmmbLgRsbLgbLibLiLgbLgLsLsLsmmbLiLsbLsLsmbLhLsbLiRs
bLsLgLsbLibLiRsbLcbLgbLgLsbLiLsbLgbLgbLgLsbLgbLibLgbLgbLibLgbLibLibLgb
RhbRebLibRebRsbRiRsmbRibLjLibLjbRgbRjbRebRiRsmbLjbLgRsbLibLjbRobRhbRsb
LhbRgbRobRjRgbLgRsbLcbLcbRgbLgbLebRjbRgbLgbLgbLcbLsbRjRsmbRgbRibRjbLsb
RebRsbLgbLebLcbLhbRsbRebRiRsRsRimmbRhbRjbRcbLibLgbLebLebLsbLsLsLsLemmb
LebLgLebLgbLgLgLiLgbLsbLiRsbRjbRobRhbRiRsRsmmbRebRobLibLhLgbLgbLcbLgbR
gbRcbRibRgRjbLcRsbLibLibLiRsbRsRsRsmmbLcbRsbLiRsLsLsmbLsbLsLsLgLeLsLem
bLebRgLsLsLgmbRsbLsbLhLsLgLebLebLsLsLsLsLgLgRsLemmmbLsLjbLcRsbsbLcRsbL
iLsbLiRsbLgbLjbLgbLcRsLsLsLsmmbLiLsbLjbLiLsbLgLgLsLsLsLiLemmbReRsmbLib
RsbRgLsRsLsbRsbLgbLgLsLeLsbLiLsLgbLiLsRsbLibLeLsbLsLgbLebLgLsbRsbLiLeR
sbLsbLebLgbRsbLgLsLsLsLsLsmmmmbLgLsbLjLgRsbLsLsRsRsmmbLhLsbLgbRebRiRsL
smbLgRsbLiLgLsRsbLebLhLsLsmbLgLsLgbLgLiLeLgLhbLgLeLgbLgLsLgLgLsLsLsLem
mbLgRsRsLsmbRsbLjbLcLsmbLcbLibRiRsRsRsmmmbsbLjbRjbRcbRjbReRsRsRsmmmbRg
RsRsRsmmmbRsRsRsRsRsmmmmbRebRhbRcbRsbLjb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 35; Drug: PCAP2 3 然 Apo 50 然
bRgbLsLsmbLsbLsLsmbRsbRsbRsbRsbRsbRsRsmbRsbRsLsbRgLsbRsbLsRsbRsbRsbRsb
RsRsmbRsbsbRsRsLsmbLsRsbsbRsbRjbLsRsLsbRsLsbRsbRsRsmbRsLsbRsbRsbRsRsmb
RsbRgbRsbRsRsmbRsRsmbRsbRsbRsbRsbRsbRsLsbRsRsRsmmbRsbRsRsmbRsbRsRsmbRj
bLgRsbRsLsbRgbRsRsmbRsbRgRsmbRsbRsbRsRsmbRsRsmbRsbRsbRgbRsbRgbRsRsmbRs
bRgbRhbRibRsbRjRsmbRibRibRgLsLsmbLsbRsbRsbsbRsbsbsbsbRibsbLsRsbRgbRsbR
sLsbRgbRsbRsbLsbRsbRsRsmbRsbRgRsRgRsmmbRgbRsRsmbRsbRsbRsRsmbRsbRsRsRsR
smmmbRsbsbRsLsbLsbRsbRgbRsbRsbRsRsmbRgRsmbRsRsmbRsbLgbRsbRgbRsbRsRsmbR
gbLsLsmbRsLsbRgbRsbRsRsmbRsbRsbRsbRsbRsbRsRsmbRsbRgbRsRsmbRgbLsbLsbRib
RiRsRgmbRsbRibRsRgbRsRsmbRsLsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 36; Drug: PCAP2 3 然 Apo 50 然
bLsbLsLsmbsbsbRsbLsbLsbsbRsbLsbLsbLsbLsbLsbLsbLsbLsLsLsmmbLsLsmbsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 37; Drug: PCAP2 1 然 Apo 50 然
bLgbLgLsbLgbLsLsLsLsLsLsLsLsmmmmmmmbLsbLibLgLsbLgLsbLgLsLgLsLsmbLgbLgb
LgbLsLsLsmmbLsLsLsLsmmmbLgbLiLsLsmbLgLsbLiLsbLgbLgLsLsmbLhbLobLebLiLib
LgLibLeLiLsLsmbLiLeLebLobLgbLobLgLsbRjRsmbRiLsRsRgbLjbLcLsLsmmbLsLibLh
LsRsbLcbRjbRebRsbRibLjbLeLgbLebLgbLibLibLeLsbLibLhbLgbLobRibLoLsmbLiLe
LsbLsbLsbLiLsRsbLgLsLsLsLsmmmbLsLsLgLgLsLsLsLsmmmmbLsLsLsLgLsLsLgmmmbL
gLsLsLimbLsLsLsmmbLiLsbRsLsbLgbRjbRcRsLsmbRhbRcbRiRibLiLsRsbLibRcbLiLs
bLgLiLebLiLiLiLsbLhLsbLebRcLsbRebRgRsmbRgReRsRsmmbRgbLcbLgbLiLsbLiLsLo
bLhLsLiLeLibLeLebLcLiLebLsLsLsLsmmmbLgLsLsLsmmbLsLsLimbLgLeLsbLgbLsLsR
smbLibLeLsbRsbLiLsLeLebLibLgbLsLgLgLebLhLsReReRebLobRjbLcLsmbRibLiLsbL
jLsLgmbLgLsLsLsLsmmmbLgbLsLsmbLiLsLsLsLsLeLeLeLgLsmmmbLgbRjRsmbRjbLhLs
LsmbLsLsLsmmbRsbLgLsLgLgLsLeLiLsLsmbRcRsmbLibLgbLgRsbLjbLgLiLsLsmbLgbL
iLsbLgbRsbLhLsbRibRibRibLjLsLsmmbRgbRsbRgRsmbRsbsbRsbLsbLgRsLsRsLsbLsL
sLsLgmmbLiLsbRhbRcLsbRoRsRsmmbLgbLgLgLsLgLgLgLiLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 38; Drug: PCAP2 1 然 Apo 50 然
bLsLeLeLsbLhLiLsLsmbLgLsLsLgmbLgLgLsbLgLsLgbLgLsbLsbRsbLgRsRsLsRsmbRcL
sbRibRibRiRebRibLcbLiLgbLgbLsLsLsmmbLeLsbLgLsbRsbLibRsbLgLsbLiLsLsLimb
LsbLsbLsbLgLsLsLgLsLsmmbLgLibLgLsLgbLgLsbLgbLgbLgLgbLibLibLcLeLeLgLgbL
ebLgbLsbLeLgLebLgbLibRibLsbLgbLgLgLsLsmbLgbLsLsLsLiLiLiLsmmbLiLsLsLgLe
LembLsLgLgbLhLeLiLsLiLsLgbLsbLgbLibLiLsbLcLsmbLiLsRsbLiRsbLibLiRsbRsbL
cLiLgLsLsmbLsbRcRibRgbRsbLcbLibLiRsLsRsbLsLsmbRjbRjbRcLsbRsbRgLsbsbRsb
RsRsmbRjLsbRgLsbRiLsbRiRiLsbRiRsRsRsmmmbRibRiLsRgRsmbRibRibRjRsmbRhRsR
gLsRcmbRgbLsbLsLibLhbLiLhRsbLsbLgbLsLgbLsbLgLsLsLgmbLgLsbLibRsbLgLsLgL
sLsLsmmbLgLgbLeLsLeLgLgLsLebLgLsLgLsLgLeLgLsLsLsLgLsmmbLiLgbLgLsLiLibL
gLiLsLsLsmmbLiLsbLgLsLsmbLgbLgLsbLgRsbLibLsLsLgmbLgbRjbLiLsRsLsbLsbsbL
iLsLgLsLsLeLeLsLgLgmbRgbRcbRibRibRjRiLsbLsRcbRiRiRsmbRiRgRebLcLsmbRjbR
ibRiRsmbRjRsmbRsbRgbRgRsLsRsReRgRsReRemmbsbRsRsLsmbRsbsbRiRsReRembsbsb
LjbLjbLibLcLsmbLcLsLsLsmmmbLhbRibLcLsmbLibRhbRcbRsRsmbRgRsmbLgbRsbRjRs
mbLjbLiLsbsbRcbRibRibLjLsmbLiLsbRcRsRsmmbLcbLobLibLcbLcbLiLsbLcLsmbRiR
smbLibRibLjbLibLgRsbLsbLsbLgLsbLibsbLsLsLsLiLsLsmmmbLgLgLsLsLsmmbLgbLs
LsmbLjRsLsbLjRsbLjRsLsbLcbLhbRsbRibRcbRsbRgbLsLoLsmbLibLibLibLgbLiLsLi
LgLgLsbLgbLeLsbLgbLgLsLsRsmbLgbLhLsbLjLsmbLibLjRsbLhRsbLibLgbLhLsLsmbL
sbLiLsLgbLgRsbLibRhbRibRgbLjbRhbLcbLjbLcLsmbLhbsbLgbLsbLgbLgbLiLsLsmbL
gLsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 39; Drug: PCAP2 1 然 Apo 50 然
bRjbRcbRhRsmbLcLsmbLhRsbLcbRebRcRsmbLcLsmbLhRsbRibRsbRgbRjRsmbLgRsbRib
RiRsmbRgRsmbRibLjbRjbRjbRgbLcRsbRjbLobLcbLhbLibRgbRibRhbLibRcbRoRsmbRo
bLcbRcbRgbRibLjbLcbLebRgbRjLsbRcbRgbLsLcbRibRiRgbRgRgRibRgbRgRgbRgRgbR
gRsRsmmbRgbLgLgbLgbLiRsbLgbRibLobLibRsbLiRsLsbRjbLhLsbLeLsLsLsmmbLgRsb
LibLcbRcbRcbRibRiLsbLgbLcbLobRibRiRsmbRibRgbRibLcbLcbLibsbLcbRgbRjbLiR
sbRjRjbRcbRgRhbRsbLcbRsLgbLcbRjbRsLoRsbRibLcbRjbLibLiRsRsmbLibLobRcbRi
LsbRjbLcbLjbRgbRibRgbLeRgbLibLsbRjRgRsmbRibLhbLsLcbRcbRiLsbRiRsmbLcbLi
bLhbRsbLsLhLsbLibRsbRgbLobLiLsbRebRjbRjbRobRjbRcbLcLsmbLcbRibRgbLeLsbL
iRsbLhbLcbRgbRcbLcbRjbRhbRgbRibLcbLcRsbRcbsbsbRsbLsLsmbRjbRsbLcRsRsmbR
ibRgRsRgRsRsRsLsmmmmbLsLsmbRjbRibRsbLoRsbLobLcLgLsLsmbLibRoRsmbRibRsbR
cbLgbLibRibRcbRgbRhRsmbRgbRibRgRobLibRjRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 40; Drug: PCAP2 1 然 Apo 50 然
bRsbRhbLcLsmbRcbLjLsmbRibRsRgRsRsRsRgRsRsRsRsRsmmmmmmmmbLcbRcbLobRhRsm
bLjbRcRsRsRsmmmbRcbRhbRobLsbRjRsmbLcLsmbLibLcbRhRsRsmmbLsLsRsmbRcbRsbR
sRcRsmbRibLsRsRsRsRsRsRsmmmmmbRgbRcbsbRcbRgRsmbLsbLcbRcbLjbRjRsRsRsmmm
bRgRsmbRibRcRsmbLhbRhbRhbLgRsbRoRsmbRhLsRsbRibRsbRsRsmbRsbRsbRcbRiRibR
sRsRsRsRsRsmmmmmbRibLhRsbRcbLibRjbRgRsmbsbRsRsRsmmbRsRsRsmmbRcRsmbRsRs
RsRsRsRsRsRsmmmmmmmbRcbsbRsRsRsRgRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmmmmbR
gbRcRsmbLsRsRsRsRsmmmbRcbRgRsmbRoRsmbRiRsmbRcRsRsmmbLsRsbLibRhbRhRsmbR
cbRjbLcLsRsmbRsRobLcLsmbRiRsmbRsRsmbRcbRcRsmbLcLsmbRjbRoRsmbRcRsRsRsRs
RsmmmmmbRsRsRsRsmmmbRiRsRsmmbRsRsRsRsmmmbRcbRsbRsRsRsmmbRibRibsb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 41; Drug: PCAP2 1 然 Apo 50 然
bLibLsRsbLcbRoRsmbRcbRsbRibRcbLgbLjbLgLiLsLsmbLsLsLsmmbLsLobLobLiLsbLg
bLsLsLsmmbLgLsbLsLsLsLsLsLsmmmmmbLcbRobRcRsmbRcLsbLsbRcRsmbRibRoRsmbRc
ReRibRgbRgRsReRsmmbRsRsReRsmmbRiReRsRgRsmmbLsbRibLsbRsLsbRhbLsbLsbRibL
sLsmbLsbsbRgRsRsLsmmbRsLsbRsLsRsRsRsLsmmbLsRsLsbRsRgbRobRobRcRsmbRobRc
RebRgRsRsLsmmbRibRiRsmbReRsmbRgRsRsRsRsRgmmmmbRgRsRsmmbRsRsLsmbRsbRibL
gbRhbRcRsmbLsLsmbLjLjbRiRsRsRsRsRsmmmmmbRgRsRsmmbRsLsbRsbRobReRgRibReb
RsRgRgbRgbRsLsLsmbRhbRsRsmbRcLsbLsbRhRsmbRcRgRsRiRsmmbRcRsReRsRsmmmbRg
ReRsRsRsmmmbRoLgbRibLsbLhLsbRoRgbRsRsmbRhRsRgRsRgRemmbRebRhLsbRiRsRsmm
bRsRgRsmbLsLsLsLsmmmbsbsbsbsbsbsbsbsbRgRsRemb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 42; Drug: PCAP2 1 然 Apo 50 然
bRiRsLsRembRebRhLsbRibRiRsmbRgRsRiRsRsmmmbRebRhRibRhRcRibRebRiRsmbRibR
gRsmbRjLeLibLgbRgbRcRsmbRgRibLsbRiRgRsmbRiRhbRhRsRsRiRsRgRimmmbRiRibRg
bRiRsmbLsRibRgLsRgbRebRiRiRibRiRsmbRgRsmbRgLsRsLsbRibRhRgbRobReRsmbRgb
RsRsmbRibRibReRsmbRgbRgbRibRgbRgRsmbRebLsbLcLiLsbLgLsLibLgbLhbLhRsRsLi
LsmbLiLebLcLibLiLeLsLsmbLcbLgLibLibRibLcLsLimbLcbLeLsbLiLsbRsbLgbRjbRc
bRsbRgRgRsRsRsmmmbRiLsLsRsmbRhRgRsmbRgRsReRembRibRhbRgbRobRibLjbLibLgb
LcbLgbRibRiRhRgRsmbRgbReRiRsRembRebRibRjbLgLsLsmbLgbRjbLeLsLeLsLebsbRe
RgbReRsmbRjLsLsmbRsbLibRjbRcbRgbLcbLgbRibsbRjLsRsbRjbRsbRgLsLsLsRsmmbR
iRsRsmmbRjbRiLsLsLsLsRsmmmbLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 43; Drug: Control Apo 50 然
bRcLsbLcbRcRsmbLgLsbRgbRhbLsbRobRcLsbRcRebRoLsbLsbRcRsmbRcbLhbLeLibReb
RcbRhLsbRebLjbLcbLebLgLsbLgLsLsLgLsLembRebRhRsmbRsRsmbRgRsmbRcbRiLgRsL
sbRgRgbRiRsRsmmbRibRiRsRgmbRibRebRcbRsRsRsmmbRgRebRcLsbLeRgbRibRibRobL
gbRjbRibRsbLsbRjbRsbRcbRsbRcbRhRgbLcbLcbLebRsbRsRsmbRjbRibRhbLsbRgLgbR
cLsbRcbRiLgLsbLjLsLimbLsLsmbLsLsLsRsmmbLgLsbLcLsmbLcbLcLsLsmmbLsLsmbLi
LgLsbLgbRsbLgbLcbLobLcLiLsLsmbLibLiLeLibLoRsLibReRsmbRgRiRsmbRgLsbRjbL
sbRsbRsbLsRjbRsLsbRcbRibRcbLsLsLsmmbLsbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 44; Drug: Control Apo 50 然
bLsbRsRgbRgRsmbRibLsRsRsmbRsbRgbLsLsmbRibRgbLgbRiRsmbRebRsbRibRgbRgbRe
bLjbLsbRsbLsbLgLsbLhbLeLsbLsRjbRsbRsbLebRgbRcbLgLsbRebRgbsbRibLiLsbReb
RsbRibRiRsRsmmbRcbRgbLgbLibLgbLibRgbRgbLibLgbLibLgbLgLsbLgbLgbLibLiRgb
RibRibRcbRgbRhbRhbLgbLiLsLsmbLiLsbLibLibRsbLgbLiLsbLibRiRsmbLgbLibRgbL
ibLebRsbLgbRsLsbLibLsLiLsbLgbLiLsLibLgLgbLgbLgbLebLibRgbRibRibRgbRgRsm
bRgRgbLsbRgbRibRibLgLsbLsbRgRsmbRibRsRsmbRgRsmbRgRsRsmmbRsbRgbLsRsLsbR
sRsRgmbRgbRgbRibLgLsbRgRsmbRgbRsbLsRsRsRsRhmmbRgbRgbRebLgbsbRibRibRgRs
RsmmbRsbRsbRsRgRsmbRsRsRsRgmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 45; Drug: Control Apo 50 然
bLibRebLsbRcRsmbRobRhLsRsbRsRcbRibReRsRgRjmb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 46; Drug: Control Apo 50 然
bLgLsbLcbLeRsRsmbRhbLsbRibLibLiLsbLiLsbLgbLebLibLebLibLgbLgbLeLsbLiRsb
LiLsbLgLsLsmbLgLsbLhbLebLibLebRgRsmbLebLibLibLgbLgbLgLsbLibLibLibLibLi
bLibLgbLibLebLibLgbLibLibLebLgbLebLgbLcbLiLgLsbLebLgLgLsbLebLebLebLgLs
bRsbLgLgbLhbLibLgLgbLsbLsLebLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 47; Drug: Control Apo 50 然
bRjbRhbRibRhbRcbRibRibRibRcbRsbLjbLhbLibLeLsbLebLhbRhbLjbLgLsbLcbLcbLe
bLibLsLsmbRjbRhRsmbRiRsRsmmbRibRibRibRibLsbLibLgLsLiLsbLgLobLcLsmbLhLs
bLgbRgLsbRcbRhbRhbRcbRcLsbRibLibLebLiLsbLgRsbLibLhbLjbLgLsbLibLhbRcbRc
bRcbLsbLcLiLibRsRsmbRebLebLiRsbLsLsLgLsLcmbLsRsbLcbLibLgLsbLibRsLsLcbL
gbRibRiRsmbRebRhRebLebLsRsbLhLhbLibLebLgLsbLgLsLgLsLsmbLibLgLsLibLibLh
bLibLcbRhbRjbLobLjLsmbRjbRcbLjbLcbLibRcRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 115526; End: 120026;
Recording: 6-1; Individual: 48; Drug: Control Apo 50 然
bLiRsbRsbLibRibRobLcbLgbRcbLhbLhbLibLsbRsRhbRibRibRoLsbRiLsbRgRsmbLibL
ibLibLibLibRobRibRsbRibRibLhbLiLsbLcbLibRcbRibRgbRgbRibRibLcbLhbLgbRjb
RcbRsRibLcbLcbLibLibRhLsbRjbRhbRibRcbRibRibRibRibRgbRhbRgbRhbRibRcbLsb
LgbLsRoLsbRibRgbRobRhbLiRsbRsRibLebLiRsbLibLcbLcbsbLibLsbLsbLgbLibRgbL
ebRjbRebLgbRibRoLsbRhRsRgmbRcbRcRsRsRiRgmmbLjbLibLibLibLgbLjbRgbRibRgL
sbRiLsbLsbLjbLebLsbLibRebLebLhbRsbRibRcbLgbLobLibLgLsbLjbLhbLjbLebLcbR
sbLibLgbLgbLgLsbLhbLsbRibLibLibLibLgbLibLibLgbLcbRgbLgbLgbLibLiLsbRsbR
jbRcbRibLgbLgbRgbLiLsbRcbRibRhbRibLebLsLsmbRsbLgLsbLgRsLsRsRsmbLhLsbLi
bLibLibLibRgbLibLcbRgbLibLgbLhbRsbLgbLibRhbRibRiRsmbRibLcbRsLsbRebRgbR
gbRgbRcbLibRjRgbLsbLibLsbLcbLibLgbLgbLgRsbLsbLhbLibLgLgbLibRgbRibRgbRc
bLjbLsbLibRcbLhbLiRsbLsbLibRhbRibRibRgbLsLebLiRsLsbLibLgbLgbLgbLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 1; Drug: PCAP2 10 然 Apo 50 然
bRsbRibRsRsmbRsRsmbRsbRsRsLsmbRsbRsLsbRgbRsRsmbLsbLsbRsRsmbRgLsLsmbRob
LgbLsLsmbRcbRsbRgbRiLsbLoLibLgbLsbLgbLgbLgRsbLsbLsbLiLcbRobRobLsbRsLsb
RsbLsbLsbRobReRsmbRsbRsbRobRjbLsbRgbRsbRgbLsbRsbRiRsRsmmbLsbRgbLebLoLe
LhLsbRobsbRgRgbRsbRsbRsbRgbRsRsmbRsbRgbRsLsbRsbRgbRsbRsbRsbLsbLgLsbLsb
LsLsmbLsRsbLsbRsLsbLsbLibRebLsLsmbLsLsRsmbsbsbLgbLsbLsbLsbsbLobLsbLsLs
mbLsRsbLsLsmbLsLgbLsbLsLsmbLsbLsbLsbLsLsmbLsbLsbsbLsbLsRsbLsRsbLsbLsbL
sbLsRsbLsbLsbLsLsmbRgbRsbLgLsbLgRsbRsbRcbLiLsbLsRsbLcbLgbLsbRoRsLcmbLg
bLgbRgLsRsbRcRsmbRsbLebLcbLibLobLsLsmbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 2; Drug: PCAP2 10 然 Apo 50 然
bRiRsmbLibLsbRhbRhRcRsmbRiRsmbRcbRgRsmbRsRcRsmbRcRsmbRibRcbRibRcbRiRib
RiRhRsmbRgbRiRsmbLsLsmbRgbRgRsmbRsRsmbLjbRsRiRsRsmmbRibRhRsmbRsLgbRcRi
RibLsRsRsmbRibLsbLsbLsRsbRgbsbsbsbRgbRsRibLcRsbsbReRoRsmbRgbRobLibRobL
ebLjbLcRsbLsRsbRoRsmbRsbLibLsbRcbRsbRcRsmbRibRcRsmbLsbRgbRibLsbRgRsRsm
mbLsbRiLsbRoRsmbLobLoRsbRsbRsbRsLsbRsbRobRsbRcRsmbRibRcbLsbsbLsbRjbRsR
smbRgRsmbRsRsRsRsmmmbRcbLgLsbRsLgbRebRcRsmbLsbRsRgbRsRsmbRgbRjbLibLibL
gLsbRsbRsLsbsbLjLgbRgLsbRcRsmbRsbRcbLsbRhbRoLsRsbRebRgRsmbLjbLobRoRsmb
LgbRjRsmbRhRsmbRgRsmbRcRsmbLgRsbRgbRhbRcbLgRsbRjRsmbRsbRsbRsbRsRsRsRsm
mmbsbRsbRibLgbLsbRsRsRsRgRsRsRsmmmmmbsbRsbRibLsRsbRsRsRsRsmmmbRsRsmbLs
Rsb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 3; Drug: PCAP2 10 然 Apo 50 然
bLjLsLgLsmbLsbLhbLobRcbRcbRibRobRobRobRiRgLsbRsbReLsLsmbRsbRsbLsLsmbsb
LeRsbRebLcRsbRhbRhRgbRsbRibRiRsmbRgLobLobLobLiRsbLobLobRibRobLsbLobRoL
sbRsbLcbLiRsbRhbLeRsbsbLeLsbLsLgbRjbRsRcRsmbRobLgbLobRsbLjbLhbLebRgbLg
RsbRibRoRsmbRebRcRsRsmmbRgbLsRsbRsbRcRsRsmmbLsbsbRgbRcRsRsmmbRebRsbLob
RjbLsLibLsbRebRcRsmbLiRsbRibLobLsbLgbLobLebLiRsbLjbReRsmbRcRsmbRgbRgRg
LsbLsbLibRcRgRsmbRsbRgbLibLsbLsbLsLsmbRsRsmbLiRsbLsbLgbLsbLsbRgbsbRsbR
jbRcbRiLsbRobRoRsmbRcRsmbRobLiRsRsmbLhbLgbLibLsbLsbLobRcbRcbLibLhbLobL
sbRjbRibRsbRsbLgbLsbLsbsbsbRsLsRsLgbLsbsbsbsbRebRobRebLsLsmbRibsbRcbRj
RsRsmmbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 4; Drug: PCAP2 10 然 Apo 50 然
bsbsbsbRgbsbsbsbsbsbsbRsRsmbRsbLsLsmbsbRsLsbsbLsRsLsLsmbRsRsmbLsLsmbRs
LsRsbsbLsLsRsmbLsbLsbRsLsbLsbLgbLsbRsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 5; Drug: PCAP2 10 然 Apo 50 然
bRgbsbRgbRgbRsRsmbRgbRgbRgbRgbRgbRsLsbRgbRgbRsRsRsmmbRsRgbRgbRsRibRsRs
mbRsbRsbRsbRibRsRsmbRsRsmbRgbRsbLsbLsbLsbRgbRsbRsRsmbRsRsmbRsRgbRgbRgb
RgbRsRsmbRsbRgRsmbRgbRgLsbRsbRgRsmbRsRsRsRsRsmmmmbLsRgbRgbRgbRgbRgRsLs
mbRgbLsbRgbRgbsbRgbRgbRsbRgLsbRsRsmbRsLsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 6; Drug: PCAP2 10 然 Apo 50 然
bsbLsRgRsmbRhbLsLsRsmbRsbLhbLgbRgbLsLobRcbLoLsmbLobLeRsbLobRgLobLiLsLs
mbRhbRcRsmbRgLsbLsbRibRibLeLsLsmbRobRhLsbLoLsmbLgLgLebLgbLiLgbLibRjRgb
LebLcbLsLobRcRibRsbRsbLebRobLgLsbRobReRsmbLjbLebLhLoRebRsbLobRebRcbLgb
LjbLibLcbLcbsbRiLsbRsLsLsmbLsbsbsbRsbsbsbRgRsLsmbRsLsRsbRgbRjbLgRsbLob
RhbRcRsmbLobLebLsbLgbLgRsbRiRoLsbLsLsmbRhbsbLibRcbRsbRebRcbLgLsLsmbRjb
RibLibRibRobRsbLsbRibLsbsbLiLgbLcLsmbLiRsLsbLsbRoLsLsmbLeLsLobLobLcbLo
RhbRoRcbLibRobRjbLibLsbLeLsLsmbLibRhRcbRgbRhRsmbsbRgRsmbRsbLsbLiLsLsmb
RebRsbLcbRhbLgbRjbLebRebRgbRsbsbRiLsLsLsmmbLibLsLsmbRibRobRobRoLsLsLsm
mbRcbLobRsbRoRsmbRgbRobLjbRgbRgLsbRobRebRsRsRombRoRsmbLobRebLsbLeLsbRi
RsRsmmbRibLgbLhbLcRsbLcbsbLebRiRoLsbRcbRebRhbRobRsbRibRebRgbsbRgbLsRsb
RhbRebLebLoLcbLobRgRsmbRcbRgbsbLgbLgRsLgbRoRsmbLoRsbLobRsbRgbRibLjb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 7; Drug: PCAP2 3 然 Apo 50 然
bLsbLsbRsbLsbsbRsbsbsbRsbLsbRcRsmbLsbLsbLsRsbLsRsLsbRsbLsbRsbRsbRsbLsb
LsLsmbRsRsRsmmbsbRsbRsLsbRsbRjRsRsmmbLsbLsbsbRjRsRsRsmmmbsbRsbRsbRsbRs
RsLsmbLobLsbLsbsbsbRibRsbLsbRsbRsbRsbRgbLsRsbLsbsbLsbLsbLsRsbLsbRsRsRs
mmbRsbsbRgbRjLsLsmbRsRsRsRsmmmbRibRsbRsRsRsmmbLcbRcbRiRcReLcbRsbRsbLsR
sbRsbRsbRsbRsbRsbLsbRsbRsbsbLsbsbRsRsmbRsRsmbRsRsLsmbsbRsRsRsmmbRsRsmb
RgbLsLsmbRsbRibRsbRgbRhRsmbRsLsbLsbLsbLsbLsLsRsmbsbRibsbsbsbRibLsbRgRs
mbsbRsRsRsmmbRsRsRsmmbRjb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 8; Drug: PCAP2 3 然 Apo 50 然
bRgbRcbRsbRhbRjRcbRhRsmbLjbLiLsLcbLobRjbRcRsmbRcbsbLsbRobLsbLcbRoRsmbR
ibReRsRsmmbRebRoReRsmbRsLsbRcRsmbRiLsbLibsbRcRsmbRcRsmbLhbLeLsbLgbLcLs
mbLcbLgLebLiLebLhbLibLcLgbLcbLebLhLsRsbLgLgLcbRsbReRsmbRsRsRembsbLjbLc
bLcbLgbLgbRcRsRsmmbRsRsmbRcRsRsmmbRsbReRsmbRgLsbRcbRebRcbLibLcbRsRcRsm
bLoLsmbLcLsmbLibLcbLsLhLsbLhLiLibLcbLgbLiLebLoRsbLeLsLiLgbLibLcbRgbRcR
sRsRjmmbRoRsRjRcmbRobLibLcbLibLcLibLcbLcLsRsmbRcbRoRcRsmbRibRiRiRsmbLc
bLcLsmbLiLsbLebLcLsLsmmbLsbLiLiLobLjbLcLsmbLgLsLsLsLsLsLgmmmmbLcRsbRgb
RhbRhbRobRobRibRobRgbLibLcbRebRebRjRsmbRcbRcRsRsRimmbLibReRsmbRsbRcRsm
bLibLhbLjbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 9; Drug: PCAP2 3 然 Apo 50 然
bRgbRcbRiRsRsRsRgmmmbLsbLjbLhbLibRibRsbRiRebRgRgRsRhmbRebRebRebLsRsbLs
RibReRsReRsmmbRebRjbRcRsRsmmbRcbRcRsRsmmbRgRgRsmbRsRgRiRibRhRsmbRgbLsL
sLsmmbLsRsRsRsRsRiRsmmmmbRgLsbRsRgLsbRibRsRsRsRgRsRsRgReRgmmmmbRgRsmbR
ebRebRhbRiRsRsmmbLsRebRebLjbLebLebLcbRcbReRsmbRjbRsRsmbRsRsmbRiRgbRibL
sbRsbRsLsbRsbRgRsmbLgbRgbRsRsRgmbRsbRsRsRsRsRimmmbRibRsRsRsRsmmmbRgRsR
sRsmmmbRsRgbRsbsbRibRhLsbRebRiLsbLibRgRsmbRsRgRsRsRsmmmbRgRsmbRsRgbLsR
sbRsRgRgRsmbRsRgRgbRibRgbRibRibReLsbRibLsbLsLsmbRcbLgbRgbLgLsbLhRsbReb
ReRsmbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 10; Drug: PCAP2 3 然 Apo 50 然
bsbsbsbsbsbRsLsbLsbLsbRsbsbRsbLsbRsbRsbLsbRsRsmbLsbLsbRsbLsRsbRsbRsbRs
bLsbRsbRsbRsbRsbLsRsbsbRsbLsbLsRsbsbsbsbRsbRsbRsbRsbLsLsmbsbLsRsbLsbsb
RsRsmbRsLsbRsbRsLsbRsRsmbRsbLsLsmbLsbsbLsbsbRebLsLcLsmbLsLcLibLhbRibRe
bRibLibRebReLsRobLsbLsbLgbLiLsLsmbLsLjbLsLsLsmmbLiLsbLobRsbRsbRsRsLsmb
RsRsmbRsbLsbsbRiRsmbLcbLsbLgLhLgLsLgbsbsbRobRibRib

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 11; Drug: PCAP2 3 然 Apo 50 然
bRsbRsbRsbRsbLsRsbRsRsRsmmbRsRsmbLsRsbRsbRsbRsbRsbLsbRsbRsbRsRsmbRsbRs
RsmbRsbsbRsRsmbRsbRsRsmbRsbRsbLsRsRsmbLsbsbRsbsbRsbLsbRsbRsbLsbRsRsmbL
sRsRsmbRsbRsbRsbLsRsbLsRsbRsbLsRsbRsRsmbRsbLsRsbRsRsmbLsbRsbRsbRsRsmbL
sRsbLsbRsRsmbRgbRsbRsbRsbsbRsbRsbLsbsbRsbRsRsmbRsbLsRsbLsRsbsbRsRsmbRs
LsRsbRsbRsbRsbRsRsmbLsRsLsbRsbLsLsmbRsRsLsmbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 12; Drug: PCAP2 3 然 Apo 50 然
bRhbLsbRsRsRsRiRsmmmbRsRsRgmbRgRsRgmbRsbRsRsRsmmbRsRsRsRiReRgRgRgRsmmm
bRsRsRsRsmmmbRsRgLsRsLsLsRsmbRsRgRsRsRsRsRgRsRsmmmmmmbRgRsRsRgmmbsbRiR
smbRsRsRsRsRsmmmmbRgRsRsmmbRibReRiRsmbRgRgRsmbRsRsRsRgRsRsRsmmmmmbRsRs
RsRsRsRsRsRsRsRsRsRsmmmmmmmmmmmbLsRsbRgRiRsRgRsRsmmmbRiRsRsRsRsRgRsRgm
mmmmbRibRgRsmbRsRsmbRgRsReRsRgmmbReRsmbRsRgRsRsRsmmmbRsRgRsmbRsRsRsRsR
sRsmmmmmbRsRsRsRsmmmbRsRsRsLsRsmmbRsRsRsRsmmmbRsRsRsRsmmmbRsRsRgRsRsRs
RsmmmmmbRsRsmbRgRsRgRsRsmmmbRsbRsRsRsRsRsRsmmmmmbRsRsRsRsRsmmmmbRsRsRs
RsRimmmbRsRsRsRsRsRsRsRsRsRgRsmmmmmmmmmbRgRgRsRsRsmmmbRsRgRsmbRsRsmbRs
RgRsmbRsRgRsRsRsRsRsRsRsRsRsmmmmmmmmmbLsRsbRsbRgRsRsmmbLsbRsRsmbsbRgRg
RgbRibRibRsRsRgRsRgmmbRsRsRsRsRsRsLsmmmmmbRsRgRsRsLsmmbRsbRgRsRsRsRsRs
RsRsRsRsRgmmmmmmmmmbReRgbRgRsRsRsRsLsmmmmbRgRgRsmbRgRsRsRsRsmmmmbRsRsR
sRsRsRsRsmmmmmmbRsRsRgmbRgRgRsmbRsRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 13; Drug: PCAP2 1 然 Apo 50 然
bRhbRhbRcbRebRiRsmbRibRibRhRsLsRsmbRsLsbsbRsbRsbsbsbRgbRcbRcRiLsbRiRgb
RsRsRsmmbLsRsRsRsmmbRibRcRgbRjRsmbRhbRibRibRiRgRsRsmmbReRsmbLibRhbLcLs
mbLobLjRsbLhbRgRgRsmbRoLsbRibReRgRsmbRgLsLgbsbRiRsmbLsbLsLsmbsbRsRiRsm
bRjbRcLsbRibRcbRcbRhbLgbRiRgbRsbLgbLsLjbLcLsmbLcbLhbLcLsmbLhbReRsmbRsR
sLsmbRiLsbRjRsmbRgbRjRsRsmmbLsRcbRcRiRsmbRebRcLsbRjbLhbLcbRiLsbRibRibR
cbRebLsLsLsmmbLiLebRsbLjbLjLsLsmmbLjLgbLcbLibLcbLobRiRsRsRsRcReRsmmmmb
RsbLcbRgbLiLsbLiLsbLeLsbLcbLcbLcLsmbLcLsLhmbLsLsLsRsmmbLibRjbRcbRhRsRs
RsmmmbRgbRhbRsbRsLsbRgbRibRebRebRiRibLsLebLcLobLhbLsRsbRhLsbRgbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 14; Drug: PCAP2 1 然 Apo 50 然
bsbsbRsbsbLjbLhbRsbLebsbLcbLiLsbLcbLebLebLgLsbLgbLsbLsLsRsmbLibLibLebL
hbLiLsbLebLebLgRsbLgbLsLgbLgbLgRsLsbLibLiLgLsbLibLobRiRsmbRibRgbRgRhRs
mbRcRsmbRcRebRcLsbRgbRgRsmbRhRsmbLibLibLcLsmbLhbLcbLiLsbLibRgbRcRsRsmm
bLsbLiLsbLebLcbRgbLjbLhbLhbLsbLcLsLimbLgbLgbRsRsLsLsLsLsLsmmmmmbRsRsRs
mmbLsbLhRsbRgbRcRsmbRibRiRsmbRibRibRgbRibRgbRgbRibsbRgLsbRgRsRsRsRhRsm
mmmbRgbRgbRiRsmbRsbRgbRgbRgRsmbRiRcbRibRibLsbRgbRsbRiRsmbRsbRsRsmbRhbR
sRsRsRsRsRsmmmmmbRgRsRsmmbRsRsmbRsRsmbRgbRsbReb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 15; Drug: PCAP2 1 然 Apo 50 然
bLebLeLsbLiRsLsbLjbLjLsmbRsLjLsmbLeRsbLebRgRsRgRsmmbRhbRjbRgbRsRsRsmmb
RibRcbLcbRsRsRsRsRgmmmbLeLsLsLsmmbLcbLhbLiLsbRsRhbsbLcbRcbRcbRibRgbLsR
cbsbLebRgRsRsmmbLjLsmbLcLsmbLcbRsbRjbRgRsRsRsmmmbRibLgLsbLcLsmbLjLsLsm
mbRjbRcbRcbRhbLjLgbLjLsmbLcbRjbRobRhRsmbRibRcbRcbLgbRebRgRsRsRsmmmbRib
RiRsRsmmbRiLsLsmbRsbRobLgbLibRcbRobLgbLcLsmbLeLsbRiLsbRhbRcbRsRsmbLeLs
bLgbLhLgbLeLsbRsbRjRsmbRibLsLcbLebLcLsmbLhLsLsmbLiLsLgbLcLsmbLeLibRjbL
gbLibLhbLjLsmbLgLsbLeLsbRgRsmbRgbRebRiLsbsbRsbRobRgbLsRsRsmbLsRcRsmbRi
RsmbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 16; Drug: PCAP2 1 然 Apo 50 然
bRsbRgbRgRgRsmbRsRsmbRgbRsbRsRsmbRsbRgbRsRgbsbRsRgbRebRsRsmbLsLsmbRsbL
sbLeLibLgbLibLgbLgLsLsmbLibLgbLsLgLsbLsbLsLibLgLsLgbLsLsLsmmbLgbLgLsLs
LsmmbLsbLgbLsRsbLsLsmbLgLsbLsLsmbLsLsmbLgbLgLgbLgLsLsLsLsmmmbLsLsLsLsL
gRsmmmbLgbLibsbLgbLgbLgLsbLsLsmbLsbLsbsbsbsbLgbLgbLgLsbLgLsbLgLsbLgLsb
LgRsbLgLgLsbLgbLgbLgLsLgbLsbLibLgbLsbLgLgbsbLgLibLsLsmbLgbLsLsmbLsLsmb
LgRsbLsLsmbLgbLgLsLsmbLgLsbLsLgbLgLsbLgLsLsmbLgbLgbLgLsbLsLsmbLgLsLsLs
LsmmmbLsLsmbLgLsbLiLsbLgLsbLgLsbLgbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 17; Drug: PCAP2 1 然 Apo 50 然
bLsbLibLibLiLibRsbLcbRjbRjLsbRcbRcbRgLsbRibRgbRibRjbLsbRibRibRibRhbRib
LsbRcbRjRhRsmbRhbRgbRcbRcbLcbRcbRgbRcbRcbRobRibReRsmbRibRobRjbRcbsbRcb
LcLsmbLgbRcbsbRibLcbLcbLcbRcbRiRgRsmbRiRsmbRjbLibLsLcbLcLcLsmbRoRsmbLg
LcbRsRsLsmbRcbLebLibLcbLjLsmbRjbLobLcbRgLsbRiLsbLebLcLsmbLeLsLsLsmmbLs
LsmbLobLoLsmbRobLcLsLsmmbLcbLeLsbLiLsbLibLiLsbLibLobLebLebLsLsmbRoRibR
iRgbLcbRobRoRsmbRobRhRibReRsRgRsmmbRsLcbLibLibLobLibLoLsmbLcLcbLeLsbLc
bLhbLibLhbLgbLsLsmbRhbRobLgbLibRjbLeRsbLiLsbLsLgbLibLebRiLsLsmbRgbRsbL
cbRsbRibRgbRiRsRsmmbLebLcbRsLsLsmbLibRobLjbLjbLhbRjbLebRebRiRsRsRsmmmb
RgRgRsLsRsmbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 18; Drug: PCAP2 1 然 Apo 50 然
bRhRsmbRsRsmbRobsbLibLibLgbRjbRcRgRsRgmbsbRibRhbLcbLcLsLsmmbLoRsbRcbsb
RhbRcbRiRsmbRsRsmbRibRhbRhbsbRobLgbLcbLibLcbLjbRiLsLsmbLjbLiRsbRgbLobL
ibReRgRgbRiRsmbLsLsmbRcbRebRcbRiRsmbRsbRhRsmbRjRgRsmbLhbLobRcRsmbRibLj
bLjLsmbsbRhbRsRgRgRsmbRcbRcbRcbLsbLsRsLsRsRsRsmmbRcRsReRsmmbRcbRiLsbRg
bRsRsRsmmbRsbRsRebsbRebRcbLibLhbLibLiRsbLsbRjRgbReRsmbRcbRiLsbRsRsmbRg
RsRsRsRgmmmbRcbReLsbRsRgbRsRsRsRgRgmmbLsbRhLgLgbLgbLibLibLiRsbLsRsRsRs
RsmmmbRsRsmbsbRgRsmbRebLib

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 19; Drug: Control Apo 50 然
bLebLsbRsLsRsbLebLgbLeLgLibRsbLsLsmbLgLsLsmbLsLibRsbLiLiLsbLgbLsLsmbLi
LsLiLsbLsLgRsbRsbLsbLebLibLgbLebLiLsbLibsbLgLsLsmbLgbLebsbLsbsbRsbRsLs
bLsbRsRsLsmbRsbLsLsmbRsbLsbLsbsbLsbLsLsmbRsbLiLsbLsbLeLsbLiLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 20; Drug: Control Apo 50 然
bRibRsbRgbRibRsRgbRgbRsbRsRsmbRsRsRsmmbRsbRgRsmbRsRsmbRgRgRgRsmbRsbRgb
RgbRgbRgbRsbsbRgbsbRsbRsRsReLsmbRgbLcbRgbRobRjbRibRobLhbRgRsmbRgbRcRsm
bRgbRgbRebLjbLgbLebLsRhbRjbRgbRhbRgbRjbLsbRsbLgbRgbRcbLgRsbLgLsLgbLsbL
sLsLsmmbLgbLsLgLsbRebLibRsbRsbRsbRebRgbRgbRjbLsbLgbRibRgbLebLcbLebLgbL
jLjbLgbLobLcbLebRobLibRsbRcbLsRsbRebReb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 21; Drug: Control Apo 50 然
bRebRibRcbRcbRsbRibLjbLcbLibLgbLgLsbLsLsmbLiRsbRcRsmbRgbRcRsmbRebRibRg
bRibRibRibRgbRcbLjbLoRsbRiRsmbRibRibLsbRjRsmbRcbLjLsLgmbLsbLsRsbsbRjRs
LsmbLcbRibLjbRcRsmbRgbRiRsmbRebRhbRsbRhbLcbsbLiRsRsRsmmbRsbRjRiRsmbRcR
sRsmmbRcRsmbLiLsbRobRjbRcbRcbLcbLiRsbLobRgbLebLibLgLgbLiRsRsRgRsmmbRcR
smbLsRsRsRsRgRgRgmmbLsRsbLcbLiRsbRcbRcbRhbRcbLsbRcbRiRsmbRgbRcRsmbRhbR
jRsRsRsRsmmmmbRiRsmbRcbRcbRiRsRsmmbRhbRiRsmbRsRsmbRcbRcRsmbRibRsRsRsmm
bRcRsRsmmbRhRgbRibRiRsRsmmbRebRcRsmbRcbLjbLibRcbRhbRsRgbRcbRsRsmbRhbRc
RsRsmmbRgbLibLcbsbRhRsmbLiLsbRjbReRsmbLobLeLsbLgLsLgRsbLsLsLsLsmmmbLsL
sLsLsmmmbRsLsbLibRoRsmbRibRcbLgRsbRhbRiRsRsmmbRcbLgRsbRjRsmbRsbRgRsmbR
ibRcbsbRhbRhbRcbRebRiRsmbRhbRcbLjbLcbRgRsRgmbRgbRiRsmbLsbLobRsRsmbLiRs
bRgbRcbRcbRebRgbRsbRebLibRiRsmbRcbsbLcbRhRgbRcbRhbLsbRibLjRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 22; Drug: Control Apo 50 然
bRcbRcbRcbRebRcRsmbRcbRcbRcbLsLsmbLhbLcLsmbLobRcbRcbRcLsbRcbRcbsbLibRc
bLhbRcbLiRsbRjbLcbLcLsmbLobLcbLcbRcRsmbRcRsmbsbsbLhRsbRhbLcbLjbRcbLsLs
mbRsRsmbsbsbRjRsmbRcbRobLoLsmbLibLgLgbRobRcRsmbRibLgbLoLsmbLhbRcbRcbRe
bRcRsmbRcbLsLcbRibsbRcbRcRsmbRcbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 23; Drug: Control Apo 50 然
bsbLibLcbRjbRibsbRjbRibLsbLcbRibRgbLjbLibRebRjbLhbLibLgbRgbLsbLibRsbRg
bLeLsbRjRsmbLibRibLibLcbRgbRibRcbRgbRibRgbRgbRibRsbRgbRiLsbLsbLibRhbLj
bLcbRcbLhbRjbRebRibLsbsbRsLsbRgbRibRibRgbRgbRsbLcbLibLcbLgbLibRhbRgbRi
bRibRgbRgbRibRgbRibRsbRgbRgbRsbRibRibRibRibRgbRebRgbLsRcbRibLjbLobLhbL
ibLibRjbsbLcbLibLibLibLibRjbRibRgbLhbLibLgbsbRobRibRsbRgbRibRgbRgbRiRs
mbRsbRgbRsbRjbLsbRcbLibRibRjbLgLsLsmbLgbLsRsbRibLibLobRjbRiRsmbRgbRsbR
gbLgLsbRibLgbRgbLgbRgbLgbLcbRjbRsbRcbLsbLsbRhbRcbRcbLgbRjbRibRsbRibRsb
LsbRibRibLibRcbRibRgbRcbRsRsmbRibRhbLsbRhbRgLsbRibLibRgbRsbRsbLsRsRgbR
gRsmbRsRsRsRsRsRsmmmmmbRsRsmbLsbLsbLcbLibLsLgLsbLgLsbLgbLgbLcbLibRgbRg
bRsbRgLsbLgLgbRibRibLgbLibLibLgRsbLgbLsbRcbRsbRsbRgRgbRsRsmbRsbRsRsmbR
gbRgbRibLsLsLsmmbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 24; Drug: Control Apo 50 然
bLjLsmbLibLhLsbLjLiLsbLebRhRsmbRibLebLhbLhbLhbLiLiRsbLibsbsbLibLcRsbLs
bLcbLiRsbLjbLhbLjbLjbLsLcLsmbsbLsLhbLhbLsLsmbRebRcbRgbLebLcbRobRhbRibL
sbLgbLhbLgLsbsbLhbLeLsLsmbLhLsbLiLsbLjLsmbLjbLcbLhbLibLibLiRsbLhbLcLsm
bLibRhbRcbRibRibRcRsmbRgbRibsbRiRsRsmmbRsbRcbRiRsmbRgbLjbRiLsbLhbRcRgb
RcbRcbRgbRcbLjbLgbLcbLibLibLsbRgbRcRsmbRebRgbRiRsmbRgbsbRiRsmbRibRcbLs
bLhbLibLgbLibLcRsbLcLgbLiRsLgLsbRibLibLcRsbLibRjbLiLsbLeLsbRcbLebLibLi
bLjLsmbLjLsmbLebLibLibLibLibLiLsbLibLiLhLebLebLebLebLebLebLibLeRgRsmbL
cLgRgbLjbLjbLeLeLsbLcbLcbLibLhLsLsmbLcLgbLjbLhLebLeLsbLhLsbsbLsLibRebR
cRsmbLgLsbLcbLibLjbLsbRcbLcLsLsmmbLcbLibLcLsmbRcbRibRcbReRsmbRsbRebRgb
RebRcbRjRsmbLsLiLcbLibLcbLhbLgbRhbLibRebRhbRcbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 25; Drug: PCAP2 10 然 Apo 50 然
bRebLsLsmbLhLsbLgbsbLgLgbsbRsLcbLiLebLhbRjbLsRsRsmbRsRibRibLsbRibLsbRo
bLsRsbLsbLsbLsRsbLgbRsbRjbLibLoRsbRgbRsbRebLgbRsbRsRsRsRsmmmbLsbLobsbs
bsbLebLeLibRjbLsLsLsmmbLsLsmbLgLsbLgbLgbRsbRsbLsbLgbLsbRsbLsbLsbRiRsmb
LgbRgbRoRcbLgbRhbRobRoRsmbRibRibLibLsbRsbRebRobRcbReRsRsRsRsRsRsmmmmmm
bRibRgbRgbLsbRcRsmbLcbLibsbLsbLsbReLgbRsbLsbLgLsbRiRsmbLcRsbRcbLsbLsbR
gbLsRsRsmbRsbRsbsbsbRsbRjbRsbRsbLsRsbRsbLsRsbRgbLjbRgbLcbLobRsbLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 26; Drug: PCAP2 10 然 Apo 50 然
bLsLsmbRsbLsLsmbLsLsmbLsbLsbLgbLsbLgbLsbLsbLsbLsbLsbLsbLgRsbLebsbsbsbR
sbLsbLgbLsLsmbLsLgbLsbLsLsmbLsbLsbLsLsRsLsmbLgLsbLhRsRsmbLhbLsbLsbLsLs
mbLsbLcRiRcbsbRsbLsLsmbRsbRsbRsbsbRsbsbsbsbsbsbLsbsbsbsbsbsbsbsbsbsbsb
RsbsbsbsbsbsbsbsbsbsbsbsbLsbsbsbsbsbLsbsbRsbLsbRsRsmbLsbLsbRsbRsbLsbsb
sbLsbLsbLsRsLsRsbsbsbsbLsbsbsbLsbLsbLoLhbRsRiRsRsmmbRsRsmbRsRsmbRcRsmb
LibLgbsbLsbLsLsmbRsLsLsLsmmbsbsbLsLsmbsbLsLsmbsbLsbLsLsLsLsmmmbLgbLibL
hbLgbsbLsbLsbLsLsmbLsbLsbLsLsmbLsLsLsLsmmmbLsLsRsLsLsmmbsbsbsbLsLsmbLs
bLsbLsLsmbLgRsbLsbLsbLsRsbLsbLsbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 27; Drug: PCAP2 10 然 Apo 50 然
bLgbLibsbLsbRsLsLsmbLsbLsbRsLsLsmbRiRsmbRsbRgbsbRcRsmbRsRsmbLcLsmbLiLs
bLobRibLsLsmbLiRsLsbRsLiLsbLobRhRsmbRhRsmbLcbLcbLgbLgbLgLsRsbLgRsLsbsb
sbLgLsbRobRibRibLsLsmbRgbRsRsmbRgbRsRsmbLsRsRsmbRsbLgbRobRhRsRsmmbRgRg
RsRsmmbRiLsbLgbLsLibRsbLsbRsbLibLgbRiRsmbRgbRiRsmbLjbLcbLgbsbLobLibsbL
sLsLsRsLiLimmbLgRsbLgbLgbLibRsbLgLsLsmbRjbLiLsLsmbRiRsmbRobRcbRcbRsbRe
RsmbRgbRgbRsbsbRsbRsRgRsRsRsmmmbRgRsmbRsLsbLjbRsbsbRiRsmbLsLgRsbRgbsbs
bRsRsmbRsRsmbLjbRibRgRsmbRsRgRsmbRsbRgbsbLjbRjRjRsmbLsbLhLsRsbLgLsbLsb
LcbRsbRhbRsRgbRgbRsRsmbRcRsmbRsbRgbRebRobRcbsbsbLjbRgbRsbRsRsmbRgbReRs
mbLsLsmbRibLgLsbRsLsRsbRsbRsbRsRiRsmbLgRsbRobRsRsmbRobRgRsmbRiRsmbRgbR
eRsmbLsbLjbLeLiRsLsLhbLebLibRibRobRsbRcbRibRsLsLsmbLhbLgLsbLibsbLgbLsR
sbLsbRgRcRsmbRibLsbRebReRsmbRiRobRebRsRibRiRsRsmmbRcbRsbLcbLiLsbLibLiL
sbLsLebLgbLibRsLiLsbsbLsLsmbRsRgRsmbLsLsmbLebLibRjbRibReRsmbRcRsmbRgRs
mbRgRsRgRsRsmmmbRgRsmbLsLsRsRsmmbRsRsRsmmbRsbLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 28; Drug: PCAP2 10 然 Apo 50 然
bReRsLsmbRiLsLsmbLjbLsbLsLgbRibLhRsbRjbLibRsbRjRsmbRcbRjLsLsRsmbsbRibR
gRsRsRsmmmbRibLibLhRsLsbLiLsRsbLiRsbLgbLibRhbRobRcRsRsReRimmbLoLgLsbLh
LsbLibLibLobRiRsmbLibLgbLiLsLsmbLiLsbLgbRoRibRiRsmbRibRibRiRsmbRiRsmbR
gbRsbRgbRsRsRgRsRsRgRsmmmmbRhRsRhmbRiRsmbRsbLhLhRgRsmbLsbLgbLibRsRsmbL
sLgbLoRsRsReRiRimbRoLsbRcbRiRsRsmmbRiRhbRhbRcLsbRhbRhRiRsRsmmbRcbRiLsL
smbLgbLjbLgbRcLsbRcbRiRsRgRsmmbRsbRjbLsLsmbLsLsRsRsRsRsmmmmbRgRiLsLsmb
LeLiRsbLiRsbLjLsmbLibRcbReRcLsbRibLobLhbLiLiRsLsLgbRjbLjLsLgLsmbRjbRjb
LgbLibRgbLcRsbRsRsmbLgbRibLhLsbRgLsbRgbLgLcbRibLcbLgbLgbLsRsbLcbLgbRsb
LsbRsbLcRsbRiRibRgRsmbRebRoRsmbRsbRiRiRibRiLsLsLsRsmmbRcbRhbRobRgbRcLs
RiRibRibRgRsRsmmbRebRsRsLsRsRsmmbRiRsRsRsRsmmmmbRhRsmbRcLjbRibRiRiRiRs
mbRgbRgLsbRsbsbRhLsLsLsRsmmbRsRsRsRsRsRsRsmmmmmmbRgRsmbLgbLsRsbLsbsbLs
bRhLsbLhbLoRsbLgLgbRhbRibsbRsRsmbsbsbRhRebRgRsRgRsmmbRgRsmbLjbRsbLjbLi
bLiLsbLjLsmbLebLsbLjbRsbRjbRsbLsLsRsLsLsLsmmmbRhRsmbRibRhbRhLsbRiRsmbR
jbLsRsbRsbRjLsLsLsLsmmmbRgRsRsmmbsbLsbRgLsLgRsRgRgRsRiRsmmbRiRsLsmbLsR
sbRsRsmbLsbRhb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 29; Drug: PCAP2 10 然 Apo 50 然
bLibLgbLsLsmbRebRgRsmbRgbRibRgbRibRgLsRgbRiRcLsRgLsbRebRsbRgbsbsbRsRsR
smmbLcbLiLsbsbLcbLsbLibLsLsLsmmbLjbLgLsbLgbLgRsbRsbLsRsbRsbsbsbRcbRibR
iRiRgbRibRsbRgRgRgRsmbLgbRgRsmbRgRsmbReRiLsRgRsLsmbRibRgbRibRibRsbLsRs
RsRsmmbsbRsbLobLhbLgbLsLsmbLsbRsbLsbLgbLsbLgLsbLsbsbLsLsmbLsLsmbRsLsbL
sbRsbLsbsbsbsbLibRjbRjbRcbRgbRcRsRgmbRhbRsbRibLsRsbRsbRsbRsbRibsbLjLsL
smmbLsLsmbRibRgbLsLsLsLsmmmbRiRsmbRsRsRsmmbRcRsmbLibLgLsbLjbLsRsbsbLib
LibLsbRobRiRsRsLsmmbRsRgRsRsmmbRgRsRimbRsRsRimbRgbLibLiLsbLiLiLsbRsbLg
bLhLsLgLsLsLsmmbRsLgLsbLjbLsLiLsbRgLgLsbLibsbLgLsLsLgLsLgLsmbLsbLobRsb
RhbRsRobRcbRsbLcbLcLiRsLsbLiRsbLsbRgRsmbRgbRsbRibRoRsRsmmbLibLibLsLsmb
sbRjbLibRhbRoRsmbLjLgLsLsmbLgbLcbLgbLsLsmbLibLobLibLibRobLsbRoRgRibRiR
sRiRiRsmmbRhbLgbRobRgLgbRebRgRgbRhLsbLibLsbLeLebLgbLsbRsbRsbLgbLsbRsLe
LsbsbRsbRibRsbRiRsmbRcLsbRoRsmbLsbRibsbLsLgbsbRcbLhRsbLiLsbLibLsLsmbLi
bsbLsbLsbLgbLgbsbLiLsbRsbRgbLjLsmbLibLhLsLsmbLibLgbLjRsbLgLsbLsLsLsLgL
smmbLsRsbLobRgbRibRcRgRiRsmbRibRgbRibRgbRcLsRsLsbRcbRgRsRsmmbRiRgRsLgm
bLjbLgbLsLsmbLibsbRcbRjRibsbsbRhbRjRgRsmbLibLibLgbLibLsbsbLsbLobRsLgRs
RsRsmmbLgRebRhRgbRibLsRsRsmbLjbsbLsbRgbReRsRsmmbRgRiRsmbLsbLsbLsbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 30; Drug: PCAP2 10 然 Apo 50 然
bRiLsbLgbLsbRjbRcbLibLcbLgRsbRgbRsRsmbLcbLibRcbRjbLjbLobRibsbRgbRibRcb
RiRsmbRgbRibRhLsbRhbRobLcLsLhmbLoLsmbLcbLjRsbLsLjLibRiRgbLoRsLcbLobRob
RiRsRsmmbRibRhRsmbRibRgbRhbLsbLcbLcLsmbRgbLiLsbLibLhbLibRjRsmbLobRiRiR
obRibRebRebRebReRsmbRgRsmbRjRsmbLsbRsRsmbRebLgbRsRsmbRsRsmbRsRsRsmmbLs
bLsbLjbRsRsmbRsbLgRsbRibLjRsbsbLjbLcLgLsbLsbsbLcbRebRsbRcRiRsmbRgbLjbL
cbLoRsbRgRsRsmmbRjRsRsmmbLjbLibRgbsbsbRsbLibLibRjbReRsmbRebRebReRsmbRi
RsmbLgbLcLsmbRiRsRhmbRibRibRobRibLsbLhbRoRsRsmmbRsbRjRibLgLcbLhLsbLibR
gRsmbReRgRsmbRsRhbLcRsbLcRsbLcbRgbRibReRsmbRcbsbRgbLsLcLibLebRgbRhbRhb
RcRsRsRgmmbRcbRiLsRsbLobLibLgLsbLiLsbLibRcRsmbRhbRcbRsbRcRsmbRoRsRsmmb
RiRsmbLjbLjbLcbRjRsmbLhRsRsmbRhRsmbRiRsmbRcbRcbRibRhbRcbLjLcbLebLobLcL
smbLibRsbLobRiRsmbLjRsbRgRsLsmbRhLsbRsbRgbRsbRgbRgbRiRsRsmmbReRibLjLsm
bRcRsmbRsRcbRcRsmbLibLjbLjbLiLsbRiRiRsmbRibLhbRsLjbRcbRiRsmbsbLhbLeLsb
LcRsbLcLsmbRgRsmbRgbRhRsmbRgRsmbsbLsbRsbRsLsbLcbLsRsRsmbRsbLjbLebLeLgb
RhRsmbLgRsbLebLcRsbLgbRjRobLiRsbRgbRcbRhRsRsmmbLebLibLiLsbRgbLcbLibLhL
sLsmbLsbRhRsmbRcbRibRcbRjRsRsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 31; Drug: PCAP2 3 然 Apo 50 然
bsbsbLsbRsLsRsbsbsbRsRsmbsbRsbRsLsLsmbRsLsbLsRsbRsRsmbRsRsLsmbsbRsRsmb
RsbRsRsmbRsbRsRsRsRsmmmbRgbLsbRsbRsRsmbRsRsmbRgRsmbRsbRsRsmbRsbsbRsbRg
RsmbLsbLsLsRsmbRsbRgbRsbRsRsRsmmbRsbLsRsbRsbLsbRsLsbRsbRsbRsbRsRsLsmbR
sRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 32; Drug: PCAP2 3 然 Apo 50 然
bLsbRjbLgLsLsmbRcbRibRibRsRsmbRibRiRibRibRhbReLsbRhbRhbRibRgRsRgmbReRs
mbRgbRgbRsRsmbRgbRsRsmbRsRsmbRsRsRsRsRsmmmmbRsRsRsmmbRsRgRsmbRsRsRgRsm
mbRsbRsRgRsLsmbRiReRgLsLsmbRgbLsbLobLhbRebLsbRebRsbsbRcbRibRsRsmbRgRsm
bLgbRgbsbRsbsbRgLsLsmbLiLsbRgbRibRgbRhRsRcRsmmbRibRiRsmbRgRiRsmbRibRib
RcbRhbRhRibRsbReRsmbLibLebLgbLgbLsbLhLsbLsbRsbLgbRjbRibRibRiRsmbRgbRgR
gbRcRhRsmbReRsmbRgbRibRibRibLsLsmbRsbRsRsmbRsLsLsRsmbRgbRsRsmbRgRsmbRs
RgRgRsmbLsbRsbRjLsbLsbLsRsLsLsLgmbRibRiRsmbLsbRgbLoRsbLiLiLsbLebLcbLcL
smbLibLibLhbLgRsbLgbLgbLiLsLsmbLgLgbLgLsbLgbLgLsbLsbLgbRjbLgbLgLsLsmbs
bLsbLibLgbLgRsbRsLsbLgLgbLsbLgbRsbLsbLgbLgbLgLhLeRsbLgbLiRsbRsLhbLgbLg
bLgbLgLgbLsbLgbLgbLsLsmbRgbLgbLsLsLsmmbLsbLsLsmbLgbLsbLsLgLsbLiLsbLjbR
cbRiRgbRsRgbRsbRgLsbsbLsLsmbRcbRibRibRibRibRobReb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 33; Drug: PCAP2 3 然 Apo 50 然
bLjLgbLebLiLsbLgLsLsmbLhLsLiLsLcbLcLsLsLsmmmbLgLsLsLsmmbLobLebLjLhLgLi
LsbLgbLeLsLsLsmmbLgbLgbLeLsLsmbLcLsLsmmbLebLcbRebRibRgbRebLhbLiLsbRhbR
jRsmbRjbRibRcbRebRiLsbLeLsbRhRebRiLsbRgRibRiRsmbLhbRsLsbLgLsbLsbsbLiLs
bLiLsLsmbRiLsLsmbRcbLcbLobRsLsLsmbLiLsbLcLsmbLebLgbLcbLoLsmbLsbLoLsLjL
smmbLeLiLcLgbLcbLeLgLsLsLsmmbRsLeLebLgLsLcbLjLsmbRcbRiLsbRgbRgbRibRibR
iLsbRsRcLgbRhRsLsmbRebRgbRcbRhbLsbRcbRgLibRcbRhRsmbLeLsLsmbRsbsbsbLgbR
ob

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 34; Drug: PCAP2 3 然 Apo 50 然
bLjbLsRsbLcbLgbRsRjbLgLsbRsRsmbRgbRhRsRsmmbRiReRgRgRiRgRsRsRsmmmbRgRsR
sRsRsRsRsRsRsRsRgRgRsRgmmmmmmmmmmbRgRsRsmmbRiRgRgRgRsRembRgRsRsmmbRgRs
RsRsRsmmmmbRgbRgRgRiRsRsRsRgRsRimmmmbLsRsRsRsRsRsRsRsRsRsRsRsRsmmmmmmm
mmmmbRiRsRsmmbRsRsmbRsbRgRsRsmmbRsRsRsmmbRsRsRsRsRsRsRsRsmmmmmmmbLsRsR
sRsRsRsmmmmbRiRsRiRsRgmmbRsRgbRsbRsRsRsRsmmmbsbLsRsRsRsRsRsmmmmbRsRsRs
RgRsRsmmmmbRgRsRsRsRsmmmmbRsRsRsRsRsRsmmmmmbRsRsRiRsmmbRgRsRsRsRsRsRsR
sRsmmmmmmmmbRsRgRsRsRgRsmmmbRgRsRsRsRsRsRsRsmmmmmmmbRgRsRgRsLsmmbRsRsR
sRsmmmbRgRgRsRsRsmmmbRsRsRsRsRsRgRsRsRsRsRsRsRgRgRgRgRsRsRgmmmmmmmmmmm
mbRgRsmbLgbRsRsmbLsLsRsRsRsmmmbRgRsRsRsmmmbRsRsmbRsRsRsmmbRsRsRgRsmmbR
ibRgRsRsRsRsRsRsRsRsRsRgmmmmmmmmmbRgRsRsRsRsmmmmbLsRsbRsRsRsRsRsmmmmbR
gRsRsmmbRgRsmbRgRgRsRsRsRsmmmmbRsRgRsRsmmbRsRsRgmbRsRgRsmbRsRsmbRibRsb
LiLsLsLsmmbLsLsRsRsRsRsRsRsRsRsmmmmmmmmbLsbRsRgRsRsRsmmmbLobLgbLgbLiRs
RsLsmbLcbLiLsbLcbLgbReRsmbRibRcbRgbReRgRebRjbLsbLgRsbLsRhbRiRsmbRjRsmb
RjLsRsRsmbRcRsmbLiLiLiLhRsbLgbLgbLiLsbRjbRjRsmbRgRsmbRcLsbRjRsmbRjRsRs
mmbLcbLgbLgLgLsLeLsbLsLsLsLsLsLsLiLeLgLeLiLhmmmmmbLgbRjbLibLcLsmbRhbRi
RsmbLjbLcbLgbRjRjbRebRjbRobLgLsbLsRibRcRsRsmmbReRsmbRjRgRsRgRsmmbRhbRc
bLjLsmbLhLhRsbLiRsbRcRsRgRimbRjbLobLobLgRsbRcbRcbRiRsmbRjbLiRsbRjbRibR
iRsRsmmbRhbLgRsbRibRcbRiRgRsmbRobLgbLibLjbRgbRjbLgLsLsLgLsLsLsLsLsLsLs
LsLgLsLsLsmmmmmmmmmmbLjLgbLgbRgbRobRcbRcbRibRsRsmbLhLsLsmbLgLsLsLsmmbL
sLsLsmmbLiLiLhLeLiLsbLiLsLsLsLsLsLsLsLgmmmmmmbLiLeLhLgLgLsLsLsLsLgmmmb
LiLsLsmbLgLsLsRsmbLsLsmbRjbRjRsRsmmbRcRsmbRjRsmbRcbRjRibRibRcbRjRsRsmm
bLsLsmbRjLsbRiRsmbLibRsLsLsLgLgLsLsLgLgLsLsLeLeLsmmmbLsLsLsLgmmbLgLsLe
LsbLebLebLibLiLsbLiLsbLsLsLsmmbLgLsLsmbRebRjbRcbLjbLiRsbLgbLibLgbRjbRj
LsbRsbRcbRjRsmbRjbLiLsLsLsLgLsLsmmmbLjbLebLibRsbLcLsmbLcbLgRsbLjbLiLsL
sLsLsLsmmmmbLgLsLsLgLsLsmmbLgbLgLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 35; Drug: PCAP2 3 然 Apo 50 然
bRsbRjbRsRsmbRsLcbRgbLsbRsLsbRgbLsbsbLsbRsRsmbRgbRsbRsbRsbRsbsbRsbRsbR
sbRsbLsbRgbRsLsbRsbRsRsRsmmbRsbRsRsmbRsbRsRsmbRsRsmbRsRsmbRsRsmbRsbRsR
smbRsbsbRsbRsbRsbLsRsbRsRgRsmbRsRgbRsbRsbRsbRsbRsbLsbRcbRsbRjbRebLjbLo
RsbsbLsLsmbsbRsLsbLjRsbsbRsbLsLsLsmmbLsbLsLsRsLsLsmmbLsRsbRsLsbLsRsbRs
bRoRsmbRsRsRsRsRsmmmmbRsbRsRsRsmmbRsRsRsmmbRsRgRsmbRsRsmbRsLsbsbRsbRhb
LsLsmbLsRsbRsbRgbRgLsbLsbRgRsmbLsbLsbRsRsmbRsbRsbsbRgbRgRsmbLsbRsRsRsm
mbRsbRsLsLsRsRsmmbRsbRsbRgbRsbRsbRsRsmbRsbRsLsbRgRsRsmmbRsbRsRsmbRsbRs
bRsbRsRsmbRsbRgbsbLsRsbRgbRsRsmbRsRsRsmmbRsRsmbRjLsbLsbRsbRsRsmbRgRsmb
LsbRsbRsRsRsmmbRgRsmbRsRsmbRsbRsbRsRsmbRsRsmbRsbRsbRsRsmbLsbRsbRsbRsbR
sbRsbRsbLsbLsLsRsmbRsbRsRsmbRgRsmbRsbRsLsbRsbRgbRgbLsRsbsbRsbRsbRgbRgb
Rsb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 36; Drug: PCAP2 3 然 Apo 50 然
bLsLsLsmmbLsbLsbsbLsbLsLsLsLsmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 37; Drug: PCAP2 1 然 Apo 50 然
bLsbLjLsLsmmbLcbLgbLgRsLsbRsbsbsbsbLjbLsLsLsLsLsLsLsLsmmmmmmmbLsLsLsLs
mmmbLgLgLgbLsLsLsLsLsmmmmbLgLsLsmbLgLgLsbLsLgLgLsbLsLsLsLsLsmmmmbLgLsb
LgLsbLsbRcRsRsmmbRobRobRibRibRgRsmbRcbRhbReRsmbLgbLsLsmbLsLsLsLsLsmmmm
bLgbLgbRcbRcbLgbsbLiRsbLhbRsbLsbLjbRsbRgbLsbLjRsLsbRsLsLsLsLgmmbLsLiLh
bsbLsLsLgLsLsLiLgmmbLgLibLsLsLsLsLgLsLsLsLsmmmmmmbRsLsbLgbLsLsRsLsmbLg
LsLsmbLgLsbLgLsbRsbsbRcbRiRsmbRhLsbRsbLgLsbLgbLcbLhbLiLsbLsbLgbLjLibLs
bLoRsRiRsmbRgRsmbRiRsmbRcbRibRsbRhbRsbRcRsmbLjbRibRgRsmbRgbRiLsRsbRsbL
sRsbLjLsmbRsRsRsRsRsRsRsRsRsRsmmmmmmmmmbRiRsmbsbRsbRsRsRsRsRsRsRsRsRsm
mmmmmmmbLsRsRsmbRgRsmbLoLsmbReRsRsmmbLoLsmbLgbLiLsbRsLsbLcbRsbLiRsLiLs
bLhbLibLsbLsLsLsmmbLsLsRsLsmbLsLsmbRiLsbRsbsbsbRsRsmbRgRsRsmmbRsLsRsbR
sRsmbLjbsbRsbRsLsRsbRgbRsRsRsRsmmmbLsRsRsmbRgbLcbLibLsLsmbLibRsLsbRsLs
bRsbLjbRsbLcbLibLgbLibLgbLeLsLsmbLsLsLsLsLsmmmmbLgbLgLsbLiLsLsLhmbLgbL
ib

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 38; Drug: PCAP2 1 然 Apo 50 然
bLibRjbLhLsbLibLhLsbLibLgbLibLiLsLsLsLsLsmmmmbLsbLibLsbLsbLibLgbLibLgb
LgLsbLgbRcbRhbLcbLgLsLsmbsbLibRiLsbRhbRibRsbRibRibRibRgRsmbRibRgbRgbRj
RsmbRibLcLsmbLhbLgLsbLibLibLgRsbLgbLgLsbLibLibLgLsLsmbLgbLgbLcbRsbLiLs
RsbsbLsbRjLsbLjRsbRsbLsbsbRsLsbsbRjbRhbLcLsmbLgbLibRsbRsbLgbLgbLgLsLgL
sbLsRsbRjbLcLsmbLiLsLebLgbLgbLgLgLiLiLgbLeLibLiLsbRjbRobRibRgbRibRgbRi
bRibRibRibLjLsmbLiLsLsmbLiLsbRgbLsLsLsLsLimmmbLibLgLsbLgLgbLgbLgbLgbLs
bLiLsbLiLsbRjbLibsbLsbRjRsmbRcbLebLibLiLiLsLibLibLiLsLsLsLsmmmbLibLsLs
mbLhLsLibLgLsLgLsLgLsbLgLgLsLsLsLgRsmmbRsLsbLgLsbLiLibLsRsbLiLsbLsbLgL
sbRcbRjbRcbLsbLsbLibRibLjbRibLiLgLsbLjLgLsLsmbLiLsLsmbLibLhLsLsmbLobLh
bLsLsLsmmbLibLiLsbRsbLiLsLgLiLsLsmbLgbRsbRjRsmbRhbLcbLgLsbLsbLgbsbLcLs
LsmmbLcbLgbLsbLsLsmbLgbLhLsLsLsmmbLiLsLsmbLeLsLsmbRsbLgbLhLsbLgbLgbsbL
sbLibRsLsbLiLsLsLsLsmmmbLibRibRibRcbLeLsbLiLsbLibRsLsbsbLhbRiRsmbLsLcL
smbRsbRsbLhbLhLsLsmbLgbLsbLibLgLsLsmbLcbLibRsRsmbRgRsRsmmbRsRsRsmmbsbs
bRiLsbLjbRibLhbLgbLhRsbsbsbsbLsLsmbRjRibsbLjb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 39; Drug: PCAP2 1 然 Apo 50 然
bLsbRjbRobRgbRhbRibLgbRhRsmbRibRjRsmbRjbRgbRiRsmbRjbRibRgbRjbRcbRibLob
LoRsbRjbLoRsbRibRjbRjbRsLgbRjRgbRgLsbRgRsmbRgRsRgRsRgmmbRgbRgRsRgRgRsm
mbRgbRgbLjbRibRgbRiLsbLibLhbRcbRsRhRsmbRibLhbRibRibRibRibRgbRgbRcbLjbL
hLsLsmbLcbRsbRcbRsbRgRsmbRhRsLsmbRjRgbRibRjRibRjRsmbRsRjRsRsmmbLhbRjbR
iLsbLsbRjbLgRsbRsbLsLsmbRebRcRsmbRhbRjRsLsmbLcLsmbRjbLcRsbRjLsbRibRibL
iLsbRhRsmbRcRsmbRjbRiRsLsRsmbRhbLoRsbLiRsbLgbLhRsRsmbLsbRgLsbRjRgbRoLs
bLobsbRibLobLcbRjRcbRsRjbLsbRcRsmbRoLsbRibRjRjbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 40; Drug: PCAP2 1 然 Apo 50 然
bLcbLcbLcLsmbRjRsRsRsmmmbLgRsRsReRsRsRsRsmmmmmbRhRsRsmmbRhRsmbRsbLgbRc
bLgbRebRhRsmbRiRsmbRcbRgRsRsmmbRhRsRsmmbLibRcRsmbRebRebRcbRibsbsbLjbLc
bsbRebReRsRsmmbRgbLobRcRsmbRibRjRgbRsRsRsRsRsRsRsRsRgmmmmmmmbRgRsRsRsm
mmbRsbRgbLgbRiRsmbRhbLsLsLsmmbRcbRsRsRgRsRgmmbRcbRsRsRsRsRsmmmmbRsbLib
RhbRhRsmbLgbLcbLcbRebRoRsRsmmbRgbRcRsRsmmbRhbRsbRsRsRsRgmmbRibRsRsRsRg
mmbRsRsRsRsRsRsmmmmmbRsRsRsmmbRsLsbRsRsRsmmbRgRsRsmmbRcbRsRsRsRsmmmbRs
RsRsmmbRcRsRsmmbRsbRcbRcRsRsRsmmmbLgbRcRsmbRgbRcRsmbRhbRebLgbLsbRsRsRs
mmbRgbRcRsmbRgRsRsmmbRgRsRsRgmmbRjRsRsRsRsRsRsRsRsRsmmmmmmmmmbRebRhbLi
bReRibLsbRsbRiReb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 41; Drug: PCAP2 1 然 Apo 50 然
bRiLsRsbRibRcRsmbRobRcRsmbRiRsRsmmbRiRsmbRcbRhbRebRgRebRhLsbRcRgRsmbRi
bRiRsmbRibLsbRiRsRhRgmbLjLjbRcbRiRsmbRgRiRsmbRiRsmbRiRhReRsmbRiRgbRhbR
cRsmbRiRsmbRsbRsbsbLebRcbRsLsbLsLcbsbRcbRcRsRsmmbRgbsbRiRsLsmbRsLsbRiR
smbRcRsRimbLcbLhLsbLsLgbRibRcRgRsRgReRsReRgmmbRcRsRsmmbRcRsmbLebLhbLgb
sbsbsbsbLsbLsbLsRsbsbLibLcLsmbRcbRibRiRsRsmmbRsLsbLcbLcLcbLcbLiLsbLiRs
bLiRsbLgbLiLsbsbLhLsbLgLsLsmbLiLsLsLgmbRcbRiRsmbLjbRhbRcbRoRsmbRsLsbRc
bLjbLebLsLsLgLsLsmmbLcbLcbLibLgbRobsbLjbRcbLsRsbRcbLcbLcRsLsbRobRhRsmb
RcbRiRsRsmmbRcRsmbLsRsbRcbRibRhbLgbLhbRcRsRsmmbLsLsLgLsmbRhbRcbLoLsmbL
hLibLoRsbLoLgLsLeRsLhRsbLhbRsbLcLsmbRsbLiLsbLcbsbLgRsLsLhbLgbsbRcbRebR
iLjbRibLsLsmbLsLsLsLsmmmbLgbLgRsbRcLsbRcbLcLsmbRcbsbRiRsmbRsbRcbRcbLgL
sLsLsmmbRcRsRsmmbRiRsmbRcRsmbLsbRibLgbRoRsRsmmbRcbRcbRcRsmbRcRsmbLibRj
RjRgbRiLsbRoLsbLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 42; Drug: PCAP2 1 然 Apo 50 然
bRibRsbRhbLgRsbLibLiLsbLjLsmbRhbLcbRiRgRsRsmmbRibRibRibLcbLjbRjbRcbRiL
sRsbRsbRjRsmbRjbsbRjRiLsLsLsLsLsLgmmmmbRjbLcbLcbRiRsmbsbRibLeLsbRiRsRs
RsmmmbRjbRjbLsbLjbLjbLjLsmbRibRjbRhRgbLjbLcLsmbRjbsbRgRgRsLsmbRibRgbLg
bRibLgbLibLhbLsLsmbRoLsbRgRsRsRsLsmmmbRibLibLeLsbRiRsRsRsRsRsmmmmmbRiR
sLsLsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 43; Drug: Control Apo 50 然
bRhRsmbRiLsLsmbRcbRcLsbLsbRcbRgRsRimbRcbRgbRsbRcbRiLsbRhbRiRhRsmbRsLsb
RsRsmbsbsbRgLsbRcbRcbLiLsbLsbsbLsbLsLgLsbRjbRhbRhbRcRsmbReRsmbRiRsmbRg
bLebLcLeLiLgbsbsbLhbLgLsbRcbRiRsRsmmbRibRgbRgRsmbRsbsbRsbRsRsmbRgbRgbR
eRsmbRgbRcbRgbRgbRiLsbReRsLsmbRhbRibRgbRgbRobLsbRcbRhRebLoRiLcbLhLsbLc
LcbLeLcbRgbLcbLsRebRcbLsbLiLsbRjbRhbRgRsLsmbRiRsmbRgbRgRsmbRiRsmbRgbRg
bRgRsmbLebLjbLiLsbLiLcbLibLibLcbLibRsbRsbRsRgRebLsLsLimbRsbLcbLcbLhbLh
bLgbLgLsLsLsLsLsmmmmbRsbLsbLsLsLsLsLgLsLsmmmmbRsbRjRjbRsRiRsmbRibRjLsb
RibRjRsmbRebRhbRhbLgRsRgbRgbRgRsRhRgmbRibRibRiRiRsRsRsRemmmbLsbLibLiRs
bRcRiRsmbReRsmbRsRgbRsRsRsRsRsRsRsRsRsmmmmmmmmbRsRsRsRsRsRsRsRsRsRsRsR
sRsRsRgmmmmmmmmmmmmmbRibRsRsRsmmbsbRsRsRsRsmmmbRgLsLsmbRibLcbRibRibLgb
Lgb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 44; Drug: Control Apo 50 然
bRgbRsRsRgmbRgbLsbRgRsRsmmbLsRsRgRibRebRhbRibRibRgbRgLsbRcbLsbLhLsbRob
RcbLibRsbRcRsRsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 45; Drug: Control Apo 50 然
bRgbRsRsLsmbRebReRsmbRsbRsbLjbLhLsbLebLsLsmbsbLsLsmbRcbRebsbLcbLebLibL
sLsmbLgbRcbRibReRgbRgRsmbRgbRcbLsbRebRgbRsbLsbLsbRgbRiRiRsRgmbsbRibRcb
RcLsbRibRgbRibLobLcbLcbLiLsbLgLgRsbRobReRsRsmmbRgRsRsmmbRibRsbRiReRgbR
ebRhbsbsbRsbRgLsbRgbLcbLiLsLsmbLibLibLcLsmbLebLsRsLsbLcLsLsLgmmbLibLgb
RobRebRhRsmbRebRebRiRebRobLebLibLibLebLeLgLgbLhLebLiLsbLsbLcLebRebRibL
cbLsbRgLcbLcbLibLcbLiRsbLsbLgLibLebRcbRebRibsbsbRgLsRsbRsbReRsmbLcbLcb
LobLcbLhLiLsLsmbLibLsLibLiLibLiLsbLibLiLebLebLoLsmbLgLsbLibRibLgLsbLib
LibLibLgRsbRgbRhbRsbRcLsRsbRiLsbLsRibLjbLibRhbRgLsbRsRsmbRibLsbRsRgReb
Rsb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 46; Drug: Control Apo 50 然
bLebLibLiLsbLhLsbsbLebLobLgLsLgbLgLsbLibLebsbLeLsbLsLeLsbLebLebLcLebRg
bLsbLgLsbLsLeLsLsmbLgLsbLsLgbLebLjLibLsbsbLgbLiLsbLgLsLgbLgbLibLsbLgbL
ebLibLgLsbLiLsLsLsmmbLibLsRsbLiLgLsbLgbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 47; Drug: Control Apo 50 然
bLsRibLobLibLcbRobRhRsmbRhbLcLcLsmbLibLsbRobRsbRsbsbsbsbLsbsbsbRebLcbR
eRcbRcbRcbRcbRiRgRgRgbRiRsmbLibLcLsLsLsLsmmmmbLgbLsLibLgLsRsbRsbLcbLib
LgbLibLcbLsbLgbLsRsbLsbLobLibLebLhbLhbLcbRcbRhbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 120028; End: 120529;
Recording: 7-1; Individual: 48; Drug: Control Apo 50 然
bLgRsbRgbLsbLhbLibLsLibLgbLibRsLibLiRsbLgbLjbRcbLibLibLibLibLhbLibRcbR
hbRibRsbRebRibRibRibRhbRgbRibRcbRibRibRhbRcbRsbLibRibRiRsmbLgbLjbLgRsb
LibLibLibLhbLibLibLibLiRsRsmbLgRsbRebLsLjbLcRsbLibLsRsbLjbLibLgbLibLeb
LibsbLgbLibLsbLibLhbLibLgbLcLsmbLgLeLgLibsbLsLgLhLhLsbLcLsRgmbLsbLcbLs
LsLgLsLsmmbLgLgbLsLgLsbLsLgLsbsbLsLsLsLsmmmbLiLsLgLsLebsbLeLsbLibRsRsm
bsbLiLsbLgbLjRsLsbLgbRgRsmbLsbLsbLgLsbLibLjRsbLsbLeLsbLiLsbLgLsbLgLgLs
bLgbLibLebLgLeLsbLgLsbLgbLgLsLsLsLgLsmmbLsbLebLcbLebLebLsLgLsLsmbLsbLs
bLgbsbLsRsbLiLsbLiLgLebLibLsbLsLsLsLimmbLebLsRsbLeRsbsbRcbLibLsRsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 1; Drug: PCAP2 10 然 Apo 50 然
bRsRsmbRsLsbLsbRobRsbRsRsmbRoLgbLsbLsbLsbRcbRsRsRsRsmmmbRsbRobRcLoLgLi
bsbLsbLsRsbRcRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 2; Drug: PCAP2 10 然 Apo 50 然
bRoLsLgbRcRsmbLsLsLsmmbRobRsRsmbRiRsmbRiRsmbRoRsRsmmbLgLsbLsbRsbsbRsRs
mbRsRsRsmmbRsRcbRcbRgbRiRsmbRcbLsbRgRsmbRcbLgbRibRsbRsbRgbLsbRsbRsbRsR
smbRsRsRsRsRsmmmmbLsRsRsmbRsRsmbRsRsmbRsbRcRsmbRgbRoRsmbsbLsLsRsmbRsLs
bRsRsRsmmbLcbRibLsbLgRsRsRsmmbRcLsbRcbsbLibRcbRiRebRgRsmbRebRgbRgRsRsm
mbLsRsRsmbRsRsRsRgRsmmmbRsbRibRsbRiRsmbRcbLgbRcRebLgbLsLsmbRiRsmbRgRsm
bRgRsmbRsbsbRhbLgbLsLsRsRsmmbRiRsRsRsmmmbRcbLgLsLsmbRsRsRgRsRsmmmbRiLs
LsmbRgRsmbRiRsRsmmbRsbRsbRhRsmbLsLsmbLsbLhbLcRsbLsbRcRsRsmmbLgbRsbRcRs
mbLsbRsbRiLsbRoRsmbLsbRgbRibLgbLobRcbRcRsmbLsLsmbLsRsbRsbRibLsRsRsRsmm
bRgRsRsRsRsmmmmbRsRsRsRsmmmbRcbLgbLsbRsRsRsmmbRibRibRgbsbRsbLsLcbLcRsb
LiRsbLsbRcRsmbRgRsRsmmbRgbRsbRobLgLsbRsLsbLsbLibRjbRcLsLsmbLgLsLsmbsbL
ibRgRsRsRsmmmbRgbsbRsbsbRsRsmbRsRsRsRsmmmbRsRsRsRsmmmbRsRgbRsbRgRsmbRi
bRhbLsLsmbLgbRibLsbRiRsmbLsLsLsmmbRsRsLsmbRiRsRsmmbRsRsmbRgbRcRsmbLsbR
sbRcbLsbLsbRsbRiRsRsmmbRibRcbRsRcRsmbLsLsmbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 3; Drug: PCAP2 10 然 Apo 50 然
bsbRibRcLsbLgbsbsbRcbRcRsRsmmbsbLsbsbReRiLsbReRsmbLcbLhbLgLsbsbsbRcbRs
bRsbRsbReRsmbRgRsmbsbRsRsmbRsRsmbLsbReRebRcbRibLjbRjbRebLsLsmbRsRsmbRi
RsmbRcbRhbLeRsbLiRsbRcRsmbRibRobRcbLsbRgbLobLiRsRsmbLgbRebRsbRebRiRsmb
LsbLcRsbRsbsbLobLibRebLeRsbRjbLjLsLsLsmmmbLcLsmbRcRsmbRjRsmbRsbRsRsRsR
smmmbRebLcbLibReRsRsmmbLsRiRsRsmmbRsRjRgbRibRibLsbRcbRcRsmbRcbReRsmbRo
RsmbLibsbLsbLsRsbRcbRsbRjbRcbRebReRsRsRsmmmbRebsbLcbRhbLsbLebLsLgbRsbR
sbsbReRsLsmbRoRsRsmmbRiLsbRhbRhbLebLsLoRsbRebRhRgRsRsmmbsbReRsRsmmbLsb
LjbsbRcbRhbRebRebRibRsbRebRsRsRsRsmmmbLsbRibRcRsmbReb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 4; Drug: PCAP2 10 然 Apo 50 然
bRjLsbLsbLobLeLsRsbLhLsbLeRsbLibLiLsLebLcbRobRjbLgLsbRgbsbLcLgbLiRsbLi
bRsbLgbLibLgLsbLgbLoLsLoRsmbReRgbLobRsLsbLgbLibLgLsbLjbLiLsRsbLsLgLgRs
LsbLgLsLgbLebLiLebLgbRjbRjbLebLcLsmbsbsbLsLgbLsbRsbLhLsbRsLsbLsLsLsmmb
sbRsbRsRsmbRsbsbRgbRsRsmbRsbRsbRiRsRsmmbRiRsRsLsmmbLsbLeLoRsRsLgmbLcLs
mbLibLgbRsbRsLoLsLiLgLhRsLeLhmb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 5; Drug: PCAP2 10 然 Apo 50 然
bRgbRgbRgbLsbsbRgLsbRgbRgRsmbRsLgbRsbRsbRgbsbRsLsbsbRsbLsRgbsbsbsbsbsb
RsLsbRebRgbLhbLibLgbRgbRsRjbRhLibRobRoRgbRsbRgbRgbRgbRsbRsbRgbsbLsLsmb
sbRsLsbRsbRgRsmbRibRsLsRsbRsbRgRsmbRgRsmbRgbRgbRsLsbsbRsLsbRsLsbRsRsmb
RgbRsRsmbLsRsbRsbsbLsbsbRsbRsLsbRgbRsRsmbRgRsmbRgbRsLsbRgbLjbRsbsbLibL
sLsLsRsmmbsbRsbLsbsbLgbsbRsbLsbRsbLsRsbsbsbsbLsLsmbLebLsbRsbLeLsbLoLsm
bLeLsLsRsmbsbLgLeLsRobLsLiLgLsbLcbLcbRebRobRebRobLsbRcbLiRsbRhLsbRebLo
bRobRhb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 6; Drug: PCAP2 10 然 Apo 50 然
bRjbLsbRsbLebLiRsbRgRsmbLgbRsRgbRsRsmbsbRcbLcLsmbRsbsbsbsbsbsbsbLsRjbR
sbLiRgbRsRsRsmmbLgbRobRcRibRhbRobRsRobRebRjRsmbRgbLebRebRebLiLsbLobRob
RobLobReLgRsbLobRiRsmbRsRcbRcbRcbRgbRcbLeLsbLcbRiRsRsmmbRgRcbRiRsmbLsb
RsbRsbRsRsmbRsbRcbLebLeLsbLcbLsbRjbsbRobRsbLibRjbRobLjbRibRcRsmbRobRjR
smbRgbLoRsbRgbRsRcRsmbLeLgLsbRsbLgLsbLsLebRiRsmbRibLsLsmbRgLobRgbLsbRc
RebLgbRibRibRebLcbRoLsLsmbRcbsbRibRobLebRgRsmbRibRhRsRsmmbRiRsRsRsmmmb
LjLcRgbRibRcbRebRobRobLcbLibLebLebRibRsbLjbRgRiRsmbRsRsmbLobRebRobRsRg
bRiRsmbRhbRsbRibRgRsmbRsLsRsRsmbRebLebRibRgRsmbLiLsbRcLsLsmbRgbRjbRsRc
LsbLcLsmbRgbRjRsReRsmmbRgbLsbLsRobLcbLebLcbRebLsbRhbRgbRibRcbRhbLcLgLs
LcbLcbRcRsmbRhbRobRcbRcbLsLcLsmbLhbRebLebLsLcbLcRsRsmbRebLsbRhbLibLcbR
hbLibRsbRsbLsbRsLsbLsbLjbRhbRsRsmbsbRgbRsbRjbLcLsmbLcRsbLobLobLobRsbRi
RsLsRsLsLsmmbRgbReRsmbRcbRibRhbRoLsbRoRsmbRcbRibRibsbLjbLcbLcbsbLcLsmb
LobRsRiRsmbRgLsRgLsbsbRgbRgbRiRsmbRgRsRgmb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 7; Drug: PCAP2 3 然 Apo 50 然
bRsbRcbRgRsRgRsmmbLsbRiLsbsbRsRsmbRiRsRsmmbRsRsRsmmbRgbRcRsmbLsLsmbLsL
smbsbsbsbRsRcbRsbReRgbRgRsmbRhbLsbRjbRobRsbRebLsLsLsmmbLgbRhbRsLsbRsbR
ibRsRsmbRsbRsRsLsRsmbRsbRsbRsbLsbsbRsbsbsbRgbsbRgbRsbRsbRgRsmbRgbLsbRs
bRibsbRiRsmbRibRibRoRebRsbsbRsRgbRebReRsRsmmbRiReRebRcbRebRebRgbRsRsRs
RsRsmmmmbReRsmbLsbRjbLsbRsbRgRhRebLsbsbsbsbLcLsmbReRsmbLsbRhbRjRsRsmmb
LcbRsbRsbRcRsmbRoRsmbLcLsmbLsbLcRsbLiRsbLeLsbLiRsbLiLsbLobLsLsmbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 8; Drug: PCAP2 3 然 Apo 50 然
bLcbLhLsbRjRsRsmmbRcRebLcLsmbLibLsbLcLsLsmmbRcRsRcRsmmbLcbLhLobLoLgbRs
bRebLibRcbRsLsLcbLcLsmbLibLobLcLibLibLibLiRsbLebLcLsLhmbLibRcbRcbLhLsb
sbRebLjbLcbLibLsLsLsLsmmmbLcbLsbLcbLcbLgbLcLsmbLcbLhbLebRcRsmbRoRsmbLi
bRcbRgRebRobRcbRoLsbsbLibRsbLsbRsbRebRcRsmbRibLcLsmbRiRsRiRsRsmmmbRsRe
bsbRcbRcbRcbLeLgLsLebLgLcLcbLibRcRsmbRibLcbLcLsmbLobLiLcbLibLsLcLsmbRh
bsbRebRcRsmbRsbRiRhRsmbLcLsLsmmbLsLoRsbLcLsLimbLcbRjbRcRebRobLcbLhbLob
LsbsbRcbRgReRsRsmmbRsRsRsmmbRhRsmbRcbLjLsmbRebLjbLcbRob

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 9; Drug: PCAP2 3 然 Apo 50 然
bRgRgRsRsmmbRhbRiRgbLiLsbRiRsRsRsRgRgRsmmmmbLsRsRsRgRsRsRsRsmmmmmbReRs
mbRhRsRsmmbReRgbRhbRhRsRsRgRhmmbLsRsbRiRgLsbLhbRobRcbLsLcbRgbLhbsbRiRs
mbRiRsmbRibRiRsmbRibReRsRsmmbRobLebLhbLcbRiRsRsRsmmmbRgbLsLjbLsLhbsbsb
RiRsReRgmbRebRebRebsbLebLcbReRsmbLcbLibLcbRsRgbLjRsbRjRsRsRsRsmmmmbRhR
sLsRsRsmmbRgbRebRgbRgRsRsLsRsRsRsmmmmbRebReRsmbRebRiRsRembRibRgRgRsmbR
cbRcbLhbLibLibRebRcbsbReRsRsmmbLsRsRgRhRgbRsRgRibRgRgbLsbRsRsRsRsmmmbR
sRsReLsmbLsbRcLsbRebLgbReRsmbReRsmbRobRgRsmbLjbRiRsRiRsRsRgLsmmmbRsLsL
smbRsbRiRgbRiRsRsmmbRsRhbReRsmbReRsRsmmbRgbRibLibLgbLgbRiRsRgRsRhRsmmm
bRgbRgRsRembRgRsmbRiLsbRebRsRsRsmmbRhb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 10; Drug: PCAP2 3 然 Apo 50 然
bRgbLiLgLgbRsbLsbLsbRjbLsRsbLsLsmbLsbsbLsLsmbLsbRsbLgbRobRibRgRsRgmbLs
RsRsRgmbRsbRobsbLgLsLsmbLiLgLsLibLjbLsLsLembLgbLhLsbLgbLibLebLebLeLsbR
gLsbLjLsmbLsLsmbRobRhLsLsmbRcbLsRsbsbLsbRsbLibLsbRgRsmbRcRgbRibRibRgbR
ibLsLsmbRibRhbLsbRobLsbLsbLsbLcLsmbLcLsmbLeRsbLsLsmbLobLiLsbRobLsLsmbs
bRsRsmbLcLsmbRgbRhbRsbReRgbRobRobRsRcbRgbRgRibReRsmbRebRibRhbRhRebRcbR
ibReRgbRjbRibRsbsbRsRsmbRsRsmbRhRsmbRsRsmbLgbLibLgbRsRsmbLgbRcRsmbRibR
obRobRcRiRsmbRiReLsbRebRhbLgRobReRsmbRoLsbRebRobRsbRebRgRsmbRgbRebRibR
gReRgRebLsRebRiRebRsReRebRhbRiRsmbRcLsbLeLgLsbLhbRcbLgbLiRsbLcbLeLsbRg
bReRsmbLgbLcbRebLjbRcbRhbRsbRsRgbRibRgRsRsmmbLhbLgbRgbLibRcbRibRgRoRsm
bRsRhbRgbRgLsbRibRgbRsRsmbRibLgbRiRsmbRgbRebRibRhbLcbLiLsbLgRsbRebRibR
sbRibRcbRjRsmbRjRhbRjRsmbRgRsmbReRsRembRebLsLgbRibLibRibLoRsbLhbLjLgLs
RsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 11; Drug: PCAP2 3 然 Apo 50 然
bRsbReReRiRebRebRobRsbRebRibRibRgbRsRsRsRgRsmmmbRibRsRsmbRsRsmbLsbRsRs
RsmmbLsRsLsbsbRsLsbLsbsbRsRgLsbRsRsmbRsRsmbRsRsmbRsbRsRsRsmmbRsbRsRsmb
RsRsmbRsbLsRsbRgbRsRsmbRsRsmbRsbRsRsmbLsRsbLsRgbLsRsbRsRsmbRsbRsbRsbRg
bRsbRsbRsbRsRsmbRsbLsRsbRsRsmbRsRsRsRsmmmbRsRsmbRsbRsLsbLsRsbRgbsbLsRs
RsmbLsbLsRsbLsRsbLsRsRsmbLsRsRsmbLsRsLsbRsRsRsRsmmmbLsRsRsRsRsmmmbRsbR
sRsmbRsbRsbRsbRsRsmbRsbRsbRsbRsRsmbLsRsbLsRsLsbRsRsmbRsbLsRsRsmbRsRsLs
mbLsRsbRsbRsbRsRsmbRsbRsbRsbRsbRsbsbRsbLsRgbLsRsbRsbLsRsbRsbRsRsmbLsRs
bLsRsbRsbRsRsRsmmbRsRsRsmmbRsbRgbRsbLsRgbRsRsmbLsRsbRsRsmbLsRsRsmbLsRs
RsmbRsbRsbLsRsRsRsmmbRsbRsRsmbRsRsmbRsbRsRsmbRsbRgbLsRsbLsRsbRsbRsbRsR
sRsmmbLsRsbRsbLsRsRsmbRsRsmbLsRsRsRsRsRsmmmmbLsRsLsRsRsRsmmbLsRsbRgbRs
RsmbRsLsRsbRsbRsRsRsRsmmmbRsRsmbLsbRsLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 12; Drug: PCAP2 3 然 Apo 50 然
bRsRibRsbRsRsLsmbRsRsRgRsmmbRiRgRsmbRgRsRgmbRgRsmbRgRsRsmmbRsRsRsRsmmm
bRsRsRsmmbRgbRsRibRsRsRsRgRsRsmmmmbRgRsmbRsRsRsRsRgRsRsRsRsRsmmmmmmmmb
RsRsmbRgRsRsRsRgRsmmmmbRsRsRsmmbRgRsRsmmbRsRsRsRsRsRsRsRgLsRgmmmmmmbRg
RsmbsbsbRsRiRsmbRsbRgRsRsRsmmmbRsRiRsRsRsmmmbRsRsRsRsRsRsmmmmmbRsRsmbR
sRsmbRsRsmbRgRsRsmmbRgRsRsmmbRiRsRsRsRsRsRsRsRsmmmmmmmmbRgRgRsRsRsmmmb
RibRsbRsRgbRgbRsRsmbRsRsRsmmbRgRsRsmmbRsRsmbRgRsRsRsRsmmmmbRiRsmbRgRsm
bRiRsRsmmbRsRgRsRsmmbRsRsRsRgRsmmmbRgRsRsmmbRsRsRsmmbRsbRgRsRsRsRgmmmb
RgRsRsRsmmmbLjbRgRsRgRsRgRsRsRsRiRsRsmmmmmmmbRgRsRsmmbRsRsRsRsRsRsmmmm
mbRsRsRsmmbRgbRsbLsbLsbRibRgRgRsmbRibRgLsbRsbsbLsbsbRsRsRsRsmmmbRsRsRs
RsmmmbRgbRsRsRsRsmmmbRsRgRsmbRsRgRsRgmbRsbsbRgbRgbRsRsmbRiRsmbRsRsRgRs
RsRsRgRsmmmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 13; Drug: PCAP2 1 然 Apo 50 然
bsbsbsbsbsbLjLoLsLsLsmmmbRcRibRibRiRsmbRsbRobRsbRcRgbsbRhRsmbLsLsmbRhb
LcbRsLsLsRsmbRsbRibLebLhRsbLjLjLsmbLcbLgbLcbLhbLcLiLsbLebLibLoLcbLgbRc
bRgLebRibRiRiRsmbRjRsRsmmbRiLsbRibRobRhLsRsbRsLsbRgRebRcbRgbLgbsbRibRi
bRjRsRsmmbRcbRcRsRsRiRsLsmmmbsbRgRsRsRsRsRsmmmmmbRgbLcbLcbLibLjbLcRsRs
mbRgRsmbRibRoRsRgLsmbRcbRibLjLcbLiLgLsbRsbRsbRsbLcbLjLsmbRsRsmbRsbRsRs
mbRcbRhRsmbRibRiRsmbLsbLibLgbRjRgRsRgmbLjbLibLjbLcbLcbRiRgbRgRebRgLsbR
iRsmbRsbLjbLhbLhbRsRgbRebRgRgbLiLsbRiRsmbRiLsbReRsRimbRhRibRiRgbReLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 14; Drug: PCAP2 1 然 Apo 50 然
bLsbRebRsbRgbRgbRhRsRgmbReLsbRgRsmbRgbRgbRiRsmbLgbLsbLcRsbLibLhbLsbLib
RibLsLsmbLsbLsbRhbsbRgRsRgRgLsmbRgbRsbRibRsRsmbRsbRsRsmbLcLgbLiLsbLeRs
bLebLhLsbLibLgbLhLebLiLsLsmbLebLsLsLsmmbRsRsLsmbLsLsLsLsLsLsLhmmmmmbLs
LsmbRsbRcbRsbRgRgRsmbLgRsbRsbRhbRcbRibReRiRgbRgReRebLgbLhLsbLhbLjLgRsb
LsLhbRsbLibRibRibRiRsmbRgbRibRgbRibRibLgLsbLeLgRsbsbLgLsbsbLjbLgRsbLib
LgLsbLibLebLibRcbRiRsmbRsRsRsmmbLjLgLsbLiLsLsmbLsLsLsLgmmbLgbLsbLgbLgb
LgLsLsmbLgbLgLsbLhLsLsmbLgbLgLsRsbLsbRsbLsLsLsLsmmmbLsbLibLiLsbLibLibL
gbRibRhRsmbRibRhbRgbRibLibLgbLsLsmbRsLsbRsbRgbLiLsLgLgbLgRsLsbLgLsLsLg
LsLsmmbLiLsbLibLsLsLsLgmmbsbLgbLiLsbLgbLiLgbLibLiLsbLgLgLgLgbLiLgbLsLs
LsLsLsLsLsmmmmmmbRsLsbLcbLhbLiLgLsbLibLibLgbLibLebLgbLebLibLgbLgbLgbRs
LsLsLsLsLgLsmmmbLibLsLjLsLsmmbLeLsLsmbLhLsbLebLgbLibLhbLgLsLsLsmmbLibL
gLgbRsLibLiLsbLgbLsbLsbLibLgbLibLiLsbLeLsbLibLsLsLimbLebLibLibLgLgbLib
LhbLibLibLgbLsbLgbLoLsmbRsbLeLsbLgRsbLgbLgbLgbLgbLsbLibLibLibLgbLgbLeb
LjbRsbLibLgLsbLibLsbLsbLsbRjbRgbLgLsLsmbLgbLgbLsbLsbRsbLsbLjRgbLeLsbLs
bRgbRiRibRibLgbLibLibLgbLjLgbLgbLibRsbLsLsmbLgbRebRsbRibRgbRibRgbRsLsb
LsLsmbLeLsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 15; Drug: PCAP2 1 然 Apo 50 然
bLsLsRsmbLcLsmbRsbLebLgLsLsmbLibLsbLjLsmbLeLsLsmbLgbLcbLibLhbLcbRsRsRs
RsLsmmmbLgLsLsLsmmbLgLsbLsbLeLsbRcbRiRsmbRcbRgbRcbRsRsmbRcRsmbsbsbRibR
gbRhRsmbLhLsLsmbLeLsbsbRjbRsbLebLcbRhbLebLhLsLsmbLgLsLsLgmbLgLsLgLsbLe
bRcbReRsmbLiLsbLcbLeLsbLhLsbsbsbLeLsbRcbsbRhbLiLsLsmbLeLsbLsLsLsmmbLiL
sLsmbRibsbLebLiLgbRhRsRsLsmmbRhbRiRsmbRibRsRsmbsbRsRsRsRsmmmbLhbLsbLcb
RgRsRsRsmmmbRgLgbLjLgLsbRsRsLsmbLobLibLcbLiLgbLcbLibLiLsLgLsLsLsmmbLeR
sLsLgbRcbReRgRsRsRsmmmbRebRibRgbRsbLiLsLsLsmmbRiRsmbRibRgRsmbLgbsbRjRh
b

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 16; Drug: PCAP2 1 然 Apo 50 然
bLgbLgbLgbRsbLgbLgLsLsmbLsbLsbLsLsRsmbLsLsLgmbLgLgLsbLsbLgLsbLsbLgbLgL
sbLgbLsbLgbLgbLsLsmbLsbLsbLsRsLsbLgbLsLsmbLgLsbLgLsLsmbLsbLgbLgbLgbLgb
LgbLgbLgbLsLsLsmmbLgbLgbLgLsbLgbLgLsLsmbLgbLgbLgbLgLsbLgbLgbLsbLgbLsbL
gbLsLcbLgbLsbLsbLsbLsLsLsmmbLgLsbLsbLsbLgbLgbLgbLsLsLsmmbLsLgbLgLsbLsL
smbLgLsbLsLsmbLsLsmbLsbLsbLgbLsbLsbLsbLsbLgbLsbLgbLsbLibLsbLsbLsbLsbLs
bLsbLsbLgbLgbLsbLsbRsbLsbLsbRsbLsbLgbLsLsmbLsbLsbLsbLsbLsbLsLgLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 17; Drug: PCAP2 1 然 Apo 50 然
bRgbRiRsmbRibRebsbLsbRjbLjbRibLcbLcLsLsmmbLcLgbLibLcbLibLcRsbLhbLiLsLs
mbLibLibLebLgbLibRgbLibLjLibLcbLgbLhbLiRsbLgbReRobRibLhbLcLsmbLibRsbLg
bRjbLsbRjRibRibsbRsbsbRibRcbLeLsbRobRobRhLsbLcLsmbLeLsbLibLoLsmbRsbLeb
LobLiLsbLiLsbRoRgbRgbRobRgbRcRsmbRoLsbLsbLcLsmbLebLcLibLcbLcbLcLsmbLib
LibLiLsbLibLhbLobLgLsbLibLcLcbLjbLjRsbRhbLibLcbLebRobRibReRgbRcbLsLsmb
RgbRsbRgbRsRsRsmmbRiLsLsmbRibRibRcbsbRobLcbRibRibRibLeLsbLcbRob

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 18; Drug: PCAP2 1 然 Apo 50 然
bRebRiRsmbRcbLoLsmbLibLibRsLsLsmbRjbRiRgbsbRsRsRsLsRsmmbLsbLgbRsbLjbsb
RsRsRsRsmmmbsbRsRgRsRsRsRsmmmmbsbsbLgLsbLsLsLsLsLsmmmmbLiRgRgbLhLsbRsR
smbRsRsmbLiRsbLgbLsLiLsbLgbLgLsbRebRgbRgbRiRsLsmbRcbRcRsmbLsbLhbLibLgb
LibLgLsbLcLsmbRibLsbLsRsbRhLsbRobLgLsbLiLsbLobRgbLcbLiLsbLgLsbRsRsmbLi
LibLgRsRsRsmmbLsbLiRsbLgRsbLjbLgbLjbsbRsRsmbLsRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 19; Drug: Control Apo 50 然
bLsLgbLeLeLgbRsbLsbRiLsbLebLgbReRsmbLebRsbsbLsLsLsmmbLebLgbLebLsbLsbLs
bLiLsbLsLsmbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 20; Drug: Control Apo 50 然
bRibLobLjbLibLsbRcbRoLsbLibRhbRgbRjbLsbRsbLcbRsbRibRcbLsLsmbRsbRebLcbL
cbLsbLibRcbRhbRebLgbRgbsbLsbRibLjbLebLcbRjbRsbLgbLcbReRsmbRgbLibRibRcb
LsbLcbLibRiRsmbLsbLgbLibRebRgbLgbRsbRebLgbLsbLsbRibRsLsbRibRebLsRsbLsL
gbRsLsLsmbLsbRsLsLsRsLsLsLsLsLsLsLimmmmmmbLibLsbRhbLsbRgbRgbRsbRebRibR
sLsbLgbLjbLebRsRsRsRsmmmbLebRebLsRcbRsbRsbRcbRgbRgbRebLsbRibRgbRibRibR
hbLgbRibRgbRibRibLsRgRebLebRibRgbLgbRcbsbLgbRibRgbLjbRibRibRgLsbLsbRgb
RsLsbRsbRjbRgbRgbRgbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 21; Drug: Control Apo 50 然
bRcRsRsRsmmmbRiRsRsRsRsRsRsmmmmmmbRiLsbsbRcbRibLcbLibLgLsbLibLebReRsRs
mmbRsRsmbsbRsRsmbRibLjbLibLcbRsbRsRsmbRibLsLoLsmbLiRsRsRsmmbLeLiLeLgbL
iRsbLgbLiLiLsbLobLsbLebLgbLgbLeLsbRcbRcbRsLgbLcLgbLsbLhRsbLgbLhbLibLib
LobLiLibLibLcbLgbLgbLgbLsLibLgLgbLsLsmbLibRcRsmbRibLsLsmbRcbRsRsmbLgbL
ibLibRibLjbLiLsbLsLsLsLsmmmbLibLiLgbLgLibLsbLibLibLgbLgLsbLiLeLsLsmbLg
LiLsbLibRcbRgbLjbRiRsmbRcbRhRsmbRgbLgbRcbRsRsRsRsRsmmmmbRcRsmbRiRsmbLi
bLibLibLibLhbRsbRjbLjRsbRibRsRsmbRjRibRjbRsRsRsRsmmmbRjbLibReRsRsRsRsR
smmmmmbRiLsbLgbLcbLibRgRsRsRsmmmbLobLeLgbLiLsbLgLsLsmbLgbLhbLibLsbLobR
gbLibLibLgbLsbLsLhbLsbLhbRsbLsLcbRgbRsbRcbRgbLiRsbRiRsRsmmbLsbLibLjbLi
bLgbLcbLgLsLsLsmmbRcbRibRsbRsbLcbLiLsbLgbLgLsbLibLsbsbRcbRebRsbRgbRgbL
cbLcbLiLsbLsLsLsLsmmmbRibRsRsRsmmbRsbRgRsmbRgbRiLsLgbLjbLsbLgbRsbRgbRc
bLsbRcbLsbLsbLcbLibLibLibLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 22; Drug: Control Apo 50 然
bRcbRcRsmbRcRsRgmbLjbRhRsmbRcRsmbRcbRcbRebsbsbLibRhbLibRcRsRsmmbLibRcb
RcbRcbRcbReRsmbRcbLibLhbRcbsbRibRcbLcbLcbRsRsmbRcRsmbRcbRhbRsbRobRcbsb
LhbReRgbRcbRebRebRibRcbRsRiRsRsmmbRiRsRsRgRsmmmbRebLcbRcRsmbRebRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 23; Drug: Control Apo 50 然
bLgbRcbLsbRgbRsRsRsmmbRsRsRsRsRsRsRsmmmmmmbRgRsLsmbsbRsbRcbLsbLiLsLgbL
ebLcbLgbLibLgbLcbRcbRhbRcbLgLsbRsRgbRgRsmbRcbLebLhbLibLgbLgbLsLsLsLsmm
mbLebLeLsRsbLiLsbRgRsLsmbLhbLgLsLsRsmbLsbRcbLgbLsLsmbLgbLcbLjbLebLcbLs
bRcbRcLsbLgbLgbRjbRibLgLsbRiRsmbRiRsmbLibRsbRsbRhbRgbRibLgLsbsbLcLsmbR
cRsmbLsbRebRobRcbRgbLsLsmbRiLsLsmbLjbLsLcbLebLhLsbLcLsmbRjbLgbLgbLebLc
bLcbLcbLcbLhbRebRebRibRibRibRsLsbLsbLsbRibRgRsmbRgbRgbRibLsLsmbLgbRcbR
gRsRsmmbRgbRhbLhLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 24; Drug: Control Apo 50 然
bRcbRcbRcbRgbLgbRcbRjRsmbRebRjbRibRcbRcRgbRiRgbReLibRsbRobRibRibRibRgR
smbRgbLjbLibLjbLibLibLiLsbLcbLcbLcLsmbLcLsmbLhbLhbLibLiLsbLibLibLgbLib
LcbLgbRjbLiRsbLibLcbLibLibLjbRsbLibLibLjbLhRsbLibLibLgbRcbLibLhbLhbLcb
LibLhbLcbLibLgbLhbLcbLibLibLebLibLiLsbLiLsbLibLsbRebRibRhbRsbRhRsmbRgb
LibRhbRsRiRibRgbRibRcRsmbLibRjbLjbsbLsbsbLibLcbLibLibLiRsbRjbLibLcbLcb
LhbLcbLsbLsLgbRjRsmbLibsbRgbLeLsbLcLsmbLjbLebLibLibLebsbLgbsbRjRsmbRib
LebsbLibLiLsbLcbLhbLebLibLjbLhbLibLibLcbRcbLebsbRcbLibRhbLibRhRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 25; Drug: PCAP2 10 然 Apo 50 然
bLsbLsbLsbRgbRsbRsbRsRsRembLsRsbRgbRebLjbRiRsRsmmbLoRsbLsLcLsmbRsRsRsm
mbLcbLgRsbRjbLgRsRsmbRiRsRsmmbLsbRsbRsRsRsmmbLibReLsbRobLeLsbLsbRjbLgb
LsbRcRsmbRsbLsbRsLsbRsbLsbRsRsmbLjbRsbRebLebLebLsbLsbLsLsmbsbLsbLsbLsb
LsLsmbLsbLsbLsbLsbLsbLsLsRsmbRsbLsLsLsLsmmmbLjbLsbLsLsmbLsbLsbLsbRsbLs
LgbLsbRsbLsbLsLsmbRsbLsbsbsbsbRobRobRgbRiLsbRsbsbRsbRibLgbLhbRebLibLsb
RcbRcbRcbLjbLibLsLhbLgbLgRgbRcRsRsmmbReRsmbRibRsRsRsmmbRsbsbRsRsRsRsmm
mbRgbRsbLsbRjbRebRhRsmbLebRsLsLsLsmmbLsbRcLsbRjbRgLgbRgbLgbLsLsLsmmbLs
bRsbLsbRsbLgbLsLsmbLsLsmbLsbRsLsbRsbsbRsLsbsbLsbRsbRsbLsbLgbLsbLsLsmbL
sRsbLsbLiLsLsLsLsLsRsmmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 26; Drug: PCAP2 10 然 Apo 50 然
bLsbRsbRsbRsRsmbLsbLsLsLsmmbLsLsmbLsLsmbLsbLsLsmbsbLsLsmbLsbLsLsmbRsLs
LsmbLgLsbLoRsbRsRsRsmmbRsbRsbRsLsbRsbsbRsRsmbRsLsbRsbRsbRsbRsRsRsmmbRs
LsbRgLsbRoLsbRgLhLoLcRsbRsLsLiLiLsbLhbLsbRsLsbLcbRgRsmbRsRsmbsbsbsbRsb
RsbRsbLsbsbsbsbRsbRsbLsbRsbRsbRsbLsbLgbRsRsRsmmbRsbRsRsmbRibsbRoLsbRgb
LibLoLibLgLsbLgbLsLsmbLgbRsbLsLsmbLsbLsbRsLsbsbRsbLsLsmbsbLsbRsbLsLsmb
LgLsbLsbLsbLsbLsbLsbLsLsmbLsbLsLsLsmmbLsbLoRsbRiRsmbRsRsRsmmbRgbsbRsLs
bRsbRsbRsRsRsmmbRsRsRsmmbRgRsmbRgbLsbRsRsmbRgRsmbRgRsmbRsbRgRsmbRsbRsb
LsbRsbRsLsbRgRsmbRcRsmbRibRgbLoLsLimbLcbLsLsmbLsLgbLgbRsbLsRsbRsRsmbLs
bRsbsbLsbLsLsmbsbsbsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 27; Drug: PCAP2 10 然 Apo 50 然
bLhRsRsmbLgLsbLsRsRsmbLsLsmbLibsbRhbLgbLsbLgRsRsmbRsbsbLgbLgbLiRsLsbRo
bLoLsmbLjLgLsbLgbLgRsbRcRsRsmmbRgbLjbLibLsbsbLsLsmbLibLgbLiLsbLsLsmbRj
bRcRsmbRibRibRcRsmbRibRsbLcRsbLoRsRsmbLsbLhbLiLebLibLhbRiRsmbLgbLcRsRe
bLeRsRsmbLiRsbLebLgRsbLcbLhbLhbRjbLhbLiLsbLgRsbRhbRobRhRsmbRgRgRhbRgbL
jbLgbLhbLgbsbLgbLeLsbRjRjbsbsbLsLhLsbLsbLsRsbRsbsbsbsbLiRsLsbLsbLsLsLs
LsLsRsmmmmbsbLcbLibLsRsbLcRsbLsLibLiLibLsbLsRsLsbsbLsLsLgLsLsmmbReRsmb
LiLsbLibLibLgbLsLsLsLsmmmbLgLsbLgLsRsbLsRsbRsbRibRibRgbLsRsbLsRsRsmbLi
bLsLiLsbRiRsmbLsLsmbLsRsbRsbsbLgRsbLiLsbLsLsmbRoLsbRiRsmbLsbsbLjbRsLgR
sbLgbLsLsmbLgLsRsbRsbLgbsbRsbLsbLsRsRsmbReRsmbLgbLibLsLsRsRsRsRsmmmmbL
sbLcbRiRsmbLsbRjbRjRsRsmmbRibRibLjLsmbLibLibLibLiLibRcRgRsmbLoRsRsRsmm
bLiLsbRobRgbRibLsbsbsbRsbLsRsbRiRsRsRsRsRemmmmbRsRebRibLsbRiRsmbRgRsmb
RgbRobLjLgLsbLgbLibLhRsbRcRsmbRibLsRsbsbsbLsbsbRsbLsRsbsbLsLgbsbLiLsbL
ebLibLhLsLsmbLsbLsbLgLsbsbRgRsmbLiLsLsLsLsmmmbLgRsbLiLsRsbLgLsLsmbLsRs
RsmbLsLsmbRjbLsRsbsbRiLsbRgbLsbRgbRcRsRsmmbLgbLibLibLibsbLgLsLsLsmmbLg
LsRgRsmbsbRsRjRsRimbLsbRsRsmbLsRsbRsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 28; Drug: PCAP2 10 然 Apo 50 然
bRiLsLsLsRsRsRsmmmmbRgRgRsRsmmbLsRsbRgRsRsmmbRobRiLsbRiRsmbReRsLsmbRiR
sRsmmbRiRsmbRgbLjbLobLgbLibLiLsbLgbLeRsbRcbRsbRiLsbLsbLjbLcbRsRsmbLhLs
RsLiRsbLcbLgbRsRsmbRjRsRsLsRsRsmmmbLgbLhLsLhLsbRibLjLsLsmmbRibLsbLhbRj
LsbLiRsRsmbRcRsmbRiLsbRcRsRsmmbRiRsRiRimbLsRsbRibRgLsbLcbRsRsmbRsRsmbR
sRsRgRsRsRsmmmmbLjbRibRiLsLsLsmmbLsRsRsRsRsRsRsmmmmmbLjbRobsbLgLsRsbLs
bRgbLjRgRsRjmbRgbRibLcbRgbLiRsbRcbRsRsRsRsmmmbRiLsLsmbRjRsRgmbRibLgbRs
LsbLiRsRsmbsbLsbLsLsmbRgbLjbRcRsmbRsRsRsRsmmmbsbRiLsRsRgbRsLsbRgbRsRsR
sRsmmmbRgRsRsmmbLjbLobLgbLgLsbRibRsRibLjbRgbRibLjbRsRjbRebLcbLsRsbRsbR
gbLsLsmbRgRsmbRibRibLsRsRsRsmmbRsRiRsRoLsmbLsRsRsmbLgbRgRsRsRsLsLsmmmm
bRgRsmbRjRsLsLsLsmmmbLjLsmbLcRsbRibRiRsmbLhbRibLjbReRsmbLcLsmbRgbLgbLj
bRgbRsbLjbRcbRoRsmbRsRiRsmbLgbRhbRebReRsmbLjbLcbRjbRhRgLsbRebRgbRibRgb
RsbLgRsbLoRsbLsRsbLiRsLsbLsbRsbRjbLhb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 29; Drug: PCAP2 10 然 Apo 50 然
bRiRsRgmbLsbRiRsRsmmbLgRsbRhRsmbRcbLhbRsbsbLobLiRsbRsLsbsbLhLsbLsbsbRs
RsmbsbRjbRebRiLsRsbRobRsbLobLgbLiLsLgRsRsmbReRcbReReLsbRjbsbLgRsbRibLs
RsbLsbRsbRsbRhbLsLsmbRsbLsbRsbsbsbRgbRsbRsRsmbLsRgbsbLjbRjRhRsmbLiLsLs
mbLgbLgbLiLsbRobRiRsmbRibRiRsRsmmbRsRsmbRiRsLsmbRgbRibsbLsRsbLsbRcbRoR
smbLsLsmbRcbRiRsRsmmbRibRiRsmbRibRiRgbRiRsmbLsbRoLsbLsbRiRsmbRsRsmbRiR
sRsmmbRsRsmbRibLgRsbLcbLibLgbLgLsLsmbLoRsRsmbRgRgRsmbLibRiRibLobLcbLob
LhRgbRibRiRsRimbRibRsbRibRjbRebRibRsbRsReRsmbRjbRsbRgbLsLsLsLsmmmbRgbR
sLsbRsbRgbRsbsbsbsbsbRsRsmbRgRsRsmmbLsbsbRgbLsRsRsRsmmbRiLsRsRsmbLibRh
bLgbRsRsmbRiRsRsRsmmmbLsLibRhRsRsmmbLobLiRsbRsbRiRsmbRhbLibRiRsRsmmbLc
bLibLsbsbRhbRobRibRhRsmbLibLcLsmbLgbRsRsmbsbRsbsbRsbLsbLibLcLsmbLgRsbR
oRibRcbRibRcbRibRgRsmbRibRibRiRsRsmmbRgbRibRiRiRgbRobRsLsbLgbLoRsbLcbL
cbLgbRgbRibRcbRiRsmbRgbRgbLsbRgbRebLsbLiLsbLcbLsLgbRgLsLsRsmbRhbRebLcb
LibLsbRsbRebRgRsmbRgbRsRgbRsbRjbRjbLjbLcLibLgbLsLibLiRsRsmbRsRgRsLsmbR
ibRgRsRsmmbRgbRibRibLibLhbLgbRsbLibLibLgbLgbRhRhbRibLebLeRsLsbRjbLjbLs
bLsbRsbRjbRcbRhbRgRibRgbRcbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 30; Drug: PCAP2 10 然 Apo 50 然
bRebLebLcbLcRsbRjbRhbLjbLoLsmbRibRiRsmbsbRobLeLsbLcLsmbLebLibRsRsmbReb
RcbLsbLhbRcLsLsmbReRsmbLsLsRsmbRsbRhbReLsbLgbLgbLcRsRsmbRgbRibRibRgbRc
bLjbRhbRibReRsmbLsbLjbLgbRiLsbLibLgbLgRsbLgbLobRsbRgbReRgbRoRibLhbLibR
gbLcbLgLsbLcbRebRibRiRsmbRgbLcbLoLsLsmmbsbLcbRiRsRsRhmmbRhbLcbLcbLhRib
RebRgbLhbLcbLgbLjLsLsLsmmmbLobRhRsmbLsRsRsmbLhbLhbLsLsmbLsbLebLibRgbRs
RgbRoLsbLsLsmbLhbRcbRhbRgLsRibLobRebLjbLgbLoLsmbRcbRiLsbRsRcbRcRsmbLhb
LibRsbLcbLcLsmbLcbLgbLhbLibRcbRjbRibReRiLoLgbLsLhRsbLhbLsLsmbRjbLhLsLs
mbLibRhbRibRgbRhRsRimbRgbRhRsmbRcbLgLsbRjRsmbLsRsbRgLsRsRgbRgLsRgbRgbL
sLjLsmbLhbRcbLjbLiRsbRjbsbRiRsRsmmbLiLcbLgbRgbLiLsLsmbLibLibRsbRibLjLh
bLgbRcbLebLibRsbRcbsbRgbsbLcLsmbLsLobLibLcLgLsbRiRsLgmbLebLgbRgbLgbLeL
sbLcbLgbLjbLiRsbRobRhRgbRsRsmbRsRgReRhRsRsmmbLcbLibsbLsLsLcLsmmbRcbRgb
RcbRiLsRsbRcRsRsmmbRsbRcbRibsbRsRsmbLsRsbRiRsmbRiRsRsmmbRiLsbRibLibRcR
smbRibRiRsmbRiRsmbLibLjbLeLsbLcbRhRsmbRiRsmbRhbsbLibLcbLibRjRsmbRsRsmb
RjRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 31; Drug: PCAP2 3 然 Apo 50 然
bRsbRsbRgRsmbsbsbRgLsbRsRsmbRgbRhReReRgbRsLsbRebRebRcbRebRibRebReRsRsR
smmmbRsRsmbRsbRebLgbLhbLgRsRsLiLembRobRobLiLgbsbsbRjbLcLsLsmmbLibRcbsb
sbRsbRsbRiRsmbRibRiLsbRsReRsmbRiRsmbRsbRsRsmbRsbReRgbRgbRebLsLsmbLsLgb
LsLsmbRsbLsbLsbLsbRsbLibLjLsmbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 32; Drug: PCAP2 3 然 Apo 50 然
bRiRsmbRibRsbLsbRcbRhbRcbRgRsmbsbsbRiLsbLcbLsLhbLcbLibLiLsbLebLibLibLi
bRiRsmbRobRcRsmbRobRcRsmbRhRsmbRibRhbRgRsmbRsbRibsbRsbLsbsbRgbRsbsbLsb
LiLsbRsRcbLjbLebLibLiLsbRobRsbRebsbLjbLjLgLsbLjbLcbLobLsbRcbRjbRcbRibR
jbLobRcRibLsbLjLsmbRgbLiLsLsLsLsLemmmbLiLgLsbLibLsLsmbRgbLsbLjLsmbLebL
ibLebLibLgbLibLgLsLsmbLibLgbLgbLgRsLebLiLsbLgbRsbLsbsbLibLsbLibRsLcbRc
bRiLsbRibRsbRsRsmbLsRsRsmbRsbLsbRsbLsbLhbLibLgbLibLibLgLsLsmbLjbLobLhb
LjbRobRebLcbLjLjbLibLgbLsbRsbsbLgbLsLsLsLsLsmmmmbLsbLsLsLsLgmmbLsbLsLs
LsLsmmmbLsbLsLsLhLsmbRsLsbLiLsbLgbLsLsmbLsbLsbLgbLsLsLgmbLsLsmbRsLsbLs
LsmbLsbRsLsLsmbLsbLsLgbLsbLgbLibLhLeLsbLiLsbLebLibLibLgLsRsbLiLsbLsbRs
bLsbRjbRibLsbRibReLsbRibLebLjbRcbLhbLcbLobLibRiRsmbLibLgbLjLgbLgbLsRsb
LgLsbLsRsbLsbLsLsmbLsLsmbLsbLsLsLsLsLsmmmmbLsLgbLsLsmbLsLsmbRsRsmbLsbL
sLsmbLsLsmbLgLsLsLsmmbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 33; Drug: PCAP2 3 然 Apo 50 然
bLjbLsbRobLcLiLoLsmbLcLsmbLiLsLsmbLeLsbRsLsLsLsmmbLiLsbLcLsmbLeLsLsLgm
bLcLsLsmmbLcLsLiLsLsmmbLcLgbLibLcLsLembLcbLcLsLsLemmbLsLsmbLhbLcbRcbRi
bRiLsLsmbRibRiRsLsmbRiRsmbRgbRcLsbRcbReRgbRgRsmbLjbRjbRiRsRsmmbsbLcbRc
RgbRcbRcbRhbRibsbsbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 34; Drug: PCAP2 3 然 Apo 50 然
bLiLsLgbLiLsbLibLgRsbLibRoLsbRhbRcRsmbRiRsRsRsRsRsmmmmmbLsbRsRiRsRsRgR
immbRgRsRsRsRemmmbRgbRsRsRsRsRsRsRsRsRsmmmmmmmmbRsbRjbLsLsRsmbRcbRsRsm
bLgbLgLsLsLsLsLgmmmbLsLsLsLgLgLsLgLsLsLsmmmmbLjRsLsbLsbLgbLhbLiRsRsRsR
sRsLsmmmmbLsbsbRsRsRsRgRsRsRsRsmmmmmmbRsRsRsRsRsRsRsRsRsRsRsRsmmmmmmmm
mmmbRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmbRjbLjLsLsLsmmmbLiRsLsRsbLgbLsRsRs
LsmbLsbLgLsbRsLsLsmbLsLsLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmmbRjbRjRsRsRs
mmmbRgRsRsRsRsmmmmbLsRsbRsRsRsRsRsRsRsRsRsRsRsRsRsRsRsRsRgRsmmmmmmmmmm
mmmmmmbLsRsRsRsmmbRgRiRsReRsmmbRibRsRsRsRgRiRgRsmmmbRiRsmbLsRiRsRgRgmb
RsRsRsRsRsmmmmbRjRgbLgbRjRsRsmmbRcRsmbLgbRgbsbRsRsRsmmbRcRsmbRiRsmbLib
LsLsLsLsLsLsLsmmmmmmbLgLiLgLebLgLsbLsLeLsLsLsmmbLsRgRsRsRsRimmmbRiRsRs
RsmmmbRsRgRgRsRiRiRgRsmmbLsbRiRsRsRsRsRsmmmmmbRgRsLsRsLsLsLsmmmbLgLsLs
LsLsLsLgLsLsLgLgLgLgLsLsmmmmmmbLsLsLsLsLsLsLsLgLsLsLsLsLgmmmmmmmmmbRsL
sLsLgLsLsLsLsmmmmbLsLsmbLsLsLsLsRsLsRsmmmbLsLsLsLsLiLgLsLimmmbLgLsbLsR
cbRibLsLsmbLsbLgLsbRsbLsLsLsmmbLsLsLsLsmmmbLjLgbRsRsRsRsRsLsmmmmbRebRs
RsRsmmbLsLsRsRsRsmmmbRsRsRsRsmmmbRsRsRsRsRgRsRsRsRsRsRsRsRsRsmmmmmmmmm
mmmbLsRsReRsRsmmbRsRsRsmmbRsRsmbRsRiRsRsRsRsRsRsRsRsLsRsRsRgmmmmmmmmmb
RsRsRsRsmmmbRgRgRgRsLsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmbRsRsRsRsLsRsRsRsR
sRsmmmmmmmbRsRsRsRsRsRsRsRsRsRsLsLsRsRsRsRgRsmmmmmmmmmmmmmbRsRsRsRsRsR
sRgRsRsRsRsmmmmmmmmmbRsRsRsRsRgRsRsRsRsmmmmmmmbRsRsRsRsRsRsRsRsRsRsRsR
gRsRsRsmmmmmmmmmmmmmbRsRsRsRsRsRsmmmmmbRgRsRsmmbLsLsRsmbRsRsmbRsRsRsRs
mmmbLsbRsLsRsLsRsRsRsRgRsmmmbRgbRsbLsbRsLsRsRsRsRsRsRsRsRsRsRsRgRgRsRs
mmmmmmmmmmmbRgRsRsRsmmmbRsRsRsRsRsmmmmbRebRjRsmbLsLebLsbLiLsbLibLgLsLs
LsLsLsLsLsLsRgLsmmmmmmmbRsRsRsmmbLebLgbLsLsLsLsLsRsLsLsmmmmmbLgLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 35; Drug: PCAP2 3 然 Apo 50 然
bsbRgbRsbRgbRsRsmbRsbRsRsmbRgbRsbRsbRsbRsbRgbRsRsLsmbRgbRsbRsbRsbRsbRj
bLsbRsbRsLsbRsRsmbRsbRgbLsRsbRsbRsRsmbRsRsmbRgbsbRgLsbRsRsmbLsRsRsmbRs
RsmbRsbRsbRgbRsLsbRgLsbsbRgRsmbLsbRsbLsRsbRjbLsbRsbLsbRsbLsbLsbRsRsmbL
sbRsbRsbRsbRgbRsbRsRsmbRsbRsbRgbLsRsbRsRsmbRsbRgLsbRsbRsbRsRsRsRsmmmbR
sbLsbRsRsmbLsbRsbLsbLibLsbLsbRgbRsRsmbRsbRsbRsbsbsbRgRsmbRsbRsbsbRsRsm
bRsbRgbRsbRsbRiLsRsLsbsbRsRsmbLsRsLsRsbRsbRgbRsbRgbRsbRgRsmbLsRsbRgbRg
bRgbRsbRgLsbRsbRsbRsbRgLsbRsbRgRsmbRsRsRsmmbRsbRjbRsbLsRsbRjbRsbRsbRsb
RsRsmbRsbLsbLsbRgbRsbRsbRsbRsRsmbRsbRgbLsbRgbRgbRjLsbRsbRsRsmbRsbRgbRs
bLsbRsRsmbRsRsmbLsbRsbLgbRgbRgbRsRsRsmmbRsbRsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 36; Drug: PCAP2 3 然 Apo 50 然
bsbsbLsbLgbLsbLsbLsbLsbsbsbLsbLsbsbLsbLsbLsbLsbLgbLsLsLsmmbLsbLsbLsRsb
LsbRobLcbLgbRsLsbLsbLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 37; Drug: PCAP2 1 然 Apo 50 然
bLibLjLgbLhLsbRgbLoRsLsbLhLsLgLsbRsLsbLsbLgbLgRsLsLsmbLgbLsLsLsLsmmmbL
sLsLsLsmmmbLsbLgLgLsbLsbLiRsbLcLsmbRgbRiRsmbsbLjbLsLgLsLsmbLsLsLsLsmmm
bLsLsmbLsLsmbLsLsmbLgbLsLsLsmmbLgLgLsbLgLgbRcbRsRsRsmmbRsRsRsRsmmmbRsR
smbRsbRsRsRsmmbRgRsLsmbRsRsRsmmbRsRsmbRsRsRsmmbsbLjbLgbLgLsbLgLsLsmbLs
LsmbLgLsbLiLsbLibLeLsbRsbLiLsbLsLsmbLgbLsLsmbLsLsLsmmbLsLsLsmmbRsRsLsR
smbRsLsbsbRgbLsLgLsbLjRsbRiRsRsRsmmmbRsRsRsRsmmmbRsRsmbRsRsRsRsmmmbRsR
sRsRsmmmbRsbRgbLcbLhLsbRsLgbRcbRcbLsLsmbRebLsRsbRcRsRsmmbLgLsbRgbRiRsm
bLsRsbRiLsbLcLgLsbLiRsbRsbLiRsLsRsbLebLibRibRjRsmbRhRsmbRiRsRsmmbLsRsb
RgbRsRgRsRsRsRsRsRsmmmmmmbRsRsmbRsLsbRsLsbRsbRgbRcbLibRsbLcbLgbLibRgRs
mbRgRsRsmmbRsbLjbRsbsbRsRsRsmmbRsRsRsRsRsmmmmbRsLsRsRsRsRsRsmmmmbLsbRi
RsRsmmbRibLsLsLsRsmmbsbsbsbRsRsmbRsLsLsLsLsmmmbLsbLsbLsLsmbLsLsLsLsmmm
b

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 38; Drug: PCAP2 1 然 Apo 50 然
bRibLeLsbRibLcbLsLsLsLsLsmmmmbLgbLhbLsbLiLsbLcLsmbLibLeLsLiLsbLgbLgLsL
sLiLiLiLgLgLembLgbLsbLibLsLsLsmmbsbLgLsbLhLsLsmbLiLsLsLsmmbLiLgLsLsmbL
iLsRsLsbLsLsmbLgbLiLsbLcLsLsmmbRcbLcbLhRsbRsbLsbLgLsLsmbsbLgLsRsbLsLgb
LiLibLgLiLsLiLeLeLsbLibLeLsLiLsLibLsLsmbRcRgbLjLjbsbLjLsLsmmbLgbLsbLsL
smbLiLsLsmbLiLgLsbLibLgRsbLibLhbsbLibLibLsLsLsLsLimmmbLsLsLsmmbLibRsbL
cLsmbLgLsbLhLsLsLsLsmmmbLhLgLsLgLsbRjbRjRsmbRjRsmbRgbLcbLcLsmbLiLsbLeR
sLsLsmbLsLsmbLsbLsLsLsLsmmmbLsLsLsmmbLsLsmbRsbLsbLsLsLsLsLsmmmmbLgbLsL
smbLgLsLgbLibLibLsLsmbLhRsbLcLsLgLsmbLiLsbLsbLhLgbLibLsbLsbLiLsbRsLsRs
LsbLiLsLsLsmmbLgbRsLsLsmbLhbLgLsLsLsLsRsLsmmmbLhbLiLsLsLsLsLsLgLsmmmmb
LcbLgbLsbsbLgbLsbsbLgLsLsLgLsLsLsLsLsLsLsmmmmmmmbLibLeLsbLebLgbRsbLsLs
LsLsLsLsLsLsLsLsLsmmmmmmmmmmbLgLsbLgLsbLibLiLsLsLgLsLgLgLsmbLsbLgLsbLi
LsbLsRsLsbLsbLsbLsbLsbLsbLiLsbLebLsLsmbLhLsLsLsLsmmmbLsbRibRsbRsRjRsmb
LsLsLsmmbLcbLgLsLsLsLsLsLsLsmmmmmmbLsLsmbLhLsbLjbLcLsmbLiLsbLgbLiLsbRs
bLeLsbRsRsmbLhbLiLsLsLsLsLsLiLsLgmmmmbLgLsLsmbsbRsbLsbRjRsmbRjbLhbRcLs
bLcbLcbRsbRsbLsbLsbLhbLiLsbLsLsLsmmbLiLsLsmbLsbLibLibRibLhbLcLsLsLsLsm
mmmbLhLsLsLsmmbLgLsLsLsmmbLiLsLsLsLsLsLsmmmmmbLsLsLsLsLsLsLsLsLsLsLsLs
LsLsLgLsLsmmmmmmmmmmmmmmbLsbLsbsbLibLcLsLsmmbsbRsLsLsmbLebLgLsLsmbLibL
sLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmbLsLsLsLsLsLsmmmmmbRjbLcLsRsmbLiLsLg
bLebLiLsLgbLsLiLsLibLiLgbLiLsLsLsLsmmmbLgbLibLcLsmbLgbRibLsLibRsRsmbLh
bsbLibLhLsRsbRibRsbLhb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 39; Drug: PCAP2 1 然 Apo 50 然
bLjbLsRsbLiRsRiRsmbsbLcbRjRsRsmmbsbsbRibLcLsLsmmbRiRsmbLcbRcbRobRibRsR
cbLsbRobRsbRjRsRsmmbRiRsmbLhRsbLcRsbRcbRoRsmbRsbRcLsbRjbRcbRjRibRibLob
RjRsmbRibLiLgLsLgLgbLibRibRgbLhbLhbRjbRgbRhbRjRsRsmmbRobRgRsmbRjbRjbRe
bRhLsbRjbRgbLhRsRsmbRhRsmbRgLsLsmbRcbRsRcRsmbRcbRibRibLibLcbLeLsbRgbRe
bRiRsRsmmbRebRibLebLgLebLhRsbRgbRibLsbLsRsbsbRsbRsRsmbRjLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 40; Drug: PCAP2 1 然 Apo 50 然
bRebRsReRsmbRgRsmbLsRsRsRsmmbRibRgbRgRsRsmmbRebRibRiRsmbRibRgbRgbRibRg
bRhRsmbRhRsmbRsbRcRsmbRgRsmbLcbLjbRcRsmbRsbLcLsmbReRsRsRgRsmmmbRsLsbLs
RsbRgRsRsLsmmbRsRsRsRsRsRsmmmmmbRsRsRsmmbRgRsmbLcbsbReRsRsmmbLgRsbRcbL
sRgbRhRsmbLgRsRibRgbRgbRsbRsbLgRsRsRsRsmmmbRcbLsbRsRsRsRsRsRsRsRsmmmmm
mmbRsRsRsRsRsRsRsRsmmmmmmmbRsRsmbRibRgRsRsRgmmbRcRsRgRsRsmmmbRsRsmbReR
sRsmmbRcRsRsRsRsRsmmmmmbsbsbRsbRiRsRsRgRsRsmmmmbLeLsbLsbRsbRcLsbRsbsbR
gRsmbRhbRhRsmbRgRsmbRcRsmbLiRsbRjbLcLsmbRgbLcLsLsmmbReRsRsmmbLcLsmbRsb
RsRsRsmmbLsRsRsRsRsmmmbLcLsmbRebLcRsRsmbRjbLcbLcbRhbLeLsLsmbLsLsmbRsbL
gRsRsmbLgLsbLgLsLsRsmbLsbLgbLhbLibLiLsLiLgbRsbLiLsbRcbRibRcbLjbLcRsbRg
bLsLcbLibRcRsmbRobLiLsbLibRcRsRsRsRsRsRsRsRsRsRgRsmmmmmmmmmmbRsRsmbRsR
sRsRsmmmbRsbRcRsmbLgbLsbLgbLibRibsbsbLiLsbRebLcLsmbRjbRsRsRsRsRsRsRsRs
RsRsRsRsRsRsRsmmmmmmmmmmmmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 41; Drug: PCAP2 1 然 Apo 50 然
bLsLsmbRiRsmbLjbLhbLgLsLsLsmmbRoRsRsRimmbRhbLibRcLsLsmbRoRsRsmmbRhbLsb
LjbLeLsbLsLsmbRobRcRsmbRoRsmbRoRsRsmmbsbLebRcRsmbLiLsLgbLcLsLsmmbLoLsL
smmbLobsbRoRsRgmbRcRsmbRcRsmbRobLgbLiLsbRoRsmbRhRsmbLsLsmbRcRsRsmmbRcb
LcLsLsLsmmmbRobReRsmbLebRobRiRsmbLsbRhRsmbRcbLcLsmbRcbRcbRcRsmbRcbLibR
cbRjRgbLgbLobLibLibRjbRibRcbLsLsmbLhLsbLsLsLsLsLsmmmmbLsLsmbLsLsmbLgLg
LsLgbLcbRcRsRsmmbRcbRiRsmbRcRsmbRhbRcRsmbLebLhbLgbLhbLebLiLsbLiLsLsmbR
cRsmbLhLgbRcbLcLsmbLcbRobRcbLjbLhbLsbLjLsmbRcbRobLjLsLsmmbLhRsbRcLsbRc
bRobRcRsmbRiRsmbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 42; Drug: PCAP2 1 然 Apo 50 然
bRjRibLsbRiRsmbLsRsLsbRcLsRgLsbRcbLiRsbLsbRgRsRsLsmmbsbRsRsRsRsRsRsRsR
sRsRsRsRsRsmmmmmmmmmmmmbRsRsmbLsRsRsRsRsmmmbRgLsbRiRsRsmmbRsRsRsLsRgRs
mmmbRsRsRgRsmmbLgLsbRgLsLgLsLsLsmmbRiLsRsbRhbRgRsLsLsmmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 43; Drug: Control Apo 50 然
bRsLsbLsbsbsbRgbLhbRsLsRsbLiLsbRcbLcbLcbRsRsmbRsbRsbRsbLgLsbLcbLcRsbLh
LiRsbLcbRsbLgLgbLgLsbRebRiReLsbRsRjbRcbRcbRibRgbLsRebRgbRhRcRhbRcbLjbs
bLiRsbRcbRhLsbReRsmbRiRsmbRgRcbRibLjbLcbLebLibRjbLjLsmbLcbLsbLsbLhLsbL
jRsbLobLcbLsLhbLebLobLibRebRiRsmbRgbRiRsmbLgbLjbLibRjbRhbRebRgLsLsmbLs
LsLgLgmbLgLsLsLsmmbLgLsbLgbLsLsmbRcRsmbRibLjbLcbLsbLgbRsRcbRgRsRsmmbRs
bRebRhLsbLgLsbRjbRjbRcbsbLebLobLgbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 44; Drug: Control Apo 50 然
bRcbLibRobLsLsmbLebsbRebRgRsRgmbRsRsmbRsLsbRsRsmbRsRsmbLsbsbRibRgbRsbL
gbLsbRebRobLsLsRsmbReRsRsRsmmmbsbRsRsmbRgRsRsRsRsmmmmbRsRsmbRsRsRsmmbR
sRsRsRsmmmbRsbRsRsRsRgRsRsmmmmbsbsbRiLsbRsbRsRsmbRebLgRibRgbRgRsmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 45; Drug: Control Apo 50 然
bReRsmbLcRsbLhbLcbLcbLcLebLiLibLgRsbLeLsbLsbRsbLgbRebLcLsmbRjbRjbLibLh
bLcRsbLibRcLsbLobLsRsbRebRgRebRgbRebRgbRcbRoRgbRcbRibRibLsRsReRebReRsm
bRebRibReRibRcbRebRgbLsbRebRgbRiLgbRibRebRcbRibRibRgbLsRcbRibRibLibLjb
LhbLibLjbLebLcbLjbLjRsbLgbLgLibLgbLcbLgbRibLcbLgbRjbRhbRobLibLgbLgbRoR
smbRgbRsbLibRgbLjbRcbLsRsbLcbRcbRjRsmbRcbLgbRebLcLsmbLibLgbRsbLsbRsbLc
bLgbLibRibLgbRgbRcbRsbRibRcbLhbLcbLgbLsbLibLibLcbLsbLgbLsbLhbLibLibLgb
RsbRcbLsLgbRcbRsbLhbRiRsmbRcbRsbLgbRcbRibRebLsbRibRcbLsbRhbsbLebRebLjL
gLsLsmbLjLsmbRjRsmbRebLcbLgLsbLcbRebRsRibRjbRebLcbRsRhbLjbLibLebRebsbR
eRsmbLjbRibLgbLjbRgRsRsmmbRsRjbRgbLjLgLsbRebRebLebRcRsmbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 46; Drug: Control Apo 50 然
bLibRsbLsLsmbLibRsbLeLgbLebLsLgRsbLsbLibLebLgbRsbLeLsbLeRsbRgRsRsmmbsb
LibLiLsbLgbLgLsbLgLsbLibLsLsmbLsbRjbLsLsLsmmbLhbLebRsbRsbLgLsLsLsmmbLe
LsbLebLibLiLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 47; Drug: Control Apo 50 然
bRsbsbRsRgRsmbsbLjbsbRsbLsbLsbsbsbsbRiRsmbLcbLcRsbRebLcbRcbRcbLcbLcbsb
RebRiRsmbRobReRsmbRibRhRebLgbLebLibLgbLhLsbLgbLcbLibLibLcbLiLgbRgbLobL
gbLiLsbLgLgbLcbLgLsLibLgLibLgbLsbLcbRsbRcbRjRiRiRgRsRgRembRibLobLeLsbL
ebLiLibRoLsbRhbLsbRebRebRibLjLjLsmbRcbRibRibRiRsRsmmbsbRibsbRjbLibLcbR
cbRhbLsLsmbLoLsmbLoLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 120530; End: 121030;
Recording: 8-1; Individual: 48; Drug: Control Apo 50 然
bRsbLgRsbLsbLsbsbRibLjbRgbLgbRhbLgbRjRibLibLcbsbsbRsbRgbLsbRgRsRsmmbRg
bRibRgRsRsRsmmmbRgbRgRsmbRsRsmbLebLcbLgbLgLsbLsbsbLgbLibLgbLiRsLcbRhbR
cbRibRibLibRjbRgbLjbLsbLsLsmbLgbLsLsmbLsbLsLsLsmmbLgRsbRjbRsRsmbRiRsmb
RsbRsRsRsRsLsmmmbRsRsRsmmbRsRsRsRsRsRsRgmmmmmbRsRsRsLsmmbRsbRsRsmbRgbR
jRgbRsbRibRgRsmbLsLsLsmmbRsbRsbRsbLgRsbsbRsRgRsmbLsbLsRsbRsRsRsRsRsmmm
mbLsRsbRsRsRsRsRsRsRsRgmmmmmmbRgbRsbRgRsRsRsmmmbRiRsmbRgbLgbRgbRsbRsbR
sbRibRsRsRsRsRsmmmmbLsLsLsLsmmmbLsRsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 1; Drug: PCAP2 10 然 Apo 50 然
bRsRibRsbRjbRebLsbRsLsbLjbLebRsbLebLsbLsbRebLebRsbRebRebLsLsmbLsbRebLs
bLobLsbRebRsbRgbLsbRebLsLebRsbRsRebLebRsRsmbRsRsLsmbLsbRsbRsbLsbLsRsLs
bRsbRsbRsLsbLsRsbsbLsbRsRsmbLsbRsRsLsmbRsbRsRibRsLsbLsbRsbsbsbLsRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 2; Drug: PCAP2 10 然 Apo 50 然
bRsbRiRsmbsbRgbLibRsRsmbRhbRcRsmbLgRsbRcbRebRiLsRsbLsLsLsmmbRgbRobLibR
sLsLsmbRhbsbsbRsRsRsRsRsRsmmmmmbRgRsRsmmbRgRsmbLjbRcRsmbLsRsbRgbLsRsbR
gbRhbLgLsLsmbRgbRsRsRsmmbRsbRsRsRsRsRsRsmmmmmbRsRsmbRsRgRsmbRibRsRsmbR
gbRhbLsLsmbRsRsRsRsmmmbRjRibLgbRiLsbRsbRsRsRgRsRsRsRsmmmmmbRsRgRsmbRgb
sbRsbRibLhbLcbLsLsmbLsLsmbLgbsbsbLsLsLsLsmmmbLgLsbRhRsRsmmbsbLsbRsbRgb
RgbRibRiRsmbRsRsRsmmbRgbRgbsbRsbRsRsRsmmbRsRsmbRsbRsRsRsRsmmmbsbRsbRsR
sRsRsRsmmmmbRsRsRsRsmmmbRsRsRsRsRsmmmmbRgbRibsbRibLhbLcLsmbLibRgbRhbRc
RsmbLsLsmbRhbRcbLsLsLsmmbLgRsbRsRsRsmmbLjbLcLsmbsbRsRsmbLcLsmbsbRcbLsb
RsbRgbRgRsRsmmbRsRsRsRsRsmmmmbRsRsmbRsRsRsRsRsRsRsmmmmmmbRibRsRsmbRiRs
mbRsRsmbRiLsbLiLsRsbLcbLebLsLsLsLsmmmbLsRsRsRsRsRsRsRsRsRsmmmmmmmmbLsb
RgRsmbRcRsmbRsbRcRsmbLsRsbsbLsLsmbLcLsmbLobRsbRsRsmbLibLhRsbRsbRsbRgLs
bRgbRsRsRsRsRsRsRsRsmmmmmmmbLsRsRgRsmbRgbRibRgbRcRsmbRsRsmbRcbLsbLsRsb
RsRsmbLcLsmbRsLsLsmbLsbsbRcRsmbRiRsRsRsmmmbRibRcbLsLsmbLgbRibRsbRsbLsb
RsbRsRsRsRsRsmmmmbRsRsRsmmbRsbRgbRgbRgbRgRsRsmmbRgLsRsbRibLgbRiRsmbRsb
LsLsRsRsRsRsmmmmbRsRsmbLsRsRsmbLsRsbRsRsRsRsmmmbRsRsRsRsRsmmmmbRsRsRsR
sRsRsRsRsmmmmmmmbRgRsmbRsRsRhLsmbLgbRgbRgbRibRgbsbRsRsRsRsmmmbRsRsRsRs
RsRsRsRsRsRsRsRsRsmmmmmmmmmmmmbRgbRibRsbLcbLcLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 3; Drug: PCAP2 10 然 Apo 50 然
bsbRibsbRcbReRsmbLhbRiRgbLgbRgRgRsmbRsRcRsmbRebLsRcbsbRcbLsbLsbLsbLsbR
sbRsbsbRibLsbLsbRsbRsbLjbRsbLsbRsbRsbsbsbRsbsbRsbLsLsmbLsbRsbsbRsbLsbs
bLsbRsRsmbsbsbsbsbsbsbsbsbRsbRsbsbsbRebRobLcbLibLcbRibReRsmbRibRiRsmbL
sbRcRsmbLcRsbLibLcbsbRcRsmbRiRsmbRjRibLobLibLibLobRebRibRibRsRobRhRsRs
mmbRsbReRsmbRcRsmbRsRiRsmbLcbsbsbRcRsRsRsmmmbLgbRiRsRsRgmmbLsRsRgbsbsb
LsRgbsbRsbRsbRsbLsbRiRsmbRobRhRsRsmmbLebRcbRebLiLsRsbRcbRhbRhRsmbReRsm
bLhLsbLgLsLibLibRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 4; Drug: PCAP2 10 然 Apo 50 然
bLsbRsLsbsbRibRgbsbsbRibRsbRgLebLgbLjbLoRsLsLsLsLsmmmbLiLsbLiLgLsbLhLg
bLsbRjbRiRsmbRibRsRsmbRsbsbLsbLsLsmbLsRsRsmbRibRibLsbRhbLsbRsRsLsLsmmb
RsbLsRsbLsbRsLsbLsRsbRsRsmbLsbRsLsbsbLsbsbRcbRsbLgbLiLsLsmbLibLibLibLi
bLibLsLsLsmmbLoRsbLiLsbLsbLsbRebLjbLibLgLsbLsLobLgbLcRsbLibLgbLobLibRg
bRcbRobRoLsbsbsbsbsbsbRobLsLsLsmmbLsbLibLhLibLeLsbLobLoRsbLibLobLsRsbs
bRibLsLsmbRgbRibRgRsmbRebLibLiLgRsbRobRgbRsRsRsmmbRgRsRsmmbRgbRgbLgbRj
bRhLsbLobLcLsmbLibLgLsbLibLgLsLsRsmbLgLgLsRsbLiLgbLibLgbLsLsLsLsmmmbRs
RsmbsbRsRsRsmmbLebsbRebRsbRgbRsRsmbRsbRgRsRsmmbRsbRsRsRsRsmmmbRjbLhbLg
LsbLgbLibLebLobLobLgLsLsmbLsLgRsbLsLsmbLsbLsLsLgmbLgbLgLsLsmbLgLsbLebL
gLsbLgbLsLsmbLgbRoRsmbRibLsbRsbRibRibRgbRhRsmbRsbRhRsmbRsLsRsbRsRsmbRh
bLebLebLibLgbLgRsbLsLsLgLgLgmbLgRsbLgLsbLobsbRsbRsRgbLsbLsbLiLibLgRsbL
gbLjbLgbLiLsbLgRsbLjbLsLsmbRsRsLcmbLgLsbLibLgbLgbLobLhRsbLjbLoLobLgbLe
Rsb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 5; Drug: PCAP2 10 然 Apo 50 然
bLcbLgbRsRsRsmmbLgbLgbRsbLibLiLibLebLsLgbRgLsLsmbLhLsbLgbLsLhbLoLsmbLi
LsLsRsmbLiLsLgbLibLgLsbLoRsbLibRoRsmbRiRsmbRcbRsRsmbRsbRsbRgRsmbLsbLsR
sbsbRsRsmbRsbLsbsbLhbLobLobLobRgLjbReLgbLibLibRjbRobRiLsRsRgbRoRgbRcbR
ibRiRhbRgbRsRgbRobLsbLhbLsbLhLgLsbLsbLgbsbLibLoLsmbLibRsbLsLsmbLebRobL
gbLobRiRsmbRibLgbLcbRobLiLsbLgbLhbLiLsbLebRgbLgbLibRgbLsbRsbLhbLsLsLsm
mbLibLiLsRsbLgbLsbRobRhRsmbLjbLobLibLgbRcbRcbRgbRibRiLsbRibRhbRcRsmbLo
LsLsRiLsmmbLcRsbLibLoLiLcbLoRsRsmbLibRcbRhRsmbRcbLgbLsbLgLgbRsRsmbRsRi
bRibRiRsmbsbRibRsbRsLsLsmbRsRsmbRsRsRsmmbLsRsbRsLgbLsLsmbRebLsbLibLibR
cbRsbLobLgbLgbsbLsbLhLsbLiLsLiLsbLiLsbRgbLebsbRoLsbRibRsbRsbsbRibRsbLc
bLibLiLgbLibLgbLebRsLoLsmbLcbRjbRobLsbLsbLhLsbLhbRsbLiLsbLsbRebRgbRgbR
cbRiRibRebRcRgbLoRsLgbLcbLgbLiLibLibLgLsbLibLsbLsbRcLsbRjbLibRobLibLoL
smbLgbRibRibLebLibLgbRobRgLsRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 6; Drug: PCAP2 10 然 Apo 50 然
bRgRsmbRsRcbRcbRibRgRsRsmmbLeLsbLebRjbRcRobRcbRibRsRsmbLoLobRcbRcLsbRc
bRobLcLsmbRobRiRsmbRebRibRiLsbRibsbRiRsRsmmbLsRsRsmbRsRsmbLjbLsbRsRsmb
RsRcRsRsmmbRhbRsbRobLobLcbLeRsbRebLobRcRsmbRobRoLsbRcbLoLcbLcLsmbRobLc
bRsbRsbRsbRgbLobLcbRibRhbRibRcbRibLsLiLsLsmbLgLgbLeRsbRcbRibRhbLoLsmbR
gbRsbsbLsbRsRsmbRsRsmbsbsbsbRjbRsbsbLsbLgLibLhLsbRibLibRibRobRcbRebRob
RjbLcbRobRcbLsbRebRobRobLsbLcbLcbLgbRebRsLsLgbLgLebRcbLsbLcLsmbLsbLsLs
mbLcRsbLobLiRsLgbLiLsbLibLebRebRoRsmbRebRsbRsbRsRsRsRsRsRsmmmmmbRgRsRs
LsRsLsmmbRgRsmbRibLsbRcbLgbLjLsLgLsmbsbRsRsRsmmbRsRgRgbRibRsbsbRcbLsbR
sRsmbRsbRcbRcbRsbRobLiLsbLoRsbRgbLcRsLsbsbLeLsbRgLsbLebRgRsRsmmbRebRgb
RgRsRsmmbRgRsmbRebRhbRibRsbRsbRsRsRsRsmmmbLjbsbsbLsbsbLsLsmbsbsbsbsbLs
bsbLgbLcbRsRsmbLsbRjbRibLsLsmbRiRsmbRsbRsRsmbLjbLsbRsLsbRsRsmbsbRiRsLs
RsRsmmbLjbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 7; Drug: PCAP2 3 然 Apo 50 然
bLsbsbLsbLsbLhbLgbsbLgLsbsbLsbLsLsmbLsbLsbRsbRjbsbsbRiRsmbLsRsRsmbLsbR
sbRsRsRsmmbRsbRsbRgbLsbLsRsbLsLsmbRsbRgbRsRgLsbRcbRsRsmbRiRiRsRsmmbsbs
bRgbRgRsRsmmbRgbRgbRgbRebLsbLibLgbLgLsbLhbRsRsLsmbLcbLsbLsbsbsbLcbsbRc
bRiRsRsmmbRsbRsbLsRsRebLsLsmbLgbRobsbRhbRibRgRsmbLsRsbRsbLobRjbRgbRhRs
mbRhbRibRgbLsbRsbRgbLsbRobRobLgbRcbRiRsmbRiReLiLsbRebRgRsmbRibRibRebRi
RibRiLibRjbLcbLebLebLgbLiRsbLsbLsbLsLsRsmbRsbsbRsbsbsbsbsbRsRsRsmmbRsL
sbLsbsbsbRibLsRsbRgbLsLsmbRibLobRsLoRsbLebLeLsbLcLsmbsbRsbsbLibsbLsbLi
LsbLibLcLsLsLsmmmbLcbLgbLiLgLsbRsbLoRcbLobLobLcRsbLsbRiLsbLobLcLsmbLhL
gbLibLsLsLsLgmmbLgLibLsbRebLobLhLebLeLeLebLibRibLebLcbRhLsbLiLebLibRcb
RibRhRhRsRsmmbRgbRebRebRhRcbLsbRjb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 8; Drug: PCAP2 3 然 Apo 50 然
bReRgRsRhmbRcbLgLiLgbLjbLiLsbRcbRoRsRsmmbRoRsmbsbLjbLsLcbLibLibLeLsRgb
RiRgRsRcmbRcRsmbRsbRobLgbLhbLcbLcbLibLgbRcRiLsRobRobRsRebsbRcRsmbLcLob
LjbRibLeLebLgbLebLiLibLcLsLhmbLobLcLcbRgbLibRgbRhRcbRcbRjRibLcbRjbRjRs
RcmbsbLjbLiLsbRcbRsReRsmbRebLeLcRsLsbRcbRebRobLcbLibLibLcbLeRcbRobRobR
cRsmbRsbRcbLcbLcbLcbLcbLcLsLsLcmmbLcbLibLcbLgbLcLsmbLebLsLgLsLgbRhRsRo
mbRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 9; Drug: PCAP2 3 然 Apo 50 然
bRebRsbReReRgbRhbRiLsbRebRebRhbLhbLsLibRcbRhRsmbRebRgbRiRsmbRgRsRsRsmm
mbRiRsRsRsmmmbsbRgRsmbLjbLibReRebReRsRsmmbLibRebRebRsRibRsbRgbRiRgbRiR
ibRiRebRgRsmbRgbRebRcbRcbLsbRgbRibRhRsRsLsmmbRebRgRebRgbRsbRibRgRgbReb
RiRsmbRsRsRsRsmmmbRgRibRebRsbRsRsRsRsmmmbReRsmbRibsbRsRebRgbRgbReLsbRi
bRsRsRsRgRsRgmmmbRiRsRiRgRsmmbRiRgbLiLgbLcbRebRsbRgRsmbRsbRsLsbRibRsLs
RsbRiRsRembRibRhbRibRgbRgbRsRsReRsmmbLibRgbRsRsRsmmbRgRsRembLjLsmbLibL
cbRibRsbRsReRsRsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 10; Drug: PCAP2 3 然 Apo 50 然
bsbRgRgbLgLsbLibRebRibRsRsmbRsRsRgRgmbRiRsmbLsbRsbRiRsmbLsbRgbRsLsbLsR
sbRsRobRgbRibRgReRhRsmbRhbReRebRoReReRebLoReRhRhRsmbRoLsLgbLsbRibLgRsb
RsRsmbRgRsmbLsbLsRsbsbRibLibRhbLgRsRsmbRsRsRsRsmmmbRsbRobRjbRiRebRcbRs
bRhRsRgmbRjbRiLgbLsLjbLsbLobLibLcbRiRsRsRgRgRhRsmmmbRsbRiRibRjRsmbLjbR
hRsmbRjbRcbRhRsmbRiRsmbRgbRsRsmbRhbRebLsRsbLsbLjbLsbRcbRsbRsLsbRsRiRgb
RgbLsRsbRsRsmbRsRsRsmmbRiRsmbRiRsmbRibRsbLibLgbLgbLsLsLsmmbLsbLsbLsbRs
bLjbRgbRjRsmbRebLhbLcbLhbLgbLgLsbRsbLsbLsLsLsmmbLsRsLsLsLsLsmmmbLgbLeR
sRsmbLhbLhbLibLibLgbLgbLgLsbLgRsbLgRsRsmbLgbLgLsLsmbLgbLibsbLsbLsbsbRc
bRcRsmbRcLsbLsLsmbLgbLgLgLsbLibLgbLhbLgbRibLgRsbLjbLobLiLgbRsbRjbLcbLi
LobRsRsmbRibRibRebRjRsRsRsRsRgRsmmmmmbRgRsRiRsmmbRgbRjbRsbLsbRibLsRsRs
LsRsRsRsRsRsRsRsmmmmmmmbRjbRgbRhRgbRgRgbRsbRgRgLgbLcbRsLsLsmbLgLsbLsbL
sLsmbLgLsLsmbLsLsLsLsLsLsLsmmmmmmbLsLsLsLsmmmbsbLsbLsbRsbRsRgRsmbRsLsR
sRsmbRibRsRsLsmbRibLhbRobRibRibRsRsRgmbRoRsLsmbLsLgbLibRjbRhbRiRiRsmbR
gRsmbRgRsRsRsmmmbRibRibRgbRebLsbRibRibRsRsmbRhRsLsmbLsbLgbLsLsmbLgbLgL
sLsLsLsLsLsmmmmmbLgLsbLsLsLsLsLgLsLgLsLsmmmmbLsLsLsRsmmbLsbLsLsRsLsmbR
sLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 11; Drug: PCAP2 3 然 Apo 50 然
bLsRsbRsRsmbLsRsRsmbLsLsRsmbsbRsbLsRsbRsRibLcbRcbLeRsbRsbRsbsbsbRsbRsb
RsRsmbRsbRsRsmbRsLsbRsbRsRsRsmmbLsRsRsmbRgbLsRsRsRsmmbRgRsRsmmbRsRsmbR
sRsmbRsRsmbRgbRgbRsRsRsmmbRsRsRsmmbRsbRsRsRsmmbRsRsRsmmbRsbRsRsmbRsbLs
RsRsmbRsRsmbLsRsbRsbRsRsmbLsRsbRsRsmbRsRsmbsbRsbRsbLsRsRsmbLsRsRsmbRsR
smbRsRsRsmmbRsbRsRsmbRgbRsRsmbLsRsRsmbRsbRsRsmbRsRsmbLsRsRsmbRsRsRsmmb
RgLsbRsRsmbRsRsmbRsRsRsmmbRsbRsRsmbLsRsbRgRsmbRsbLsRsRsmbLsRsbRsbRsbLs
RsbRsRsmbRsRsLsmbRsbLsRsbRsRsmbRgRsmbRsRsmbRsbRsbRsbsbRsbRsRsmbRsRsmbL
sbRsbRsRsmbRsRsmbRsRsRsRsmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 12; Drug: PCAP2 3 然 Apo 50 然
bRgRsRsmmbRsRsmbRgbRsbRsRsLsmbRgbRgRsRsmmbRsRgRsmbRibRgbRgRsRsmmbRhbRs
RsmbRgbRsRgbRgRsmbRsRsRsmmbRgbRgRsmbRsRsRsLsRgLsmmbRiRgbRgRsmbRsRgbRgR
sRsRsRsmmmmbRsbRibRsRsRsRsmmmbRsbRgbRgRsRsmmbRiLsbRgRsRsmmbRsRgbRsbRgb
RsbLsbRsbRibRsRsmbRsRsmbRgRsRsmmbRsRgRsmbRsbRgRsRsRsRsmmmmbRsRgLsbRsRg
bRhbRsbRgbRibRsbRgbRsbRsRgbRiRsRgRsmmbRsRgbRsbRgbRsbRgbRgRsmbRibRsbRsb
RsRsRsmmbRsbRibRgbRgRsmbRgRsRsmmbRsRsRsmmbRebRsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 13; Drug: PCAP2 1 然 Apo 50 然
bLjbsbLjRsbLjLsmbLgLsbLjbLhbsbLjbRcbReRsRsmmbRibRiRgbLibRgRsmbRjRsRsmm
bRcRsmbLcbsbLobLcbLhLibLgLebLgRsRsmbLiLsRsLsLsmbLjRsLsbRjbLobLhLsbLcbL
cLsmbRsLgLgbLsLcbLgLsbsbLjLgbLcbLjLeLsbLcbRgRsmbLibRobRibRhLsbRibRiLsb
RoLsbRibRibRhRsmbRgRsmbRcLsRgLjbLebRobRcbRsRgRsRsmmbRsRsRsRsRemmmbLgbL
sLjLsLsmmbLjbRsbLibLhbLgbLjbLcLsmbRsbsbLcLsmbLjLsLsmmbLcLsmbLiLsbLhLsb
LibLebLcLsLsLgLsLsmmmbLgbLebLcbLcLsLsmmbLgbLhLsbRcbRiLsbRgbRsLsbRibLgL
hbRiLsbLjbRjbRsRhbLiLsbLcbLhbLibRebLsbsbLjbLiLsbLjLcLsmbLjLgbLcLsLsLgm
mbLebLoRsbRebRobRsRsLgmbLeRsbLjbLsLsmbRiRsRgmbRiRsRsmmbRgRiRgbRsRsmbRs
RsRsRsRgRsRgRsRsRsRsmmmmmmmmbRiLsLsmbLjbRcbRhRsmbLcbRhRsRgRgRsRsmmmbRc
bRibRobRibRiLsbLgbLhbLgbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 14; Drug: PCAP2 1 然 Apo 50 然
bLsLsLsLsmmmbRsRsmbLsbRsRsmbLgbLsLgbLiLgbLiLsLsmbLgLsbLgbLsbLgbLgbLsbL
sbLgLsLsmbLsLsLsLsLsmmmmbsbLgbLsLsLsmmbLgLsbLibLhbLgbLgbLgLgLsbLibLgbL
ibLgLsLsmbLgLibLgbLsLsmbLibLsLgbLgbLjLsmbLebRjbRibLebLgbLibLgbLgbLgbLi
bLgLsbLiLgLsbRsLiLsLsLsmmbLsLgLsLgbLgbLibLibLibLibLiLgbLhbLiLgbLibLibL
ibLiLsbLhbLibLhbLibLgbLjLgLsbLibLjbLibLebLibLibLibRgbLebLebLgbLsLibLsL
ibLibLibLsLsLsmmbLgbRsbLgbLgLsbRjbLsLgbLsLsLsmmbLsLsLgLsmbLgbLgbLiLibL
ibLgbLgbLibLgbLgLsbLgRsbLiLsbRgbLibLhbLibLibLgbLgbLibLgbLsbLgbLsLsmbLs
LgbLgbLsbLibLgLsRsLsLsLgmbLibLgbLgbLgLsbLgLsbLebLgbLibLebLgbRibLjbLiLs
bLgLsbLgbLsLgRsbLgbLsbLsbLgLsLsmbLsLgbLgbLgbLsLsLgmbLgLsLeLsLsLsmmbLsL
smbLsbLgbLgLsbLgbLgbLibLgLsbRsLhbLgLsbLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 15; Drug: PCAP2 1 然 Apo 50 然
bRsbLiLsLsmbRsLsbRjRsmbRiRsmbLsLsLgLsmbRsbRebRhbRsbRibRgbRhbRgbRgbRoLs
bRhbRoLsbRiRiRsmbRobRcbRibRhbLsbLcbLcbLgbLhbLiLsLsmbLibLjLiLsLsLsmmbsb
RhbRsbLiLgbLjLebLgLgbRibRgbRgbRsRsRsRsRsRsRsRsRsRsmmmmmmmmmbLsLsLsmmbL
hLsbRjbRcRsmbLgLsbRcbRsbsbLjLeLsLgLsLsLsmmbLebLgbRgbLibLiLsbLeLsLsLsLg
mmbLibLiLsbLcbRibLhLgbLgLsbLgLsLsLsLsLsLsLsmmmmmmbLsbRsRsmbLiLgLgLsLsL
sLgLgmmbLcbRibLgbLiLgLgLsLsLsmmbsbLgLsbLsLsLsmmbRibRcbRgbRibRsLsRsbLeb
LibLsLsmbLsRsLsbLsbLgbLgLsRsLsbLsLhbRgRsmbRsbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 16; Drug: PCAP2 1 然 Apo 50 然
bLsbLsbsbsbLgbLgbLsbLsbLsbLsbLsLsmbLsbLsbLgbLsbLsbLsbLsbLsbLsbLsbLsRsb
LsbLgbLsbLsbLsbLgbRsbLsbLsbLsbLsbLsbLsbLsLsmbLsbLsbLsbLsbLsbLsLsmbLsbL
sbLsbLsbLsbRsbRsbLsbLsbLsbRsbRjbLsbLsbRsbLsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 17; Drug: PCAP2 1 然 Apo 50 然
bRoRsmbsbRiRsmbRsRsmbRhbRhbLebRobRcbLcbLsLcbLcbLcbRobRcLsRsbRcbRhbRcRs
mbRgbLcLsmbsbLcbLeLsLsmbLebLcbLeLsbLcLgbLjLibsbLsLsmbRjbReRsRimbRobsbs
bRgbLebLebLcLsmbLcbLcbRgbRoRcLsRsbRhLsRsLsbLebLebLebLcRsbsbsbRsbsbsbRi
bLsLhbLebRibRgbLgRsbLjbLebLcbLobLcbLgbRjbLebRcbRcRsmbLsLcbLcbLsbLjbLhb
LibRjbRebLcbLibLsbLoLsmbRsbLibRjbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 18; Drug: PCAP2 1 然 Apo 50 然
bLgRsbRgRsmbLgLsbsbLsLsRsmbLiRsRsmbLiRsRgbLcbsbLgbRsRsmbLoLsRsmbRebLsR
sRsRsRgRsmmmbLibLiLsbLibLgLsbsbLibRobRebLgbLgbLjbRebLhbsbLjLebLebRebRc
LsbLibLgbLibLiLsbsbLgRsbRsbLibLiRsRsmbLhLsbLiLsLgLsbLgLsbLsbLobRcRsmbR
hbRcRsmbRoLsbRsRsmbsbLsbRsbsbsbRjbLebLgLsbLibLebLebLebRsbRebLoLebLgbsb
sbRsRsmbLgRsbRsLsLsmbLsbLibsbsbRhRsmbLjbLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 19; Drug: Control Apo 50 然
bLibLjbLgLsbLsLsLgmbLjbRgRgbRcbRsbRiLsLsmbLcbLsbRsbRibRcLsLsmbRjbLeLgb
RcbRsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 20; Drug: Control Apo 50 然
bRsRsmbRebRebLsbRibRobRibLibLsbLgRsbLobRibRibLsbRjbLebLcbRhbRebLibRcbR
ibRibLjbRibLsbRgbRgRsmbRgbLgbLsbLebRsbLcbLcLsmbRebRgbRsRsRsRsRsRsRsRsR
smmmmmmmmbRsRsmbsbRsbsbRsbLsbRebRobRebLsbLibRhbRgbRsbRsbReLsbRiRsLsmbR
iRsmbRsRsmbRibRsbLgbRibRsRsmbRsbRsRsRsmmbRsbRgbRgbRsbRsbRibLsbRsbRgRsm
bRgRsRsRsRsmmmmbRsRsRsRsRsRsRgRsRsmmmmmmmbReRsRsRsRsRsmmmmmbRiRsRgmbRg
RsmbRgbRsRsmbRibLsbRgbRgRsRsRsRsmmmmbLsRiRsmbLsbLsLsmbLsbLsRsbRsRsmbRg
RsRiReRsmmbRsRsRgRsRsRimmmbRhbRgbRiRsmbRibRgbRgbRcbLgLsLsmbRjbRgbRgRsR
smmbLsbRgRgRsRsRimmbLsbRsbRgbRibRibRgbRgbLeLsbLsLsmbsbLsbLsbLsLsLsLgmm
b

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 21; Drug: Control Apo 50 然
bLsbRsRibRgbRiRsmbLsLsmbLebLsbRibRcbRgRsmbRcRsmbRgbLobLebRsbLgLsbRcbRg
bRgLsbLeLsbLcbRgRsRsmmbRiRsmbLsRsbRsbLjbLibRsbRhbRibRcRsmbLsbReRsmbRsR
sRsRsmmmbsbsbRcbRcbRcRsmbRgbReRsRsmmbRgbRcbRsbRhRsmbRiRsmbRcbRsbRsbRcb
RhRsmbRibLsRsRsRsRsmmmbRoLsbRcbRhLsbLsbRebRsRibRiRebRgRebReRsRiRsmmbRi
bLsbRibRiRiLsbLeRhbLgbRebRibRebReRebRsbRibRgbRibLgbRhRsmbRibRgbRsbRgbL
sbRcbLsLsmbRebRgbRsRsRsmmbRsRsmbRibRhbLgLsbRcbRgRsmbRibRsbRcRsmbRgbReb
RgRsmbRgbRcbLgbRiRsRsRgmmbRebRgbRgLsRsbRiRsmbRgbRiRsRsRsmmmbRcRsLsmbRs
bRebRibReRsmbLsbRhbRibRgRsmbRgbRgbRiLsLsLsRsRsmmmbLjbLobLgbRjbRcbRsRsm
bRcbRsRgRsRgmbRcbRgRsRimbRcRsmbRsRsmbRsRgRgRsmbRcRsmbLsbLjbRcRsRsRsRgL
smmmbRgbRgRgRsmbRiRsmbRebLgbRibRhbRcbRgRsmbRiRsRgmbRhRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 22; Drug: Control Apo 50 然
bLcLsmbRcbRibRibRcbRcRsmbRhbRcbRhbRibRebLibRcbRibRhbRebRcbReRsmbRcbRcb
RgRcbRebRibRcbRebRsbRcbRgRgRsmbRibRiRsmbRebLgbLhLsbLcRsbRobRgbRibReReb
RiRsmbRgbRibRsbLcbLhLsbLiLsbLibLiLsbLiLiLgbRhbLcLsmbLibLsRsbLgbRjbRcbR
iRsmbsbLibLcbRiLsbRcbRobRgbLobLibRcbRibRibRgRcRsLsmbLgbRebRcbRhbReRsmb
RsRsmbLebLiLsbRcRsmbRebReLeLsLsmbLgbLibLhRsRsmbReLsbRobRcbRcbLsbLcbLib
LcLsLsmmbLsbLcbLeLsbRjbRcbRebRebRiRsmbLjbLibRjbLcbLgLhbLgLibLjLsmbLgLi
bLjLsmbLhbRjbLgbLcLsLsmmbLibLgRsbLeLsLsmbRcbRjbRebRebRcRsmbRjbRsRgRsmb
RibLcbRsRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 23; Drug: Control Apo 50 然
bLgbLibRsbRsbLsbLsRsbLsLsLgmbLsbLsLsLsLsmmmbLgbRsbRhbLgbRibRhbRgbRsbRg
RsmbLsbsbRjbLibRebRibRibLgbRsbsbRibRcbLgLsRsbRcbLibRsbsbRsbLsbRcbLgbRc
bRibLgbsbRcbRibRgbRibLcbLgbLgLsRsLsbLsbsbRcbRgbRsbRgbRgLsRsRsRsRsRsRsR
smmmmmmbRsbRsRsmbRsbRgLsbLsbRsbLcbLibLibLgLsbLibLhbLcRsbRsLsbRsbLsLsmb
RibRibLibLcbsbLjbRgbRsbRgRsRsmmbLsbRsRsmbRgRsmbRhRsmbRcbRibRcbLsLibLhb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 24; Drug: Control Apo 50 然
bLjbLjbLcbLcbLsbLibRcbLjbRibLiLsbLibLiLsbLcbLibLibLhbLibLibLibLiLsbLhb
LibLhbLcbLibLibLhbLibLibLibLibRebRcbRjRebRcbRsbLibRcRsmbRgbRcRsmbRcbRg
RsmbRcbLhbLcbRhbLjLsmbLcbLibLhbLibLjbLcbLiLsRsbLebLjbRsRsmbRsbLiRsbLgb
LcLsmbLgbLibLjbLibLibLhbLgbLhbRhbRgLsbLibRibLsbLgbLgbsbLjbLsbLibLjLsmb
LcLsmbLcbLcbLhRsbLcbLibLhbLibRgLsbLibRcbRibLjbLcbLcbLhbLibLcbLgbLiLsbL
ibLhbLibLcLsmbLcbLiLsbLsbLcbLibLgbsbLibLibLibLcbLhbLibLebsbLibRcbRibRc
bRhbRcbRcRsmbRibRcRsmbRsbLgbLjbLsLsmbLgbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 25; Drug: PCAP2 10 然 Apo 50 然
bRsRsmbRebsbLsLsLsmmbLiLsbLgLsbLsLsmbRsbRibLsLsmbRsbRsbRsbRsbLsbRsbLsL
smbRjbRsbsbLsbLsbsbLsbLsbsbRsbRsbRebRhbRsbLgbLsLsmbRebLeLcLsmbRcRsmbRi
bRebLsbLibRebRgbRgRsmbRiLsbRgbLibRgbRobLsLsmbRgLsbRgbRobsbRgbRsbRhbRsR
smbRjbRgLsbReLiLebLcLsmbLiLsbLgbLiRsbRsRsmbRsbLsbLgbLgbRsbLjLsmbLgLsbL
gbLoRsbLoLsLsmmbLhbRsLeLsbLhbLhbLcbRgRsmbRjbRjbLiLsbRsRsRgmbRsbRsbLibR
gRibLeLsbRsbRgbLsbLsbRsRsmbRibLgLsbLcbLjbLsLsmbRgLgLsbLsbLgbRsbLsLsmbL
sbLibLjLiLsbLibLsbLjbLeLsbLcbLgbRsRsmbRebLibRgRsmbLebLgbLgbRsbRgbLgRsb
LcbLiLsbRebRgbRsRsmbRsRsmbRsRgbRgbRsbLsbRgRsRsmmbRsRsRsmmbReRsmbLcbLsL
smbRgLsbLibRobRiRsmbRsRsmbLgbRgRsRsmmbRibRsRsRgRsmmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 26; Drug: PCAP2 10 然 Apo 50 然
bLsLsmbsbsbsbsbsbsbRgbRsbRsbRsbsbsbLsbLsRsRsmbLsRsLsLsmbRsRsLsRsmbLjbL
cbRsbRsLsbsbLsbsbLibsbsbLsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbLsLsRoRgmbsbRgb
RhLsbLgbsbLsbsbsbRibRobLsbRsbRgRsRsmmbRiRiLjbRsbRebRcbRebRebRebRebRibR
ebRgbRibReRsRsRemmbRebRgRebRibRgbRibRsbRgbsbRgRgRsmbRgRsmbRgbRiRsmbRcb
LgbsbsbLebLsLsmbRsLsbLsbRsbRjbRcbRebReRsmbLibLhLsLsRsmbLcLsmbLsbsbRjbR
cRsmbRiRsmbRibLsbRoRsRiRsRsmmmbRsRibLhLcbLoRsLobLhbLibLoRsbLoRsbLhbRcR
oLebLsbLsRsLgbLgRsbRibRiRsmbRibRiLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 27; Drug: PCAP2 10 然 Apo 50 然
bRiRsmbLjLsmbLjbLgLsbRgbRcRsmbRsRsRsmmbRsRsRsmmbLsbLhbLsbRgbLsbsbsbLib
RjLsbLsRcbLebLiLsbLgbRsRsRsRsLsmmmbRsRsmbRsRcRsmbLsLgbLibLjbLeLsbLiLsL
smbRebRsRcbRsRsRsmmbLsLsRsRsmmbRsbLsbRibLjbLsLiLsbLgbsbRsLsbLiRsbLgLsb
LsbLsbLsRsRsmbsbLsbRsbsbLgLsbRjRhbLgbRcbLsLsRoRsRsmmmbLibLjbLsbLiLsbLg
RsbLgLeLsRsbLhbLebLibLsRsbLiLsbRoRsRgmbsbRgRsRsmmbLhbLiLgLhbRsLhbLibLi
bRibRsLiLsbLiRsbLhbLobRgbRiRsmbRsRsmbRcbLsRibLgbLhbLgbRsbLsLsmbLsRsbRs
bRsbLibRcbsbLhbLgRsRsmbLibLgbLsbRsLsbsbLsLsmbLgbRebLiLsLsmbLgLsbsbLgLs
LsLsmmbRsbLgbsbLgbRgbLibLgLsRsLsbLgLsbLibLgRsLsLsRsmbLgLsbLsRsbLcLsmbR
sRsmbLibLgbRsbLibLiRsbLjLgLsLsmbRhRgbRebRhbRhbRcRsmbLjbRcRsRsmmbLsbLhb
LsLsLsmmbLiRsbLsLsmbLgLsLsmbLsRsbRgbsbLsbLibRgbRcRsmbLsbLjbsbLhLsbRjbR
hRsRsmmbRsRsmbRgRsRgRgRsRsRsRsRsmmmmmmbRsbRsRsRsRsmmmbRebLebLobLsRjbRc
bRiRsRsmmbLibLiLsLsLsmmbLsRsLsbLibLgbLgRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 28; Drug: PCAP2 10 然 Apo 50 然
bLjbRcLsbRgRgRsmbLjbLibRgbRjbLjbLsLsLsmmbLsRsbLjbRsbLsLsmbLjbRsRsmbRjb
LjbsbRsRsmbLgLsbLgLoRsRsmbRiLsbsbLgbRcReRsmbLsRsbLsLsLsmmbRiLsbsbRibRs
RsRhLsmbRgRsRembRibsbReRsRsRsRsReRiRsmmmmmbRibRebRibLjLsmbRobLiLsbLoRi
bLsRsLibLcRsRsmbLiRsRsmbRjRsmbLsbLsbRgbRgRsRsmmbsbRgRsRsRsmmmbLsLsRsmb
LjbLhLsbRibsbsbLgbLgRsbRgLsbLiRsRsmbLsRsRsmbLsLgLsbLgLsLsLsLsLsLsLsLsm
mmmmmmbsbLcbRsReLsbRiLsRsRgRsmbLsLsmbRcRsmbLsLsmbLiRsbRjbRiRsmbLibRgLs
bLibLiLsbRsLsLsLsRsLsRgmmbLiRsbsbLsbLcLsmbLiLsLsLsLsmmmbReRsmbLjbLiLsb
RcbRhLsbRcLsbLsbReLsbLjLsRsmbRobRcRsmbRgLsbRiRsRhmbLjbLjbRibLgbLsbLibR
sLcbLsbLjLsmbLibRibRcRsmbRcLsbLhRsbRgLsLsmbRgRsmbRcbRcbRgLsRsRsmbRsbLi
LsLsmbRibLjbRjRsmbRgbLjbLeLsLsmbLiLsbLjLsLcmbRsbRiRsLsmbRhbLibLjbRgbRg
RsRsRsmmmbLcbLibLibRgRgbsbLibLsLsLsmmbRcLsbLcbLjbRjbLgLsLsLsLsmmmbLibR
cRsmbRhbLsLsLsLsmmmbLsbLgbLsRsbLsbRgLsLsRsRsmmbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 29; Drug: PCAP2 10 然 Apo 50 然
bRobRibRgbRibRgRcbLjLsmbLhbRsRsmbRjRsRsmmbRibRcRsmbRhbRjRgRsmbRobLjbLg
bRjRsmbRjbLsbLibLsbLcLsmbRibLibLibLibLibRiRsmbRobRiRsLsmbRiLsbLibRebRg
bRsLcbLiRsbLoLsmbRhbRhRibRcbRjRgbRibLcbLiLsbRiRsmbRiRsRsmmbLjbRhRsmbRs
bLjbRsRibRibRsbRsRsmbRsbLjbRgRsRsRsmmmbRibRsRgbRgRsmbsbRebLsLsmbRobRhR
smbRsbRgbLhbLiLsbReLsbRsRcRsmbRsRsRsmmbLcbLhbLibRcRsRsRsmmmbLjbsbLgLgL
sbsbLoLsmbRebRhbLcLsmbRcbRibsbRcbRgbLibRibRgbRhbRcbLibRiRsmbRoRsmbLsLs
LsLsLsmmmmbRsRsmbRgbRgbRcbRhbsbRgbLgbRibRiRsmbRsbRsRsRsRgRsmmmbRgbRiLs
bLgbsbRobRgRsmbRibRsRsmbRgbRcbRhbRcbRgbRgRsmbRgRsmbLsRsLsbRgbRgbRiLsbL
sbRiRsRsRemmbRjRsmbRhRsmbLebRsLsbLgbLgbLibLibRcRsmbRibLobRcbRjRsRsmmbR
cLsbLjbLhLsbRiRsmbRibRcRsmbRibLjLsmbLhbLibRcbRcRsmbRgbRebLgbLjbLhbRcRs
mbLjbRhbRcRsmbLsRsbLiLgbRobRibRibLcbRebRcbLsLhbRsRibRcbsbLcRsbRibLsLiL
sbRgbRhbRibRhbRiRsmbRgbLibLgLsbLgbLiRsbRhbLhbRibRjbRhbsbRiRsRsmmbLjLsm
bLsbRhRhb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 30; Drug: PCAP2 10 然 Apo 50 然
bLobRsLsbLcLsmbLjbLobRiRsmbRcbRcbRibLhLcbRibLobLgRsbRcRsmbRsbRsbRsbRcR
sRsmmbRobRhRsmbRsRsRsmmbLsbLoRsbLibRsbLsbLhLsbLibLsbLgbLsRsLsLcbLsRebL
cLsmbLhbLcLsmbLhbLcLsmbLeLsbRiRgbLhbLcLsRsmbLsLgLsbLsbLibLgbRjLsbLibLs
bRgbRoRsRsmmbRibsbLsbLcbLcRsbRjbRibRsbRibRsbLcbLcLsmbLsbLhbRibLcLebRsR
smbsbLsbRibLsRsbsbRcLsbRiLsbRiRsRsmmbLjbRebLgbRiRsmbLcbRsbLcLsmbRgLebs
bRgbRgbLsbLsRsbLcbLcRsbLibRcRsmbRgLsbLobLcRsLsbLhLsbRcbRobRcbRebLgbRjb
LhbLcbRebRibRsRsmbRgbRhRsmbLsLgbLhbLibLsbLhbLjbLoLsmbRibRibRibRgbRhbRi
bLibRgbLgbRsbLoLcbRsbLibLibLcbLsbRsbLiRsbLgLibRebLoLsLsmmbLsbLhbLiLiLs
bLcbRebRsbRcRsmbRcbRcbRgbLoLsmbLjRsbRgLsbLsbLsRebLoRsRsmbRiRsRsmmbRgLs
bLsbRgLsbRgRsRgmbLobLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 31; Drug: PCAP2 3 然 Apo 50 然
bsbRiLsbRjbsbRjbLsbRsRsmbLsbsbsbsbRsbRsbsbRsLsRsbRsbsbsbsbLsbLsbLsbLsR
sbsbRsbLeRsbRgRsmbLsbLiLgLsbLsLsmbLgLsbRsbLsbRsLsLsLsmmbLsbRsbRsRgbRsL
jbLjbLibRsbLsbLgbLeLsbLibLsLsLsmmbLsbLsbRsLsbRsLsbRsRsmbRsbLsbLsRsbLsL
smbsbLsLsLsmmbLsLsLsRsmmbRgbLibLsLsmbsbRgbsbsbsbRsRsmbsbsbsbRsbLjbLsLs
mbLsLsmbLsLsmbRsbLsLsRsmbsbLsbLsLibLcbRsRsmbsbsbsbsbRsbLsbRsbLsRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 32; Drug: PCAP2 3 然 Apo 50 然
bRgbLgbLsLsLsLsmmmbLsLsLsLsLsLgmmmmbRsLgLsbLsLsLsLsLgmmmbLgbRsLsbLgbLs
LsLsmmbLgLsLsmbLgbLsbLsLgLsLsLsLsmmmbLsbLsbLsLsLsmmbLsbLsLsmbLsbRsRsmb
RjbRibLobLiLsbLcbLgLsbLibLibLgbLibRsbLibRibRoRiRsmbRiRobRibRhbLcLiLsbR
eRsRsmmbRgRsLsmbReRsmbRgbRgbRsRsmbRsbLjbLiLsLsLsmmbLsbLsbsbsbRsbsbLsbs
bLgbRsbRjbLebLgbLgRsbRcbRhbRibRobRgRiRebRsbLsbLgbLibLibLeLsLebLiRsbLib
LcLsmbLibLcbLiLsLsLhLsRsmbLgbLgbLjLsmbRsRsmbLgbRibRsbRgbRiRsmbRgbRibRi
bLsbRiLsbRibRibRobLcbLiLsLcbLcbLcbLibLgLsLsmbLgbLgbRsLsLsLsLsLgmmmbLeb
LgLsbLgbRjbLiLsbRgbLibLgLsLsmbLibLiLebLiLebLhLebLgbLebLgLsLcbLgbLcbLgb
LgbLibLgLsLsLsLsmmmbLgRsRsmbLsbLsbRjbLsbLsbsbRsbsbLsRsbLsLebRsbRsLsbLg
LsLsmbLsbLsbLiLsbLibLebLsbLeLsbLibLhbLcLsmbLcbLibLeLsbLgLsLsLsmmbLgLsL
sLgLsmbLgbLgbLgbLsLsmbLsLsLsLsmmmbLsLsLsLsmmmbLsbLsbLsbRsLsLsLsmmbsbLs
bsbLsLsLsLsmmmbRsbLsLsmbRsLsbLgLsbRsLsLsmbLgbRsbLebLcbLiLsbLibLsLebLgb
LibLgLsbRgbRoLsbRhRiRibLjLsLimbLebLgLsbLibLgbRsbLgbLsRsbLgbLgbLsRsbLib
LgbReLsRcRibLjLeLebLibLibLgbLgLsLsmbLsbLibRsLsLsmbRsLgbLsLsLsLsmmmbLsL
sLsLsmmmbLsLsmbLgLsbLgbLsbLsRsbLsbRsLsbLsbLgbLibLiLsbLsbLeLsLebLiLsbRc
bRgbLgbLjRsLhLsbLeLsbLebLebLebLgbLgbLibLebLgbLgbLiLsbLoRsbLsbLobLobLib
RgbLgbRjbLhb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 33; Drug: PCAP2 3 然 Apo 50 然
b

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 34; Drug: PCAP2 3 然 Apo 50 然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>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 35; Drug: PCAP2 3 然 Apo 50 然
bRgbRgRsmbLsRsbRgRsmbRsbRsbRgbRsbLsRsRsmbRgRsRsmmbRgRsmbRsbRsbRgbRgbRg
RsmbRsRsmbRsbRsRsLsmbRsbRsbRgRsmbRsbRgbRsRsmbRsbRsbRjbRsbRsRsLsmbRsRsm
bRsbRsbRiRsmbLsLsmbRsbRsbRsRsmbLsbRsbRgbLsbRgbRsRsmbRsbRgLsbRgbLsbRsbR
gRsmbRgbLsRsRsRsmmbRgLsLsmbLsbRsbRgbRsbRsbRsbRgbRsRsmbRgbRgRsmbRsbLsbR
ibRobsbLsbRsbRgbRgbRsRsmbLsbRsRsmbRgRsLsmbRsRsmbRgbRobRsbRsRsRsmmbRiLs
RiRgbRiRsmbRsbRsRsReRsRsRiRsRoLsRcRcRgReReRsmmmmmbRibLgbLebLgLsbLsLsRs
mbLsbLsbsbsbRibRgbRiLsRebLeLsbLiLsLsLsmmbRsbsbLsbLhLsbRibLsbRsbLsRsRsL
sLsLsLsRsLsmmmmbLhbLcbRsRsmbRibRsLsbRgRsmbRsRgRibRebLsLsmbRobLsbRiRebR
oLsLsRgmbRcRsRsmmbRgRsRembRhRiLsLibLgbLeLsbLeLebLobRibRsbLeLsbsbRebRcR
smbRjRsRsmmbRcLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 36; Drug: PCAP2 3 然 Apo 50 然
bRsbLsLsmbRgbLsbLsbLsbLsbLsbRsLsbLsbRgLibLsbsbsbRsbLsLsmbsbLsbLsRobRib
LsbLsLsLsmmbLsbsbsbsbLsbLsLsLsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 37; Drug: PCAP2 1 然 Apo 50 然
bLsbLhLsLsmbRibLgLsbLcbLsLsmbLiLsLebLhbsbLgLsbLgLsLgLsbLgLsbLcLsmbRibL
cbRgLsRsbRsRsRsmmbsbLsbLsLsLsLsLsmmmmbsbRsbLsLsLsLsmmmbLgLsbLgLsLsLsmm
bLsbLhbLibLibLgLsLsmbLgbLsLsmbLibLcLsmbLsbLibLgLsbLsLsLsmmbRsRsmbLsRsL
sbLsRsbLibsbRsLsbRsRsmbLsLsLsLsmmmbLsLsmbRgbsbRsRsRsRsRsmmmmbRsbRsLsRs
bRsRsmbsbsbRgLsbLsLsmbRsLsRsbLhbLsLsLsmmbsbLsLsmbLhLsbRcRsRsRsRsmmmmbL
iLsRsbLsbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 38; Drug: PCAP2 1 然 Apo 50 然
bLhbsbLhbRibLhLsLsmbsbLiLsLsLsmmbLhLsLsLsLsLsmmmmbLibLsbLsbRjRsmbLsRsL
sLsLsLsLsLgLsLsLsLsLsLiLsLgLsLsLsLsLsLsmmmmmmmmmmmmmbLsbLsLsLsLsLsLsLs
LsLsLsLsLsLsLsLsLsLsLsLgLsLsLsLsLsLsLsLsmmmmmmmmmmmmmmmmmmmmmmmmbLsLib
LebLhbLibLhLsbLcbLhbLgbLibLhbLgLsRsLsbLiLsbLibLgLsLsmbLgbLibLsLsmbLgbs
bLibLgLsLsLsLsmmmbLhbLoLsmbLsbLsLsLsLsmmmbsbLjRsbLibRsbLsLsLsLsLsLsLsL
sLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmmmmmmmbLsbLiLsLsLgLsLgmbLsLsLsLsLsLsLs
LsLsLsmmmmmmmmmbLsLsLsLsLsLsLgLsLsLsLsLsLsLgLsLsLsLsmmmmmmmmmmmmmbsbLs
bLgLsbLsLsLsLsLsLsLiLsmmmmmbLeLgbLgbLsLebLiLsLsmbLgLgbLgbLiLsbLiLsbRsb
sbLsLgbLiLsbLiLgLsbLgbLiLgLsLsmbsbRibsbLhbRiLsbRsbRcbRsLsLsmbsbLsLsLsm
mbLiLgLsLsLsmmbLhbLsLsLsLsLsLsLsLsLgmmmmmmmbRsLhbLiRsbLcbLibRsLsRsLsLs
mbRjbRcbLsRibLsLsLsmmbLcbLsLsLsLsLsmmmmbLsLsLsmmbLjLsmbLsLsmbLhLsLsRsm
bRibRjbLsLsLsLsLsLsmmmmmbLjLsmbLhLsLsLsLsLsLsLsmmmmmmbRsRcRsmbRsRibRsb
LjbRcLsbLjbLcbLsLsmbLsLsLsLsmmmbLsLsLsLsLsLsLsLsLsLsLsLsLsLsLiLsmmmmmm
mmmmmmmbLsbLgRsLsbLgLsLsLsLsLsLsmmmmmbLiLsLibLgbLiLsbLgRsLsLsLsLsLsLsm
mmmmbLhLsLibLiLebLgLsLsLsLsLsLsLsmmmmmmbLgLsLsLsLsLsLsmmmmmbLgLsbLgRsb
LibLgbLiLibLsLsLsLsLsLsLsmmmmmmbLgLsLsmbRjbRjbRibsbLsLsmbLsLsmbLjbLiLs
bRjbLgRsbLhLsLsLsmmbLsLsLsLsLsLsLsLsLsLsLgLsLsmmmmmmmmmmbLcLsLsmmbLsbL
ibRibLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmmmmmbRsRsLsLsLsLsLsLsL
sLsLsLsLsLsLgLsLsLsLsmmmmmmmmmmmmmmmbLiLsLsmbRjbLsLsLsLsLsLsLsLgLsLsLs
LsLsLsLsLsmmmmmmmmmmmmmbLiLsLsLsmmbsbRsbRsLsLsLsLsLsmmmmbRjbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 39; Drug: PCAP2 1 然 Apo 50 然
bRsRsmbLsLsmbRsbRiLsLsmbRiRsmbLcLsmbRjbRcbRjRsmbRjLsbLibRsRhbRcbRobRob
RcbRobLobLebLibRjRcRsmbLsRsLsbRiRsmbRebRcLsbLgbRcRsmbRgLsbRiRcbRhRsmbR
ibLiLsbLcLsmbLiLsbRjbRiRsmbRgbLoRsbLcbRcbRibRcbLibRibRcbRjLsbLibRjRsmb
RibsbRibRgbRsLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 40; Drug: PCAP2 1 然 Apo 50 然
bRiRsmbRhLsbRsRsRsRsRsRsmmmmmbRiRsRsRsRsRsRsRsRsRsmmmmmmmmmbRjbLsRsRsR
sRsLsRsmmmbLcbLgbLibLgLsRsRsLsRsRsmmbRsRsmbsbsbsbLsLsmbLjRgbRsLsRsbReb
LebRsbRhbLobsbLsbRsRsRsRgmmbRibLgRsLsbRsRsRsRsmmmbRsbRsRsLsRsmbRsbLsRs
bLobRebLcbRgRsmbLsLsmbLgbLgbLsRsbLgLgbLgbLebLgLebLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 41; Drug: PCAP2 1 然 Apo 50 然
bRcRsmbRcbRcbRhRsmbRcbLcLsLsLsmmmbLcbLibRhbLgLsLsLsLsLsmmmmbLobLhRsbsb
RcbLjbsbLcLsmbLiLsLsLsmmbLsLcbLhLsLsmbLcLsLsLsLgmmmbLcbLcbRsRsmbReRsRs
RemmbRgbRgbRjbRgRsRsRsReRsRimmmmbRiLsbRsbRcRsmbRsbRsRsmbRiRsmbRgRgbRiR
sRgRsmmbRibRibRgRsmbRgLsbRsRsRhmbRiRsRsLsmmbLebsbLeLsLsmbRsRsmbRhbRiLs
bLhbLcbRiRsRsRsmmmbRcRsmbRcbRcbRiRsmbRcbsbRhbLibRcRgRsRsmmbRibRiRsmbRs
bRcRsmbRsRsmbRibsbRcbReRsmbRebRhbLsbRcbLcbLeLsbLsbLsLsmbLcbLcLsmbRcRgR
smbRhbRsRhRsmbRiRsmbLsbLgbRsRjbLhLsbLsbRsRsmbRcbRhbRiRsmbRobLgLsbRcRsm
bRcbLibRcbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 42; Drug: PCAP2 1 然 Apo 50 然
bRjbRibsbLsbsbsbRjbsbsbRjbLjLsLsLsLsLsmmmmmbRsbRgRsRsmmbRsbLjbLibRsRsR
smmbRsRib

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 43; Drug: Control Apo 50 然
bsbsbsbLsbRjbRiLsbsbLjLcRsbLeLsLsLgmbRjbRebRgRsmbLiLsLsLsLsmmmbLibRobR
ibRcbRiLsbRcRsRsmmbRibRibRcbRibRhbRiRsmbRgRsmbRibRobReRsmbRibRcbRgRiRs
RiRsmmbRcbLjbRcbRebRjbRhbRcbRjbLebRsLsbLsLgLsLsLsmmbRcbsbRgRsRsRsRsRsR
smmmmmmbLgbLsLsLgmbLgLsLsLsLsLsLsLgmmmmmbRjbRhbRebRcbRibRsRgRiRsRsmmbR
gbsbRebRcLsbRsbRcLsbRebLhLsLsmbLobLhbLgLsbLgbLcRsbLhbLibRsRjbRsRjbRcLs
bRebRiLsbRsbRcbRjbRcbRjbRebRcbLibLebLhbLiLcbRsbLibLhbRsLsbRjbRhbLsLsRs
mb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 44; Drug: Control Apo 50 然
bRsRgRsmbRsRsRsmmbRsRsmbLsbLsbRsRgbRgbRiRsmbLsLsmbRsRsmbRgRiRgbRgRsRsR
smmmbLsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 45; Drug: Control Apo 50 然
bRhRsmbRsRsmbRsRsmbRsbRibsbRiRsmbRgRsRsRsmmmbsbRcRsRsmmbLsLsmbRsRsmbLs
RsRsRsmmbRsRsmbRebsbsbLsRsbRsbRgRsRsmmbLsLsmbRgRsmbRjbRgbRsRsmbRgRsmbR
ebRgbsbRsbRsLsbRgRsRgmbsbRsRsRsRsRsmmmmbRhbLsLsmbLsbsbRgRsRsmmbRsbRsRg
RsmbsbRgRsmbRiRsRsRsmmmbLsLsRsRsmmbRgbRebRsbLsbRsRsRsRsLsmmmbRjRibRebR
sLsbLsRsbLjbLsRgbLcbLibLgbLgbRjbLcbLcbRsRhbRebRgbRiLsbRsbRibRibRsbRsLs
bRsbReRsmbRsbRgbRgRsmbRhbLcbLibLcbRsRsmbRcbRgRsRgmbRibRiLsbLibRcbRhb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 46; Drug: Control Apo 50 然
bLsbsbLsRsLgbLsLibLebLibLsLibLebLibLibLjLgLsbLiLgLsLiRsbLibLcbLgbLiLsb
LgbLibRsbLiLsbLibLgLsbRsbRobRoLsLibRsRsmbLsRsbLiLcbLeLsLsRsmbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 47; Drug: Control Apo 50 然
bLcbRcRsmbRibLibRebLibLcbLeRsbLobLoLsmbRsbRjbRcbLjLsmbRjRsRsmmbRcRsmbR
obRcbLibRcRsmbRibLcbLcbLibRsRsRsmmbRsRcbLcbLebLcbLcbLeLsbLibLibLcbLebL
oRsbLgbRhbRsbRcRsmbRhbRgRsmbRebRcbLgbLhbRsRoLsbRsRcRibRiLsbRgRgbRibLjb
LjLsLsmmbRcbRiRsmbRgRibLjbLebLgRsbsbRjbRsbsbLsLsmbLcbRcbRhbRibRcRsmbRo
RsmbLsRobRibRebRhbRsbRcbRibLobRcbRiRsmbLjbLiLsbLcbLebLibLebLiRsbRibReb
RibRgbRsbRcbRibRhbRsbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 121032; End: 121532;
Recording: 9-1; Individual: 48; Drug: Control Apo 50 然
bLgbLsLsmbLgLsLsLsLsLsmmmmbLsLsLsLsmmmbLsLsmbLsLsmbLsbLgLsbRgbRjbLhbLi
bLibLhbRgbLjbRjbRhbsbRsRsmbLsLibLjbLjbLjbLibLibLiLsbLcbLhbLcLibLiRsbLi
bLibLibLgbsbsbLibLsbLibLgbLsbLiRsbLgbLiRsbLgbLibRebRibLiLsbLiLsLsmbLsL
sLsmmbLsLgLsLsmbsbRsLsbRibRiRsmbRiRsmbLsLsmbLibRhbLjbLibLibLibLhbLgRsb
LgRsbLibRgbLibLsbLsbLcbRcbRebRgbRgbRsLsbLsLgLsbRsbLsbLiLibRsLsbRjbRsLs
RsbLsbLgLsLsLsLeLimmbLgLgbLsLsmbLibLgRsRsmbLgLsbLiLebLsbLgbLibLsLcbLib
LgbLebLibLgbRjbRcRsmbRibRgbLiLsbLjbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 1; Drug: PCAP2 10 然 Apo 50 然
b

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 2; Drug: PCAP2 10 然 Apo 50 然
bLsbLsbRsbRsbRgbRsRsmbLjbLcbRcRsmbLgRsbRgRsmbRibRsRsmbRgRsmbRgbRibLibR
cbLgRsRsmbRsRsRsmmbRsRsmbLsRsRsRsRsmmmbRsRsRsRsRsmmmmbRsRsmbRsRsRsRsRs
mmmmbRgRsmbRsRsRsRsmmmbRsbRibRiLgbLsbRcbRsRsRsRgmmbLsRsRsmbRsbRsRsmbRs
RsmbRsRsRsRsRsRsmmmmmbRsRsRsRsRsRgRsRsRsRsRsRimmmmmmmmmbsbRgbLsRsbRsbL
gbRiRibLgbRsLsbLsbLoLsLsmmbLebLsbRsRsRsRsRsmmmmbLiRsbRhbRcRsmbLsbRcbLs
bLsbRsRsmbLhbLobLsbRsRsRsmmbRgRsmbRiRsRsmmbRhbLsbLsRsbRgbLgRsbRgRsmbRs
RsRsRsRsmmmmbRsRsRsRgmmbsbRsRsmbRcLsbLibRcRsmbRibLsbLsRsRsmbRsRsRsRsRs
mmmmbRsRsmbRibRsRsRsmmbRgLsbRibRiRsRimbRebRgbLgbLoLsmbLibRsRsmbLsbRsLs
bLcLsmbLgLsbRsRsRsRsmmmbRsRsRsRsmmmbRgbRibLsLsmbRsRsRsmmbRsRsRsRsRgmmm
bRgRsmbRsRsRsRsRgRsmmmmbRsRsRsLsmmbRsRsRsRsmmmbRgbLsRsRsRsmmbRiRsmbLgL
sLsLsmmbLcLsmbLcbLsbLsbLsRsbLiLsbsbRsRsmbRgRgbRgRsmbRsRsRsRgRsRsRsRsmm
mmmmbRibRsRsmbRsbRhbLsbRsbRcbLgbRsRsRgRsmmbRcRibsbLsLsmbRcbLgRhbRsbRsR
sRsRsRsmmmmbRsRsmbRcbLsLsRsRsmmbRsRsmbRhbRsbRoRsmbLsLsLsmmbRcRsmbLoLsm
bLoLsmbLgbLsLsmbRcRsmbLsLsLsmmbLibLiRsbRibRsbRsbRsRsRsmmbRsRsRsmmbRibR
ibLsRsbRsRsRsmmbRiRsmbLgbRsLsbLsLsLsRsmmbRhbLsLsmbLsRsRsmbRsbRsRsRsRim
mbRsRsRsRsmmmbRgbRgbRsRsmbRsRsmbLsLsmbRcbLsLsLsLsmmmbLsRsRsmbRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 3; Drug: PCAP2 10 然 Apo 50 然
bRgRsmbRhbLgbRgbRsbRsRsRsRsmmmbRsRgbRsbRgLsbLsbsbLsbRcRsmbRiRcbRsRsRsm
mbsbRiRsRsmmbRsbRsRsmbRsRgbsbsbsbRsbLgbRsLsLsmbLjbRsbRebLsRsbLsRibRsRe
bRobLjbLsbLoRsbRcbRjRsmbsbRsLsbLgRsbLsLsLsLsLsRsmmmmbLsbRsRsmbLsbsbRgb
sbLsRsbRsbRgLsLsRsmbReRsmbsbRsRsRsRsRsLsmmmmbLsbLsbRsbLsbRsbLsbLsbRsbR
sbLsbRibLsbLsLsmbRgRsmbReb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 4; Drug: PCAP2 10 然 Apo 50 然
bRgRsmbRsbRsRsLsRsmbRobLebRgbRsbsbLsbLsRsbsbLsbRsbRsRsLsmbLsLsmbRsbsbs
bLsbsbRsbsbsbRsRsmbsbsbRsbRiRsmbsbRgRsmbRsRsmbRobRobRgbLsbRsLsbRsbRsbL
sRsRsmbRsbRgRsmbRsRsRsmmbRsRgbRibRgRsRsRsRsmmmmbRgRsmbRgbRsLsbRsbsbsbR
sRsmbRgRsRsmmbReRsmbRgRsmbLebLibLobLgbLhLsbLgLsbLoRsbRsbLsbRsbRsbRsbRs
RsmbsbsbsbsbLsbRsbLsbLsbRsbRsLsbRsRsRsRsRsmmmmbRgbRsRsRsRsRsmmmmbRgLsR
sbRgbRsRsRsRsRsmmmmbRsRsmbLsRsRsRsRgmmbRgRsRsmmbRgRgbRgbRgRgRgRibRgRsm
bRgbRgbRgRsmbLibLebLsLsmbsbRsbLsRhLsLsmbRgbRsRsRsmmbRsbRgbRsRgLsbRsRsR
sRgmmbLsRsbRgRsRsmmbRibRgRsRsRsRsmmmmbRgbRsRsmbRgbRsRgLsbRsRsRgmbRsRsR
sRgmmbRsbRsRgRsRsmmbRsRiRsmbRgRsmbRgRsRimbRgbRgRsmbRgbRsRsmbRgbRsRgRgR
gRsmbRgRgbRgbRsRsmbRsLsbsbRgbRgRsmbRgRsmbRgRsmbLsRsbRsRgRibRsRgRiLsbLs
RsbRsRgReRsmbRiRsRsmmbRgbRsbRgRsRsmmbRsRsmbRgbRsRsRsRsmmmbRsRsmbRsRgRs
mbRgbRibRibRhRsRsmmbLgbLiLsLsmbLsLsmbLiLsLsmbLiLsbLibLibLsLsmbLsLsLgLs
LgLsmbRsbLsbLgbLsRsbLsRsbLsbLsLsmbLibLgbLobRsRsRsRsRsLsmmmmbsbLeLsLsmb
RsbLoLsRsmbLsLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 5; Drug: PCAP2 10 然 Apo 50 然
bLsRsbLsbLsbLsbLsbLsbsbLsbsbLgbLgbLiLsLsmbLgbLhbLsbsbLsbLsbsbLgbLsbLgb
LsLsmbLibLibLibRsLsLsmbLgLsbLgbLgbReRibRcbRibLcbRgbLhbLgbLsLiLiLsbLgbL
gLsbLgLhLoRsbLcbLobLhbRsbLhRsbLhRsbRobRoLsbRibLgbRgbLhbLgLsbLgbLgLibsb
LibLibLgbLiLsbLgbRsbsbLgLgLsLgbLiLsLsmbLgLsLsmbLgbRebRiLsbLgRsRibRiRsR
smmbRobLgbLeLsbLibLhRsbLjbLibRhbLiRsbLibLsbLiLsbLgLiRsbLsbLgbLiLsLsLiL
smbLcbRibRhbRibRcbRjbLsLsLsmmbLgLsbLjbRsRsLsmbRsRsmbLgLsLgLgbLiLsLsLsm
mbRcLsbRgLsbLiLsbLgbLgbLcbRsbRhRgbRhbRgbLsbRhbLsRsLsbRiRsmbRibRgbRgRsR
sRimmbRsRibRgbLhbLebRsLebLgLsLsmbLgLsbLibLsLsmbLgbLsbLiLsLsmbLibLgbRsR
hRibRibRibRobRiRsmbRibRiLsbLebLibLgbsbRsbLsbsbLsLsmbLgLsbLiLsbLgbLsbLs
bLsLgLsbLiLgbLsbLibRsLsbLiLsbLsRjbRsRsmbRgbRcbRibRiLsLsRsmbRgbLgLsbLsb
RibRgbRgbRsbRsRiRibLsRgRsRsRimmbRibRsbRhbRgbRcbRhbLgbLibLobLobLgbLibLs
bRobRibRibRiLsbLsRsbLibsbLgbsbLiLsbLebLebLjRsbLgLsbLiLsLsLgmbLeRsbLgLi
LsbLgbLsLgbLibLsLgbLgbLiLsbLgLhbLoLsLsRsmmbRgbRoRsmbRibRiLsbLibRsRhRsm
bRgbRibRibRgbRibRebRibLjLgbLsLsLsLsmmmbLiLsbLibLsRsbLgbRjb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 6; Drug: PCAP2 10 然 Apo 50 然
bRsbLsbLsbLhLsbLsLsmbLsLgbRjbLebReRsmbRsbLsLsmbLibReRsmbRobLsLsmbLgbRc
bRibRibRobLeLsLsmbRsLsbLgLsLsLimbLebRgbLebRiRsRsRsmmmbRiRsmbRjbLcLsmbL
ebRjRsmbRebLsRsbLjbLsbLsbsbRcbRsRsRsRsRimmmbRgRsmbRgbRgbRgRsRimbRgbRib
LcbLcbLsbRsRsLsmbRcRsRsRhRsmmmbLsLsLsLsLsmmmmbLhbLsbLgbLiLsLsLsLsmmmbR
jbRhRsRsRgRsRsRsmmmmmbRsRhbLibRsbLcLjLsmbLibLgbRhRsmbLibLiLsbLcbRsRsmb
RsLsbRibLsbRiRsRsmmbRgbRgbRsRsmbsbLsRsRsmbLsbRjRcRsmbLsRsLsLsLsLsmmmbs
bLsbRcbRibLsLsmbLsRsbRibRcbLeLsLgbLhbLsRgRsmbRhRgbRhRsmbLsLsLsLsRsLsmm
mbLeLsbLobLobLibLcRsRsmbLsbLgbRiRsmbRsRsmbRsbLsbRiRsRsRsRsmmmmbLgbLsLs
mbLsLeLsLsmbRhbLhLsbRebRsRsmbRgbLsbRgbLsLcbRsRsRsRsRsRsRsRgmmmmmmbRsRs
mbsbRcbLiLsLgbLsbLcbLobLeLsbsbLsbLsbLsbLcbLsLsRsmbLsRsbsbLsbRsbLeLsbLe
bLcLsmbLsRsRsRsmmbsbRgbRgRsmbLsbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 7; Drug: PCAP2 3 然 Apo 50 然
bRsbRcbRsLsbsbRsbLsbLjbsbLsbLsLsmbsbRsRsRsmmbRsbLsRsbRgRsRgmbLsbLsLsmb
RsbRgbRcRsRgRsRsmmmbRobsbsbReRsmbRebRibsbLeLsbLsbLcbLebLebLcbLiLsLcbLc
bLcLsmbLjbRgbRobLcLsmbLibLibLiLsbLgLsbLibLgLsbLibLeLsbLibLibLgbLgbLgbL
gbLsLsmbRsbLsLsmbLgbLsLsmbRcbRibRgbRiRgRsmbRsRsmbRibRibRsRsRembRgRsmbR
sRsRsRsRgRsRsmmmmmbRsRsmbRsRsmbRsRsRgRsmmbsbLsbLsbRsbRsRsRsRsmmmbsbRgR
smbRgbRsRsRsmmbRsRsRsmmbsbRsbRsRsmbRsbLsRsbRsLsRsRsRsRsmmmbRsRsmbRgRsm
bLsLsmbRsbLsLsmbLsbRsbLsbRsRsmbRsRsmbRsRgRsRsmmbRgRsmbLsRsRhRiRsRgmbRg
bRibRgRsmbRibRgbRsbRsbRibRsbRibLsRsbLibLcbLgbLebLsLsmbsbRgRsRsmmbRsbLe
bLhLsLsRsmbLcLsRsmbLobLibLiLsbRjbRcbRhbRsLsbRgbRcbRsRsmbRsbLcbLcbLibLi
bRhbReRsmbRhLsbRgbLsbLsbLibLsLgLgLsLsmbsbLibLsbLgLsbRsbLgRsLsLsmbsbLsL
sLsLgLgmmbLsLsmbLsLsRsLsmbRsbLsbLsLsLsmmbLgLsLsLsmmbLsLsLsLsLsLsmmmmmb
RsLsLsLsLimmbRsbLgbLsLgbLsbLsLsLsmmbLsLgbLgRsLsbLsbLsbLsLsLsmmbLsLsLsL
sRsmmmbLsbLcbLcLsmbLgbLiLgLsLsmbLiLsbLsbsbLsbLsLsmbLsLsLsmmbLsbLsbLgLs
LgbLsLsLsLsLsmmmmbLsLsLsmmbRsLsLgLsLsmbLgLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 8; Drug: PCAP2 3 然 Apo 50 然
bRobRobLibRcRsmbRsbLibReRsmbRsRsmbRebRgbRcRsmbRgbRibLsbRibLhLsbLoLsmbL
cLsLsmmbRsLgLsbRiRsmbRcbRsbRcRsmbLiLsbLcLsmbRcRsRsmmbRsbLiLsLsmbLobRhR
cbLcLsmbLcbLjbLcbLibLiLsbLeLsbsbRsRibRjRsmbRjbRcbLcbRsbRjbRiRsmbRjbRcR
sRsmmbLjbLiLsLsmbLebLcLsmbRcbLcLsmbRsRcbLeLiRsbLoLebReRsRimbRcbRgbLhbL
hbRiRsmbLcLsLsmmbLibLeLeLcbLoLsmbLibLibLcLsmbLcbLjLibLibRjRsmbRhbLiLjL
smbLcbsbRebRcRsmbRiLsLsmbLsLsLsmmbLsLsLsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 9; Drug: PCAP2 3 然 Apo 50 然
bRjbRgRgRsmbRsbRsbRsbRsRsRsRgmmbRgRsRsRsRsRsmmmmmbRgRsRsRsRsRiRemmmmbR
sRiRsRsRsmmmbRsRsRgRsRsReRgRhmmmbRgRgRsmbRsRgbLebLgRsbLsbRgbReRsRsRgmm
bLjbLcbsbRjbRibRgRgbLjbLibRsbsbRgRsmbRgRsmbLsRsLsRsbRgbRiRsmbRgbRgbRsb
LsRsbRgbRgRgRhbRgRsmbRibRibRgbLsRiRsRsmmbRgbRcRsmbRjbRjbReRsmbRebRsRsR
sRsRsRsmmmmmbRgbLjbRebRsRgbRiRsmbRiRgRgRgReRsRsRsRgmmmbLsRsbReRhRsRiRe
mbLibLiLsbsbsbRgbRgbReRibRsRsmbRgbRiRsRsmmbRiRsRiRsRiRsmmmbRgRsmbRsbRs
LsbRsbRsbRsRsmbRsRsRsmmbRsRsRsmmbRgRsRsmmbReRgRsRsmmbRgbRgRebLibLsbRcR
smbsbLsbLjbLsbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 10; Drug: PCAP2 3 然 Apo 50 然
bLsbLsbLsbLibLgLsbLsbsbsbLsLsLsmmbLsLsLsLsLsLsLsLsLsLsLsLimmmmmmmmmmbL
sRsLiRsbRsbLsbLgbLiLsLsmbLsLsLsmmbLsLgLgLsLsLgLgLeLsmbRsbLsbLsbRsRsmbL
sbLgbLsbLsbLiLgbRibLibLsLsmbRsRsmbRgbRjRsLsRsRsRsRsRsRgLsmmmmmbRsbRsRs
LsmbLsbRsbRcbLebRibRcRsmbLsbRsRsLsRsmbRsRsmbRsRgRsRsRsRsmmmmbLsbLobRjb
RcRcbLsRsbRebRibsbRcRsmbRgRsRsmmbRiLsbRebRsbRibRsbRgRsRsRsmmmbRebRibRg
RsRsmmbLibRobRibRebRibRobLgbRibLgRsbLcbLoRsbRsRgLsbRsbsbRsbRsbRsbRsbRg
bRsbRsbRebRsbRebRgRsReRembRsbReRsRsmmbRsRsmbRsLsbRsbRsRsmbRsRsRsRsmmmb
RsbRsbRiRsmbRgRgbRsbRsRsRgRsmmbRsbRgRsRsRgmmbRgbRsLsbRsbRsRsmbRsbRsRsR
gmbRsRgRgRsRsmmbRgbRgRibRgbRsRgRsRsRsRsRsLsmmmmmbRsRsRgmbRsRgRsRsRsRsR
sRsRgLsmmmmmmbRsRgRsmbRsRsRiRsmmbRsRgRgbRsRgbRsRsRgLsmbRsLsRgbRsRgbRgR
smbRgRgbRgRgbRsRsmbRsbLsRsRsRsRsRsRsmmmmmbRgbRsRsRsRsRsRsRgmmmmmbRgbRs
RgbRgRsRsRsmmmbRsRsmbRgbRgRsmbRsRsmbRsRsRgmbRgRsRsRsRiRsmmmmbRgRgRsmbR
gRgRsRembRiRsmbRiRibRiReRibRgRsRimbRebRgRgRgRhbRibRsbRgRsmbRibRgRgbRgR
sRgmbRgRsmbRsRsRgRsRiRsRgmmmbRgRsRsmmbReRsmbLsbLsLcbLebRjRsmbRjRsmbRhb
RobRebRibLsbRsbRsbRgRsRsmmbRgbRcbRjRgRsmbRiRsmbRiRsmbReRsmbRgRsmbRhbRe
bRiRsRsRsRsmmmmbRcRhbLsRsbRjbRebsbRsbRsbRiLsbLgbRsRsRsRsmmmbReRsmbRiLs
bRgbRibRsLsbRjRgbRjRsmbRibRgLsRsbRsRsmbRsbRsRgRsRsRgRsRsmmmmbRhRsmbRhb
RsRibRiRgRebRgbRgbRgRsReRsRhRsmmmbRgbRsbRebReRiRgRibRsRsmbLsbRgbRebRib
RsLsbLsRsRebRebRgRsmbRsRsRgmbRibRgRgbLsRsRibLsbRgbRibRibRibRsbRjbRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 11; Drug: PCAP2 3 然 Apo 50 然
bRsRsRsLsRsmmbRsRsmbRsRsRsmmbRgRsmbLgRsbRcbRobLoLsmbLcRjbRgbLsbLsbLibL
gbRsLsbLsLobRsLsRsbLobLcbLebLebLeLsLjbRjbRiRgbRebRsbLsbRiRsmbLcbLibLeb
LgbLibRsLibRcbRgRsmbRebRobRcReRsmbRhbRgbRcRsRhRgRsmmbReRsmbLcbLcbLobRs
bRgRebReRebRibLjbLibRcRebRebRebsbRgbLcbLibLsRsRsLsmbRsbLobLjbLgRcbRcbL
jbLibRgRsRsmmbRgRsmbRcRsmbRhRsmbRsbLhLsbLiRsbRsbRsbLibLsbLoLsmbRsbRsbL
cbLgbLgbRibRsbLobLebLiLiLsbLiLsbLgLsLebLoRsbLibRibLcbLebLebLebRjbRsbLi
RsbLsbRcbRibsbRgbRsRsmbRgRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 12; Drug: PCAP2 3 然 Apo 50 然
bsbsbsbLsbLsbLsbsbRsbsbsbRsbLsbsbLsbRsLsbRsbLsbRsbRsbsbRsLsbRsbRsbLsbL
sbRsbRsbLsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 13; Drug: PCAP2 1 然 Apo 50 然
bLiLsLsLsmmbLsLcLsmbLibLcLsLsLsmmmbLsLjbLcLsmbLjbLeLsbLibLjbLibLhbLcbL
eLibLgLsLsmbLsbsbRjbLjLsmbLcLsmbLibLhLsLsmbLcbLhRsLsLsRsmbRjRsRsRsRsRs
mmmmmbsbRjRsRsRsmmmbsbLhbLjLsmbRgRsmbsbRjbRibRsLsbRgRsRsRsRsRsmmmmmbRs
RsRiRsRsRsLsLsLgmmmmmbLebLjLsmbLiLsbRsRcbRjRiLsbRcRsmbRiLsLsmbRhRhbRsR
sRsRsRsRsmmmmmbRsbRsbRsRsRgmbsbRjRsmbRjbRcbRebRsRsRsRsLsLsmmmmbsbsbLeb
LcbRjRsRsRjRgRsRsLsmmmmbLeLsbLcbLcLsLsmmbLeLsbLoLsLsLsmmmbLiRsbRjbRcLg
LsLsmbReRsRsRsLsLsRsmmmmbRsbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 14; Drug: PCAP2 1 然 Apo 50 然
bLsbLsbLsLgbLgbLgbLgbLsbLiRsbLgbLibLibLibLgbRoLsbRibRhRsmbLsbLgbRsLiRs
LsbLsLsmbLsbRjbLeLsbLsbLhLsLsmbLgLsbLgbsbLgLsLsmbLeLgLsLsmbLgLsLgLsbLg
LsLiLgbLibLgLsbLgbLgLsbLibLiLsbLhbLhbLsbLgRsbLsbLobLcbRobRiRgbRgbRgLsb
LjbLgbLiLsbLgbLsbRsLsRsRsLsmbLsbLhbLiLsbLgbLgbRiRsmbsbLsLsRsLsmbLsLsmb
LsLsLsLsLsLsLsLsmmmmmmmbLgLsbLsbLsbRsLsbLsbRsLsLsLsLsmmmbLibLhLsbLsLgL
sLsLsLsLsmmmmbLsLsLsLsLsLsmmmmmbRsbLsLsLsLsLsLsmmmmmbLsLgbLsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 15; Drug: PCAP2 1 然 Apo 50 然
bLgbLibLiLsbLibLsRsbLibLgLsLibLcbLiLsLgLsLsLgLgLgmbLiRsbRsRsmbRgbLebLg
bLibLsbRsRsRsRsmmmbLgbsbRsbRsbRsbRsbRsLsLsmbRiRsmbRgRsRsmmbLgbLgbLsLsm
bLsRsbRsLsLsmbLebRsbLsbLibLibLgbLcLsmbLebRgbRebRibLgbRgLsLgbLsLsLsLsmm
mbLsLeLsLsmbRgRsRsRsLsLsLsLsmmmmmmbLgLgLsLebLsbLibLgLsbLgbLgLsbLgbLgbL
sbRsLiLsLsmbLgbLgbLebLibRgbLiRsbRsLgLsLibLibLsbLibRgLsLgbLsbLgbRsbRhbL
jbRgbLsRsbLiLsLsLsmmbLsbRsbsbsbLebRiRgRsRsmmbRsRsmbRebRgRsmbLsRgbRgLsb
LsbLgbLibRjbLiLsbLsbRsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 16; Drug: PCAP2 1 然 Apo 50 然
bLsbsbLsbLsbLsRsbRsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 17; Drug: PCAP2 1 然 Apo 50 然
bLcLsmbRiRsmbsbLgbLsbsbsbRhbLcLsmbRibsbsbLsbRsRsRsmmbRsbRhRsRsmmbLgbRc
RsmbRobRcbLcbLcLsmbRsRsRsmmbLsbRjbRibsb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 18; Drug: PCAP2 1 然 Apo 50 然
bsbLsbRsRsRsmmbRgRsmbRsRsmbLsbLibsbRgRgRsRsmmbRsRsRgRgmbLjbLoRsbLibLgb
RgbRgRgRsLsmbsbRsbLjbLsRsbRjbLiRsbRiRsRsRsRsmmmmbLsbLcbLiLgbLgbsbLsbLg
RsRsmbRibRibLsbRcbLobLiRsbLibLgbLeLsLsmbLgbLgbsbLcLsmbLgLsbsbLsbRsbLhb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 19; Drug: Control Apo 50 然
bsbLsRsRsmbLsbRsbRsbRsbLsbRsbRsbsbsbsbLsbRsbRsbRsbRsbRsbRsbRsbRsbRjbRs
bRsbLiRsbsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 20; Drug: Control Apo 50 然
bLsLsLsmmbRsLsLsLsLsLsLsLsLsLsLemmmmmmmmbRsbRsbRgbRsRsmbRgbLgbRsLsbLsb
sbRgRsRsRsRsReRsmmmmmbsbRiReRsRsmmbRjbRgbRgLsbRebRhbRibRgbRgbRsbRgbLgb
LebLgLsbsbLeLebLebRhbRsbRgbRsRebRibRgbRibRgbRgbRibRgbLebLsLsLgLsLimbLs
bRsbRgbRgRsmbRibsbRgRgRsRsmmbsbsbsbsbRsRsmbLsbRsbLsbLsbsbRsbsbLsbLsbRs
bRsbsbsbsbRsRsmbRsRsmbRjbRebRgbRsRgbRgbLebLiLsbLcbLgbLgbLebRgbRcbRibLs
bRsRcbRgbRgbLsbRibLsbsbRsLsbLsLsmbRsRsmbRebRebLsbRgbsbsbsbRiRsRsRgmmbR
eRsmbRgLsbRsbLjbRsbRgbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 21; Drug: Control Apo 50 然
bsbRgRsRsRgmmbRobRgbRhbRibRiRsmbRgRsRimbRebRcbLgbRiRsRembRibRibRcRsmbR
ebRebLhbRobRibRgRsRsmmbRsRsRsRsRgRsRsRsmmmmmmbLibLgLsbLiLsLsmbLobLgbLh
bRcbRsRcbRibRiRsmbRiRsmbRgRsmbRgRsmbRobLcbLeLgLsLsRsmbsbsbsbLsLsLsLsLs
LsmmmmmbLgLsLsLsLsLgmmmbRobRebRibRhRsmbRgbRobRcbLcLgLsLgLsbLsbLgbLgbRc
bRgbRgbLsLsRsmbRsbRsRsRsRsmmmbRsRgRsLsRsRsmmbRgbLcbLgbLibLgbLibRiRcRgb
RhbRibRiRsmbRgRsmbRiRsmbRgbRgbRcbLgbRsbLsLsmbRsbRsRsmbRcbRgbRibRgRsmbR
ibRiLsLsLsmmbRcbRcbLgbRhbLsbRsbRgRgRsRsmmbsbRjRsmbRgRsmbLjbLcbLibLsLsL
smmbRjbRibRiRsRsRsmmmbRgRsmbRgbRhbRibRcbRcbRiRsmbRibLsLsLsmmbLibRhRsmb
RcbLiRsbRsbLsbRcbRgRsmbLebLcLsRsmbLgbLebLhbLebLiLsLsmbLiLeLsbLebLgbLgb
RhRcbRsRsmbRcbRibRcbLsbRjbsbsbsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 22; Drug: Control Apo 50 然
bRjbRgbLcbLcbRhbRcbRjRsmbRebRcbReLsbLgbRhbsbsbRhbRjbLibRebLhbRcbLjbRhb
LobRebRcbRcbRebLjbRcbLjbRcLsbRhRsmbRebRebRjbLibRcbLjbRhbRebRcbRcRsmbRe
bsbRhRsRsmmbReRsmbRebRcbLibRcbLibRebRcbRjRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 23; Drug: Control Apo 50 然
bLsRsbLiRsbRcbRgRsmbRgbLjbLibRjbLibsbRsbsbRgLsRsbLsRsRsRsRsRsRsmmmmmbR
ibLcbRsRcbRebRcbLgbRcbRsbRjbRebRcbLgbRsRsmbRsRsRgmbLsLsmbRibLgbRobRibL
gbRgbRiRsLsmbRobLcLsmbLebLsLibLibLjbLgbLebLcbLebLcbLibLebRjbRjbRibRsbL
sbRibLhbRcbRebRgLsbRgbRibRhbLebLibLcbLibRiRsmbRebRhbLsbRobLcbLibLibLiR
sbLcRsbLibRcbRgbRhbRsbRgbRhbRgbRibRibRibLibLhbRibLib

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 24; Drug: Control Apo 50 然
bLhbLsbLjbRiRsmbLjbLjbRcbsbLjLsmbLsbLsLsmbLjbRsbRiRsmbLsbLibRibsbRsLsb
LibRhbLjbReb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 25; Drug: PCAP2 10 然 Apo 50 然
bsbLcbLgLsbLhLsLsmbRhbLobLibLsbLcbLsLsLimbLgbRgbRebLsRsbLsLobRsRsLsmbL
ibLoLsLsmmbLsbRsbsbRsbLgbLgbLsbsbLsbsbsbsbLsbLsbLsbLsbLsbLsbRsbRsbRgbR
iLsbRsbLibRsbLibsbLcLsmbLsRsLsLgLgbLsbsbsbsbsbLsbLsLsmbLjbRibLibLgbLgb
RsbLiLsbRobLsbLhbLsbLsbRsbLebLobLiLsbRsLsbRsbLgbLsbRgbRgbLibLibLsRsbRs
RcLsbRcbRibRjRsmbRsRsmbRsbRsbRgbRsbRsbLibLgbLsbLsRsLsbLsLsLsmmbLsbLgLs
bRsbRjbRsbRibRsbRsbRsbRsRsRsmmbRsRsmbLsLjbRsbLsbLhbLsbLsbRsbLsbLsbRsbL
gbRsbRsRsmbRcbLjbRgbLsbLjbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 26; Drug: PCAP2 10 然 Apo 50 然
bRsbRgbLsbsbsbLsRsbRsRsRsmmbRobLgbLoRsbLcbRsbRhbRhRsmbLsRsRsmbRibRibRs
bRibsbsbRsRsRsmmbLsLsRsmbRcRsmbLibLcRsbLibLhRsRsmbLcLsRsmbLobLsbRiRsmb
LsLsmbLoRsbRcbRebRcRsRsRsmmmbRcbLhbRsbRebRebRebRcbLsRsbRsbLsRsbLsbRsbR
gRsmbsbRgbRiRsmbReRsmbRobLgbLibLsbsbRsbRsbRsbRsbRsbLsbLsbRsbsbsbsbsbsb
sbLsbLsbLsbLsbsbLsbRsRsmbsbsbLsRsbsbLsbsbsbRsRsmbLgbLsbRsbRgbLsbLsbsbR
ibRsbRhbsbLhbRcRsmbRebRhbRsbLeLibLeRgbRgLjbRgbLoLsmbLoRsbRjbLsLsmbLcbR
gLsbLcbRgbLgbsbsbRsbRsbLsbsbsbsbRsbLsbLibLhLsbRiRsmbLiLibRsbsbsbsbsbLe
LsbRsbLebLsLiLsbLibRjbRgbRsRsRsmmbRiRhRibRiRsRsmmbRiRsmbLobLgbLgbLgbsb
sbLebLsRsbLsLgbRsbLgLsbLgbLebLsbLsbLsbLsbLsbLsLiLsbLibLibRibRobRebLsbR
gbLebLcbLibLgbLgRsbLeRgbRobRhLsbLibLsLsmbLebLibLsLsLsmmbLsbLebLebRgbRj
bLobsbLsLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 27; Drug: PCAP2 10 然 Apo 50 然
bRhRsRsmmbLgLsbRgRsmbRibRiRsmbRibLjLsmbLebRsbLhRsRsmbRsRsmbRsbLsbLsbsb
LsRsRsmbsbRsRgLsRsbRsbLgLsbLgRsRsmbRsRsLsLsmmbRsRsRsRsmmmbLhLsbLgbLsLs
mbLsLsLsRsRsLsRsmmmbLsbsbLsLsLsmmbLgLsRsbLsRsbLsLsmbLgLsLsLsmmbRsbRsRs
mbLsbsbsbLgRsbLiLsbLsLsLsLsLsLsmmmmmbRsbLiLsbRibLgRsbLsbRsbRgbLgbLsbLi
RsbLsLsLsmmbRsbLibRjRsmbsbsbLsLsmbRiRsRsmmbLsRsRsRsmmbRsbsbRibLsRsRsmb
RsbRsbLibsbsbLiLsbLsLgRsRsRsmmbRgbsbLgbsbLsbsbsbsbsbLhbRsLsLsmbRsbLjbL
sbRsbLiRsLsbRgbLebLsRsRsmbLsbLgLsbLsLsLsmmbLsbLsbLsLiLsbRgbLiLsbLcRsbs
bLeLsLsmbRgbRcRcRsmbsbLgLsLsLsLsRsmmmbLibLgbLsLsmbLsLsRsLsLsRsmmbRsbsb
LiLsLsmbRsLsRsLsRsbLsLsLsmmbLgLsbLsRsLsLsmbLsRsbRsLsRsbLibLsLsmbLgLsRg
bRgRsRgRsmmbLsbLiRsbRcRsRsmmbLhbLiLsbLsbsbsbRsRsmbRsRsLsLsmmbLgRsRsRsm
mbRsbLsLsLsLgLsmmbRebLsbsbLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 28; Drug: PCAP2 10 然 Apo 50 然
bRcLsbRcRsmbLiRsbRgbRibsbLsRsRsmbRgbLjLgbLsLsLsmmbRjbRcRsmbLibRsRsmbsb
LsbLgLsbLsLsRsLsLsRsRsmmmbLibRibRgRiLsLsRsRsmmbRgRsLsmbLjLgRsRsRgmbLib
RcRsmbLcLsmbRsbRsRsRsmmbsbRjRsmbRiLgbLcLsLsRsRsmmmbRsbRsbLibRiRsmbLsbL
cbLgRsRsRsRsmmmbRsbRjbRgbLibsbLgRsbsbLgLsLsRsRsmmbsbsbRgRsmbRjRsRsmmbR
iLsLsmbLjbsbLgbLibRibLgbRjbRjbLjLsmbRjbRsbLjbRsbRgbLibsbsbLsLsmbsbRsRs
mbRsbLsbLsbLjRsbLsbLsLsLsmmbLjbRibsbLsLsmbLibRhbsbLsRsbsbLcLsmbLhLsLsL
smmbsbRgRsRsRsRsLsRsLsmmmmbLsbRiLsbRcbRgRsRsRgRiRsRsmmmmbRcRibRcbRobRc
LsbRhLsRsbRgRsRsRsRsRsRsRsmmmmmmmbRcbLgbLibRsbRiRsmbRsRsLsRsRgRsRsRsmm
mmb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 29; Drug: PCAP2 10 然 Apo 50 然
bRcbRcRsmbLjLsmbLsRsbsbRibRibRgRsmbLsLobRcbRgbRsRsmbRgRsRsmmbLgLsLsmbR
gbRibRcbRsRsRsRsRsmmmmbLibRiRsRsmmbRcbLsbRgRsmbRsRsRsmmbRsbRgRsmbLjbRi
bRgbRjRsmbRibLsbLgRsRgbRcRsmbRiRsmbRcbRcRsmbLsbRhbRibLsbLsRsbRibLsLsLs
RsRsmmmbRcRsmbLhbLhbsbRcbsbRsbRcbLjLibRgRiRsmbsbRgbRgRsRsmmbRsRsRsRsRs
RgmmmmbRsLsRsbRsRsRsRgRsmmmbLsbRsRgRsRsRsRsRsmmmmmbRsRsRsRsRsRsmmmmmbL
ibReRsRsLsmmbRsRsRsRsRsmmmmbRsRsmbRsbLibRhbLgbRcRsRsRimmbRhbRibRgbRcbR
sbRcRsmbRiLsbRibLgbRiRgbRgbLgRsbRsbsbRgbLsbRiRsRsmmbsbsbRsbRsbLcLcLsLs
mmbsbRsRsLsmbRcRsmbsbLcbLibRjbRibRgRiRsRgmbRgbRsbsbRsRsmbRsbRsRsmbRsRs
mbRgRsmbRsRgRsRsRsmmmbLsRgRsLsmbRsRgRsmbRsRsRsmmbRsRsRsRsmmmbRsRsRsRsR
sRsRsRsRsRsRsRsRsRsRgRsRsRsmmmmmmmmmmmmmmmmbRsRsRsRsRsRsRgRsLsRsRgmmmm
mmbRgbLjbRjbsbRcRsmbRsRsmbLsLsmbLgLsbRjbRsbLsbLgbLsbRjbLjLgLsbRsLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 30; Drug: PCAP2 10 然 Apo 50 然
bLsbLcbLcLsmbLibRgRsRsRsRsmmmmbLgbLcbLhRsbRgbLibRibReRsmbRcbLgbLsbLebR
cbRgRsmbRgbRobLibRebLjbsbLcbLiRsbLsLsmbLhbRcbLgbLhRsbRgRsmbLsbLcLsmbLe
LsbRcbRhRsmbRoLsbRobsbLebLgbLcbRibLjLcbLjLsRgmbRhbLgbRcbRcbRibRjRibRcR
smbLsLibLsbLcbLhbLiRsbRcbRhbsbLsLobLsLsmbLiRsRsmbRhbReRsmbLsbLiRsbLgbL
ebLibLsRsbLgRsbLgRsbRjbRcbRcbRibRsRhbRgbRsbReRsRsmmbRcRsmbLjbReLsbLsbR
ibRcbLgbRsLsRsbLjbLsLsLsLsLsmmmmbLcbLiLsbLobLibLhLsRsbsbLcLsLsmmbRibLj
LsmbRjRsmbLjLsLsmmbLiLcbLibLeLsbRcRsRsmmbLsLsmbLoLsmbRjbRiRsmbRibLhbLc
bRoRsRsmmbRhbLibLcbLhbLsLsRsmbRjbLcLsmbRibLebRsRsRsRsRsRsmmmmmbLsbRhbR
ebRcbLiLsLsmbLsRsbLjLiLsLsmbLgbRsRsmbLsbReRsmbRoRsRsRsmmmbsbLobLsLsmbL
iLsbRjbRsRoRsmbsbLjbRiRsmbLsbLjbLjbLibLibLsLsmbLiRsbRsbRsRsmbRiLsbRsbL
gRsRgbLcLsmbLsbLgbRcRsRsmmbRgLsLsmbRibRsLsbLsbRhbRiLsbLhLsbRcRcbRcbRsb
RhbLibLcRsbLsbLeLsLsmbRibLjbLibLcLibLgbRiRsmbRgRsmbRcLob

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 31; Drug: PCAP2 3 然 Apo 50 然
bsbLjbRobLsbRebLobRsReRgbRsRsRsRsmmmbRsRsmbRsRsmbRsbsbRsbRsRsmbRsRgLsb
RsRsRsRsmmmbRsRsRsRgRsRsmmmmbLsbLsbLsbsbLsRsbRsbRsLsbsbRsRsRsmmbLsbRgR
sLsmbLjbsbLgbLebLiLsbLhbRsbRibRebRiRsRiRembRebRsRgbLsRsLsbLsRsbRibRgbR
sbsbsbRsbRiRsmbRgbLgbRjRsRgmbRgRsRsLsmmbRhbRgbRgbRibRsbLsLsmbLsLiLsLsL
sLimmbLsbLsbLsbLsbRcRgbRgbRgbRibLsbLsLsLsmmbRjRsmbRsRsmbRsRsRsLsRsLsRs
RgRsLsRsmmmbRsRsmbRgbLsbRgbRsbRsRsmbRsRsRsRsRsRsRgRsmmmmmmbsbRsbsbRsRs
RgmbRsRsmbRgRibRsLsRsbRsRsmbRsRgRsRsRsmmmbLsRsRsRsRimmbRgRsRgmbRsLsRsR
sRsRsRsLsmmmmbRgRsRsRsRsmmmmbRgRsmbRsbRibRsRsRsLsRsRsmmmbRsRsLsLsRsmmb
LjbsbLsLibLibLibLsbsbRsRsRsRsmmmbRibRgbLsbLgLsLsLsLeLsmmbLsLsLgLsmbLsb
LsLsmbRsbLsLsLsmmbRsRgbLsbLibLsLsmbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 32; Drug: PCAP2 3 然 Apo 50 然
bLibRgbRobRibRibRhRiRiRiLsbRsbRibsbsbLsLsmbLsLsmbLsbsbLsbLsLsLgLsLsmmb
LsRsbLsbLsbLgbRsRsLsmbLibRhbRibRibRgbRgbRgbRibRsLsbLsLsRsLsmbsbRsRsRgR
sRsRsRgRsRsRsRsRsRsRsmmmmmmmmmmmbsbRsbRsbRsRsRsRsRsRsmmmmmbsbRgbLsRsbs
bRsRsmbRsbRsRsLsRsRsRsRsRsRsmmmmmmbLjbRgRsmbLeLsbRjbRebRsRibRebLobLcbL
ibLibLibLcbLsLobLjbLobLcbRcbLhbLcbLgbLjbLcbLibLibRgRibReLsLsmbRibLgbsb
LsRjbRgbRobRibRibRobLsbRiRsmbRibRibLibRsRsmbRiLsRsRsRsmmbLjRsLibRjRibR
ebRsbRsRsmbRibRsLsbRhRebRgbLibRgbLsbRgbLsLsmbLhbRjbRhbRgbRgLsRsbLgbRib
RgbLgbLhbLgLsbLsbLsLsLsmmbLsbLsLsmbLgLgLsLsLsLsmmmbRsbLsbLjLgbRibRcbLc
bLsRsbLsLsmbLsLsLsmmbLgbLsbsbLsLibRjRgRsmbLsLsLsmmbsbLgbLgbRgbLsbsbRjb
RibLibLgLgLsLsmbLsbLgbLgbLsLsLsmmbLibsbRsLsLsmbLsbLsLsmbLsLsLsmmbLsbLg
bLsLsLsLsLsmmmmbLgRsbLsLsmbsbLsRsbLsbsbLgLsLsLsmmbsbLsbLsLsmbLsLsLsLsL
sLsLsLsLsmmmmmmmmbLsbLsLsLsmmbLsLsmbLsLsmbLsLsLsLsLsLsLsLsLsRsLsRsRsmm
mmmmmmmbLsbLsLsLsLsLsmmmmbLsLsLsLsLsLsLsLsmmmmmmmbLsLsLsLsLsLsLsmmmmmm
bRsRsRsmmbLsbLsLsLsmmbLsLsmbLgLsbLsRsLsbLsLsLsLsLsmmmmbRgLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 33; Drug: PCAP2 3 然 Apo 50 然
b

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 34; Drug: PCAP2 3 然 Apo 50 然
bLsLsLsLsLsLsLsLsLgLgmmmmmmmbLsLsLsLsLsmmmmbLsLsLsLgLsLsLsmmmmbLsbLsLs
LsmmbRsLsLsLsLsLsLsLgLsLgLsmmmmmbLgLsbsbLsbLsLsLsLsLsLsLsLsmmmmmmmbLsL
sRsLsLsLsLsLsmmmmmbLsLsLsmmbRsbLsbLsLsLsLsLgLsLgLsmmmbLgRsLsLsmbLsLsLs
LsLsLsLsLsmmmmmmmbLsLgLsLsmbLsLsLsmmbRsLsbLgLsLsLsLsmmmbLsLsLsRsmmbLsL
sLsLsRsLsLsLsLsLsLsLsLsmmmmmmmmmmbsbLsLsmbRsbLsLsmbLgLsLsLsLsLsLsLsLsL
sLsLsLsLsLgLsLsmmmmmmmmmmmmmbLsLsLsLsmmmbsbLsbLsLsLgLgLsLsmmbLsLsLsLsL
sLsLsLsLsLsRsmmmmmmmmmbLsLsLsLsmmmbLsLsLsLsLgmmmbRsLsLsmbLsLsmbLgLsLsL
sLsLsLsLsLgLsLsLsRsLsmmmmmmmmbLsLsLsLsLsLsmmmmmbLsLsLsmmbLsLsRsmbLsbLs
bLsLsmbLsLsLsLsLsLsLsLgmmmmmmbLsRsLsLsLsLsLsLsmmmmmbLsbsbRsLsbLsLgLsLs
LsLsLsLsLsLsLsmmmmmmmmbLsbLsbLsLgLsLsLsLsLsLsLsLsLsRsLsLsLsLsmmmmmmmmm
mmbLsbRsbLsLsLsmmbLsLsLsLsmmmbLsbLsbsbLsLsmbLsLsLsLsLgLsLsLsLsLsLsLsLs
LsRsmmmmmmmmmmmbRsLsLsmbLsLsLsRsmmbLsLgbsbLsLsmbLsLsLsLsLsLsLsmmmmmmbL
sLsLsLsLsLsLsLsmmmmmmmbsbLsLsLsLsmmmbRsLsLsLsLsLsLsLsLsmmmmmmmbLsLsLsL
sLsLsmmmmmbLsLsLsmmbLsLsLsLsLsLsLsLsLsLsRsRsmmmmmmmmmmbsbLgLsbRsLgLsLs
LsmmbLsLsLsLsmmmbLsLsLsmmbLsbRsLsbLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsmmmm
mmmmmmmmmmmbRsLsbLsLsLsLsLsLsLsmmmmmmbLsLsLsLsmmmbLsbLsLsLsLsLsLsLsLsL
sLsLsLsLgmmmmmmmmmmmbLsLsLsLsLsRsmmmmbLsLsLsmmbLsLsmbLgLsbLsLsmbLsLsLs
LsmmmbLsRsLsLsmbLgLsLsLsmmbLsLsLsLsLsLgLsLsRsmmmmmbLsLsmbLsLsLsLsLsLsL
sLsLsmmmmmmmmbLsLsLsLsLsLiRsLsLsmmmmmbLsbLsLsLsLsRsLsLsmmmmbLsLsLsLsLs
mmmmbLgbLsbLgLsLsLsmmbLsRsLsbLsbLsLsLsLsmmmbsbLsLsmbLsLsLsLsmmmbLsLsRs
mbLsbLsRsLsLsmbsbLibLsLsmbsbsbLsLsLsmmbLsLsLsLsLsLsLsLsLsmmmmmmmmbLsLs
LsmmbLsLsmbLsLsmbLsLsLsmmbLsbRsLsbLsLsLsLsmmmbLsLsmbLsLsLsLsLsmmmmbLsL
sLsLsLsmmmmbLsLsLsmmbLsLsLsmmbLsLsmbsbsbLsLsLsLsLsLsLsLsLsLsLsLsLsmmmm
mmmmmmmmbLsLsLsLsLsLsLgLgLsLsLsmmmmmmmbLgbLsbLsLsmbLsbLsbLsbLsLsLsmmbL
sLsLsLsLsLsLsLsLsmmmmmmmmbRsLsRsLsLsLgLsmbLsLsLsLsmmmbLsbsbLsLsLsLsLsL
sRsLsLsLsLsLsLsLsmmmmmmmmmmmbLsLsLsLsmmmbRsLsLsmbLsLsmbLgLsLsmbLsLsmbL
sLsLsmmbLsLsmbLgLsLsmbLsLsLsLsLsLsmmmmmbLsLsLsLsLsLsLsRsmmmmmmbLsbRsLs
LsLsLsLsLsmmmmmbRsLsLsLgmbLsbLsRsbLsbLsLsLsmmbLsbLsLsmbLsLsLsLsmmmbLsb
LsLsmbLgLsLsLsmmbLsLsmbRsLsLsLsLsLsLsLgLsLsLsLsLsLsLsRsLsmmmmmmmmmmmbL
sbLsbLsLsmbLsbLsLsmbLsRsbLsbsbLsLsLsLsLsLsLsLsLsLsLsLsRsmmmmmmmmmmmbRs
Lsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 35; Drug: PCAP2 3 然 Apo 50 然
bRsRsmbRgRsRsRsmmmbLcbLobLibLhLibLibLgbLibLgLsLsmbLhRsbRibLcLsLsmmbRgb
RcbRsbLsbRsbRcbRcbRgLsbReRsRsmmbReRjRgbRcbRcbRsRsRsRsmmmbRgRsmbRibRsRs
RsmmbRgbRgRsRsmmbRsbLcLsLimbsbLcbLgbLeLsbLgLsbLiLsbLsLsmbLgLsbLhLsbLsb
LiLibLibLibLcLiLsLsLgmbLibLgLsbLgLsLsLsmmbLgbLiLsLsmbLgLsbLgbLgbLgbsbs
bLgRsbLsbLiLsbLibLibLcbLeLiLsbLiLsLsLimbLeLsbLhLsbLibLsbRibRhbLgRsbRib
RgbRgbRgbRgbRgRsmbRiRgRsRsmmbRgbRsRiLebRcRgRiReRsRimbRiRhRsReRgmbRiRsR
imbLibRcbRiRsmbRgReRebRsLgbRjbLibRsLcLgbLiLgRsbLgRsbLeLsbLsLsmbLoRsRsm
bRsbRhbLeLibRcbLsRiRsmbRcbRibRgbLcbLibLgLsbLsLsmbsbLgLsbLsLsmbLgbLcbLh
RsbLibLiLsLhLsLgLgbLgbLgLsbLgbLibsbLebLiLsbLiLiLsbLcbLeLeLhbLhLibLiLhL
gbRgbRobRiLsbRgRsmbRgRsmbRgbRgbRsLsbRgRsmbRgbReRsmbRgbRsbReRsmbRgRsmbR
ibRsRsRsRsmmmbRiRsmbRibRibRibRgbLcbLeLcbLhRsbLgbLibLgbLibLgLsLsmbLiLsb
RgbRjbRibRiRsmbRiRsmbRgRsmbRgbRgRsmbRiLsbRibRgbRgbRgbRibRgbRiRiLjbLhbL
sbLgbLgLgbLgbReLsbRiRsmbRjbRhRsmbRebLibLibLobLibRcReRsRembRgRsmbRebLcb
LibLibLsLebLibRibRhbRcbRgbLsRgbRibLebRhbRiRsmbRsRsmbRcbRsbRjbRibRsbRgb
RhbRhRsmbReRsmbRsbRcRsmbRgLsRsbRiLsbRsRsmbRiRsRsmmbRibRibRcLsRsbLsRcRi
RsRgRiRgmbRibReRgRiRgbRebReRgbRgbRgRsmbLcLgbRhbLeLsbLgbRcbRgbsbLsLcLgL
sbLeLsLsmbRibRcbRibRcbsbReRsmbRiRsmbRgbRibsbRgbRgRibRgRsmbRiRsmbRcRsmb
RhRsRsRgRsmmmbRibRiRib

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 36; Drug: PCAP2 3 然 Apo 50 然
bLsbLsLsmbLsbLsLsmbLsLsmbLsbsbLsLsmbRgbLiRsLgbLgbLibLgbLsbLgbRsbLsbLsb
LsbLgbLsbLgbLsbsbLsbLobLibLcbRsbLsbLsLsLsLgmmbLsbRsbLibLebLsbRsbsbsbsb
RsbLibLcbLcRibRsbRcbRsbRhbRebRibLiLsRsbRsRgbRjRgbRsbRsRiRsRsmmbRgRsmbR
ibRiRsmbLibRiRsmbLsLsmbRsLsbLhbLsbLgbsbLsbRgLsbLoRsbReRsmbRcbLsbRjbRsb
RgbLsbRiRsmbLsRsbRgRsmbRgLsLsmbRibLsbRhRsmbRsbRsbRhbRibRsRsmbLsbRibLsb
LgLsRsbsbRibLsbLcbRhbRiLsbRsbRibLgbLcbLcbRgbRsbLgbLcLsmbLgbLibLcbLsbRs
bLiLsLsmbLebLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 37; Drug: PCAP2 1 然 Apo 50 然
bsbLjLgLsLsmbLiLsbRjbRhRsmbRsLsRsbLjbsbRsRsRsRsRsmmmmbRsRsRsRsmmmbRsbL
sLsmbsbRsbsbRsRsmbsbsbLsLsmbRsRsmbRhbLjLsmbLgRsbRgbRcbLcLsLsmmbLgRsbRe
bRcbRhbRcbRibLsLsRsRsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 38; Drug: PCAP2 1 然 Apo 50 然
bRcLsbRsRsmbLsLgLsbLibLgLsLsLgLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmbLiLgLsLsL
sLsLsLsLsLsLsLsLgmmmmmmmmmbLibLibLsLsLsLsLsLsLsLsLgLsmmmmmmmbLiLgLsLsL
sLsLsLsLsLsLsLsLsLsLgLgmmmmmmmmmmmbLsLsLsLsLsLsLsmmmmmmbLsLsmbRsRjbRcR
sLsmbRsLsbLebLsLsLsLsLsLsLsLsmmmmmmmbLgLsbsbLsLsLsLsLgLsLsLsLsLsLsLgLs
LgLsLsmmmmmmmmmbLjLsLsLsLsLsLsLgLsLsLsLsmmmmmmmmmbRjRsmbLsLsLsLsLsLsLs
LsLsLsLsmmmmmmmmmmbsbLgbLeLsLsLsLsLsLsmmmmmbLhLsLsLsLsLsmmmmbLsLsmbsbL
sbLsLsLsmmbsbLsLsLsLsLsLsmmmmmbLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsL
sLsLimmmmmmmmmmmmmmmmmmmmbLsLsLsLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmmmbLh
LsbLsLsLgLgLsLsLsLsLsmmmmmbLiRsbLhLsLsLgLsLsLsLsmmmmbLebLibLiLsLsLsLsm
mmbLibLiLsLsLsLsLsLiLsLsLsLsmmmmmmmbsbLsLsLsLsLsLsLsLsLsmmmmmmmmbLiLsL
gLsbLiLgLsbLiLgLiLgbLgbLgLsLgbLhLsbLsLsmbLgLgLsLsmbLgLsLsLsLsLsLsLimmm
mmbLgLsLgLsLsLsLsLsLsLsLsmmmmmmmbLsbRjbLsLsmbRsLsbRiRsmbRsbLsLsLsLsRsR
sLsRsRsmmmmmbRibLjbLiLsLsLsLsLsLsLsLsLsLsLgLsLsLgLsLsLsmmmmmmmmmmmmbLi
bLsLsLsLsLsLgLgLsLgLsLsLsLemmmmmmbRsLsbLsbRjbRiRsmbRsRsRsRsRsRsRsRsmmm
mmmmbRsRsRsRsRsRsLsmmmmmbLcbLsLsLsLsLsLgLsLgLsLgLsLsmmmmmbLiLsbLiLgLsL
sLgLsLsmmbLibLgLsRsLsbLiLsLgLsLsLsLsLsLsLemmmmmbLiLibLgLgLsbLgLsLibLgL
gLsLsLhLsLsLgLsmmbLgLsLsmbLgLgLibLebLibLibLsbLgbLgLibLgbLgbLgLsLsLsLsL
sLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmmmmmmmmmmbLsbLsLsLsLsLsLsm
mmmmbLsLsLsLsLsLsLsLsLsLsLsLsLsLsLgLgLimmmmmmmmmmmmmbLgLsbLsbLsLsmbLgb
LsbLgbsbLsLsLsLsLsLsLsmmmmmmbLsLsLsLgLgLsLsRsmmmbLgLsbLgLsLsLsLsLgLsLs
LsLsLsLsLsLsLgmmmmmmmmmmbLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsL
sLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmmbL
sLsLsLsLsLsLsLgLsLsLsLsLsLsLsLsLsLgmmmmmmmmmmmmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 39; Drug: PCAP2 1 然 Apo 50 然
bRebLoRsbRcRsmbRcbsbRjbRgLsbRsLsRgRsmbRiRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 40; Drug: PCAP2 1 然 Apo 50 然
bLsRsbRsRsmbRsRsRgRgRsRsRsmmmmbRebLeLiLsbLibRgLgbLsLibRhbLcLsmbLgbRsRs
RsRsRsRgRgRgRsmmmmmbRcRsmbLsRsRsRhmbRsRsRsRsRsRsRgRsmmmmmmbsbsbRsRsRgR
embRebLsRebRebLsReRsmbRcbLjbRsbRcbRgbLjRsRsmbRgRsmbRcbRiRsRsmmbLeLsLsm
bLgLsbLgbRibLgLiLibsbLsRsbRiRsmbLsRgReRsmbRiRsRsmmbReRsmbRibRgbLsRsRsm
bLsRsRsmbRgbReRsmbsbReRsmbRgRsmbRgRsRsRsmmmbRiRsmbRgbRjLsRsbLgbRcbRsRi
RsmbRgRsRsRsmmmbsbRsRsRsRimmbLgbLsRibRhbReRsmbsbRgRsRsRsRsmmmmbRibRgRg
RsmbRibRgRgbRibRiRsmbRcbLibLibRib

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 41; Drug: PCAP2 1 然 Apo 50 然
bLhbLsbLcbRebRebRibsbRhbLgLsLsmbRcRsmbRebRgRsReReRsRsRsRsReRsmmmmmmbRg
RebReRsmbRcbsbsbRsbsbsbsbsbRsbsbsbsbsbsbsbLjbRobLsbRjbLsbLiLsLsmbLgLsb
RobLjbRjbRsbLcLsmbRoRgbRiRgRsRsRgmmbLsRsRsRsmmbRiRsRsmmbRsRsRsRsRsmmmm
bRsRgRsmbLsLsRgmbRsbRiRgbRgbRhRsRsRsmmmbRibRgReRsReRembRibRcbLcbLcbLhR
sbLcbLeLsbsbRcRsmbRoRsmbLsLsmbRgbLjLsmbLgbRcbLcLsmbRcbLiLsbRhbLcLsLsmm
bRibRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 42; Drug: PCAP2 1 然 Apo 50 然
bRgRsLsLsmmbRsRsRsRsmmmbRsbLcLsmbLgbRcRsmbRsbsbsbsbsbsbRsRsRsRsRsRsmmm
mmb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 43; Drug: Control Apo 50 然
bLibLgLsLsmbRjbRebRsRsmbRsRsRsRsRsRsRsRsmmmmmmmbsbRsRsRgRsRsRsRsRsmmmm
mmbRibRiLsbRjRsmbLhRsRsmbRiRsmbsbRsbLsLgbLsLsLsRsLsLsLsLsLsLsLsLsmmmmm
mmmmbsbsbRsbsbRsbRgLsbLsbLsRsbLjLsLhmbLgLgLsLsLsLsmmmbRjbRcbRebLcbLsLs
mbRsLsLsLsLsLsLsLsmmmmmmbLgLsLsLsLsLsLsLsLsmmmmmmmbLsbsbReb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 44; Drug: Control Apo 50 然
bLebLobRobLhbRebLobLibLobRobLgbLobLibRibRobLebRobLcbRibRobLobLobLgbLeb
LobLcbLebRcbRcbLgbRobLobRobRobRebLobRobRobRcbLebLobRobRsbRcbRebRobLebL
cbRobRibRobRhbLobRobLobLgbRibLsbLobLebLobLgbRsbLobLobLobLcbLcbLibRhbLo
bRebRobLgbRhbLibRobLobLibLebRebRebLobLgbLobLobLsbLebRobRibRjbLebLobReb
RebLcbLgbLhbRsbRgbRobLobRobLobRcbLobRebLcbLcbLcbRobRobRobLibRsbLobLebL
cbLibRsbLobRobRobLgbLcbRobRhbLobLibRebRibLibRobRobLgbRobLgbRebRobRobLe
bLcbLobRobLibRobRcbRebRcbLobRebRebLibLibLebRobLibLobLibRobLobRobLcbRcb
LobLcbLobLobLobRsbRebLobRobLobLobLcbRgbLobRobLcbLebRebRcbRibLobRebRcbR
sbLibRobRebLobLebRobRebLobLcbLibLobRcbRebRgbRebLebLobLobLebRgbLobLcbLe
bRobRobLebLobLebLebRibRobRebLobRobRhbLhbRibLebLhbRcbLobRcbRibLebLobRib
LobLobRsbLebRobRibLebLgbLebRebRebRsbRobLgbLobLobLcbLgbRobRebLobRebRebR
ebLobLebRsbLhbLcbRobRcbRebRobLobLobRebRobLebLebRsbRcbRhbRobLebRcbRgbLo
bLobRibRebLebLobRobRebRsbLcbLebRobRobRebRgbRibLobLobLibLobLibLsbRebRcb
RibRsbRsbRsbRcbRhbLobLgbRobRcbRebRebLebLgbRobLsbRobLibLebRgbRgbLgbRobR
ebRcbLobRcbLobLebRebLsbRgbLhbRobLgbRobLebRcbLobLobRobLebRibRebLcbLibRo
bRebRibLebLcbRobLobLibRcbLobRcbRobLibRgbRebLebLcbRebRebRobLebRcbLebRsb
RobLobRebLcbRibLobLibLsbRobLcbRibRobRebLebLebLebLebRgbRobRobLibRsbRibL
cbLebLobLebRobRgbLebRibRebRebRcbRobLibLebLcbRcbRsbRcbRcbLebLgbRebRgbRo
bRobRhbRcbLibLobLsbLhbRsbRcbRgbRobRebRcbRcbRobLobRibLhbLobLobRebRobReb
RhbRgbRobLebLebRgbRebLebLebRcbLgbRsbLcbLobLcbRebRibRobLcbLebRcbRobLobR
ibRebLobLcbRobRobLhbRebRcbRebRcbLebLobRobRcbLcbRcbRsbLebRobRibLebLobLo
bRobRobRebRobLobLobLibLebRobRibRebRibLgbRebLgbRobRcbLibLobLobLobLobLib
LebRcbLcbLobLcbLsbLobLebRhbLobLcbLobLibLibRibRobLebLibRebLobLobLobRobL
ibRcbLebRobRobRebRobRcbLobRibLcbLobLcbLobLobLobRgbRebLcbLebLobLgbLibLo
bLcbLebLobLobLebLobRcbLebLcbLjbLobLgbRobRcbRebRebRobRebRobRobRhbLobRsb
LcbRobLcbRhbRcbLobLobRebLcbRobLobRobLebRsbRobRobLcbLobLobLobRobLcbRobR
obRobLobRcbRebLobLcbRebRebRjbRobRobRibRebLebRobRobRibRobLobLebLobLcbRo
bRebLobLibRibLebRcbLebLibRobRebLobLibLgbLebLgbRgbLobRgbRebLobLobLebRsb
LobLobRobRobRobLcbLobRibRgbRjbLebLcbRhbRobRobLobLcbLgbRobRsbRobLgbLebL
ebRobLcbRsbRebRobRobLebLibLebRobLhbLebRebLobRibRobRgbLobRobRebRobLcbLo
bLhbLgbLgbLibRhbRobRebRobRobLgbLebRebRcbRobLcbLgbLobLebRebLhbLebLobRob
RobRebLgbLebRebLobRobLebLobRibLebRcbRibLebLebLgbRcbLcbLobLobRibLcbLhbR
ebRcbLgbRibRsbLebRibRcbRcbLobRobRibRebLobRcbRgbLcbRebRobRobLebLobLobLo
bRibLobLgbRebLgbLebRcbLobLobRobRobRebRsbRobRcbLebRebLobRibRcbLcbLebRcb
LobLgbLobLcbLcbRebLobLebRebLebRjbRobLgbLobLobRebRobLebRebLobLobLibRobR
gbLibRcbRcbLobLobRsbLobLgbRhbLebRebLobRcbLobRhbLcbRibRebLobRobRebLobLe
bRobRebRobRobLebRobLsbLobLebLebLibLobRobRcbRcbLibLsbRcbLebRobLcbLebRgb
RobLobLcbLsbRgbRobRebRobRobRebRebRcbLcbLcbLobRgbRobRcbLobRsbRcbRobLobR
ibLcbRibRgbLobLgbLcbRebRgbRebRob

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 45; Drug: Control Apo 50 然
bRibRebLsbLgbRsbsbsbReRsmbLebLcbLgRsbRebLgbRibRibRibLsbLsbRsLsbLsbRsRs
RsmmbRsRsLsmbRsLsRsRsRsRsRsRsRiLsmmmmmbRsRsRsLsRsRsLsRsLsLsRsmmmmbRgbR
sRsmbRjbLsLsmbReRsmbLsRsbRiLsRsLsLsLsRsmmbRibRgbRsbRsRsRsmmbRsbRsRsRsR
sRgmmmbRgLsRsRsRsRsRsmmmmbRgLsbRsLsbRjRsRsRsmmmbRsbLsRsRsLsRsRsmmbRgRs
RsLsLsLsmmmmbLsbRgRsRsRsRsRsRsmmmmmmbRiRsRsRsRsRsRsRsRsRsRsRsRsmmmmmmm
mmmmmbRsRsRsRsRsRgLsmmmmbsbRsRsRsRsRsmmmmbRgbRsLsLsRsRsRsRsRsRsRsRsRsR
sRsRsLsRsRsRsRsmmmmmmmmmmmmmmmbRsRsRsRsRsRsRgRsRsmmmmmmmbRgRgRsRsRsRsR
sRsRsRsRsRsRsmmmmmmmmmmmbRsbRibLebRcbRsbRsLsbRgbRsLsRsRsRsmmbRgRsRsRgR
sRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmmmmbRsRsRsRsRsRsRsRsmmmmmmmbRgRsRsRsRsR
sRsRsRsRgmmmmmmmmbRsRsRsLsRsRsRsRsmmmmmbRsbRgLsRsRsmbRgRsRsLsLsmmmbRsL
sRsRsRsRsmmmbRsRsRgRsRsRsRsRsRsmmmmmmmbRsRsRsRsRsRsRsRsRsRsRsRsRsRgRsR
gRsRsRsRsmmmmmmmmmmmmmmmmmbLsRsRsRsRsRgRsRsRsRsRsRsRgRsmmmmmmmmmmbRsbR
gbRiLsLsLsmmbLsbRsbRsRsRsRsmmmbRgbRsRsRsRsRsRsLsRgRsRsRsmmmmmmmmbRsLsb
RsRsRsmmbRgLsRsRsRsmmbRsRsRsmmbLsRsRsRsRgRsRgRsRsRsRgRsmmmmmmmbRgbRgRs
RsLsmmbRibRgRsRsmmbRsbRgLsbRsRsRsRsRsRsRsLsRsRgRsRsRsmmmmmmmmmbRgbLsbR
gRsRsRsmmmbLsbRsRsmbRgRsmbRgRsRsRsRgmmmbsbRgRsRsRiRsmmmbRgRsRgRsLsRsRs
RsmmmmbRsRsRsRsLsRsRsRsRsRsRsmmmmmmmmbRjbRsLsLsRsRsRsRsRsRsRsRsRsRsRsm
mmmmmmmmmmbLsRsRsRsRsRgmmmbsbRgRsRsRsRsRsRsmmmmmmbRsRsRsRsRsRsmmmmmbLs
RsbRsRsmbRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmbRsRsRsRsRsRsRsRsRsRsmmmmmmmm
mbRcRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 46; Drug: Control Apo 50 然
bRsRsmbLsRsbLsRsbRsbRsbRsbRsbLsRsbLsRsbRsbRsRsmbLebLgbLhbsbRoRsRsmmbsb
RsbRsRsRsLjmmbRgbRibsbRsbRsbLsRsRsRsRsRgmmmbLsRsRsRsRsRsmmmmbRsbLsbRsL
sbRsbRsRsRsmmbRgbRsbRsbRsbRibLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 47; Drug: Control Apo 50 然
bRgbsbRhbLcLsmbLhbRcbRcbRsRhbLibLhbLhbLhLsbLcbLhbRibLebLcbLgLsLsLsLsLs
mmmmbLhbLgbRhbLjLsLsmmbLsLsmbRcbRcbLhbLeLsbLibLcbLhbLsbsbLibRhbRibRsRh
bRibRcbRsLsbRjbLobLcbLcbLgbLhbRsRsmbRcbRibLibLgLgLsLsLsLsLsLsLsmmmmmmb
LebLgbLsbLibLjbLcbRcbRhRsmbRsbLcbLibRhbRhbRcbRibRsbLibLhbLiLibLsLsLsmm
bLgbLibsbLsbRcRibRgbRgbRgbRibRsRsRombLsLsmbRsbRobRibLsRsbLobLibLebLobR
obRcbRibRcbRgbLhbLibRibRibRcbLcbLibLcbRebRhRsmbLsLsmbLsRsbRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 121535; End: 122035;
Recording: 10-1; Individual: 48; Drug: Control Apo 50 然
bLiLiLsbLsLgLsLsLsLsLsLsmmmmmbLjLgLsLsmbLiLibLgbLsbLsRsbLibRjbLibsbsbs
bRsbLsbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 1; Drug: PCAP2 10 然 Apo 50 然
bRiRsmbLeLsbLiRsbLsRsRsmbLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 2; Drug: PCAP2 10 然 Apo 50 然
bRsbLiRsRgbRibRgRgbLsRsbLsRsbRsRsRsRsRsmmmmbRsRsmbRsRsRsRsRsRsRsRsRsRs
mmmmmmmmmbRgbRgbRibRsRsRsRsmmmbRsbRsLsbRiRsmbLhbRcRsmbLsRsRsmbRibLsLsL
smmbRsRsmbRsRsmbRsRsRgmbRsbRibRsRsRsRsRsmmmmbRsbRsLsLsRsmbLjbLoRsRsmbR
sbRcbRsRsRsRsRsRsRsRsRsRgRsRsmmmmmmmmmmbRgbRcbLsLsLsmmbLsLsmbRsRgRsRsR
sRsRsRsmmmmmmbRgRsmbLgRsbRsRsRsRsRsmmmmbLsRsRsRsRsRsRsRsRsRgmmmmmmmbRs
RsRsRsmmmbRsRsmbRsRsRsRsRsmmmmbRsbLsbLobRiRsmbLsRsRsRsRsRsmmmmbLjbLcbL
sLsRsRsRsRsRsRsmmmmmmbRobRiRsmbLsRsRsRsRsRsmmmmbRsRsRsmmbRsbRsRsRsRsmm
mbRibLsRsRsRsRsmmmbRgRsRsRsRsRsRsRsRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmmmm
mmmmmbRgRsRsRsRsRgmmmmbRgbRsRsRsRsmmmbRsRsmbRsRsmbRcbLsLsmbLsbLsbLsbRs
bRsRsmbRsbRsRsRsRgmmbRgbRcbLiRsbRcbRebRhRsmbRsRsRsRsRsRgmmmmbRgRsRsRsm
mmbRsRcRsmbLsbLsbRsRsRsRsRsmmmmbRjRsmbRgRsmbRgRsmbRsRsRsRsRsRgmmmmbLsR
sRsmbRgbLgRcbRsRsRsRsmmmbRgRsmbRibLsbRgRsRsRsmmmbRgbLsRsbRsRsmbRsRsmbR
sbLcbLcRsbRgRsmbRsbLsRsbReRsmbLsRsRsRsRsmmmbRsRsRsRsmmmbRgbRgRsRsmmbRi
bLgLsRsbRibLsbLsLsRsmbRsbRgRsmbRsRsmbRgRsRsRsmmmbRsRsRsmmbRsRsmbRsRsRs
RsRsRsRsmmmmmmbRgRsmbRcbLgRsRsRsmmbRebRsRsmbRsbRsRsRsRsRsRsRgRsRsmmmmm
mmbRsRsRsmmbRgbsbLsbRibRsRsRsmmbRgRsRimbRibLgbRsbRsbRsRsRsmmbRsRsmbRgR
gRibRgRsRsmmbRsbRsRgbRsbRgbLsRsbLobLcbLcbLsbLsRsRsRsRsRsmmmmbRiRsmbLsR
sRsRsRsRsRsRsRsRsRsRsRsRsRimmmmmmmmmmmmbRhbRcRsmbLgRsRsmbRibRsRsRsRsRs
mmmmbsbRsRsRsRsRsRsmmmmmbRsRsRsRsRgRgRsmmmmbRibRcRsmbLgRsbLsRsbRsRsRsR
sRsmmmmbRsRsRgmbRsbRsRsRsRsmmmbRgRsmbLsRsRsRsRsmmmbRibRgRsmbRgRsmbLgLs
RsbRibRgRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 3; Drug: PCAP2 10 然 Apo 50 然
bRsbsbRsRsmbRsbRsbLsRsbsbLsLgbLsLsmbRsRsLsLsRsmmbRsbRsbsbsbLsbRsbsbsbs
bLjbLsbsbRibLsbsbLsRgbRsbLsLsmbLsRsRsmbRsRsRsRgRsRsmmmmbLgbRjbsbRgRsmb
RgRsRsmmbRoRsmbLgbLgbsbRsRsmbRsRsmbRsLsRsbRsbRsbLgRsbLebLgbLsLsLiRsmbL
ibLsLsmbRsbLgbLiLsbsbRsbsbLibRsbLgbRsRsRsmmbLsRsRgbRsRsRgRiRsmmbsbRebL
sLsmbRsbRsbRsbLsbRsbLsbsbsbsbLjbRsbsbsbRsbLsbRsbsbsbRsbsbRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 4; Drug: PCAP2 10 然 Apo 50 然
bsbRsbLsRsbLsLgbLsRsbLebLobRgbsbRsbRsbRgRsRsRsmmmbRgRsmbRsRgbRsRgbRgLs
bRgbRsRsRsRsRsmmmmbRsRsmbRsRsRsmmbRsRsRgmbRgRsmbRsRsRsmmbRsRibRsRsmbRg
bRgbRgLsbRgbRgRgbLsRgRsmbRgRsmbRsRsRsLsmmbRibRsbLcbLgRsbLsbLhLsbLibLib
LebLibLsRsbLhLgLgLsbRsbLsbRsbLhbLcbLsRsbLsRsLsLsmbRsbsbLsbRsbsbsbLsbsb
LhLsbLiLsbLsbLiLsbLebLgbRsbRsRsmbRsbsbRsLsbsbLsbLsbLsbLsbLsLibLsRsbLsL
smbLibLgbLibRgbRsbRsbLibLcbRgbLcLsmbLgRsbLsLsmbLiLgbRsbLibRsLsbLgRsLsL
sRsmbLiLsLiLsLsmbLjLebLhLsbLgbLgLsLsmbRibRsbLsbLgbLsRsbLibLgbLgLgbLsLs
LsRsmmbLsLsmbLgLsbLgbLgbLsbLgbLsLsmbLsLsmbLsbLsLsLsLsLsLsLsmmmmmmbsbLg
bLobLeLsLsmbLibLgbLsRsbLgbRsRsmbsbLsLsLsmmbLgRobLsRsbLibRcRsLsmbRsbsbL
iLsLsmbLhLsLhbLibLsbRsLsbRsLsbLsbLsLsLsRsmmbLsLsmbLsLeLsbLsbRsRiRsRhmb
LsLsLsLsmmmbRsbsbRsRsmbRsbLsbRsbRsbRsRsmbsbsbRsRsmbRsbsbRsLsRsLsbRsRsm
bRgRgbRiLsLsmbLeLeLsLsmbLgbsbRsRsmbLibLhbLsbRsbLsbLibLsRsRsLsmbLgRsbLg
LsbLsLsmbLibLsLsmbLsLsmbsbLsRsbLiLsLsLsmmbLeLeLsLeRsbLibLiRsbLsLsmbRsb
LgbLsLsmbLsbLsLsLsmmbLgLsbRsbLgLsLsmbLgLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 5; Drug: PCAP2 10 然 Apo 50 然
bRobLibRgbRibRsbLjbLjLsmbLsLsLsmmbLsLsmbLibLgbRgbLgbLgbRgLsbLgLsbLgLiL
ibRjbRcLsbRsbRsRgbRgbRgbRibRsRsLsmbRgbLsRsbRebRibLgLsbLjLsmbRjbLsRibLe
bsbLsLsmbLiLebLhbLibLibLgbLgLsbLsLgLgbLhLsbLgbRsbRibRobRhRsRsmmbRibRiR
smbRgbRjLsbRibRsRiLsbLiLsbLhbLsLgLsbLhbLgbRcbLsRsRsmbRgbRsbRibRsRsRsRs
mmmbRiLsbRgbRsRsRsmmbRsbRsRsLsmbRibLgRsbLibLiLsbLsLgbLibLebLsLsLsLsmmm
bLeLsbLgLiLgbLsLgbRgLsbRjbLgLsbRjbLibLibLibLgbLgbRjbLiLsbLsLgbLhbLgbsb
LgbRoLsbsbLhbRgbLgLsLsLgmbLgLsLsmbLsbRjbRhbsbLgbLsbLibLgbLeLsbLgLgLgLs
bLsLebLgLgLgbRsbLhbLgLsbLeLsLsLembLiLgbLgLiLsbLgbRsbLiLsLsmbRsLsLgbLgb
RoRsmbRsbRsRsRgmbRcRsmbLsbLibRibRsbLjbLiLsLsmbLebLsLsmbRcRsmbRoRsmbLib
LebLibLhLsbsbLsLsLsLsLsLgLsLsLemmmmmbRsbLgLgLhbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 6; Drug: PCAP2 10 然 Apo 50 然
bLgLsLsmbLgLsbRsRsRsRsRsRsRsRgRsmmmmmmmbRgbLjbLebLiLsbLcbLebLhLsbLgLsL
smbLsbLsbLhbRsRiRsRgmbRebRsbRsRsRsRgmmbRiRsmbRgRsRsmmbRcRsRsmmbRgbLcbL
cbLgbLsbRsbLsbLsLsRsLgmbRibRgbLobLcbLsLsmbLsLsLsmmbLsbLcbRibReRsRsRsRs
RimmmmbRgRsmbRcbRsbLcLsmbLcbLsRsbRgRsRsRiLsmmbLgbLsbRsbRiRsmbRoRsmbLcb
LsLsLsLsmmmbLsbLebLibRsRsmbRgRgRibRobLgLsLsmbLgbLsbLcbRsbRsRsmbRgRsmbR
sRsmbRgbRhRsmbLgbLcbLobLcLsmbLebRhbRcbRsRsmbLibLcRsbLgLsLsLsLsLemmmbLi
bRcbLgRsbRgRsRsmmbRgRgRsRsRsRiRsRsmmmmmbRsbLsbRgbRgRebRsbLsRsbLsLsmbLe
LsLsRgmbRgRsmbRhbRgRsmbRcbLebLibRcbLibLcbLcLsLsmmbLsbLcLsmbLgbRjbRcbRg
bRcbLgLsbLcLsmbLcbRsbRsRsRsmmbRiRgbRobLsbLebLebLeLsLsmbRobLsbsbLsbLebL
sLsLsLsRsmmmbLsbLsLsLsmmbRsbLhbLsbLcbLcRsLsbLjbLcbLgRsbLibRcRsmbLsbRsb
RcbLsLsmbRsRsRsmmbRsbRgbsbRsbRgbRibRsbRsReRsRsRhmmbRobLcbRsbLsbRsRsRsm
mbLsLsmbLsbRsbLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 7; Drug: PCAP2 3 然 Apo 50 然
bLsbLcbLcbsbLgLsbLgRsbLsbLcbRsRcbRibRiRsmbRsRsRsmmbLsRsbRgRsmbsbLsbRsR
smbRsbRsbRsRsmbRgRsRsRsRsRsRsmmmmmmbRgbLsbRsbRgbRgbRgRsmbsbLsLeLsbLoLs
mbLebLsbLiRsLsbLsLsmbLsLsLiLsmbLgbRsbLsbRsbLsLiLsLgbLgbLsbRebsbLhbLgbL
sLgLsRsLsLsmbLcLsmbLcLsLsmmbsbLgLsLsmbLgLsbLiLsLsLsmmbLgbLgLsLsLsLgLgL
smmbLsbLebLgRsbLsbLibLibLsLsLsLsmmmbRsRsmbRsbLsRsbsbLsRsbRsRsmbsbsbLsL
ibLsbLsbLsbLcbLhbLibLsLsmbLoLsmbLibLjLgLsbLhbLgLsbLibLcbLebRibRjRsmbRg
RsRsRsmmmbRgbsbRgbRsbRcbLsRsbRjRgRsmbRibRibRibRhbRiRsLsmbLjbLhbLcLsLsm
mbLsbRgLsbLsbRgRsRsmmbRgbLjbRjRsRsmmbRiRsmbLjLsmbLebLobLgbLcbLibLgbLgb
LiRsbRjRsmbRebRiRibRgLsbRgRgbRgLsbRiLgbRgbRsbRsbRsbRgbLsRgbRsRibRsRsRg
mbRibRgRibRgRebRgbLsRsRsmbRsRsmbRgRsmbLgbRgRsRsRgRemmbRsRsRembRiRsmbRe
bRgbRhbRiRsmbRgbRibRhRsmbLgbLibLcRsbLsRsRsLsmbLgbLeLgbLgRsbLgbRjRsmbRg
bRgRsRsRsRsRsmmmmmbRsRsRsRsmmmbRgbRsRsRsRsRgmmmbRsbRgRgRsmbRsRsmbRsRib
RibRsbRgbRgbLgbRsRsRsRsmmmbRsRsRsmmbRgbRhLsbRsbRsRsmbRsRsRsmmbLsRgRsRg
mbRgRsRsmmbRsbRsbRsRsmbRsbRsRsLsmbRsRsmbRsRsmbRsRsmbRsRsRsRsRiLsmmmbLs
bRsbLsRsRgRgbRsbRsRgRsmbRgRsmbRgbRgbRsbRsRsmbsbRsbRsRsmbRsRsmbRsRsRsmm
bRgbRgbRsRsmbLsRsbsbsbLsbRsLsbRsRsRsRsmmmbRsLsbRsRgbRsRsRsRsmmmbRsRsRg
mbRsRsRsRsmmmbRsRsRsRsRsRsRsmmmmmmbsbRgbRsRsRsRsRsRsmmmmmbRsbLsRsRsRsR
sRsmmmmbRsbRsRsRsRsRsRsmmmmmbsbRsRsmbRsbLsbLsbLsRsbRsRsRsRsRsRsRsmmmmm
mbRsRsRsRsmmmbRsRsRsmmbRsRsmbRsRsRsmmbRsRsmbsbRsRsmbRsRsmbRsbRiRsmbReR
smbRsbLsRsLsbLgbRsbLsbLsbRsbLsbRsbRsbRjbRsbRsbRsRsRsRsmmmbRsbLsbRsbRsR
smbRibRgbRgRsmbRgRsmbRgLsbRgbRsRsmbRsbRgRsmbRsRsRsRsRsmmmmbRsRsRsmmbRs
bLsbRsbRgbRsRsRsRgmmbLsRsbRsbRgRsmbRiRsRgRsRsRsmmmmbRiRsmbRsRsRsRsRgRs
RsRsRsmmmmmmmbRsRgRsRsmmbRsbRsLsbRsRsRsmmbRgbRsbRsRgbRgRgRsmbRgbLsRsbR
sRsRsRsRsRsmmmmmbRgbRsRsmbRsbRsRsRsmmbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 8; Drug: PCAP2 3 然 Apo 50 然
bRcbsbRcRsRcRsmmbLsbLibsbLjLsmbLcLsLsLsmmmbLsbLcbLobReRsRsmmbRcbRebLjL
iRsbLibRibRcRsRsmmbLjbLcbLsbsbLcLsLsmmbLebLsLcbLcbRsRsmbRcRsmbRiLsRsbR
cRsRsmmbRcbRibRcbRjbLeLsbRsRsmbLcbsbLebLjbLgLsbLcLsLjmbLgbRjbRgRsmbRgb
RcbRcRsRsmmbRebRcbRibRebLibLgbLcbRsRsRsRimmbLcbRgbRsRcbLobRibRibRsbRsR
sRsmmbLcbRibsbRibRsRjbLiLsLsmbLeLsbLiLsbLcbLcbLgbLgbLibLjbRgRobLgRsbLg
bLcLsmbLsbLgbLsLsmbLcbRhLsbRoRsmbRgRgRsRsmmbLiLsbLhbLcbsbLebLgbLiLsLgL
sLsLsLsRsRsRsmmmmmbRebLoLsmbReRcRsmbRebLgbRcRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 9; Drug: PCAP2 3 然 Apo 50 然
bRiLsbRebRgRsmbRsReRiRsmbRgRsRsRsRgmmmbRgRgbRsRsmbRsRgbRebRgbRibRsRgbR
sRsmbRgRsRsmmbReRsmbRjbRebRhbReRsmbRsRsmbRobRibLibLgbLsbReRgRsRimbRgRs
mbRgbRgbRsbRebRcbRsLcbRcRsmbRebRiRsmbLibLcLgbLsRsLsbRjRsmbRiRsmbLjbRsR
ebRgbRibRgbRsRgbRgRiRgbRgRgbRiRsmbLsRsbsbRibRgbRsbRebRobRsbRsbLsbRgbRg
bRgbRsbRsbRebReRsmbRiRsmbLibLcbRebRiRsmbReRsmbRiRibReRsRsmmbLsbRgRsRsm
mbLgbRsRsLsmbRibRebRebRebRgRsRsmmbRiRsRsmmbRsRsmbRsbRgbRsbRgbRsbRsbRgb
Rsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 10; Drug: PCAP2 3 然 Apo 50 然
bRibLgRgbRibRhbRiRsRsmmbRsbRibRiRsRgRsmmbRhbRebRibLsbLgbLibLibLjbLsLsL
smmbRibRjLsbRsbRsRgRiRsRiRsRimmbRgRebRgbRhbRsbRhbRcRsmbRsbRsRsmbRgbReb
RiRgbRiReRgLsbReRsmbRgRibRebRgbRgbRgReLsbRgbLsRsRsmbRsRsmbRsRsRembRsRs
mbRgbRsbRsRgRsRembLsbLhbRibRibLgbLibRsRsmbRsbLgbRsbRebRsRsReRsReRgRsmm
mbRgbLgRsRsRsRsRgRsRgRsmmmmmbRsbRsRsRsRhmmbLsRsRebLsbRgbRgRsmbRebRibRs
bRsRsmbRsbRsbRgRsRgRsRsRgRsRsRsmmmmmmbLcbLobLhbLiLsbRjRibReRsRsmmbRiRs
RsmmbRsRsRsRsRsRsmmmmmbRgRsRsmmbRsRsRsmmbRibRsbRsRsRsRsRsRgRsRiRsRsRsR
sRsRsmmmmmmmmmmmbRsRsmbRsRhRibRsRsRsRsRsRsRsLsRgRsRsRsRsmmmmmmmmmmbRsR
sRgRsmmbReRsmbRsRsRsRsRsRemmmmbRsRsmbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 11; Drug: PCAP2 3 然 Apo 50 然
bsbRsRsmbRsRsmbsbLsRsbRgRsmbRgRsmbRgbRcbRibRsLsbsbsbRsbRsLsbLsRsbRsbRg
bRsbLsbRsRsmbRsbRgbRobsbLjLsmbRjbRjbRsbRgRsmbRsRsRsRsRsRsRsmmmmmmbRsbR
sRsmbRsbRsRsmbRsRsmbRsLsbRsbRsRsmbLsbRsbRcbReRebRsRsRsmmbLsRsRsmbRsbsb
RsbRsbRsLsbLsbRsbRsbLsbLsLsmbRgbLgRsbRsRsmbRsRsRsmmbLcbLjbLhbRsRsmbLob
LibRgbsbLsbsbLsRsbRsbRsLsbRsLsbRsbRsRsmbsbLsbLsLsRsLsLsmmbLgLsbRsbLibR
jbLsRsbRsRsmbRsbsbRsbRsRsmbLsRsbRsRsRsmmbRsRsmbRgbRgbRsbRsRgbLobLsbLib
LgbLgbLoRsRsmbRgbRiRsmbRgbRsRsRsmmbLsbLsRsbRsbRsRsmbRsbRsbRsbRsRsmbRsb
LsRgbRsRsmbRsbRsLsbRsRsRsRsmmmbLsRsRsRsLsLsmmmbRsRgLsbRgRsmbRgRibRibLi
bRsRsmbRgbRsbRgRsLsmbRsRsRsmmbRgRsRgmbRsRsmbRgLsRsbRsRgbRsbRsbRgbRsbsb
RsRsmbRsRsmbRsRsmbRsbRsRsmbLsRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 12; Drug: PCAP2 3 然 Apo 50 然
bRsbLobLsbLgLsbLgLsbLsLsLsmmbRsRsmbRsbLsbsbsbLsLsmbLsbLsbLsbLsbLgbLsbL
gbLgbLsLsmbLsbLsbLsbLgbLgbLgbLgbLsbLsbLsbLsLsmbLsRsbLsbLsLsRsmbLsLsmbL
sLsLsLsLsmmmmbLsbRsbLsLsmbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 13; Drug: PCAP2 1 然 Apo 50 然
bRjbRhbRgbRjRgbRcbRiRsRgRsRimmbRibsbsbLsbsbsbsbsbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 14; Drug: PCAP2 1 然 Apo 50 然
bRsRsRsRsRsRsRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmmmmmmmbLsbRsRsLsRsmbRsRsR
sRsRsRsRsmmmmmmbRsRsRsRsRsmmmmbRsRsRsRsRsRsRsmmmmmmbLsbRsRsRgmbRsRsRgR
gRembRsRsRsRsRsmmmmbRsRsRsRsRsRsRsRsRsRsmmmmmmmmmbLgbRsLsbLiLsLsmbLsLs
mbLsLsmbLsbLsbLsLsmbRhRsRsRgRsmmmbLsRgbsbsbLsLsmbLsbRsLsLsLsmmbRsbsbsb
LsbsbLsLsmbLsRsLsLsmbLsbRsRsmbRsbRsRsRsRsRsRgRsLsRgRsRsRsRsRsmmmmmmmmm
mbRgRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 15; Drug: PCAP2 1 然 Apo 50 然
bRsRsmbRsRsmbRibRiRsRgRgRsRgRsmmmbRgbRebLiLsLsmbRsbLibLsbRsbLsLsmbLsbL
sbLsbLgLsbLhbLiLgLsbLsLebLibLibLibLhbRgLsbLgbLsLgbLsLsmbLgbRgbsbLebLsL
sLembLgbLibLsLsmbLsbsbsbRsbLsLsLgLsLsmmbLebLeLeLgbLgbLcbLgbLiLsLsmbLib
LgLgbLgbLebLgLsbLsbLsLgbLhbRibRsbLjbLgbLibLebLgLsLebLhbLgbLebLhLsbLiLs
bLibLibLebLibLgbLsbLgbLsbRsbLebLebLibLeRsbsbsbsbLsbLiLgLsbLsLiLsbLibLg
LsLsmbLsbLhLebLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 16; Drug: PCAP2 1 然 Apo 50 然
bsbsbLsbsbsbsbsbRsbRsbsbLsbsbsbLsbsbsbsbsbsbsbsbsbLsbsbLsbsbsbsbLsbsbL
sRsbsbRsbsbsbsbsbsbsbsbsbLsRsbRsbRsbRsbRsbRsbsbLsbsbsbsbLsbRsLsRsbLsbR
sLsLsmbsbLsLsRsmbLsRsbLsRsbsbLsbsbRsbsbRsbRsbsbLsbLsbsbsbsbsbsbRsRsmbL
sLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 17; Drug: PCAP2 1 然 Apo 50 然
bsbsbLebRibLeLsbLcbRcbRcLsLsmbLcLsLsmmbRobRcbLsbLsbLsbRsbRiRsRsRsRsmmm
mbLebRcbRgbsbLcbRcbLhbRoRsmbLcLsmbLebLjbLebLibRcbRcLsbsbRobRobsbLcLsLs
mmbRsRhbLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 18; Drug: PCAP2 1 然 Apo 50 然
bRibLgbLgLsbRsbRsbRsLjbRibsbLjbLhbRgLsbLcLsmbLgRsbLebLsLsmbLgbLoLsmbLi
bLjbLibLibRsbRcbLgRsRsmbRgbRibRsbLsbLsbLsRsbLsbLsRsbsbLsbLgLsLsRsmbLiR
sbRebLcbLiLsLsmbLgbLobRibLcbLiLsbLhbLgRsRgbLibLobLgbLgbLsLsLsmmbLjLsLs
mmbLsRsbLhbLhLsbRibRibLgLsbRiRsmbRibLgRsbLgbRsbRsRgbRgRsLsRsmbLsbRibRi
bLjbLobLiLsbLgRsRgbLhbLgbLgLsbLsbLsbLgLsLsmbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 19; Drug: Control Apo 50 然
bLsbLsRsbsbsbsbRjbRsRoLsbRjbRsbsbsbRebLjbLsbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 20; Drug: Control Apo 50 然
bRibLcbLgbRsbLsbRsbLeRsbLobLgbRsbLebLobRibRsbRsRsmbRgbRsbRcbRsbLgbsbLi
bLsLsLgmbLebRibLsLgLsbsbLsLsLsLsmmmbLgbLibRsbRjbLsbRcbLsbRebLibLgLsLsL
sLemmbLgbsbRsbLsLsmbLgbLgLsbLsLebLobRcbRsbRgbRgbRgLsbRsRsmbRibRsbLsRgb
LsbRsbRsbRsRsmbLsbRsbRsbsbRcbRsbRsbLgLebLeLsbLcbLsbLsbLsbLebRebLsbRhbR
ibRibRsbLgbRgbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 21; Drug: Control Apo 50 然
bRgLsbRebRsbRgbRcRsRsRsRsRhmmmmbLgRsRsRsRsmmmbRsRibRhbLsbRhbRsLsLsLsmm
bRcbRiRsmbRsbReLgbLhbRcRsmbRcRsmbRhLsbLcbRebRibRiRsmbLsLsLsRsmmbLhbLcb
LibLibRgRsRsLsRsmmbLibsbRjbRiRsmbRsLsbLjbReRsmbRebRgbLhbLsbLcbLsbLhbRg
RsmbRcbLoLgLgLsLsLsLsmmmbRebRibLjbsbRsbRebLsbLsbRgRsRsRsmmmbLsbLibLhbL
iLsbLebLhbLebLeLsLsLiLembLebLeLsLiLhLsbLiLiLsbLibRibRcbRhbLibRcbsbRsbs
bsbsbRibsbRgLsLsRsmbLjbLebLebRibLhbLebRsbLhLiLsbLgLsbRsbLhRsbRgRgRsmbR
hbsbsbLgbLsbLcbRsbRobRibRiRsmbRibRibRsRsmbRibRsbRibLsbLsbRcbRhbsbRsRsm
b

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 22; Drug: Control Apo 50 然
bLjbLgRsbRcbRebLoRsbLoRsbLcbLhbRgbRcbRibRiRsmbRiRsmbRiRsmbRibRibLgbLeL
sbLhbLiLsbLibLiLsbRcbRibRgbRgRsmbLsbLjLsmbLsbLsLsRsmbLibRibRgbRjRsmbRg
bLcbRcbRibLsbRiRsmbLcLsmbLibLcbLibLsbLcLsmbLobRgbRhbReLsbLgbLiLsbLgRsb
LibLhbLcbLibLiLsbLgbLhbLiLibLgLsbLibLibLiLsbLibLibLhbsbLgbLsbLgbsbLsbL
ibRcbLcbLibLobLibsbLsbsbLjLibRjb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 23; Drug: Control Apo 50 然
bRjbLsbRcbLhbLibLgRsbRjbRhbRsbRsRsRsRsmmmbRgRgbRsbRhbRgbRsbRsbLibRsRsm
bRsbRibLsbRsRsmbRibLsbRgbsbLgbRiRsmbLsbRsbRebLebLobLebRgbsbLsbsbsbsbsb
LsbRsbRsbsbsbRsRsRsmmbsbRsRsmbLsbRcbsbLsbLcbLibLcbLgbLibRsRsmbRcbLjLsm
bRcbRiRsmbRibLsbRebLsbRibLsbRcbLcbLibLgLebRibLgLsbLhbRcbRgbRgbRhbLcbsb
sbsbRibLibLsbLgbLgbsbLsLsRsmbRjbLebLsbRcbRgbLsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 24; Drug: Control Apo 50 然
bLsLsmbLgbRebLjLsLsmmbLjbRebLibsbLibLjbRjbRcbLjbLsRsbRiRsmbLjbLhLsbLcL
sLsmmbLcbLibLhbLsbsbRcbLgbsbsbRibLibRhRsRsmmbLsbRibLibLgbLsLsRsRsRsmmm
bLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 25; Drug: PCAP2 10 然 Apo 50 然
bLsLsLsmmbLsLgbRsLsLsmbLsbsbLsbLsbLsLsmbLsbLsbRsLsbLsLsmbRsbRsbRgRsmbR
sbRsRsmbRsbRsbLgbLsbRsbRjbLcLsmbLsbLhbLsbLsbRsbLebLgRsbLsRsbLgbRsbRebR
gbLiRsbLjbRoLsbLibLsLsmbLsbRsLsRsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 26; Drug: PCAP2 10 然 Apo 50 然
bLgbLgbLibRgbLsbsbLgbRsbsbLgbRjbLsbRsbLibRsLsLsLsmmbLsLsmbsbRjbLhbRsbL
gbLgbLebLebLsbLgbLgbRsbLsbLsbsbsbsbsbsbLsbLebLsbLibLgbLibLibLgLsbLiLsb
RjbLsbLhLgbLgLsbLsLsmbLibRsbLgbLgbLsLsmbRsbLsbLgbLibLibLebRibRsbLsbLsL
ebLoLibRebRobRsbRgbRgRsmbLjbRsbRsRgbRgbRibRsbLsbRsbRsbRsbRsbLgbLjbRsbL
sbLjbLsbsbRsbRsRibRgReRsmbReRibRgLsbRgbRsbLoRsbLobLobRjbLsLobLibLiRsLs
LsmbLsLsLgmbRsbLibLibLgbLgLsbRsLgbRsLsRgbLgbRgbLgbLsRgbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 27; Drug: PCAP2 10 然 Apo 50 然
bsbsbsbLgLsbLsbRsbLgbRsLsbLsLsLsLsLsmmmmbLsRsRsRsmmbLiLsbLsLsRsRsLsmmb
RsLsbLgbLsLsLsmmbLsLsLsLsmmmbLsRsbLibRjRjbRjbsbLsbLsLsmbsbsbLsLsLsmmbR
sRsmbRsbsbLjLsLsLsLsmmmmbRgbRsRsLsRsLsmbLsLsmbLsbLiLsRsRsLsmbLiLsLsLsm
mbLsLsLsLsLsLsmmmmmbLsLsLsRsmmbLsbLsRsbLsbsbRsbLgbLeLsbRgRsmbRjbRcRsmb
LeLsbLiLsLsmbsbLsLhLsLsmbRebLcLsLsLsLsLsRgLsmmmmmbsbLgLsLsLsLsLsmmmmbL
gLsRsbRsbLsLsLsLsLsLemmmmbLsRsRsLsLsmmbLgRsbLgRsbLiLsLsmbRgRsmbRsbLiLs
LsmbLgLsbLsLsLsLsLsLsLsLsLsLsRsmmmmmmmmmbLsLsmbLibLgLsbLsLsmbsbLsLcbRs
RsRsRsRsmmmmbLebRjbRcRsmbsbLebLiLsLsmbRsRsmbLiLsRsLsbRsRgbRgbLhbLsLsmb
RcbRsRsmbRsbRsRsRsmmbRsRsmbLjbRsRsRsLsmmbLsRsRsRsRsRsmmmmbRsRsRsmmbLsL
sLsmmbRjRsRsRsmmmbRsRsRsRsRsmmmmbRsLsbLgRsRsmbLsRsRsmbRsRsmbLsRsRsRsmm
bRsbRsRsRsRsRsRsRsRsmmmmmmmbLgRsbRsbRgRsRsRsRsRsRsRsRsmmmmmmmmbLsRsRsR
sRsRsRsRgRsRsRsRsRsRsRsRgmmmmmmmmmmmmbRsbRsbRsRsRsmmbRsRsLsmbRsRsmbRsR
sRsRsRsmmmmbRsRsRsmmbRgRsmbsbsbLsbLibRiRsRsRsmmmbLhLsbLsLsLsmmbRsRsRsR
sRsRsmmmmmbRsRsRsRsmmmbLsRsbRsRgRsmbRsRsLsLsmmbRsbLeLsLsmbRjbLiLsbRgRs
mbsbRgbRsRsRsmmbRgbRsRsRsRsmmmbRgRsRsRsmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 28; Drug: PCAP2 10 然 Apo 50 然
bRiRsRsmmbLgbRcRsmbRsRgRsmbRsLjLebLiRsbLiLsbsbRsLsRsRsLsLsmmbRcbLiRsbR
jLsbRibRgbRiRsRsRgRsRsRsRgRgRsRsRsmmmmmmmmbRiRsmbRgRsRsRsRhmmmbRiRsmbR
gbLsLsRsRgLsmbRgRsmbRsRsRsRgRsRsRsRsRsRsRsLsRsRsmmmmmmmmmmbRcRsmbRgRsR
sRsRsmmmmbRhRsRsRgRsRsLsRgRsLgmmmmmbRiRsLsRsRgRsmmbLsbRibLsRsLsRsRsRiR
gmbRcbRgbLcbLsbLsLsmbLsLsmbLgLsbRsbRiRsmbRsRsRsRgRhmmbLsbRiRobLgLsbLsL
sRsRsRgmmbRebRgbLsbLjbRsRiRsRsmmbLjbRsbRsbRiRsmbRiRsRsRsRsRsmmmmmbLgLs
bLiRsbLjbLjbRsRiRsRgRsRsLsLsReRsmmmmmbLjbRsRsRsRsRgRgRiRsmmmmbLsbLgbLs
bRsReRsRsmmbRgRsRsmmbLsbLjbRsRsmbRsRsRsLsLsRimmmbLsLsmbsbsbRgbRsbsbsbs
bLjbRsRsmbRgRsRiRiRsmmbRsRiRsmbLhRsbLjbsbLjbRsRsRsRsRsRgLsmmmmbsbRjbRs
RsmbLibReLsbRsRsRgRimbsbRgRsRsmmbRsbLjbRjbLsRsRsRiRsRgRsmmmbRcbLebLsbR
gLsLsLsmmbLsRsbLjbLsLsLsmmbsbLjLsLembLgRsRibsbLjbLgbsbsbRsbsbRsbsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 29; Drug: PCAP2 10 然 Apo 50 然
bLsLsLsLsLsLgmmmmbLsLsmbRebRibRsbRsRsRsRsRgRsRgRsRsRsRsmmmmmmmmbRsRsmb
RgbRgRsmbRsRsmbLibRcbRiLsbLcbsbRsbReRsRsRsRsRsmmmmmbRiRsmbLcbLibRjRsmb
RiRsmbLsbLsbRgbRsRsmbRsbRsRsRsRsRsmmmmbRsbRgRsmbLgRgLsbRsRsmbRgLsbLsRs
RsmbRsRsRsRsRsRsRsmmmmmmbRgbRsbRsRsRsRsRsmmmmbRsRsRsmmbRcRsmbLgLsLsLgL
sLsLsmmmbLsLsmbLsLjLgLsbRjbRhbRsRsRsRsmmmbRsRsRsRsRgRsRsmmmmmbRsRsRsRs
RsmmmmbRsRsRsmmbRsRsmbRsRsRsRsmmmbRcRsmbLsRsRsLsLsLsLhLgmmmbLhbRgLebLs
LgLsLsmbRsLsbLsLsLsLsLgmmmbLgLsLsLsLgLimmbRsbLsbLsRsbLsbsbRhbLjbLsLibs
bRsLsRsbsbLsLsmbLsbsbLsLsLsLsmmmbRibRcbsbLgbRjRibRcbLsLsLsLsmmmbRibsbR
gbLsRsbLjbRibsbRsRsmbRsRsRsRimmbLsRsRsRsRsRsRsmmmmmbRgbRgRsRsRsmmmbRsR
smbRsLsRsbRsRsRsRsRsRsRsRsRgRgmmmmmmmbRsRsmbLsRsRsmbRgbLsLsLsRsmmbRsRs
RsRsRsRsRsRsLsmmmmmmmbRgRsRsRsmmmbRgRsmbRsRsRsRsRsRsRsmmmmmmbRsbRsbLsb
RsRsRsRsmmmbLcRsbLcLsmbRsRhbRsRsRsRsRsRsRsmmmmmmbRsRsRsRsmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 30; Drug: PCAP2 10 然 Apo 50 然
bRsbLcRsbLgbLsbRsbRhRsmbRibRsbRcLsbRgbLcRsbLcbRcbLcbRsbLsLhRsbLsLsLeLs
mbRsLsbLsLsmbLiLsLsmbLebLoLsmbRsRcRsmbRibRibRobLcLsmbRcbRcbRcRsmbsbLsb
RibLjbRiRsRsmmbRsLsbLsbRsLsRsbLeLsbLebRibRibRgLsRsLsbRcbLgLsLsmbLibLhb
RgbLcbLsLsmbRhbRgbLiLibLebRsbLsbRjbLibLiLsbLcbRiRsmbRsRsRsmmbReRsmbRhR
smbLgbLjbLibRjbLcbRebRoRsmbReRsmbRcbLgbRsbLgbsbLsLsmbRsbLjbRsRsmbRsbRc
RhRsRsmmbRgRebRobRebLsbLebLsbRgbReRsmbRgRiLsbLjbLibLoLobRsRsLsLgmbLgbL
cbLibRibRebLobRcbRsLsRsbLsbRebRibRgbLgbLgbRsbLsbLibLgLsLsmbLgbRcbLiLsb
LibRcbRcbRsLsLsmbLgbRobRcbLgbRobLsLsmbLjLsmbsbLcbLgLgbLcbRiRsRsRsRsmmm
mbLjbLcRsbRcbLjbLgbRcbRsbRiRebRiLsbLjLsmbLcbRgbRjbLgRsRsmbRhRsmbRgbRsR
sLsmbLsbRsbLhbRjbRsbsbsbLjbLgLsLsLeLsmbRhLsbLjLsmbLcLsRsmbRibRiRsmbReb
LeLcbRsbLibLoLsmbLibLibLcLsLsLsmmmbRiLiLibLsRsbLsbLsRsbsbLgLsLsLsRsLsm
mbLsbLcLsmbRsbRcbRobRiRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 31; Drug: PCAP2 3 然 Apo 50 然
bsbLsbLiLsbLgbLsLoLgLsbRgbsbLsbsbLsRsLsbLsLsLsLsLsLsLsmmmmmmbLsLsLsLsL
sLsLsLsmmmmmmmbRsLsLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmbRsLsLsmbLsLsmbRsb
LsLsmbLsLsmbsbsbRsbRsRsmbsbRsbsbLsLsmbLsRsLsbLsLsLsLsLsLgLsLsmmmmmbLsL
gLsbLsbLsLsmbLgLsLgLhbLsLsmbLsLsLsLgLsLsmmmbLgLsLiLsLsmbLgbLsbsbLsLsmb
LsLsLsmmbLsLsmbsbsbLsLsLsLsRsLsLsLsLsLsmmmmmmmbLgLsbLsLsLsLsmmmbLsRsLs
bLsLsLsLsLgmmmbLsLgLsLsLgmbLsLsLiLsmbLgbLsLsLsLsmmmbLsLsmbLgbRsLsLsmbL
sLsLsLsLsLsLsLsmmmmmmmbLgLsLsRsmbLgLsLsRsLsLsLgLsmmbLsLsLsLsLsmmmmbLgb
LibLsLsLgLsLsmmbLiLgLgbLsLsmbLsLsmbLsLsLgLsLgmbLibLgbLsLgLsLgbLgLgbLib
LsLsLsmmbRsbRsbRjbRiLsRiRhbRibLsbLjbLsbLsLsLsLsLsLsLsLsLsLsLsLsmmmmmmm
mmmmbLsLsLsLsLsmmmmbLsLsmbLsbRsLsRsLsLsLsmmbLsLsLsLsLsLsLgmmmmmbLebLgL
sRsbLgLsLgLsLsmbLsLsLgLsmbLsbLsbRsbRsbLsbsbsbsbLsbLsLsmbRsbLsbLsbLsRsb
LsLsLsLsLsLsmmmmmbRsLsLsLsLgmmbLsLsLsLsmmmbRsbRsLsLsRsLsmbLsLsLsmmbsbL
gLsbRsLsLgLsLsLgmbLsLsLsLgmmbLgbsbLgbLsLsLsmmbLsbLsLsLsLsmmmbRsLsbLsLs
LsLsmmmbLsLsmbLsLsLsLsLsLsLsLsLgLsLsLsLgmmmmmmmmmbRsbLsLsLsLsmmmbLsLsL
smmbLsRsbsbLsbLgLsLsLsLsLsmmmmbLsLsLsmmbLsLsmbLsLsmbLsbLsbsbRsbLsLsmbs
bLsbsbRsLsRsLsLsLsmmbRsLsLsRsmbLsLsLsLsLsLsLsmmmmmmbLgbLgLsbRsLsLsLsLs
LsLsLsLsLsmmmmmmmmbRsLsbLsLsLsLsLsmmmmbLsbsbRsLsLsLsmmbLsLsRsmbLsLsLsL
sLsLsmmmmmbLsRsRsLsLsmmbsbsbRsbRsRsLsmbRsLsbRsLsLsmbLsbLsLsLsRsLsmmbLs
LsLsLsLsLsLsLsLsmmmmmmmmbLsLsLsLsLsmmmmbLsLsLsmmbsbRsRsLsLsLsLsLgLsmmm
mbRsLsLgLsbLgLsLsmbLsLsLgmbLsLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 32; Drug: PCAP2 3 然 Apo 50 然
bRsLsLsmbLsLsmbLsLsLsLsLsLsLsLsLsmmmmmmmmbsbLjRgbLsbLsbLsLsLsRsRsRsRsL
smmmmmbLsbLsLsLsmmbLsLsLsLsLsLsLsLgLsmmmmmmbLsLsLsmmbLsLsLsmmbLsLsLsLs
LsLsLsmmmmmmbLsbLsbLsLsLsLsLsmmmmbRsLsLsmbLsLsmbLsLsLsLsmmmbLsLsmbLsbL
sLsLsmmbRsLsbLsbLjbLsLsLsmmbLsbLsbLsLgbLsbRsLsRsLsLsLsmmbsbLsLgLsLsLsL
smmmbsbLsLsmbLsbLsbLsLsmbLsLsmbLsbLsLsLsLsLsmmmmbLgbsbRiRsmbRsRsRgLsmb
sbsbLsRsRsRgRsRsRsmmmmbLsbLsLsLsRsRsRsRsRsmmmmmmbRsRsRsRgmmbsbRsRsRsRs
RhmmmbRsRsRsRgReReRgmmbsbRcbRiLsbLcLsmbRibLcbsbRsRgRsRsRsmmmbRsRsmbLgL
sLsmbLsLsmbRsbLgRsbRsLsLsmbRsRjbRsbRjRsRsmmbLsbsbLsLsmbLsLsLsmmbLsLsLs
mmbLsLsmbLsbLgbLsLgbLgbLgbLgbLsLsLsLsmmmbsbLsbLsLsmbLsbLsbLsbLsbRsbLsb
LgLsLgbLgbLgLsRsRgLsbLsLsLsLsLsLsLsLsLgmmmmmmmbLsLsLsmmbRsLgbLsbLsbLgb
LsLsmbLgbLgbLgLsbLsbRsbRsbLsRsbLsLeLsbLsLiLsbLgbRibRsbRsLsbRsbLsbRsbLs
bRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 33; Drug: PCAP2 3 然 Apo 50 然
bLsbsbsbsbsbRsbLiLsbLsLgLsbLcLsmbLeLsLibLobLeLiLsRsbLcbLcLeLsLsmbLeLgL
sLsmbLiLsLsLeLsmbLcbLcLsLembLiLsLebLgbLcbLeLsbLebLeLibRsLsLsLsmmbLiLsL
sLsLeRsmmbLhbLebLcLsLsmmbRibRiRgbsbRcbRhLsbRiLsbRcbRiLsRsbRiRsLsmbLsbR
sRsRsRimmbRsbRibLibLibRhbRcLsbRibRgbRgRsmbRiLsLsLsmmbRcbRiLsRsRsmbRcLg
bLcLsmbLcLeLsbLcbsbRibsbsbRibLcLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 34; Drug: PCAP2 3 然 Apo 50 然
bLsbLsbsbLsbLsRsLsbRsLsbLgLsbLsbLsbRsLsLsLsmmbLsLsLsLgLsRsmmbLsLsmbLsL
smbLsbsbLsLsmbsbLsLsLsLsLsLsmmmmmbsbRsLsLsmbLsbsbLsLsLsLsmmmbLsLsmbLsL
sLsLsRsLsRsLsmmmbLsLsLsLsmmmbLsLsLsmmbLsLsmbLsLsLsLsmmmbLsLsmbLgLsLsLs
mmbLsbLsLsLsLsmmmbLsLsmbLsLsLsmmbLsbRsbLsLsmbsbLsbLsLsLsLsLsLsLsLsLsmm
mmmmmmbLsbsbLsLsLsLsLsLsmmmmmbLsLsLsmmbLsbLsLsmbRsLsbLsRsLsLsLsmmbLsLs
mbLsLsLsmmbLsbLsRsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmbLsLsmbLsLsLsmmbLsLsLsL
smmmbLsbLsLsLsLsLsLsRsmmmmmbLsRsbLsLsRsLsmbLsLsLsLsLsLsmmmmmbLsLsmbLgL
sLsmbRsLsbLsbLsbLsbsbLsLsLsmmbLsbLsLsmbRsRsmbLsbLsbLsLsLsLsmmmbLsbLsLs
LsLsLsLsLsLsLsmmmmmmmmbRsRsLsLsLsLsLsLsLsmmmmmmmbLsLsLsLgLsLsLsLsmmmmm
bLsbLsRsLsbLsLsLsLsLsmmmmbsbLsbRsRsmbLsbsbLsLsRsLsLsLsmmmbLsbLsbLsLsLs
LsmmmbLsLsLsRsmmbLsbsbLsbLsLsLsLsmmmbLsRsLsRsbLsLsLsLsLsLsLsmmmmmmbLsb
RsRsRsmmbRsbRsbRsRsRsRsRsRsRsmmmmmmbRsRsRsRsRsRsRsmmmmmmbRsRsRsRsRsRsR
sRsRsRsmmmmmmmmmbsbRsbRsbRsRsRsRsRsRsmmmmmbRsbLsRsRsRsRsRgRsRsRgRsRsRs
mmmmmmmmbRsRgRgRsRsmmbRsRsRsRsRgRsRsRsRsRsRsRsRsRgRgRsRsRsRsRsmmmmmmmm
mmmmmmmmbRgRsRsRsRsRsmmmmmbRsbRsRsRsRsRsRsRsmmmmmmbRsRsRsRsRsmmmmbRsRs
mbRsbRsRsRsRsRsmmmmbRsRsRsRsRsmmmmbLsRsRsRsmmbLsRsRsmbRsbsbLsbRsRsmbsb
RsbRgRsmbLsbRsLsbRsRsRsRsmmmbRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmbRsbRsRsR
sRsmmmbLsRsRsRsmmbLsbLsRsRsRsRsRsmmmmbRsRsmbRsbRsbRsbRsbsbRsRsRsRsRsRs
mmmmmbRsbsbLsbRsbRsbRsLsbLsRsbRsRsRsRsRsmmmmbRsRsRsmmbRsRgRsmbLsRsRsRs
RsRsmmmmbRsRsmbRsRsRsRsRsRsRsmmmmmmbRsRsRsRsRsmmmmbRsbRsRsmbRsbRsRsRsR
sRsRsRsRsRsRsRsRsmmmmmmmmmmmbRsRsRsmmbRsRsmbRsRgRsRsRsLsmmmbRsRsmbRsbR
sRgRsRsmmbRsbRsRsmbRsbRgRsRsRsmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 35; Drug: PCAP2 3 然 Apo 50 然
bLgbLiLibRcbLhLsbRibRebRcRsmbRiRgLsbRcbRiLgbLcLeLgLhLsbReRsRiRiRgmbRiL
gbReRsmbRoLsLsmbRcbsbLsbLibsbLsbRsbsbRsLsRsLsbLsRsLsRsbRsbLsbLsbsbLeLs
bRcbsbRsbLsbsbRsbLeRgbRgbRhbRoRsRsmmbRhbRcbsbRiLsbRgbRsRsRsRsmmmbRgRsR
gmbRgRsRgRsmmbRiLsLsmbReRsmbRcbRcbRsLsbRsRgbRgRsmbRgRsRsmmbRsbReRsmbLo
LsmbsbRjbRiRsmbRibRcbRcbRebRgRiRgRsmbRgRsmbRgbRsRhLsbRcRsRsmmbRjRhbRgL
sbRibRcbRsRebRebRgbRcRsRiRsRiRsRsRgmmmmbLsbRiRsmbRcbsbRiRsmbLsbLsbRcRs
mbRcbRhbRobsbRhbRsRibRgLsbRgRsRsRsRsRsmmmmmbRjLsRgRsmbRibRhRsmbRiRsmbR
gRsmbsbRiRsmbRiRgbRibLcLsmbLhbLeRsLsbRgRsmbRibRibRoLsbRgbRsbLsbRjbLsLs
LsRsmmbRibRgbRgbRebRiLsbLcbRcbsbLgbsbRjbsbLeLsRsbLiLiLeLsbRjbsbLhbLsRs
bsbsbsbRjbRjRsRsmmbRhRsmbsbRjRiRgbRcLsbRiRgbRhLsRsbRgRcbRiLsbRjRibRibR
hbRiLsbRiRibRiRiRgRsRsRsmmmbRibRhbRiReRiLsbLibRhbRgRsRiReRsmmbRibRgRsm
bRibRgbLsbLcLiLibLgbLgbRibRibRiRsmbRibRgRsLsmbLsbRsbRsRsRsmmbRgRgbRsRs
mbLcLsmbLeLsbRsbLgLsbLsLsLsmmbLjbRjbsbRiRsmbLjbRjbRibRibLeLsbLsLsmbLgL
sLsLsRsmmbRjbLsLsmbsbReRsmbLebLcLcbLiLgbLibLsbLgbsbLebLib

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 36; Drug: PCAP2 3 然 Apo 50 然
bRibLsbRsbRibLibLsbLibLiRsbLibLgbRsRsmbLsRsbLsbRsbLsbRsbLsbRsbRsbRsbsb
LsLsLsmmbsbsbsbsbsbsbsbsbRsbRgbRiRsmbRjRsRgRsRsmmmbRiRsmbLsbRgbLibLsRs
LsbsbsbsbsbRsbRsbLsLsmbsbLsRsbRsbLsRsbsbRsbLsbRsbLsbRsbLsRsLsbLsLsLsRs
RsLsmmmbLsLsRsmbRsbRsbsbLsbRsbLsLsLsmmbLsLsRsLsRsLsRsRsmmbsbsbLsbRsRsR
smmbLsRsbLsLsRsRsLsmmbsbLsLsRsLsRsLsLsmmbLsRsbRsLsRsLsRsbRsbRsLsbLsbLs
LsRsmbLsbLsbRsbLsbRsLsRsbLsbLsRsbLsbRsbLsbLgbLsbRgRsmbRhbRsbRsbRsbRsbR
sbLjbRsbLsbsbRgbRsbLsbRsbLsRjbsbRsbLgRsbsbRsRibRgbsbRsRsmbRiRgbRgRsRsR
sRsmmmmbRgbRsbRebRibsbRebRgRibRibRgbRgbRjbRebLeRsbLgbLhLgbLebLebLsbLgL
sLsmbRjbRebRsRgbRibLgLgbLsbRsbLjbRibRjRsRsmmbRgRsmbRsbRsRsRsRsRgmmmbRs
bRsbLsbRsbRgRibLsbLjbsbRgbLjbLsRsbRsbsbRsLsbsbRsbsbsbsbRjbsbsbsbRsRsmb
Lgb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 37; Drug: PCAP2 1 然 Apo 50 然
bRsRsRsRsmmmbRsLsbRsRsmbRsbRsRsmbsbsbRsRsmbRsbRsRsRsRsmmmbRgbLsLcbLcbL
hLsbRibRsRsRsRsRsmmmmbLibsbRsbRsRsRsRsmmmbLsLsmbLsbLsbRjLsLsmbLsbLsLsm
bLgRsbRcbRobRcRsRsmmbRoLsbLgRsbRjbLsLsLsLsmmmbsbLsbsbRjbRsRsRsmmbRsbRs
RsRsRsmmmbRsRsRsmmbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 38; Drug: PCAP2 1 然 Apo 50 然
bLsLgLsLsLsLgLsLsLsLemmmmbLeLsLsLsLsLsmmmmbLebLebsbLsRsbRjbRgRgRsRsmmb
LsLsRsmbRjbLsRsRsmbLgbLeLsLsLsLsLgLgLsLsLimmmmbLhLsLsLsmmbRjbRsLjbRsLs
LsLsLsLsLsLsLsLsLsLsLsLsLsLsLgLsLsLsLsmmmmmmmmmmmmmmmmmbLiLsbLjLsLsLsL
sLsLgLsLsLgLgLsLgLgLgLgLsLsLgLsLsLemmmmmmmmbRjbsbRiRsmbLsLsLsLsLsLgLsL
gLsLsLsLsLsLsLsLsLgLsmmmmmmmmmmmbLsLsLsLsLsmmmmbRsLsLsLsLsLsLsLsLsLsLs
LgLsLsLgLsmmmmmmmmmmbLsLsmbLgLsLsLsLgLsLsLsLsLgLgLsLgmmmmmbLiLsbLsLsLs
LsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmmmbLiLsLsLsLsmmmbLsLsLsLsmmmbLsLsLsLs
LsmmmmbLsLsmbLgLsLsLsLsLsmmmmbsbLgLsLsLsLsLsLsLsmmmmmmbRsLsLsLsLsLsLsL
sLsLsLsmmmmmmmmmbLsLsmbLsLsLsLsLsLsLsLsLsLsLsLgLgLsLgLsLsLsLsLgLsLsLsL
sLsLsLsLsLgLsLsLsLsLsLsLgLsLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmmmmmmmmmmm
mmmmmmmmmmmmmmmbLsLsLsLsmmmbLsLsLsLsLgLsLsLgLsLsLsLsLimmmmmmmbLsLsLsLs
mmmbsbLgLsbsbLsLsLsLsmmmbLsLsLsLsLsRsLsLsLgLsLsLsLsLsLsLsLsLsLgmmmmmmm
mmmmmmbLsLgLsLsLsLsLsLsLsLsLsLsLsLsLsLgmmmmmmmmmmmmbRsbLsLsLsLsmmmbLsL
sLsLgLsLsLgLsLsLsLgLgLgRsLgLsLsLsLgLsLsLsLsLsmmmmmmmmmmmbLsLsmbLsLsLsL
sLsLsLsLgLsLsLsLsLsLsLgRsLsLsLsLsLsLgLsLsLsLsLsmmmmmmmmmmmmmmmmmmmbLsb
LhLsbLeLsLsLgLsmbLhbsbLsLsLsLgLsmmbsbLsLsmbLsLsmbLgRsLsLsLsLsLsLsLsLsL
sLsLsLsLsLsLsLsmmmmmmmmmmmmmmmbLsLsmbLsLsLsLsLsmmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 39; Drug: PCAP2 1 然 Apo 50 然
bRibsbRibRjbRcbRsRjRsmbRebRhbRcbLoRsbLoRsbRcRsmbRebRibLobRhbRjRsmbRcbR
cbLobLcLsmbLobRcRsmbRcbLobRcbRsbsbRsLcLsmbRhbLobLcbLcbRjbRjbRjLsbRobRi
RsmbRibRcbRgRhbLibLibLcbRjbLoRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 40; Drug: PCAP2 1 然 Apo 50 然
bLsbLsLgLsLgLgbLiRsbRgbLgRsbLsLeLsbLsbLgbLsLgLgbLgLsbLibLsLgLsbLgbRsRs
mbsbLsbLsLsmbLiLsLgLsbLsLsLsLgmmbLsLeLsbLsLgbRsbLeLsLsLsmmbLhbLsbRsbLi
LsbLgLsLgLsLsmbLebsbLgbLsbLgLsbLeLsLgbLibLiLsbLebLcbRgbRgRsRsmmbReRgbR
gRsRsRsmmmbRgRibRsRiRsmbRgbRgRsmbLgRibRibRebRibRsRsmbRgbLobLiRsbLibLjb
RibReRsRsmmbRsbRsbLebRsbLgLsbRgbLhbLibRebRgRsmbLsRsbRsRsRsRsmmmbRsRsRs
RsLsmmmbRgRsmbRgbRgbRibRsRgRsRsRsmmmbRgRsRsmmbLsRibRcRsRsmmbRcRsmbRgbR
sRsmbLsbLiRsRsmbRcbLsRsbRiRsmbRgbRsRsmbRsRsRsRsRsmmmmbLsRsRibRgRgbRiRs
RsmmbLsbLsRgRsmbRsRsRsmmbRibRgbRsRgRsmbRcbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 41; Drug: PCAP2 1 然 Apo 50 然
bRgbLsRsRsRsRsRsRsmmmmmbLsRsRsRsmmbLsRgRebRiRsRimbRgRsmbReRsmbRgbsbRiR
smbRhRsmbRhRsmbLibRsRcRsmbRsRsRsRsLsRsmmmbRibRiRsmbRgRsmbRgbRiRsRsRsmm
mbRcRsmbRibRsRsRsmmbRhbLjLsmbRhRsmbsbLibRcLsLsmbLsbLsLsLsLgLsLsLsLsLsm
mmmmmbRsbRjbRcbRibRsRgRsRsmmbRsRiRsmbRibRibRibLsbLjLsLsmmbLgLsLsmbLgLs
LsLsmmbLiLsbRebLiLsbLgbsbsbRsbRcRsRsRsmmmbLsLsmbLiLsLsLsLsLsLsLsmmmmmm
bLibLcLsRsmbLsLsLsRsmmbsbLebLiRsRsmbLsLibLsLsLgLsmbLibLiLsLsLgmbLcLsLs
mmbLsLsLsmmbLsLsmbLsRsRsmbLgbRjbRcbRcbsbLibRsRsRsmmbRobLgLgLsLsLsLsmmm
bsbRsbLiRsRsRsRsRsmmmmbLsLgbRjbRhRgRsmbRiLsbLiRsLsbLhLsbLhReRebRebReRi
bRebRebRebRebRebRsbLsLsmbRsLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 42; Drug: PCAP2 1 然 Apo 50 然
bRgLsLsLsLsLsLsRsRsRsRsRsRsmmmmmmmmmmbsbsbLsbsbRsbRsLsLsRsRsRsRsRsmmmm
mbRgRgRsRsRiRsmmmbRsRsRsRsRsRsRsmmmmmmbsbRgLsLsLsRsLsmmbsbsbsbRsRsRsmm
bLcbLcRsLsbLgbsbsbRsRsmbLsLsLsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 43; Drug: Control Apo 50 然
bRsRsmbsbRsRsRsRsmmmbLcLsLsmmbLsLgLeLsLsRsRsmmbLcRsLsLsmbLcbLsLsmbRcbR
cbReRibLsbRhbRsRsRsmmbsbRibRibRcbRcbReRibRgRsmbRibRcbRcbLeLsbLsbLibRgb
RcbLgRiRsRgmbRgLsRgRebRibLibRcRgbRgRsRsmmbLsbRsRsRsmmbRsRsmbRsbLhbLiLs
bRjbRcbReLsLsmbLibLgbRebRibRgRsmbRibReLsbRsbRcbRhRsmbRibRibRsLsbRibRiL
sbLibsbRcRsmbRibRgbRgLsbRgbRcbLcbLibLcLsmbLhbLeLsLgLsLibLibsbLiLebLcLs
mbsbLeLsbLcbLgbLibLgLsRsbLgLsLsmbLgbLeLsRsbLobLcLsmbLsbLsLsLsLsLsLsLsm
mmmmmbRsLsLsLsLsLsLgmmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 44; Drug: Control Apo 50 然
bRgRsmbLebRebReRsmbRgRsRsmmbRhbRobReRsmbRobsbsbsbLgbRhbRhRsmbRsbLgbRsb
LsbLsLsmbRebRsbRebLiLsbRsbRjbLobRiLsbRibLibLhbLiLsbRgbsbLsbLsLgbLibRsL
sbLsLsmbLsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 45; Drug: Control Apo 50 然
bRiRsRsmmbRsLsbLsRsRsRsRsRsRsRgmmmmmbRgRsRsRsRsRsRsRsRsRsRsRsRgRsmmmmm
mmmmmmmbRsbRsRsmbRsRsmbRhbRsLsRsbLsbRsbRiRsRsRsRsRsRsRsRsRsmmmmmmmmmbR
gbLsLsRgRsRgRsmmmbLsRsRsRsRsRsRsRgRsRsRsRsRsRsRsRsmmmmmmmmmmmmmbRgRsRs
RsmmmbRhbRsRsRsLsLsRsLsmmmbRsRgbRsRsRsRsRsRsRsRsRsRsRsRsRsRsRgRsRsmmmm
mmmmmmmmmmmbRcbLsLjbLgbReRsmbRsRsmbLsRsRsmbRsRgRsRsRsRsRsRsRsRsRsRsmmm
mmmmmmmbsbRsbRgLsLsRsRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmmmbRjLsbRsbRsRsRs
RsRsRsRsRsRsmmmmmmmmbRsRsRsRsRsRsmmmmmbRibLgLsRsRgRsmbRgRsmbRsRsmbRsRs
RsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmmmbRsbRsRsRsmmbRgRsRsRsRsRsRsRsRsmmmmm
mmmbRsRsRsRsRsLsRsRsmmmmmbRsRgRsRsRgmmbRcbRsRsRsRsRsRsmmmmmbsbLsbRsbsb
sbsbRiRsmbLjbRcRsmbRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 46; Drug: Control Apo 50 然
bLsbRgbRgbRsbRsbLsbLsbLsbRsbRsbLsbRsbRsRsLsmbRsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 47; Drug: Control Apo 50 然
bRsbRsbLjbLcbLgLsRsLsbLibRiRsmbsbRebRcbRsbRcbRiRcbLgbRhbLiLsbLjLsmbLhb
RcbRibLsbLcbLgLsLsmbLgbLcbLcbLgbRhbLgLgLsLsmbLgbRgbsbRgRsmbLebLcbRcbRc
bRgbLsLcbLcbLobRobRiRsmbRebRsbRhbLobRgbRcbLjbLoLsmbLcbLgLiRsbLgLsbLhbL
ebLgLcbRsbRhbRoRibRiLsbRiRgbRibLibRhbRobRgRhbRcbReRsmbRgRsmbsbsbLsLsmb
RsbsbsbLgLsbRcbsbRhbRcbRcbLcbLcbLebLhbRgbLcbLobLsLsmbLibRjbRiRibRcbRgb
RebLgbLibLibLgLsbRsbRebLjbLhb

>ZF Recording 2016-04-15; tW: 300s; Start: 122037; End: 122538;
Recording: 11-1; Individual: 48; Drug: Control Apo 50 然
bsbsbRsbsbsbsbRgRsmbsbLobLcbLgbLcbLibLcRsbLcbRebLsbLgbLgbLhbLgbLebLebL
gLsbLsLgLsLsmbLebRsLsbLiLsbRgbRcbRgbRgRsmbRibRcbRgRibRibRibRibRibLsLib
LibLibLgbLebLhbLibLibLibLgbRcbRhRsmbRgLsbRgbRebRibRgLsbRibRibRsbRgbsbR
hbsbsbsbLsLgLsLibsbsbsbsbsbLsbLhLsbReb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 1; Drug: PCAP2 10 然 Apo 50 然
b

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 2; Drug: PCAP2 10 然 Apo 50 然
bRgRgbRsRsRsmmbRibLsbLsRsbRiRsmbRgbLsRsRsRsRsmmmbRiRsmbRgbLsbRibLsRsRs
RsRgmmbLsRsRsmbRsRsmbRsRsRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmmmbRsbRgbRsRs
RsRsmmmbRgbRsRsRsRsRsRsRsRsmmmmmmmbRsRsmbRsRsRsRsmmmbRsRgRsRsRsRsmmmmb
RsRsRsRsRsRsmmmmmbRsRsRsRsRsRsmmmmmbRsRsmbRsRsRsRsRsmmmmbRgRsmbRsbRibR
ibRcRsmbRsbLcbLsbRcRsmbRsRsRgmbRsRsRsRsRsmmmmbRsRsmbRsRsRsRsRsRsmmmmmb
RgbRsbRiRsmbLiRsbLoRsbLcRsbRibRcRsRsmmbRsRsRsRsRsRsRgRsRgRgmmmmmmbReRs
mbRsRsRgmbRgRsRsRsmmmbRsbRsRsRsRsRsRsRsLsRsRgmmmmmmbRibRsRsRsRsRsmmmmb
RiLsbRsRsmbRibRsRsmbLsRsbRsRgRsRsRsmmmbRgRsmbLsbRibsbRsRsRsRsRsmmmmbRs
RgRsmbRgRgLsbRgbRsbRibRgRsmbLsRgRgbLcLsmbRcRsmbLsRgRsRsmmbRibLsbRsbRiR
smbRgbRgbRsRsRsRsRsRsRsRsRgmmmmmmmbRgbRsRsRgmbRsRgbRgRibLsLsRsRsmmbRsR
sRsmmbRsRsRsRgmmbRiLsbRhbLgbLcbLoRsbRgbRsbRsRsRsRsRsmmmmbRgRsmbRiRsRsm
mbLsRsRsmbLsLsRsmbRsRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmmbRgbRibRcRsmbLsLs
RsRsmmbRsRsRsmmbLibRsRsmbRiRsRsmmbRgRsRsRsmmmbRsbRibRsRsRsmmbRibLgbRhb
LsRsbReRsmbRgbLsbRsRsmbRsbRsRsRsmmbRgRsRsmmbRgbRcLsbLsRsRsRsmmbRsbRsbR
cbRsRsRsmmbRsRgRsmbRsRsRsRsRsRsRsRsRsmmmmmmmmbLsRsbRgLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 3; Drug: PCAP2 10 然 Apo 50 然
bLsbRsbLsRsbRsbRsbRsbLgbLsRgbLsRsbsbsbLsbRsbLsbsbLsbLsbRsbsbLsbsbLsbLs
bRsbLsRsbRsbLsbLsbsbLsbLsRsbRsbsbsbLsLsmbsbsbLsRsRsmbsbRsbRsbRobRsbLsb
RsbRsRgRsmbLsRsRsRsmmbRsRsRgLsmbsbsbsbRsbsbsbRsbRsRgbRgRsRsmmbRsRsRsmm
bRsbRgbRiLsRsbLsbRgbLsRsbsbRsbRsbsbRsbRsRsmbsbRsbRgbRsRsRsRsRsRsmmmmmb
RsbLsbRgbRsbRsRsRsRgmmbRgRgRsLsmbRsLsRsRsRsRsmmmbRgRsRsRsRsRiRsmmmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 4; Drug: PCAP2 10 然 Apo 50 然
bLgLsbRsbLgRsbLsLsLsmmbLgbLiLsbLgbLgLsLsmbLsbLgLsbLsLgLgLsLsLsmmbLsbLg
RsbLsRsLsbLsLsLsmmbLsbLsLsmbLgLsLsRsmbLgbLsLsRsmbLsbLsLsLsmmbsbLgLsLsm
bLsLsmbLsLsLsmmbLsLsmbLsbLsLsLsLsLgLsLsmmmmbLgLsbLgbLsRsLsLsmbLgLsbLhL
sbLsLsRsmbLgbLgLsLsmbLgLiLsbLgLsbLsLsmbLgbLgbRsLsbLsbLsbRsLsLgbLsLsLsL
sLsLsLsmmmmmmbLsbLiLsbLhLsbLgbLgLsbLgbLgbLsRsLsbLsbRsLsLsmbRsLsRsLsLsm
bLiRsbRsLsbRsLsLsmbRsLsbLsRsRsmbLgRsbLsLsmbLsbsbsbLsLsLsmmbLsbLsLsmbLg
LsbLsbLgLsRsLgRsbRsLsRsbLsLsLsLsLsmmmmbLsLsLsLsLsLgLgmmmmbRsLsbLgbLibs
bLcLsLsLsmmmbsbRsRsmbRsRsmbRsRsmbRsRsRsmmbRsRsmbLsbLsLsmbRsRsLsmbLsLsL
smmbsbLiLsbLsbLsLsmbLsbLgLsLsLsmmbLsLsmbLsLsRsRsmmbLibLgbLcLsmbLgLsLsL
sLsLsLsmmmmmbLeLibLiLsbRsbLsLsmbsbLsbsbLsLsmbLgbLsRsRsmbLsLgbLgbRsRsLs
mbRsRsLsLsRsmmbLgLsbLibRsbLgbLgLsbRsLobRgbsbRsRsRsRsRsmmmmbLjbLibLsbRs
bLsbLhbLeLsbLgRsbLgbLgbRsLsLsLsmmbLibRsbLgbLibLgLgRsbRsRsLsLsLsRsLsmmm
bLsLgLsbLgbLsLsLgLsmbLgLsbRsLsbLsLgbLgLsbRsLsLsLsLgmmbRsbLsLsRsLsLgLsL
smmbLgLsbLsLsmbLgRsbLgbLgbLsLsmbLsLsmbLsLsLsmmbLsLsLsLsLsLsLsLsmmmmmmm
bLsbLsLsLsmmbLsLsLgmbRsLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 5; Drug: PCAP2 10 然 Apo 50 然
bLsLsLsmmbLgLhbLgLgRsbLsbLsLsmbLebLiLsbLsLsmbLhLsbLgbLsbLsbLgLebLgbLgL
sLsmbLsbLsLgbLgLebLsbLsRsLsLsLgmbLsLgbLgLsbLsLsLsLsLsmmmmbLsbLsLsmbLsL
smbLgbLsLsmbRsbLsLsmbLsLgbLgbsbLsbLsLsLsLiLsmmbLibRsLeLsbLgLsbLiLeRsbR
jbLsbsbRoRsmbRsRsRsmmbRiLsbLgbLsLcbRsbLsLsmbRjbLibLiLsbLcbLsLgLsbRjbLg
LgbLebLsLgLgbLibLsLsLiLgmbRsLsLsLsmmbLsRsLsLsmbLsbLsLiLsbsbRsLsbLsLsLg
LsLgmbsbLsbRsbsbsbsbRsLsbLsbRsbsbLgLsLsmbLsLsLembRsbLibLgbLsRsbLsbLsLi
LsbLsLiLsbLsLsLsmmbLsLsmbLibLgbLsLsLiLsmbLgLeLsbLgbLsbLsLgbLsLhbLsLsLs
LsLiLgmmmbLgLsbLgLgLsLgbLsbLiLsbRsLsLsLgLgLsLsmmbLsbLgLsLsLsmmbsbsbLsb
sbsbLsLsLsLsLsLgmmmmbLsLsLsmmbLsLsLsLemmbsbRcbRhbRibsbRsbLsbLhbLsLsmbR
sbLsLsmbLsLeLsbRsLgLsLsLsmmbsbLsLsLsLsLsLiLsLsmmmmmbLgbLibLsLgLsbLgLsL
smbLgLsbLsLsmbLsbLgLsLsLgmbLsLsLgLsmbLibLiLebRcbRcbLsLsmbLsbRsbRsbRibs
bsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 6; Drug: PCAP2 10 然 Apo 50 然
bLsbLsLsmbLgbLgLsLsmbRsbRebLsLsmbRsReRsmbRcbLebRsbRsbLcLsmbLobLcRsbRcb
LiLsbLhLsRsbRsRsmbRgbsbRsbLsLgbLebRebRsbRgbRsRebRebLgbLsbLsLsmbLibLgLs
bLcbRcbRibReLsbLsbRobLgbRobLcLhbLsbLiLsbLgbLgbLgbLsbLebsbRsRsRsRsmmmbR
sbLcLsmbLgbRsbLebLgbLgbLsbLgbLibRsbRibRgbRgbRsbRcRsRsmmbLeLsbLibLgbLib
LsbLsLsmbRebRebRsbRibLgRsbRcRgbLgbRcbsbRsbRgRsmbRibRgbRsRsmbRgbRgbLsbR
cbLibRsbsbRsbRgbLebRibRoLsbRibRgbLiRsbRgbLibLsbLgbsbRjbLibLgbLcLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 7; Drug: PCAP2 3 然 Apo 50 然
bLsRsRsmbRsRsRgRsmmbRgbLsRsRsmbRsRsmbLsRsbRsRsmbRsbRsbRsRsRsRsRsmmmmbR
sbsbRsbRgbRsRsRsLsRsRsmmmbRgRsmbRgbRgRsRsmmbRgRsmbRgRsRsRsRsmmmmbRsbRg
RsLsmbLsRsRsRsRsRsRsRsRsmmmmmmmbRsRsmbLsRsRgLsRsbRgRsmbRsRsRsRsLsmmmbR
sbRsbRsRsRsRsmmmbRsRsRsmmbRsbRsRsmbRsRsRsmmbRsRsRsRsmmmbRsbLsRsRsmbRsR
sRsRsmmmbLsRsRsRsRsmmmbRgRsmbRsbsbRsRsmbRibRsbRsRsRsRsRsmmmmbRsRsmbRsb
RgRsmbRgRsRsRsRsmmmmbRsbRsbRgbLsRsRsRsmmbRsbRsRsmbRsRsRsRsRgRgRsmmmmbR
sRsRsRsmmmbRsbRgbRsRsmbRgbRgbRsRsRsRsRsRsRsRsmmmmmmmbRsbRsRsRsmmbRgbRg
RsmbRsRsRsRsmmmbRsRsRsRsRsRsmmmmmbLsRsbRsRsLsRsmbRsRsRgRsmmbRsRsRsmmbR
sRsRsmmbRsbRsbsbRgRsmbRgRsmbRsRsmbRsRsmbRsLsRsbRsbRsbRsbRsRsRsmmbRgRsR
smmbRsRsmbRsRsRsmmbRsRsmbRsRsmbRsLsbLsbRsRsRsRsmmmbRgbRgRsRsRsmmmbsbRg
RsmbRgbsbRsRsmbRsRsmbRsRsLsmbRgRsRsmmbRgRsRsmmbRsRsRsRsmmmbLsLsRsRsRsR
sRsRsRsmmmmmmmbLsRsRgRsRsmmbRgRsRsmmbRsRsmbRsbsbsbRsRsRsRsmmmbRsRsmbRs
RsRsmmbRsRsmbRsbRsRsRsRsRsRsmmmmmbLsRsbsbRsRgRsmbLsLsRsmbRsLsbRsRsmbRs
RsmbRsbRsbsbRgRsmbRgRsRsmmbRsRsRsLsRsmmbRsRsmbRgRsLsmbRsbRsbsbRsbRsRsR
smmbRgRsRsRsmmmbRgRsRsRsLsmmmbRsRsRsRsRsRsmmmmmbRsRgRsRsmmbRsRsRsRsRsR
smmmmmbRsRsmbLsRsRsRsRsmmmbRgRsRsLsmmbRsRsRsRsRsRsmmmmmbRsbRsRsmbRsLsR
sRsRsRsRsmmmmbRsbLsRsRsmbRsRsmbsbRsbRgbRsRsRsRsRsmmmmbRsbLsRsRgRsmbRsR
smbRsRsRsRsRsRgRsRsmmmmmmbRsRsRsRsRsRsmmmmmbRsRsRsRsRsmmmmbRsbRsbRsRsm
bRsbsbsbLsbRsRsRsRsmmmbRgRsmbRsRsRsmmbRsRsmbRgbRsRsRsmmbRsRsRsRsRsRsmm
mmmbRsbRsbRsbRsRsRgmbLsRsRsmbRsRgbRgbRgRsRsRsRgmmmbRsbRsRgbRgRsmbRgRsR
sRsRsLsmmmmbRiRsmbRgRsRsmmbRgRsRsRsRsmmmmbRgRsmbRgRsmbRsRsmbRsRsmbLsRs
RsRsmmbRgRsmbRgbRgbRsRsmbRsRsRsmmbRsbRsbRsRsRsmmbRsRgbRgbLsRsbRsbRgbRg
bRsbRibRsbRsRsmbRsRsRsmmbRibRgbRgbRgRsReRsmmbRgbRsRsmbRsRsLsmbRsRsRsmm
bRgbRsRsmbRsRsRsmmbRgLsbRsRgbRsRsLsmbRsRsRsmmbRgRsmbRgRgLsbLsRsLsRsRgb
RsLsbRsRsmbRgRsRsmmbRgRsmbRsRsmbRsbRsbRsRsRsmmbLsRsRsmbRsRsRsmmbRsbRsR
sRsRsRsRsRsmmmmmmbRsRsRsLsRsmmbRsbsbRsRsRsmmbRsRsmbsbRsbRgbRsRsmbRsbRs
RsmbRsbLsRsRsmbRsRsRgmbRsbRsbRsbRsRsRsmmbsbRsRsRsmmbLsbsbRsRsmbRsRsmbR
gRsmbRsbLsRsRsRgRsmmbLsLsRsRsmmbRsbRsbRsRsmbRsLsRgbRsbLsbRsbLsbsbsbsbR
sbsbRsRsmbRsbLsRsbRsRsmbRsRgRsmbRsRsmbRgbRgbRsbRgRsmbLsLsRsLsRsRsRsmmm
bRgbsbLsRsbRsRsLsmbRgbRsRgbLsRsRsmbLsRsbRsbRsRsmbRsRsmbRgbRsRsmbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 8; Drug: PCAP2 3 然 Apo 50 然
bLsLiLgLsbRgbRcbLcLsmbLgLsbRcRsmbLgLsLsmbRcRsRgmbRcRsRsmmbRcbRcbRcbRcR
smbRcRsmbRcbRiRcbLsRsbRiLgbLgbRhbLsbsbLsbRgbsbsbLsLsmbLjbLsbRiRsmbLjbR
hbLjbRibLsLcbRcRsmbRcbRhbLsLsLimbRcbRcRsmbRcbReRsmbsbsbRcRsReRsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 9; Drug: PCAP2 3 然 Apo 50 然
bRebRgbRgbRsbRsbRsbLsbRgbLsbRibRgbRgbRgbRebLgbLsbLsbLsLsmbsbsbLsbLibLs
bLsbLgbLsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 10; Drug: PCAP2 3 然 Apo 50 然
bRsRsRiRcmbLiRsRsmbRoRsmbRsRsRsmmbRsRsmbRsbRsRsRsRsRsRsmmmmmbLsRsRgRgb
LsRsRsRsRsRhRiRsRsmmmmmbRgbRgRsRsRsmmmbRhbRsRsmbRgbRcRsmbReRsRsRsmmmbL
sRhbRiRsmbRsbLsbRsRsRsmmbRsRsRsRsRgRsRsRgmmmmmbRsRsRsRsRsRgRsRsRsRsRsm
mmmmmmmmbLsbRsRsmbRsbLsRsLsbLsbRsRsRsmmbRiRsRsRsRsmmmmbRgRgbRgbRgRsRsR
sRsRsRgmmmmmbRiRgRsRsRsmmmbRsbRsbRsRgRebRgRsRsRsmmmbRgbRsRiRsmbRebRsbR
hbRibRibRgbRsRgRsRgmbRgbRsbRgbRgbRgbRjLsbLebRibRsRsmbRgbRsRsmbLiLsbLib
LsLsmbRsbLjLsLsmmbRgRsmbRgRebRcbsbRsRsRsmmbRsbRgRsRsmmbRsRsmbRibRgRsRi
mbRiRsRsRsRemmmbRgbRebRibRiRsRembLsbRsbRibRsbLsbRsRsRsmmbReRsmbsbRsRsm
bRsbRsbRgRsmbRiReRibRebRgbRsRsmbRsRsmbRebRsbRsbRgbRebRgbRsbReRsmbRibRe
RsmbLobRibRgbLsbLsbLsRsbRsbLsbLsbLsbLsbLsLsmbRsbRsLsbLsbRsbLgbLgbLsbLi
bLibLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 11; Drug: PCAP2 3 然 Apo 50 然
bLsRsRsmbRsRsRsmmbRsRsmbRsbRsbRsRsmbRsRsRsmmbRgbRgRgRgbRgRsmbRgRsRsRsm
mmbRsbRsbRsRsmbLsRsbRsbRgbRgbRsRsRgmbRgbRgbsbRsbLsbRsbLsRsbLsRsRsRsRsR
sRsmmmmmbRgbRsRsRgmbRgbRsbLcbsbRsbsbRsRsRsmmbLsRsRsRgRgRsRsLsRsRsmmmmb
RhRsmbRsRsRsmmbRsbRsRsmbRsRsRsRgRgmmbLsbRsbsbRsRsmbRgbRgRsmbRgbRsbRgbR
ibRgLsbRsRsmbRsRsRimbRgRsRgmbRsRsRsmmbRsbRsLsbRsbRsbRsRsmbRsRsmbRsbRgb
RiRgbRgbRebRgLsbRcbLcbLibLibLgbsbLsLgLgbsbLsbLsLsLsmmbLsbsbLgbLsLsLgmb
LgbLsbRjbLhbRjRgbsbLibLgbLsRsbLsbLsLsmbLsbLsbLgLsbLsbLsLsmbLsbRsLsLsmb
LsbLsLsmbLsbsbRsLsbLsLgLsLsLsLsLsmmmmbLibLgbRsbLsbLsLgbLsLgbsbLsLsRsLs
LgmbLsbLsbLsLsmbRjbsbLsbRsbRsbLsbLsbLsbRsbsbRsLsbLsbLsLsLgLsmbLsLsmbLs
bLgbLsbLsLsmbLsbLsLibLsRsbLsLsLsmmbLgbLgRsLsbLsLsRsmbRsbLsLsLgLgmbLibR
sbLgLibRsLgbLgbLsLsmbLgbLsLsLsLgmmbLsbLiLsbLgLsLsLgLsmbsbLsLibLebsbLsL
sLsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 12; Drug: PCAP2 3 然 Apo 50 然
bRsbLsbRsbRsbLgbLgLsbLibLgbLsbLgRsbLgLsbLgbLsbLsbLgbLgRsbLgbLgLsbLsbLg
bLgbLsbRsbLgbLsbLsLsmbLgbLsbLsbLsbLsbLgbRsbsbsbsbsbsbsbRsbsbsbsbsbsbsb
sbsbsbsbsbsbsbsbsbsbRsbsbsbLsRsbsbRsbLsbsbLsbsbsbsbsbsbsbsbsbsbsbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 13; Drug: PCAP2 1 然 Apo 50 然
bRsLsbLsbsbsbLsRsRsRsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 14; Drug: PCAP2 1 然 Apo 50 然
bLsRsRiRgRgRsRsmmbRgRsmbRsRsmbRsRsRsRsRimmmbsbsbRebLsRsRsRsRgRsRimmmbR
sRgRsRsRsRsmmmmbLsRgRsRsRsRsRgRgmmmmbRsLsLsRsRsRsRsRsRsRsRsRgRhmmmmmmm
mbLsLsRsmbRsbRsRsRsRsRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmmmmmbRsRsmbRgRsRs
RgmmbRsRsmbRsRsRsRsRsRsRgRsRsRsRiRimmmmmmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 15; Drug: PCAP2 1 然 Apo 50 然
bLebLiLsbLgbLhbLsLiLibLgbLgLsLsmbLsbLsbRsbLiLsbLibLibLebLiLibLgLsLsLsm
mbLibLgLgLsbLiLsbLibLibLsLsmbLibLgbRgbLsbLebLeLsLsmbLibLhbLibLgbLgLgLi
bLgbLgbLebRsbLhLsLsmbLiLebLiLsbLgLsbLgLsbLiLsbRsRsmbRsbLgbLibLebLiLsbL
sLsmbLsbLgbLgbLsLsmbLsLeLsbLibLgbLebLeLiLhLibLibLeLsbLgbLhLibLgLsLsLsm
mbLgbLebLiLiLsbLebLiLsbLiLgbLibLiLsbRgbLgbLgbLiLgLebRsbLeLgbLibLhLsbLi
bLgLsLsmbRsLsLsmbLibLgbLibLebLhLsbLiLsbLiLgbLebLibLgLgLgbLgLsbLsbLgLgb
LeLsbLebLeLeLsbLgLgLsbLgLsbLibRsRsLsmbLiLsbLibLeLsbLgbLgbLgLibLgbRsLsb
LsLsLgmbLgLsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 16; Drug: PCAP2 1 然 Apo 50 然
bLebRobLcbLsbLobLjbRjbLsbLebRobLjbLebLobLobLebLobLcbLobRobLobLobLebLeb
LebLebRobRsbRobRebLebLjbRebRobRjbLobLobLjbRsbLebRsbLjbRebRobLebLebRobL
ebLebLobRebLsbLjbRjbRjRgbRjbLobRjbLobLjbRebLobRobRebLsbLjbLebLobRobRsb
LjbRjbRsbLjbLgbLsbLibLjbLobRsbLjbRsbLjbRgbLjbRjbLjbLsbRsbLebLebRebRobR
sbLsbRsbLjbRjbRsbLsbLsbRsbLebRsbLsbLjbLebLsbRebLgbLebRcbLjbRobRjbLobRs
bLjbLsbRsbRobRjbRobRebRobRjbRsbLjbRebLobLebLjbLobLobRsbLsbRsbRebLcbRjb
RjbRjbLjbLjbRsbRebLcbLsbLebLobRjbRjbLjbLebLobLsbRebRebLjbLjbLebRebLobL
obRjbLebRobRebRcbRsbLjbLebLjbLebRjbRjbRjbLjbRgbRjbLcbLobRebRobRobRebLo
bRebRobLsbLebLobRebRjbRebLcbRjbRobLebRobLjbLebLobLjbRebRobLjbLsbLebLjb
RsbRebRsbRjbReb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 17; Drug: PCAP2 1 然 Apo 50 然
bRsRsRsRgmmbRsRjbLjbRcRsmbLiLsbLcLsLsLsmmmbRobLoLsmbRebRcRsmbRcRsRsmmb
RobsbRjRobRgbLjLcbRsbLobLsLcbLibLcbRhbRjRsRsmmbRhbLhbRsbRgbLjLebReRsmb
LebLsLsLsLsmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 18; Drug: PCAP2 1 然 Apo 50 然
bLsbRsbLgbLsbRcbRgRsRgRgRimbRsRebRsRiRsmbRgRiRebRsLsbLoLsmbLeLsbLgbReL
sbLsLsmbLiRsbsbsbRsbLiLsbRsbLgbLsLsmbLsRsbLgbLsbLsbRsbLgbLjbLsRsbsbRsb
sbLsLsRsmbLsbRsRgbLjbRsbsbRjbLibLsbLgbRsbLsbLsLgRsLsbRsLsLsmbLsLsmbRsL
sbLgLsbLsLsmbLsbRjbRsbRsRsmbRgbLgbRibRsbLsbLgbLsbLjb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 19; Drug: Control Apo 50 然
bLsLsmbRsbLsLsmbLsbsbRsbLsbLsbRsbLsbRjbLsbsbRsbRjbRibLjbLsbLgbRjbRibRs
bsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 20; Drug: Control Apo 50 然
bRsRgRsRsmmbRsbRsbRsRsmbRsRsRsmmbLsbLsLsmbRsbsbsbRjbRsRsRsmmbRibLsRsRs
mbRgbRsbRsbLsbLsRgbRsRcbRibRsbRsRgbLsbLsbReLsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 21; Drug: Control Apo 50 然
bRhbLeLsLsLgmbLsLsLsmmbLsLsLsLsLsLsLsmmmmmmbLgLsLsLsLsLsmmmmbRjbLcLgbL
cbLsLsLgmbLhbRsbRsRjbLsLsmbLsbRibLoLsmbRcRsmbRibRcLsbLcbLcbLibRsbLcbLg
bLgbRsbLjRsbLsbLibLgRsRsLsmbLgbLsbRcbRcbRgbRhbsbLibLsbLgbRgLsbLibLsLsL
smmbRsbsbRiRgRsRsRsRsmmmmbRsbReRobRcbRibRebLobLebLibLibLibRjbRgbRcbRib
LebLibRjbLcbLhbLcbRsRsmbRgbRcbRiRsRimbRjbsbsbRsRsRsmmbRsLsRsRsRsRsRsmm
mmbRgbLhbLhLsbLsbLcbLsbRcbRebRgbRcbRcbRsbRgbLsbRcbRgbRgbLhbRhRgbRgRsRg
mb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 22; Drug: Control Apo 50 然
bLibRcbLiLsLsLsmmbLgbRebLjbLjbRjbLcbRcbRgbRebRobRibRebRcbRcbLoLsmbLibL
gbLgbRcRsmbRibRsbLsRsbLcbRcbLjbRebRsbLgbsbsbLsbLsbRjRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 23; Drug: Control Apo 50 然
bsbRgRsRsRsRgmmmbRhbLsbRobRibRibLgbLsbRhbLiLsLgbLibLhbRibLsbRsbLsbRibR
gbRsbRsbRsbRgbRgLsbLsRsRsmbRsbRgRsmbRiLsbLsbRibLsbLsbLsbRibLsbLsbRgbRi
bRgRsmbRgbLjbLhbLiRsbsbLgbLibLcbLcbLibLsbLgbLibLgbLibRsLsbRsbRcbRibRgb
RgbRgbRsbRgbRsbRsbRsbRgbRsbRibRibRsbRibLgbRsbRgbRgbRgbRgbRgbRsbsbRsbRs
bLsbLibRsbLgbLsbLsbLsbRsbLsbLsbsbRsbLsbLgbRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 24; Drug: Control Apo 50 然
bRsbLjbLsbLjbRcbsbRsRsLsmbsbLsbRibLsbLgbRhRsmbRsbLhbRobLsbLibRhbLgbLjb
LjbLgbRibLgbLhLsLgbLcLsLsmmbLhbLhbRobLsbsbsbsbsbsbsbsbLgbLiLsbRjbRibLi
bRhbRcbRcbLibLoLsmbLcbLgLsbsbLjbLsbLjLsmbLcbLhbLhbLibLgbLcbLcbLibLibLi
bRsbRcbRcbsbRcbRsbRgRgbLgLsbRsbRebRibLhbLibRgLsbRhbRiRsmbRhRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 25; Drug: PCAP2 10 然 Apo 50 然
bLsbLcRsLgbRjbRcbLebRsbRsbRgRsmbRgbLsbRibRgbLjbReLsbLsbLsLsmbsbsbRsbLs
bLjbRsRgbRgbRgRsmbRsbLsbRgbLobReLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 26; Drug: PCAP2 10 然 Apo 50 然
bsbsbsbsbLsbRgbRsbsbsbLibLgbRgbLgbsbLsbLibLsbLobRcRsmbRcRibRsbLibLgbsb
LsbLsLsmbRsLsbLsLsLgmbLsbLsLsRsmbLebLhRsbRcbRgbLsbsbsbRsbsbRsbsbsbsbsb
sbRsbsbsbLsbLsbLsRsbRsbLhRsbRsRibRsbRsbsbsbRsbRsbsbRsbsbsbRgbLjbRsbRib
RiRsmbRcbRebLsbsbsbsbsbsbsbsbsbsbsbsbRsbsbsbsbsbsbRsLsbsbsbsbsbsbsbsbR
sbsbsbsbsbsbsbsbsbsbsbsbRsLsRsLibRgbLsLsmbsbLgbLgbsbLgbLibLiLsLsmbLsRs
RsLsRsLsLsmmbRsLsbRgbLgbLsbLsbLsbLsbRsbsbLsRsbsbLsbLsRsLsbsbsbRsbsbsbR
sbLsRsbLsRsbRsbLsbLsbLsbLsLsmbLsbRgbLibsbsbsbsbLsbRsRsmbsbsbsbLgbsbLsL
sLsLsRsmmmbLgLsbLsLsLsLsLsLgmmmmbLgbLsLgbLsRgbsbLsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 27; Drug: PCAP2 10 然 Apo 50 然
bRsRsmbLsRsbRsbRebLsRsRsRsRsmmmbsbRsRsRsRsRsmmmmbRsRsRsLsmmbRgRsRsRsmm
mbRsRsRsRsRsmmmmbLsRsRsmbRsbRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmbRsRsRsmmb
LsRsRsRsRsmmmbLsLsRsLsmbLsLiLsLsRsRsRsmmmbLgLsLsLsLgmmbRsLsLsLgLsLimbL
gbLgLsLsLsmmbLsLsLsLsLsmmmmbRsLsLsRsmbLsLgLsLsLsmmbLsbsbLsLsmbRsLsbsbL
sLsLgmbLgLsLsLiLsmbLebLsLgLsbRjRgRsmbLsRsRsRsRsmmmbRgRsRsRsmmmbRsLgbLi
LsbLsbLgLsLsLsLsmmmbLsLsmbRsbLgLsbLsLsRsRsmmbLgLsLsmbLsbLebLeLsbRsRiRs
mbRgRsmbRsRsmbRcbsbRgLsbRsbRsLsbRsbRsRsmbLsLsmbsbLsLgbLsRsLsLsLsLsLsmm
mmbLgbLgLiLsLsmbLgLsLsLsmmbLsLsRsLsRjmbLeLsbLsbLsLgLsLsLsRsmmbLsLsmbLg
RsLsbLgLgLsbsbsbRebRsRsRsRsRsRsmmmmmbRsbsbRiLgLsbsbLgLgbLsLsLsRsLsLsLs
LsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmmmmbLgbsbLgLsLsLsLsLsLeLsmmmmbRsRsRsmmb
RsbLgbRibLsbLsLsmbLsLsLsRsmmbLsLsmbLgbLgLsLsLsmmbsbsbLiLsbLsLsLsLsLsLs
LsmmmmmmbLsLsRsRsRsRsRsRsmmmmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 28; Drug: PCAP2 10 然 Apo 50 然
bsbLibRsbRsRsRsRgRsRsRsRemmmmmbLjbRgRgRgRsmbRsLjbLsRsbRiRsRsRsRsRsRsRs
RgRsRsRsRsRsRsmmmmmmmmmmmmmbRsRsRiRsmmbLsRsbRgRsRsRsmmmbRsRsmbRibRcLsb
LsLsmbLibLsbLsRsRsLsmbLjbRiRsmbsbLjbRibRgRgbRsbRiRgLsRsbLsRsRsRsRsRsRs
RsRsRsRsRsRsLsLsmmmmmmmmmmmmbLjbLjbRsbRsLsbsbsbsbRsRsRsRgRgRsmmmbsbRcR
smbRsRsmbLgLsbRgbLsbRsbRsRsRsRsmmmbRgRiRsRsmmbRcbLcRsRcbRhRsmbLsRgRsRs
mmbRibLsRsRgRsRgRsRgRsRsRgmmmmbRgRsmbLjbLgLgRsRgRgRsmbRsRsRsRsRsRgRgRs
RsRsLsRsRsRgRgmmmmmmmmbRcbLhRsRsmbLcbLcbRgRsmbLjbReRsmbLjbRsRsmbRsRsmb
RsRgRsRsmmbLjbRiRsRsRsRsmmmmbRsbRcRsmbRcbLiRsRsRsLsLsLsRsmmmmbLiLsLsLs
mmbLcRsRgbLibLiLsLsmbLgLgLgbRsbLgbRcRsRsRsRsmmmmbReRsmbLgLsLsLsmmbLgRs
bLsbReRsmbLgLsRsRsRsRsRsRsRsRsmmmmmmmbsbRiLsRgbLjbLgbLiRsbRgRsRiRsmmbs
bLgLsbLsLsLsLsLimmmbRsbRsRsRsmmbRsRsRsRgmmbRsbsbRsbRsbRsRsRsRsRsRsRsRg
RsRsmmmmmmmmbLjb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 29; Drug: PCAP2 10 然 Apo 50 然
bRsRsmbReRsmbLsRsbRgRsRsRsmmmbRgLsbRsRhRsmbRsRibLsLhbsbLsRsbRsRsmbRgbR
sbRsbRgbLjRsbRcbLcbRcbLsbRsRsmbRsRsLsRsRsmmbRcbRjbsbRsbRiRsmbLsbLsbRcR
sRsmmbLsLsmbLgbLsLsLgLsLgmbLsLsLsLsmmmbLsLsmbRjbRcbLibRgbRiRsRsmmbRsbR
sbRsRsRsRsRsRsmmmmmbRibRsLsLsLsLsmmmbRsRsmbRcLsbLibRjbRsRhbsbRsbRsbLsb
RgbRsRsmbRgbRsRsRsmmbRgbRibRsRsmbRsRsRsRsmmmbRsRsRsRsRsmmmmbReRsmbLsLi
LsLsmbsbRsRsRsRsRsRsRimmmmmbLsbRibRsRsRsRsRsmmmmbRsRsRsRsRsmmmmbRsRsLs
RsmbRgbRsRsRsRsRsRsmmmmmbRgRsLsRsmbRgbRiRsmbRsRiRsRgmbRgRsRsLsRsRsRsRs
mmmmmbRiRsRsmmbLcbLgbRsLsLsmbRiRsmbRgRsRsRsRsmmmmbRsRsRsRsRsmmmmbRsRsR
smmbRgRsRsLsmmbRgRsmbRsbRsRsRiRsmmbRibLibLcbLibRgbLsbLsLsLsLsmmmbRsbRs
bRjbLsLsLsmmbLsbLsLsLsLsLimmmbLgbLgLsbLsRsbLsbLsLsLsLsmmmbLsLsLsLsLsLs
LsLsLsLsLsmmmmmmmmmmbLsLsLsLsmmmbLsLsLsLsLsmmmmbLsLgbRsRsLsmbLsLsLsLsL
smmmmbLsLsLsmmbLsLsRsmbLsbLsLsLsLsLgLgLgmmmbLsLsmbLsbsbLsLsLsLsLsLgmmm
mbLsLsLsmmbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 30; Drug: PCAP2 10 然 Apo 50 然
bLibRoRsRsmmbRibLhLsLibLobRiLsbRibRgbRcbLcbLcbLcLsmbLcRsbRjRsmbRsRsmbL
sbRiRsmbLcbLibRgRsRsmmbLsLsmbLibLgbLibRobRcbRhbRhRsmbLebLgbLcbLcbLiLsb
LgbRgRsmbRibLcbRsbRjbRiRsRsmmbRsRgLsbRibRebRibLjbRhbRsRsRsmmbLiLgbLgRs
LgbLiRsbLsbLibRjRsmbRiRsmbRgbRoRsmbRebRiRsmbRhRsmbRiLsRibRgRsmbRsRsRsR
gmmbLoLsmbLcbLgbLgRsbLgRsbLiLibRoLsbLcbLsLsLsmmbLoLsmbRibRsRsRsRsmmmbL
sLsmbRsbRsRiRobLsLibLobsbReRsmbRibRhbLhbLibRgLsLsmbLcbRebRcRsmbLcbLcbL
gbRibRjbLjbLeLsbRibLgbLibRgLebLgbLiLsbLebLoLsmbRoRebLcbLcLsmbRhbRobRiL
sbLgbLcbLhbRiRsRsmmbLibLgbLcLsmbRcbRgbRebRibLobsbLgLsLsmbLgLsLsLsLsRsL
sLsmmmmbLebLebRsbRsRsRiRsRemmbRsRibRsRhbRebLcLsmbLcbRsRsmbRgLsRsRgbRib
RebRhbRhRsmbRsRsmbLgbRsbRsLsbLsLsLsLsmmmbLgbLgLgbRobLcbLcLsmbsbRsLsbLg
bLcbLobLcbRcbRcbRcRsmbLoLsmbLsbLibLgbRsbsbLsLibLcLsmbLhLsbLibLgbRobRsb
RebLcbLsbRibsbLsbLjbsbLibLgbLoLsmbLibRcRsmbLgbRcRobRcbRibRgbRsRsmbRgRs
mbRebRibRebLoLcbLobRibLgbRebRgRsmbRsRsRsRiLsRsmmbRgRgRsmbRcbLib

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 31; Drug: PCAP2 3 然 Apo 50 然
bRsLsLsmbLsLsRsLsLsLsLgmmmbLsLgRsLsbLsLsLsLsmmmbLsbLsbRsLsLgLsLsLgLsLs
mmbLsLsLsmmbRsLsLsLsLsLsLsLsmmmmmmbRsRsmbsbLsLsmbsbLsLsLsLsmmmbLsbLsLs
LsLsLsLsmmmmmbRsLsbLsbLsLsLsLsLsmmmmbLsLsLsLsLsLsLsLsmmmmmmmbRsLsbLgLs
LsLsLgmmbLgLsLsRsLsLsLsLsmmmmbLgbLgbLsLsLsRsLsLsLsLsLsLsLgLsLsLgmmmmmm
mmbLsLsLsLsLsLsLsLsLsLsmmmmmmmmmbLsLsLsLsLsmmmmbLsLsLsLsmmmbLgbRsLgLsb
LsLsLsLsLsLsLsmmmmmmbLsLsLsmmbLsLsLsLsmmmbRsbLgLsLsLsLsLsLsLsLsmmmmmmm
bLsLsLsLsLsLsmmmmmbLsLgLsLsLsLsmmmbLsLsmbLsbRsLsLsmbLsLsmbLsbLsbLsbRsL
sbLsLsmbsbLsbRsbLsbLsbLsbRsbLsbLsLsLsLsLsRsmmmmbLsbLsLsRsLsLsLsLsmmmmb
LsLgbLsLsLsmmbLsLsLsLsmmmbRsbLsLsLsLsmmmbLsLsmbLsLgLsRsLsLsLsLsLsmmmmb
LsLsmbsbsbLgbLsLsLsLsLsmmmmbLsbRsLsLsmbRsLsbLsLibLsbLiLiLiLsbLsbLgLeLs
LsLsLsLemmmbLgRsbLgLsLeLsbLhLsbRsLsLsLsLsLgLeLsmmmbRsbLsLsLsLgLsLsLgLe
mmmbLeLebLgbLebLgLsbLsLsmbLsLsmbLsLebLiLsLsLeLsmbLsbLgbLsbLsbRebRiLsbL
ebLiLsbLiLsbLsRsbLsLiLsLsLsLeLeLsLsmmmbLgLsbLsbLsLiRsbRsLiLeLebLibLebR
jbLsLsmbLsLsLeLeLsLgLsLembLebRsLsLsLimbLsLsLiLsLsmmbLgLsbLgLsbLgLsbLgL
sLsmbLsbLjbRgbLsbLeLgLiLsbLiLsbLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 32; Drug: PCAP2 3 然 Apo 50 然
bLsbLgbLsLsLsLsmmmbLsLsLsmmbsbRsLsbLsbLsLsmbLsbLsbLebRsbLsbLsLsLsmmbLs
LsLsLiLsmmbLsLgRsbLgbLgbLsLsLsLsLgLgLsmmmbLsLsLembLgbLgbLsLgLsbLgLsRsb
LgLsbLsLhbsbLiLebLsLgbLibLgbLsLgLsbLeLsbLsLsLgmbLsbLsLsmbLebLebLibLgbL
sLgbLsLsmbRgbLsRsLsLsmbLgbLebLsbLgbLgLsbLsbLgLsbLibLgbLgbLsbLgLgLsLebL
ebLibLgbLgLsLsmbLgLsbLeLgbLibLibLgbLsLsLsmmbLsLebLgbLobLgLjLsmbRjRgbLs
LiLsLsmbLsbLsLsLgmbLibLsbLiLsbLgbLgbLgbLgbLgbLsbLsLsLsmmbLeLsbLcbLsbsb
RsLsRsbRsbsbsbsbLsbsbLsbLsbRsbLsbLsbLsbLgLsbLsbLsLsmbLiLsbLhbLsbLsbLsL
gbLiLsbLsLsmbsbLeRsbLgbLsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 33; Drug: PCAP2 3 然 Apo 50 然
bLobLsRsbLsLibsbRsbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 34; Drug: PCAP2 3 然 Apo 50 然
bsbsbRsbLsRsbRsbLgbRsbRsbRsbsbRsbRsbRsRsRsmmbRsRsmbRsbsbRsbRsbRsbRsbLs
bLsbRsbRsRsmbRsbRebLhRsbRsbLsbRsbRsbRsRsmbRsbRsbRsbRsbRsbLsbRsbRsbLsLs
mb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 35; Drug: PCAP2 3 然 Apo 50 然
bLcbLiLsbLcbLcbLibLebRsbRhbLsRibRjRsmbLgbsbRsbLsbsbRsRsmbLsbsbLgbsbLjL
sLsmmbsbRgLjLsmbsbRjbRiLsbRsbRibRibRgRgRsRsmmbRcRsLsmbLcbLhLsbLcbRiRsm
bsbRgRgbRsRgbRgbRibRibRiRsRsRsmmmbReRsRsmmbRobRiRibRiRgbRiRgRgRsReRsRs
RhmmmbRcRgbRsbRiRsRsmmbRiRsmbRoRsRsmmbRibsbRjRsmbRsbRiRsmbRebRgRgRsmbs
bRgRebRibRgRsRsRgRsmmmbRgRsLsmbRiRsmbRcRsRsmmbRiRgRsmbRibRiRsmbRcbRibR
hRsRhRsmmbLgLsLcbLoLsmbLibLhbLibLsLsmbsbsbsbsbsbsbsbsbsbsbsbsbsbRsbRsb
LsbRiRsmbLsbRhbRibRiRsRgmbsbLsbsbsbRsbsbsbRibRsRsRsRsmmmbRcbLcbLjbLgLs
bRjLsbRjbRibRibRibLcbRiRsRsRoRsRsRsmmmmmbLeLsLsmbLibRsLsLsmbRjbRcRsmbR
cbRcRsmbRcbRgbRgbLobLgLsbRcbRgReRgRsmbRsbRgLsLsmbLeLsbLibRgbsbRibRibRc
bLeLsbRgbRebRiRgbRibsbRgbRgbRgbRgbLsbRebRebRibsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 36; Drug: PCAP2 3 然 Apo 50 然
bRibRsRsRsmmbRsRgbRsbRsbRsbLsbRsbsbRsRsRsLsmmbLsRsbLsLsmbRsRsmbRsbRibR
iLsLsLsmmbRsRsmbRebsbLsRsbRsbRgbsbRgbLsbLsbLibLebLebLibLgbLgbLjbLsbLsb
sbLsbLsbLsLsmbRgbLibRjbRjRibRsbRsRsmbRsbRsbRsLsbsbRsRsmbRsbRebLsbRsbLj
bRsRsRsmmbRsbRsbRsRsmbLgbLsLibLsbLebLsLsLsmmbsbLsbLgbLsbLsbRsLsbRsbRsb
LjbLgbLiLsLgLsbRsRgRgLsRgbLgbLgbLgbLgbLgbLsbsbRgbLgbLjbLsbRgLsbLgLsLgR
sLsbRsRsLsLsmmbLgbLgbLsbLgbLsbLsbLsRsbRsLsbsbLsbLsLsmbsbLsbRjbLsbLsbRc
bLsbLsbLsbLsbRsbLsbRsbRjbRjbRebLsRsbLgbRebRgbRsRebRjRsmbsbRjReRsmbRsRs
RsRsRsRgmmmmbRsbLsbRsbLgbRsLsbReReLsbLjbLibLgbLsbLsbLebRsLsbRsbLibLebL
sbLsbLgbLgbLiLsbLgbLsbLibLiLsbLgLsLebLgbLgbLsLebsbLhbLibRsbRcRsLsmbLsb
LcbLjbRjbRhbRgbRjbLsLsLsLsLgLgLsLgLsmmmbRjbLeLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 37; Drug: PCAP2 1 然 Apo 50 然
bRsRsLsLsRsRsRsRsmmmmmbRsbsbLsLsLsRsRgmmbRgRsLgmbLsLebLiLsLsmbRsLsbLcb
RsRsmbLsbRsRsRsmmbRsbRsbRsRsRsRsRsRsmmmmmbLsbsbRsRsRgmbRsbLsRsbRsRsRsR
smmmbLcLgLsLsmbLobRhRsmbLsRsbsbRsRsRsRsRsRgRsmmmmmbRsRsRsRsRsRsRsRsRsR
smmmmmmmmmbRsLsRsRsRsmmbRsRsRsRsmmmbRsbRsbsbsbLcbRhRsmbRgbRsRsmbLjbRsR
smbLsLsmbsbLsLsLsLsmmmbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 38; Drug: PCAP2 1 然 Apo 50 然
bLsbRsRsLsLgLsLsLsLsLsmmmmmbLsbLiLsLsLsLsLsLsmmmmmbLcLsLsLsLsLsLsLsLsm
mmmmmmmbLsLsLsLsLsLsLsmmmmmmbLsLsLsLsLsLsLgLsLsLsLgLsLsLgLsLgLsLgLgmmm
mmmmmbLsLsLsLsLsLsLsLsLsLsLsLsLgRsmmmmmmmmmmmbLsbLsLsLsLsLsLsLgLgLsLsL
sRsmmmmmmmbLsRsLsLsLsLsLsLsmmmmmbLiLsbLgLsLsmbRjRjbRhbRiLsLsmbRsRsRsRs
RsRsRsRsRsRsRsRsRsRsmmmmmmmmmmmmmbsbRsbRsRsRsRsRsmmmmbLsbsbLsbLsLsLsLs
LsLsLsLsLsLgmmmmmmmmbsbLgbRjbRcbLsbRsbRsRsLsLsRsRsRsRsRsmmmmmmbRibLsLs
LsmmbLgLsbLcLsLsLsLsLsLsmmmmmmbLiLsLsLsLsLsmmmmbLeLsLsLgLsLsmmbLeLebLs
bLsLsLsLsLsLgLgLsLsLsLsLsLsLsmmmmmmmmmmbLgLsLsLsLsLsLsLsLgLsLsLsLsLsLs
LsLgLsLsLsLiLgLsLsLgLsLsLsLsLsLsLsmmmmmmmmmmmmmmmmmmmmmbsbLsLsLsmmbLsL
smbLsLsLsLsLsLsLsLsLsLsLsLsLsLsLgLsLsLsLsLsLsLsmmmmmmmmmmmmmmmmmmmbLsL
sLgLsLsLsLsLsLsLgLgLsLsLgLsLsLsLsLsLsLsmmmmmmmmmmmmmbLjLgLsbLsRsLsLsRs
LsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmmmmmmmmmbLsLsLsmmbLsL
sLsmmbLgLsLsLsLsLsLgLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmmmmbLsLsmbLsLsLsL
sLsLsLsLsLsLsLsLsLsLsLsLsLsRsmmmmmmmmmmmmmmmmbLcLsmbLcLsmbRsLsbsbRibLg
LsbLsLsLsmmbLgRsbLsLsLsLsLsLsLsmmmmmmbLiLsLsLsLgLiLsLsLsLsLsLiLgLsLsLs
mmmmmmmmbLsLsmbLsLsLsLsLsLsLsLsLsLsmmmmmmmmmbLiLsLsLsLsLsLsLiLsmmmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 39; Drug: PCAP2 1 然 Apo 50 然
bRibLjbRsRiRsmbRsRjRsmbLibRjbRsbRjbLob

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 40; Drug: PCAP2 1 然 Apo 50 然
bRjLgbLhbLibLsbRsRibRsRsRsRsRsRsmmmmmbRgRgRsmbRibRiRsRsRimmbRibLcbRjbL
ibLgbRsbRsRsRsRimmbRgbRsRsRembRgbRgRsmbRsRsRsmmbRhbRhbRgRsmbRibRgbRsbR
sbRibLsbRibRgbRibRiRsmbRebRgbRebRhbRgbRebRsbRsbRgbRgbRsbLsbRhbRsRsmbRi
bLgbRiRsmbRibRgRsmbRgbRsbRsbRsbRgbLsbRgbLsbRsRsmbLibRsRhbLibRebRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 41; Drug: PCAP2 1 然 Apo 50 然
bRjbRibLibRiLsbRsbLsLsLgmbRsbRsbRebRebRebRgRsmbReRgRsmbRcbRsRsmbRjRsRs
RsmmmbsbRgbsbLsbRcbRiReRgRsmbRsbRjbLsRsbLiRsbLsLsmbsbLgbRobRsRebLsRiRe
bRiLsLsLsRsmmbRcbRebRibRgRiReRsmbRebRsReRsmbRgbReReRsmbRebReRebRebRsRs
RsmmbReRsmbReRsmbRsRsRsRsReRsmmmmbRgbLjbLjbLsbRgRsRembRhRebRebRcRsRsmm
bRgbRebRebRebRiReRsmbRsRsRsRsRgRimmmbRebReRsmbRebRib

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 42; Drug: PCAP2 1 然 Apo 50 然
bsbLsLsmbRsLsLgLsLsLsLsLsLsLsmmmmmmbRsbRsbRsRsRsRsRgRsmmmmbLsbLsLsLsLs
LsLgLiLsmmmmbLsLsLsLimmbsbLgLsLsLsLsLsLsmmmmmbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 43; Drug: Control Apo 50 然
bLsLjLgLsLsLsmmbLsLsLsLsLsLsmmmmmbLgbReRsmbLebRhRsRcmbRebRebRcRsLsmbRi
RsmbLcbRsRsRgRsmmbRsRsmbRgbLsRsRsmbLsbLiLsLsLsLsLsLsLsLsmmmmmmmbLsLsmb
LsLsLsLsLgLsmmmbLsLsLsmmbsbsbLsLsLsLsLsLsmmmmmbLsLsLsmmbLsLsLsmmbLsbsb
sbsbsbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 44; Drug: Control Apo 50 然
bRgbLsbRcRibLsbRibsbRibLsbRgRsmbRhbRibLgbLgbLsbLibRsbLcbLobRibRibRsbRg
bRsbRgbRsbRsbRgbRgbLgbsbLsbRsbLibLsbLsbLsbLsbLsbLsbsbLsbLsLsmbLsRsLsLs
mbLgLsbLsLsRsmbLgbLsbRsbLsbLsLsmbsbLsbLsLsLsmmbLsbRsbLsLsmbLibLsbLsbLs
bLsbLsbLcbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 45; Drug: Control Apo 50 然
bLeLsbRgRsRsmmbRgRsmbLsLsmbRsRsRsRsRgRsRsRsmmmmmmbRiRsmbsbsbsbLiRsRsRs
RgRsRsRsRsRsRgRsRsRgRsRgmmmmmmmmmmbRgRsRsRgRsmmmbRsRgRsRsLsRsRsRsRsRsR
smmmmmmmbRjbLsLsRsLsmbRiRsRsRsRgRsRsLsRsRsmmmmmmbRibRgbRsRsRsRsmmmbRsR
smbRsRgRsRsRgRsmmmbRgRsRsRsRsRsmmmmmbRhbLgRsbRsbRsRsmbRcbRiRsRsRsRsRsR
sRsmmmmmmmbRiRsLsmbRsRsRiRsRsRsRsRsRsRgRsRsRsRsmmmmmmmmmmmbRsbRiRsRsRs
RsRgRsRsmmmmmmbLsbLsRsRsRgRsmmbRsRgbLsRsRsRsRsRsRgRgRimmmmbRsRsRsRsLsm
mmbRsRsRsRsRgRiRsmmmmbRebRjRsmbRsRsRsRimmbRgbRgRgRsRsRsRsmmmmbRgRsRsRs
RsRsmmmmmbRgbLsRgRsRgmbRgRsRgRsRgRsmmmbLsRsRsRsRsRsRsRsRgRsRgRsmmmmmmm
mbRgRsRsRsRsRsRemmmmmbLgbRibRsRsmbRiRsRsRsRsRsRgRgmmmmmbRsbRsbRgbRsRsR
sRsRsRsRsRsmmmmmmmbLsbRsRsRsRsRsRsRgRsRsRsRsRgRgLsmmmmmmmmmbLsRgRsRiRs
mmbRiRsRsRsmmmbRgbRcbLibLsbRgRsRsRsRsRsRsRsRsRsRsRsRsLsRsRsRsRsRsRsRsR
sRsmmmmmmmmmmmmmmmmmmmmbRgbReRsmbRcbLsbRsLhbLsRsbLgbRhRsmbRsRsRsmmbRgR
sRsmmbRsRgRsRsRiRsmmmbRiRsRgmbRsRgRgRsmbRsRsmbRsbRsRgRsmbRsRsmbRsRsRsm
mbRsRiRibRcbRsbRgbRsRibRgRsRsmmbLjbLgbLhb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 46; Drug: Control Apo 50 然
bLobLcbRobRjbLobRsbLobLobRebRobRobLjbRjbLcbRjbLjbLebLobRcbRsbRcbRebRob
LcbRobRobLebLobLcbLebLjbRjbRobRjbLobLjbRebRsbRobRebLjbRebLjbLjbRjbRobL
ebRobRobLobRibRobRgbLobLjbLjbRebRebLebLebRcbLcbLobLcbLjbLjbRjbLcbRjbLo
bRobRsbLebLjbRebRebRjbLjbLebRsRsmbLjbLebLcbLsbRjRsmbLsbRebRcbLebRcbLeb
LebLebLobLobLobLcbRebRobRcbRobRobLebRebLobLebRobLebLobLgbRobLebRobRsbL
jbLjbLjbLebRobRobLhbRebRebLcbRobLebRcbRgbRsbRsbRobRobLsbRobRgbRebRcbRe
bRebLhbRobLcbRjbRcbRebLebLobLgbRobLobRjbLjbLobLjbLobRibLobRobRobLebRib
LobLobRjbLebLebRcbRobLebLebRsbLsbRibRobLebRsbRobLebRobRsbLebRcbRebRebL
obLsbRobLhbRebRjbRjbRobRcbLebLhbLobRcbRebRebRibLobLgbRobRobRobLsbRobRo
bRcbRobRobRobLcbRobLobRobLebLebLcbLebLobLobLcbLgbLobLibLobLebRcbLibLob
RobLjbLobLobLebLsbLcbRobRobLobRsbRibRobLjbRcbRcbLsbRobRgbLcbLobLobLebR
gbLobRobLibLebRobLebRobLebLcbLobLcbRsbRobRobRobRebLsbLcbLobRobRibRcbRo
bLebRcbRebRebLobLsbLobRgbLobRobLhbLcbLobRcbLjbLsbRcbLcbRobRibLsbRsbRob
RsbRjbLobRibRsbLcbLobRobLebRcbRcbRsbRebRsbLibLobRobRobLebRobLebRcbRobR
obLobLebRsbLjbLobLebRobRobLcbLebLobRobLobLobLcbLjbRobRobRsbLobRcbLebLo
bRebRebLcbLobRibRebRebLjbRjbRebLebRhbRgbRcbLobRhbRobLebLobRcbLebLjbRcb
RebRobRobRobLebLebLebRebRjbRobLsbRebRjbRjbLgbLcbRebLebLcbLsbRebRobLobR
cbRobRebRebLgbRcbRobRebRsbLcbLobRebRcbLobRobRebRobRebRobRgbLebLobRobLe
bLebRobLobRebLebRcbLebLcbRobLobRobRibLebRjbRebLebLobLobLjbLebRobLibLhb
LebLcbRjbLcbRsbLobLebLobLobLcbRgbLebLobRjbLjbRobRobRobLcbRhbRobRobRsbR
ebRebLcbLjbLebRebRobRebRebLobLebRsbLobRebRcbLobRcbRebLcbLsbLsbLobRebLo
bRsbRebRobRsbRcbLobLebRjbRobLhbLobLobLobRebLebLebRebLebLobRcbRobLobLcb
LebLebRcbLebLcbRobRobRjbRebLcbRobLjbRcbRsbRebLobRebLobRebRjbRebLcbLobR
cbRobRebLsbRcbLcbLibRobRcbRcbRebRobRobLebLcbRcbLcbRgbLobRcbRebLobLebLe
bRobLcbLebRebLobLebRobRebRebRcbLebLebLjbRsbLebRobLebLobLjbLobLobLobLsb
LebRobRcbRjbLobLcbRibRebLsbRsbLobRibLebLjbLsbRebRcbRobLobRebLebLcbLcbR
obLcbRobRobLebRebRsbLobLjbRebRebRcbLsbLjbRgbLebLcbRobLjbLjbRsbRobLobLo
bRebLebLgbRcbRsbRobLebRjbLebLebLobRjbRebLebLibLgbRobLobRobRobLobRcbRsb
RobRcbRobLebRhbLibRebLebLjbLibLcbRobRsbLebRobRjbLsbLebRobLobLibLsbRobR
obLebRhbLsbRobLebRjbRebLcbRcbLibLgbRobLobRobLobLjbLgbRobRcbRebRebLjbRe
bRobRobRsbRhbRobRobRobRebRebRobLgbRobLebRebRjbRobRobRobRobLsbLebRobRob
LsbRobRebLebLsbLobLobLibRobLjbRsbLobLcbLjbRhbLjbRcbRobLobLsbLebRobLebL
obLobRhbLebRobLgbLsbRebRebLobLcbRobLsbRjbLebRsbLebLgbRebLsbRobRobRobLo
bRobLjbRibLebRobRgbLobLcbRebRobRsbRobRebRobLobLsbLebRobRobLobLsbLcbLob
LobRobRibRobLebRjbRsbRcbLibLebLobRcbRobRebRobLobRobRobRebLebRobLsbRebL
obRobLebRobRsbLebLobRibLobLcbRebRobRebLobRjbRobRebRobRjbLobLobLhbRebRj
bRebLebRgbRobRebRebRibRsbLsbRebLebRibRcbLebLebRjRsmbRsbRebLcbRebLobRib
LebLebLobRebRobRjbLobRebRobRjbRgbRibRjbLebRobRobRobRobRsbRsbRgbLobLobL
jbLobRobRobRebLibLobLobRobRebRsbLcbLobLsbRebRobRobLjbRobRobLebRobLobLo
bRebLcbLobRsbRobLobLobLobLsbRebRobLobLobRebReRhbRcbLobRgbRsbRobRcbLobL
cbLibLobLobLobLobLibRsbRebRobLobRjbRcbLobLobRebLebLsbRgbLobLobRcbRsbRg
bLobRobLobRebLsbLcbRebRibLobRebLcbRebRcbRobRcbLibLsbRsbRebRebLsbRebLsb
LobLjbRcbLobRobLebRobRebLobLobRgbRcbRebRjbRebRobRjbLsbRobRobRobLjbLebR
ebRsbLjbLcbLebRcbRhbLebLsbRobLebLebRsbLobRsbRsbLjbRcbRebLobRjbRjbRsbLe
bLjbLjbLobRebRjbLsbLebLcbRjbLebLebRjbRcbRcbRobLsLebRobRjbRsbLsbRsbRobL
jbLsbRsbLobLebLjbLebRsbLsbLebLobRsbRebRebLsRsbRobLsbRobLobLjbLobRjbLob
RebLcbRobLjbLebRebLjRebRebRjbLebRebRebLobLobRebLebRjbLjbRobRobLobLobLc
bLebRebRebRebRjbRjbLjbLsbRjbLobRobLebLobLebLobRjbRcbRebRebRobRebLob

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 47; Drug: Control Apo 50 然
bRcbLsLgbRhRsmbLsLsmbRsRsRgRgRsRsRsmmmmbRcLsbRcbLsLsLsLsRsRsLsmmmmbRjb
LgbRsRgRsmbRgRsRsRsmmmbRsRsRsmmbsbRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmbRsR
gRsRsRsmmmbRjbRcbRcbLsLsLsmmbRgbRhbRsRsmbRsRsRsmmbLcbsbRsRsmbRsbRsRsRs
RsRsRsRgRsmmmmmmbLsbLobLsLiLsbRcbRcbRcbRobRcbRiLsbLcbLgLsLibLhbLsLobLi
bsbRsRsRsmmbRsRsRgRsRgRsmmmbRgRsRsmmbLebsbsbLsLsLsLsLsLsLsLsLsLsLsLsLs
LsLsLsLsmmmmmmmmmmmmmmmmbLsbLebRobRsLsLebRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 122539; End: 123039;
Recording: 12-1; Individual: 48; Drug: Control Apo 50 然
bRibRgbRibRibLsLjbsbLibLgLsRsLsbLebLebLgbLsbLiLsbLsLsmbLgbLgbRjbRcbRib
RsbLgbLjbLibLibLibRsbLgbLgbLebLgbLebLebLibLeLsLsmbLebLebLgbLeLsbLeLsbL
ebRsbRsRsLsmbLebsbsbsbsbLsbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 1; Drug: PCAP2 10 然 Apo 50 然
bRsbRsbRjRobRsbRobRhbLebRobRjbRobLebRoRebLjbRjbRobRobLobRjbLebRobLobRs
bLsbLsbRobRebRsbRebLobLcbRobLcbLobLobRsbLsbLobRobLsbRobLsbLsbRobRobLsb
LsbRobRsbLobLsLsmbRobRsbLobLebLsbRebLcbRsbLcbRsbLebRobLebLebLobRobLeLs
bLebRebRobLsbRobRsbLebLsbRsbLobLsbRsbLobRsbLebRsbLsbRsbRsRobRobLsbRsbL
ebLebLcbRobRebLsbRebRobLjbLsbRjbLobRobLcRsbLobRsbLsbRebLebLcbRsbRebRsb
RsbLcbLebLsbLobRobRsLebRobLjbRebLobRjbLsbLsLsmbRsbRobLsbLsbRebLsLsmbLe
bLsbLsbLsbLebLcbLsbRobRobLebRebRsbRsbLebLebRsbRebLsbRsbRebRsbRobLobLsb
LsbRsbRsbRsbRobLsbRsLsbLobLsLsmbLobLsbLsbLebLsbLsbLjbRsbRobLsbRebRsbRo
bRebRsbLebLobLsbLoLsmbRsbRsbLebRobRobLsRsbRobLsbLsbLobRebLjbLcbLobRebL
cbLsbRsbRsbLcbLsbLsbRobLsbLobRsbLsbLobLobLsbLebRobLsRsbLsbRsbLsbLsbLob
RebLsbRobLjbRsRsmbRsbLebLebLsbLobRobLsbLsbRobRobRobLobRsbRsbRebLsbLcbL
obLcbRsRsmbRsbRjbRobLeRsbRebRebLobRsbLsbRjbRebRcbRsbLjbRjbLobLebLsbReb
LsbLcbLcbRcbRsbRjbLobRsbLsbRsbRobLobRjRebRjbLjbLcbLobRebRebLebLobRebLi
bLobLsbLobLsbRsbRebLebRobRobLcbLobRobRobRobRobRobLebRcbLebLcbRobRsbRob
RebRobLebLobLjbRobLcbRobLjbLebRcbRjbRsbRobRebLobLjbLebLebLsbRjbRsbLebL
obRebRsbRobLjbRcbLjbRjbRhbRsbRobRsbRebRebRsbRobRobRjbLebRsbLjbLebLjbLe
bLobLibRsbLebRsbLobLebRobRobRsbLebRobRsbRgbLobRobLsbLsbLobLebLjbLobLob
LobLcbRobLobLjbRobLebLobRobRcbLjbRobRjbRsbLobLobRobLobLobLebLsbLobRobR
obRobLebLobRcbLsbRebRobRcbLobRobLcbLcbRsbRobRcbLsbLobLobRcbLobLobRobRc
bRsbRcbLebRsbLobRobRobRjbLobLobRcbRobRobRobLobLobLjbLobLjbRjbRobLcbRgb
RobLcbRobRsbRobRobLobRsbRebLsbLjbLobLobRobLjbRsbRobRobLobLobLobRebLobL
obLjbLjbRobLobLjbRobLobLjbRjbRobLebRobRobRcbRjbLjbLobLobRobLsbLobRobLo
bLobRobRsbLobLcbRjbRjbRibRsbRcbLcbLcbLcbLobLsbLcbRsbRobRcbLcbLjbLsbRcb
LobLobLjbLjbRcbLobLobRobLsbRebRobRobRsbLjbLebRobLobLobLebRsbRobLebRebR
obLjbRobRobLebRsbLebRobLcbLobRcbLobRobRibLobRcbLebLobRsbLobLobRobRcbRe
bRebRsbRjbRobRsbLobRcbRcbLsbLobRobLobLobLebRobLsbRobRobRobRcbRobRobRsb
RobLobRsLsbLcbLsbRsbRjbRebLsbRcbRobLjbLebRobRjbRobLsbLsbRcbRebRsbLsbRe
bLebRobLsbLsbLobRsbRsbLebLsbLebRsbLsbLjbRjbLjbRsbRcbLsbRobLsbRsbLebRsb
RsLsbLobRsbRsRsmbRobLsbRsbRobLsbRebRobRobRsbRobRobRsbRobLsbLsbLsbRsbRs
bRsbLsbRsbLebRjRsmbLsbLsbLjbLsbLsbLsbRsbRsbRsbRsbRobRsbLobLsbLsbRobLsb
LsbLsbLsbRobLobRsbLebRsbRobRsbRsbLsbRsLsbLsRobLjbLsbLobRebLsbLobRsbLsR
sbRsbRsbLsRsbRsbRsbLsbLsbLsbLsLsmbLsbRsLsRsbRsbLsbLsLsmbLsbRsbLsbRsbRs
bRsbRsbsbLsbLsbRsbLsbRsRsmbLsbRsbRsbLsbLsbLsLsmbLsbLsbRsbLsbLsbRobRsRs
mbRsbRsbLsbRsbRsLsbRsbLsbRsbRsbLsbLobRobLobRsbLsbRsbRobLsbRsbLsbRsbLsb
LsbRebLsbRsbsbRsbRobRsbRsbLsbRsbRsbRsbRsbRsbRsbRsbLobLsbLsbLsbRsbRsLsb
RsbRsRsmbLsbLsbLsbRsLsbLsbLsbLobLsbRobRsbRsbRsbRsLsbRsbRsbRsbLsRsbRsbL
sbRsbRsbLsbRsbLsbLsbLsbLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 2; Drug: PCAP2 10 然 Apo 50 然
bRsRsRsRsmmmbRsRiRsmbRsbRsRsRembRgbRebLhbLcbLsbRcRsmbLsLsmbRgRsRsmmbRs
bRsRsRsmmbRsRsmbReRsmbRgRsmbRibRgRgRsmbRhLsbLibRcbRibRsbRsRsmbRhbLgbLi
bRgRsmbRsRsRsmmbsbRgRsRsRsRgmmmbRcbLsbLcbLsbLoRsbRsbReRsRsmmbLsRsRsmbR
sRsRiRsmmbRebRsRsRsRsmmmbRsbRsRsRsRgmmbLobLgbRsbLsbLsbLsRhbRgbRibRibRg
bRgbRcbRhRsmbRiRsRsmmbRibRsbRgbRgbRsRsRsRsRsRsRsRgmmmmmmbRsbRsbRgRsmbR
sRsmbRsRsmbRgbRgbRgRsmbRcLsbLcLsmbLsbLoLsmbRsbLsbRcbRsRsmbRgRsmbRgbRsb
RsRgbRcRsmbLhbLibLcbRsRsRsmmbRsRsmbRsbRiRsmbRgRsmbRsRsmbLsbRsRsRsmmbRg
RsmbRsRsRsmmbRsRsRsRsRsRsRsmmmmmmbRibRsRsRsmmbRgLsbRibRcbLsbLcLsmbLibL
iLsbRsbLgbLsbLsbLsbLsbsbsbRibLebRgRsRsmmbRsRgbRgRsRsmmbRiLsbRobLsbRsbR
iRsRsmmbRsbRgbRsRgb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 3; Drug: PCAP2 10 然 Apo 50 然
bLsRgRsRsmmbRsRsmbRgRsmbRsRsmbRsRsLsRimbRgRsmbRsRsmbRsRhbRsbLsbRsbRgRs
mbRsRiRsmbLsLsLsmmbRiLsbRibRgRsmbLsbRgbRgRsmbRsbLsRsRsRgmbLsRsRsRsRgmm
bLsRgRsRsRsmmmbRgRsRsmmbRibLsbRsbRsRsmbRgbRsRsmbRsRsmbLsbRsRgRsRsmmbRs
RibRgRsmbRsRibRsbRsbRsLsRsRibLsRsRiRsmbLsRsRgRsRsRsRsRsRsRsRgmmmmmmmbR
gRsmbRsRsRsmmbRsRsmbRgbsbRibRgRgbRsRsRsRsRsmmmmbRsRgRsmbLsRgRsRsRsRsmm
mmbRgRsmbRgRsmbRgRsRsmmbRsRsRsmmbLsRibLsLsmbRsRsRsmmbRhRsmbRgbLsbRsbsb
sbRsRsRsmmbRsRsRsmmbRsRsRsRsRsRsmmmmmbRsRgRsRsRsmmmbLsbRsRsRsRsRsRsRsm
mmmmmbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 4; Drug: PCAP2 10 然 Apo 50 然
bRsLsbLsLsmbLsbLsLsLsmmbLgLsbLsLsmbLsLsRsmbLsbLsLsmbLsbLsLsmbLsLsmbLsL
smbRsbRsLsbLsLsmbLsbRsLgbLibLeLsLgLgLsLsmbLhLsbLgbLsbsbLsbLgLsbLsLsmbL
gLsLsLsmmbRsbLsLsLsmmbLsLsmbLsLsmbLgbLsLsmbLsLsmbLgLsbLsLsLsLsLsLgLsLg
RsLsmmmmbLgbLsLsmbLsbLsLsmbLsLsmbLsbLsbLeLsLsmbLebRsRsRsLsmmbRsbLsbRsb
LsRsbLsbsbsbsbRsbRsRsmbRibRobLibLiLsLgLsLsLsmmbsbRsLsbLgbLsRsbLsLsRsmb
LsLsLsmmbLibRjbLgbLsbLsLsmbLsLsmbLgbLsLsmbLgbLsLgbLsbLsbLsLsmbLsLsLsLs
mmmbLsbLsLsmbLsLsmbLgLsbLsLsLsmmbLgbLibRsbRsLsbLsbRsbLsLsmbRsbsbRsbLsR
sbLsLsLsmmbLsRsbLgbLsbLsbRsRsLsLsRsmmbLsbLsLsLsmmbLsRsbLsLsLsRsmmbLsbL
sLgLsLsmbLgbLsLsLsmmbLsbLsbLsbsbRsLsbsbLgbLgLsbRsbLgbsbLgRsLsbLsLsLsmm
bLsLsLsmmbRsLsLsmbRsLsLsLsmmbLsbLsbLsRsbLsLsLsmmbLhbLcLsLsmmbLibLhbLob
sbLcbRgbRsRiLsbRibRsRsmbRsRgRsRsmmbRebLcLgLsbRebRiRsmbRsRgbLsRgbRgbRsb
RiRsRsmmbLibRgRsRsmmbRibLsRsbRgbLsRgRsmbRsRsRsRsmmmbRibRsbRgbRsbRgRsRs
mmbRgbRsRsRsRsmmmbRsbRsbRgbRsbsbRgRsmbRsRsmbRsbRsRsmbRsRsmbRsRsmbRsRsR
sRsmmmbRsbRsbRgbRsbRibLebRjRsmbLsbLsLsRsmbLgLsbLsLsLsmmbLgbLiLsbLsbLgb
LgLsbLibLsLgLsLsLsmmbsbRsRsRsRsLsRsmmmbRsbRsbRsbRgRsRsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 5; Drug: PCAP2 10 然 Apo 50 然
bRsLsbRjbRsbRcRsmbLgbRcRsLsmbsbLsRsbLsRsbLsbRebRsbRsbRhRsmbRsbLsbLsLgL
sLsLsmmbLsLsmbLgLsbLsbLsbLsLsLsmmbsbsbsbRcLsRsbRsRsmbRsRsRsRgmmbRsRgbR
sbRsbLsLsLembLsLsLsLsmmmbLsbLsLeLsbRsbLsLsLsLsLgLsmmmbsbLsLsLgLsLsmmbL
sLgbLsbLsLsLsmmbLsLsLsLsRsLsLgRsmmmbLsbLsLgLsbLgbRsLgbLsLsLsmmbLsLsLsL
sLsLimmmmbLgbRsLsLgLsLsLsmmbLsbsbLsLsRsLsLsLsmmmbLsLsmbLsbLsLgLsbLsbLs
LsLgLsmbLsLsLsLsmmmbLsLsmbLsLsmbLsLsmbLsLsLsmmbLeLsbLsLibsbLsLsmbLsLsL
smmbLsLibLsLgLsbLsLsmbLsLsmbLgLsRsbLsbLgbRsLsLsmbLgLsbLsbLsLsLsmmbLsLs
LsmmbLsLsLgLsLgmbLebRibRebLsRsbLsbLsbLsbLebLgbLsLsLsLgmmbLgbLsbLsLsLiL
smbLsbRsbLsbLsRsbLsLgLgbsbsbRsbsbLsbLsbLsbLsLgbsbsbRsLsbLgLsLiLeLsbRgL
sbsbLhbLsbLsbLsLsmbLsbLsLsLiLsmbLsbLsLsLsLsmmmbsbLgLgbLsbLsLsLsLsmmmbL
iLsLsLsLhmmbLsLsmbLgLsbLsLibLgLsbLgbLgbLgbLsLsLsLimmbLsbRibRcRsmbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 6; Drug: PCAP2 10 然 Apo 50 然
bRgRgbRibLcbRibLgLsbLjLibRgbRsRsRsmmbLsbRcbRsRgbRcbLsbLsRsbRgbRsbLsbLc
bLgLsbLibsbLsbRiRsmbRibsbRsLcbsbRsbLgLgbLgbLsbLsbLgbLhLsbLsLsmbLgbLibL
ebRjbLgbLsLsmbLsbLsbLsLsmbLsbsbLgbLgbRsbLsbLgLsbLgbLibLibLebLsbLsbLebL
sbLsbLsLsmbLsLsmbLgLsbLcLsRsLimbLgbLsbLgbLsLgbRgbRsRsmbRsLcbLsbLebLsbL
sbLsbLgbLsbRebRobLobLgbLgbRsbRsbRsbLsbRsbRcbLsbRsbRjb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 7; Drug: PCAP2 3 然 Apo 50 然
bRsRsLsmbRgRsRsmmbRgbRsbRgRsmbRsRsRsRsmmmbLsRsRsRsRsmmmbLsbLsbRsbLsRsR
sRsmmbLsRsRsRsmmbRsbsbRsRsmbRsbRgbLjbRsbsbLsRsbRsbRsRsmbRsbRsbRsRsRsmm
bsbRsRsmbRsRsmbsbRsRsmbRsbRsRsmbRsRsmbRsbRsbRsbsbLsRsRsRsRsRsmmmmbRsRs
RsmmbRsbRgRsmbsbsbRsRsmbsbsbsbsbRsRsmbRsRsRsRsmmmbRsbRsRsRsRsmmmbRsbRg
RsRsmmbLsRsbLsRsRsRsRsmmmbRsRsmbRsRsRsRsRsmmmmbLsLsRsmbRsbRsbRsbLsRgRs
RsmmbLsRsbsbsbRsbRsbRsbRsRsRsRsRsmmmmbRsRsRsmmbLsbRsLsLsmbRsbRsbRsbRsR
sRgRsRsmmmbRsbRsRsRsmmbRsRsRsmmbRsRsRsRsmmmbsbRsbsbsbRsRsmbRgbRgbRsRsR
smmbLsRsbRsRsmbRsRsmbsbRsRsRsmmbLsRsRsRsLsRsRsmmmbLsbLsLsRgRsRsRsmmmmb
RsRsRsmmbRsRsRsmmbRsbLsRsRsmbRsRsRsmmbRsRsRsmmbLsRsRsRsRsmmmbRsbRgbRsR
sLsRsRsRgRgmmbRsRsmbRsbRsRsmbRsLsbRgRsmbRgRsmbRsRsmbRgRsRsmmbLjbsbLsbR
hRsmbLsRsbRsRsmbRgbRgbRsRsmbRsRsmbRgRsRsmmbRsRsRsRsmmmbRsRsRsmmbRsbRsR
smbRsRsmbRsbRsRsmbLsRsRsRsmmbRsRsRsRsmmmbRsbRsRsmbLsRgbRsRsRsRgmmbRgRs
mbRsRsRsmmbRsRsmbRsbsbsbsbRsRsRsmmbRsbsbRsbsbRsLsbRsRsmbRsbRsRsmbRsRsR
sRsmmmbRsbLsRsRsRsRsmmmbRsRsmbRsRsmbRsbsbRsbsbRsbRsbLsbRsbRsRsRsmmbRsb
RsRsRsmmbLsRsbLsRsRsmbsbLsLsRsmbRsbRsbLsRsbLsbRsRsmbRsbLsRsRsmbsbsbRsb
RsRsmbRsbRsbRsbRsRsRsmmbRsRsRsmmbRsRsmbRsbRsLsLsmbRsRsRsLsRsmmbLsbRgbs
bsbRsRsmbLsRsbRsbRsbRsbRsbLsbRsRsmbLsbRsbRsbRgRsRsmmbLsbRsRsRsLsmmbRgb
RsRsRsmmbLsRsRsmbRsRsRsRsLsRsRsRsmmmmmbRiRibRgRgbRgRsmbLsLsLsmmbRsRsmb
RgRsRsRsmmmbRgbRsbRibRsbRsbRsbRgRsRsRsmmmbRsRsmbRsbRsRsmbsbRsRsmbLjbLi
bRjbRsRsRsRsmmmbRgbRgRsmbRgRsmbRebRsRsRsRsmmmbRsRsRsRsmmmbRgRsRsRsmmmb
RgbLsRsbRsbRsbRsbRsbRsRsRsmmbRsRsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 8; Drug: PCAP2 3 然 Apo 50 然
bLcLsLsLgmmbLobLcbLibLibLcLsmbLeLsbLcbRibRhbRgRsmbLjbLibRcbsbLibLcLsLs
LgLsmmbRobRsbLibRhRsRsmmbRsRcLgbLcLsLsmmbsbRsbRsRsmbRcbLeLsLsmbsbRcRsR
smmbRobRcLsbLoLsLsmmbsbLgLsbLcLsLsLsLgLsLsmmmmbRcRsmbRoLsbRsbLjbLcLsmb
RsRsRsRsRsRsRsRiRhmmmmmmbRgRsRsmmbRgRsRsLsmmbReRsmbReRsmbRsRsRsmmbLsLs
LsmmbRsRsRsRsRsmmmmbRsbRebRcbLoLsLsmmbRibRcRsRsmmbsbLibReRsRsmmbRibRcb
LebRcRhbRebLcLcbLsLsmbRcRsRgmbLsbRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 9; Drug: PCAP2 3 然 Apo 50 然
bLsbLsbRsbLsbRsbRjbRsbLibRsbLibLgbLsbLsbLsbRsbRsbLibsb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 10; Drug: PCAP2 3 然 Apo 50 然
bLebRsbLsLgLsbRsRcbRgRsRsRsmmmbRsbLsbLsbRgRsmbReReRsLsmbRobsbLsbLsLsLg
LsmbLgLsbRjbLsRcRsmbRebLgbRsRsmbRsbRsReRsmbRgRiRsRhmbRiRibRebRebRgbRsb
RsbRsRgbRiRiRsmbLsbRgbRsbRsbRsRsmbLsbRibRsbRgbsbsbRhbRgbRibRgbRgbRsbRe
bRibRsbRgbLsbRgbRcLsbLgbRsbRgbRsbRgbRiRibRsbLsbLsbRsbRsbRsbRgbRsbRsbRs
b

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 11; Drug: PCAP2 3 然 Apo 50 然
bLsbLsbLsbLsbLsLsLsmmbLsbRsLsRsLsbRsLsLsmbLgLhbLeLsbLsbLsLsmbLsLsLgmbL
sLsmbLsLsLiLembLsLsRsmbLsLhbLhbLsLsLsLsLgLimmmbLgLsLebLsLsLsLgmmbLsbLs
LiRsbLgLhLebLebLsLsmbLsLgLsLgLsLsLgmbsbLgLsLibLsbsbRjbLhbLsLsmbsbLiRsb
LsbLiLsbRsLsLiLiLsLsmbLsbLsbLgLsbLhLsbLgLsbRsLsbRsbLsLsmbLgbLsLsLeLsRs
LeLsmbLsbRsbLgLsLgLgLsLgbsbLsbLsLsLsLsmmmbLibLgbsbRsLsbLsLsLsmmbLsbLsL
smbRsbLgbLgRsbLsRsLsbLsLsmbLsLsmbLsbLsLsmbLsLsLimbRsLsLsLsmmbLgbLsLgLe
LsbLgRsbLibLsLsLsLsLgmmmbLgLsLgbLebLsbLsLsmbLgLgLgRsbLgbRsLiLsLsLsmmbL
sbLsLsmbLsLsmbLsLsmbLsLsLsLsLsLsLsmmmmmmbLsLsLsLsLsmmmmbLsbLsLsLeLsLgL
smbLgbLgLsbLgLgLsbLgLgbLibsbLsbRsbRsbLsbLhLsLsmbLsbLsbLgRsLeLsbLsLiLgb
LebRsLgLsLgLgbLgLgbLiRsbLgLsLsmbRsLsLsLiLsLsLsmmmbLeLsbLsbLgLgLsbLsbRs
LgLsbLibLsLsLsmmbLsbRsLsbLgLsLsmbLsLsRsLsLsLsLsmmmmbLsbLgbLsbLsLsmbLsL
sLsLsLsLsLsLsLsmmmmmmmmbLsLsmbLcRsbRjbLsLsLsmmbRsbLsbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 12; Drug: PCAP2 3 然 Apo 50 然
bLebRobRebRobLcbLobLcbRobLsbLebRebLobRobLjbLjbRebRjbLjbLcbLjbRebLjbLeb
RjbRjbLcbLobRobLcbRjbLcbRobRjbLjbLcbRobLcbLsbLobLebLobRcbRebRobRcbRjbR
cbLjbLcbLcbRcbRebRsbRobRobLobLobLsbLobRobRobRobLebLobLjbRobRebRobLebLc
bLcbRjbLebRobLcbLebRsbLjbLebRobRobLobRobLcbLobRobRobLebLjbRjbRcbLobRob
RobRobLcbRobRebLjbLjbLcbRobRjbLebRjbLobRjbLjbLobLebLebRjbLebLobRjbLebL
obRjbLebLjbRebRcbLobRobLobLjbLjbRjbRobLsbRebRebRjbRjbRjbRjbLcbRebLjbRc
bLobLobRebRebLobLebLcbRobRcbLebRcbRebLebLobRebRebLjbLebRjbRsbRobRobLcb
LcbLjbRjbLebLjbRobRobRebRobLcbRobRobLebRebRcbLebLcbRobLjbRjbLjbRobRobR
jbRebRobLsbLebRebLebRjbRjbRjbRobLebLebRobLebLsbLebLebLobRebRsbRsbRcbRo
bRobLjbLcbLobLjbLjbRcbLcbRobLobLcbLebLcbLjbLebRebRebRebLobRcbLjbLobReb
LjbLjbRobRebLobLsbRobLobRjbLcbLebRcbRjbRcbLcbRjbLjbRobLobLcbRobLobRjbL
obLebLjbRebRcbLcbLjbRobLcbLebLcbLjbLcbRsbLobRcbLobLobRebLjbLebRobRjbRs
bLobRebLebLebLjbLjbRobLjbRobLjbLjbRebRjbRjbRsbRebRjbLobRobRjbLebLebRjb
RobRjbLobLebLobRebLobLebLobLebRobRcbLsbRobLibLcbLebLebRebRcbRjbRsbRebR
cbRobRobLjbRcbRebLebRobLjbLobLobLcbLebRebLobRcbLobRcbLcbRobRebRobRobRo
bRcbLobLebRcbRsbRebRjbLjbLebRjbRebLcbLebRebLebRobLebRcbLebRibLobRobLjb
RcbRobRebLcbLhbLebRibLobRobLebRebRobRebRebLobRobRobLgbRobLobLebLebRebL
jbRebLobRcbRobLcbRcbLobRobLebRebRcbLcbRgbRobLobLsbLobLsbLcbLobLobLebRo
bLibRobRobRcbLobLebRobRgbRebLebLibLebRibRhbRobLebRibRcbRobRobLibRsbLcb
LobRobRgbRsbRgbLebLcbLcbRebRobRobRobLsbLcbRobLhbLobLobLsbLebLcbLibRobR
cbLhbRibRobLebRibLcbRsbRobRcbLsbLebRcbRobLebRcbRobLobLobRobRebLobRobRe
bRobRjbRobRobLobLcbLebLibRobRebRcbRcbRobLgbLcbRobLsbRsbRcbRebLebLcbLcb
LobRcbLobRsbRcbLsbLsbRcbRobLobRobRjbLobRobRebLobLcbRibLebRebRsbLjbRebR
cbLobRobLjbRebRsbRcbLcbRobLobRsbLobRcbLcbRsbRobRobRebRebRobLcbLobLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 13; Drug: PCAP2 1 然 Apo 50 然
b

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 14; Drug: PCAP2 1 然 Apo 50 然
bRsRsRsRsRsRsRsRsRgRsRsmmmmmmmmmbRsRsmbLsbLsbsbLsbRsLsbRsLsbRsRgbRibLs
bRsRsRsRsRgRsmmmmbRsRsRsRsRsRsRsRsRsRsRgRsRsRsRsRsmmmmmmmmmmmmmmbRgRgR
sRsmmbRsbRsRsRsRsRsRsRsmmmmmmbRsbRsRsRsRsRsRgRgRsRsRgRsRgmmmmmmmbRsRgR
sRsRsRsRsmmmmmbRsRsmbRsRgRsmbRsRsRsRsmmmbRsbLsRsRsRsRsRsmmmmbRsbRsRsRs
RsRsRsRsRsRsmmmmmmmmbRsRsmbRgbRsRsRsRsRsmmmmbRsRsRsRsRsRsRsRsRgRgmmmmm
mmbRsRsRgRsRsRsRsRsRsLsRsRsRsRsRsRsRsRsLsmmmmmmmmmmmmmmbLsLsRsRsRsmmmb
RsRsRsRsRsRsRsRsRsRsRsRsRsRgmmmmmmmmmmmmbRsRsRgRgRgRhRsmmbRsbRsRgRsRgR
smmbRsRsmbRsbRsRsRsRsRsmmmmbLsRsRsRsRsRsmmmmbRsRsmbRsRsRsRsRsRsRsRsmmm
mmmmbRsRsmbRsRsRsRsRsRsRsRsRsRsRsRsRsRsRiRsRimmmmmmmmmmmmmmbRgRgRsRsRs
RgmmmbLsbRsbRsbRsbRsbRsRsRsRsRsmmmmbRgRsLsmbRsRsRsRsRsRsRsRsRsRsRsLsRs
RsRsRsRsRsRsRiRimmmmmmmmmmmmmmmmbRsRsRsRsRsRsRsRsRsmmmmmmmmbRsRsRsmmbR
sRsRsRsRsmmmmbRsRgRsRsmmbLsRsRsRsRgRsRsRgRgRsmmmmmbRsRgbRsRsRsRsRsRsRg
mmmmmbRsRsRsmmbRsRsRsRsRsRsRsRgmmmmmmbRsRsmbRgRsRsmmbRsRsRsRsRsRsRsRsR
sRsmmmmmmmmmbRsRgRgRsRsRsRsRgRsRsRemmmmmmbRsRsRsRgRgmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 15; Drug: PCAP2 1 然 Apo 50 然
bRsbRsbRsbLiLsbLgRsbRsbLebLgbLibLhLsbLgbLiLsbLsbLibLeLsbLiLsbLibLeRsbL
eLsbLsbLibLgLgbLgLsbRsLsbLgbLebLgbLgbLgbLgLgbLibLibLsbLebRsbLsbRebLjbL
ibLsbRgbRsbRgbRsbLsbLjbRib

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 16; Drug: PCAP2 1 然 Apo 50 然
bLsbLobRebLcbLobRobLobRebLjbRjbLsbLjbLjbLebLobLsbLjbRebRebLjbRgbRobLjb
LobRebLobLobRobLebLsbRobLobRibLebRsbLsbLobLobRgbLobLobLsbLsbRsbLebRebR
ibLjbRobLobRjbLebLebLebRobRebRobLobRsbRebRebLebRobRjbLsbLebLgbRobLobRj
bRebRsbLebRobLsbRebRebLebLobRobLebRobLobLobRebRebRebLobRebLobLsbRobReb
RgbRcbLcbRobRobLsbRsbRsbRebLcbLobRhbRobRebLsbRebRgbRobRobLebRobLjbLcbL
ebLobRobRobRebRobLebRebLibLobRjbLobRobRibLobLobRcbLebLebRebLsbLgbLebRo
bRebRjbLgbLebLobLsbLebLebLobRobLgbLobLebRjbLebLobLgbLsbLebRobRgbRobLib
LsbRsbRebRgbLgbLobLobLebRebRobLebRobRebLobRobLobLobRebLsbLebRgbRobLsbL
obLsbRebLobLjbRebRebLsbRobRobRobRjbLobLcbRobRsbLjbLobLobRobLjbRebLebRs
bLgbRobLobLjbRobLgbLobLobRebRcbLobLgbLebLhbRobRobRgbRobRebRjbRobLebLob
LsbRebLobRjbRobRebRobRgbRjbLobLhbLobRobRobRobRobLsbRcbLobLjbLobRebLobL
obRhbRsbLibLjbLsbLobRobRobLsbLebRgbLobRgbLibRsbRebRsbLcbLebLgbLjbRgbRo
bLsbRjbRobLcbRebLsbLebRgbLgbRjbLebLobLebLobLobRobLgbRobRgbLibRcbLcbReb
RcbRibLebLjbLjbRobLjbLebRobLobLsbRobRobRgbLsbRjbRibRgbRobLobLcbLobRobL
ebRgbLobLibLobRebLobLebRobLjbLcbRebLobRobLjbLebRsbRcbRsbRobLhbLebRjbRc
bRjbLebLobLobLobLsbLibLsbRobLebLobLibRobLobRcbLjbLobRobRgbLebLcbLebLcb
LebLebRcbRobLcbRibRcbLobLobLcbLebRobRsbLibRobRsbRibRebRebLobLobRobRjbL
ebRobLjbLobLgbLgbLobRcbLjbRibLobRgbRebLibRobRebLobLcbLobLobRobLebRobLo
bLobLcbRgbLsbRebLjbRibLsbRebRsbRhbRebRcbRobLebRobRibRobRebRcbLobRibRob
RobRobLgbRobRsbRobRobRebRobLobRobLebRobRobLsbLgbLsbLobRebRebLobRobLobL
obRobRgbRobRobLebLcbRcbLobLebRobLibRobRobLobLobRcbLebRcbLebLobLjbLobRe
bLobRsbLobRcbLobLobLjbRobRcbLebRebLcbRibRobLobLobRhbRcbRebRibRebLobRob
RcbLobRobRebLcbRsbRibLobRcbLcbRcbLebRobLobRobLobRobLcbLobRgbLjbRobRobL
jbLibLcbLobRibLebRjbRcbLobRobLibRcbLobLsbRcbLsbRobRobLgbRgbLobRgbLobRo
bLobLobLebLgbLobLebRcbRcbLobRobLobLobRobRhbRobLobLibLebRibLgbRobRobRob
RebRgbRhbRobLebRobLcbRebRobRobLjbLjbLibRobLobRsbLsbRcbRcbLsbRsbRebRebR
ebRibLebRsbRibRgbRebRcbRobLebRcbLibRobRgbLgbRobRobLobRibLobLobRebRebRc
bRebRgbRebRcbRebLobRebRobLgbLobLcbLebRobRebRibLsbRobLibLcbRobRobRobLcb
LobRgbRebRcbLebRgbRibLibLcbLebLcbRebRebRcbRobRebRobLcbRsbLobRgbLobRobR
obRgbRebRobRebLcbRobLobLobRebLhbRhbRobLobRcbRebRobLgbRcbRebLebRsbRebLc
bRebRobLobRobLebRebLcbRcbLgbRcbRibLebLebRebRgbLsbRobRobRgbRibLebLhbReb
LcbLebRcbLhbRcbLobRebRsbLobRobLobLjbLobLobRsbLcbRhbLobRsbRobRcbRcbRobR
obRjbRjbRobLebLebLcbRobRcbLobRibRobLobRobLcbRcbRobLobLcbRobRcbRebLjbLo
bLebRebRsbRcbRcbLcbLobRjbRhbRebLcbRobLebLebRobRobLobLebLobLebLcbRebLeb
RebRobLebRobLobRebRgbLobLhbLcbRobRgbLsbRobRobRcbRibRobLebLobLobLhbLebL
ibLobLobRobLcbRobLibLebLebRgbLibLcbRebLebRebRebRebRgbLobRebLobRebRebLs
bRobRebLsbRobRebRjbRobLcbRebLcbLjbRibLebLobLcbRibLebLobLebRobLebRobRob
LebLobRebLcbLebLobLsbLebRebLebRobLobLjbLebRobLobRebRobRcbRobLebRjbRjbL
gbRjbLjbLgbRobRibRobRjbRjbRsbRsbRjbLobLobRobLibLebLobLcbRobRebLobRcbLo
bLebRobRebLebLobLobRjbRobLebRobLebLobRebRobRsbLebRibLcbRhbLobLebLcbLhb
LebLobLcbRjbLebLjbRobLobLobLobRobLjbLebLobRebLebRobRebLcbRsbRebRobRobL
jbRgbLobRobLebLobRcbRcbLebRebRebLobRcbRcbLobRebLebRobRobRebRsbLcbRcbRo
bRobRobLcbRebLobLobRebLobRibLobRobRebLjbRsbRebLebRobLibRebRobRsbRobLeb
LgbRobRcbLjbRobRcbRebRebRobRobLsbRob

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 17; Drug: PCAP2 1 然 Apo 50 然
bsbsbsbsbsbsbLsbRcbsbLsbLsbLoLsmbRcRsmbRibsbLsLsmbsbRgRsmbsbLsbsbsbRcb
LiLsbLcbRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 18; Drug: PCAP2 1 然 Apo 50 然
bRsRsmbRobRsbRcbLiLsbLgRsLsbLgbLgbLsbLcbLibRibLhbLsLsLsmmbsbRibLsLgbLg
RsLsRsbRsbLgbRibRiRebRsRgbRgbRsbRgbRcRsmbRgRsmbLsbRsRsmbRsRsmbLsRsRsmb
RsbRhbRgLsRsbReLsbLsRibRsbRsRsRsmmbRiRsRsmmbRgbRcbLebLobLgRsbRhbRhRsmb
RgRibRsbRibLcbRebRjbRebRsRsRgmbRebRgbRebRebRgbRibLibRhbRgbRibLsbRiRgbR
gbsbRobLgbRibRgbRgbLsRebRgbRgRsmbRcbRsbRebLcbLgbLibLibRgbLsbLsbRgbRebR
ebRhb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 19; Drug: Control Apo 50 然
bsbsbsbsbsbsbRsbLsRsbRsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 20; Drug: Control Apo 50 然
bsbRsbRsbRgRebRebRsbRsbRsbRsbRsbRsbRsbsbsbRsbRgbRsbLebRsbRsbRsbRsbRsbR
sbRsbLsLsmbLsbLsbRsbRsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 21; Drug: Control Apo 50 然
bRsRsRsRsRsRsmmmmmbRgRsRsmmbRibLobRsbLhbRgbRhRsmbRgbRgLsbRsbRsLsRsbRcR
smbRsLsbLsLsLsLsLsmmmmbLsLsmbLiRsbRobRibRcbLebLiLsbLhbLiLsLgLibRsbRsRs
LsLsmmbsbLsRsbRsLsbRsbRsRsLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 22; Drug: Control Apo 50 然
bsbLibRcbRcbRcbRgbLcbRcbRcbLobLobsbLhLsbRcbRibLeLsbLhbRgbRcbRhbRibRobR
gbLcbLebLgbLibsbLcbRsbLsbLebLhbLcLsmbLibLobRsbRibReRcRsmbsbsbLiRsbRcbR
eRsmbLibRcbRsbRibLcbLiRsbLgLsbsbsbsbLgbRjbRcbRibLjbLibsbLgRsLsbLeb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 23; Drug: Control Apo 50 然
bRsbLsbLgbLsbLgbsbLsbLsLsRsmbLsbRgbRebRebRsbRiRsmbRsbRsbRsbRsbRsbsbRsb
sbsbRgbRsbRsbLsbLjbRsbRsbRsRsmbsbsbsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 24; Drug: Control Apo 50 然
bsbsbsbsbLjbLsbLgLsLsLsLsLsLsmmmmmbLsLgLsbLsbLsLsLsmmbLsLsmbsbsbLjbRsb
LgbRhbLsbRhLsbLhbLcLsmbLibLgbRcbsbLibLcLsmbLcLsmbLhRsbLibLcbLiLsbLcbLi
LsbLhbRcRsmbRcRsmbRhRsLsmbRcbLsbRcbRcbLibRjbsbRcRsmbRebLibLebLeLsbLibL
ibLiRsbLiLsbLhbLibLibLiLsbLcbLibLgLgbLjbRsLsbLibLebLgbLsbLgbLgRsbLsbLg
bRjbRcbRgbLeRsbLcbLhLsbLiLsLiLsbLibLcbLsLsmbLgLsLsLsLsmmmbLiRsbsbsbsbs
bsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 25; Drug: PCAP2 10 然 Apo 50 然
bRgbRgbRiLsRsRsmbsbRsbLsLcbLsbRsLsbLsRsbRjbLjbRiRsmbRebRjbLjbLsbRsbRsb
RsbRsbRsbLsbLsbRsbRsbRsbLsbRsbRjbLsbLsbRsbLsbRgbLsbLsbRsbLsbRsRsmbLobR
obRsbLsRsbLsbRsbRsRsmbLobLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 26; Drug: PCAP2 10 然 Apo 50 然
bsbLsbRgbsbsbLsLsLgmbRcbRcbRiRsRsmmbRcbRoRebRibLsbRsbLgbRsbLsbRsbRsbRs
bLgbLibsbLgbLgLsLgbsbLiLgLsbLgbLgbLobLsbLsbRsbLgLsbLhbLebLsbRibLhbLeLs
bLgLsLsLsLsLsLsmmmmmbLsLsLsmmbLgbLebLibRoLsbRsbRsbRgbRgLsbRiRsmbRoRsRs
mmbsbsbsbLibRgbLsbLiLsbLebLgLsbRsLiRsbLibLibLeLsbLgLsLsLsLsmmmbLsLsLsL
eLsmmbLeLsbLhbLgbLsRsbLebLobRebsbLibLsbLsLsLsLsLsLsLsmmmmmmbLsLsLsLsLs
LemmmmbLibLgbLhbLsLeLsbLebLebLsbLsLebLgLgLsbLgbLsbLsbLgLsbLgLsbLsbsbLs
RsbLsbRsbLgLsLsLsmmbLsLsLsLsmmmbLgbLsLsLsLiLsLsLsmmmmbLiLiLsbLeLsbsbLi
bLgbLsLsLgLsLsLsmmmbLsbLsLsmbRsLsLsmbsbLsLsLimbsbLiLsbLgLsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 27; Drug: PCAP2 10 然 Apo 50 然
bsbRsbLgLsLsLsLsmmmbLsLsmbLsLsmbLsbLsbRsLsLsmbLgLsbLsLiLgLgbLhLsLsLsmm
bsbLsLsLgmbRsbRhRsRsRsmmmbRsRsRsRsRsmmmmbsbRsRgLsbLgRsbLgbRsLsLsmbRsRg
bLeLsLsmbLsLsmbRsLsbLebLsbRsbRgbRsRsRsLsmmbLibLgLsLsLsmmbRsbRjbRsbRsbL
gRsLsbLsLsmbLsbLsLgRsbRsLsLsLsmmbLsLsLsLsLgLsmmmbLgLgLsbsbLgLsLsmbLsLg
bLsLsRsLsmbsbLsLsLsLsLsmmmmbLgbLgLsLsmbLsLsmbLeLsbLiLsLsLgmbLgLsbsbLsL
sLsLsLsmmmmbLebRibLsLsLsmmbRsRibLgRsbLsLsLsmmbLgbLsLsmbLoLsmbLebRiLsbR
sLsLsmbLgLsLsLsLsRsRsmmmmbRsRsmbRsbsbLgLsbLsbLsbLsRsRsRsRsRsmmmmbLeRsb
RibRjbRgbLsbLhbRsbLsbLgb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 28; Drug: PCAP2 10 然 Apo 50 然
bLsbRsbRsbRsRsRsRsRsRsRsRsRgRsRgRsRsRsRsmmmmmmmmmmmmbRibLgLsLsLsLsmmmb
LsbRhRsmbLsbsbRsbRsbRsRsRsRimmbRcLsLgbLjLsRsmbRsLsbLsRsbRsLsRsbLsbsbLs
bRsbRsRsmbLjLsmbRjbRsbsbLsbRsbRgbLsbRsRsRgRgRsRgRgRsRsRsRsRsmmmmmmmbLs
RebsbsbsbsbsbRsRiRsRsRsRsRsLsRsRsRsRgRsRsRgRsRsmmmmmmmmmmmbRgRgRsRsRgR
smmmbRgbRgRsRsRsRsRgRgRsRsmmmmmmbLjRsRibsbLsRsRsRsRsRsmmmmbRgRsRiRsRsm
mmbRsRgbRsbRsRsRsRsRsRsmmmmmbRsRiRsRsLsmmbLcbRebRiLsbLjLsmbsbLsbRsbLsb
RgbRsRsRsmmbLsbLsRsbRsRsRsRsRgRsRiRemmmmbLsRsRsRsmmbLsbReRsmbRibRibLcb
sbsbsbLgbsbsbRsbsbsbLsbLsbLsbRgRsRsRsRsRsRsmmmmmmbsbsbRsbRgLsLsLsRgRsR
sRsmmmmmbRgRebRsLsbRgRsRsRsmmmbRcbLcLsmbLsLsmbsbRsbRsbLsbLsbRebRsRsRiR
gRsRsRgRsmmmmbRsRgbRgbRsRsRsRsRsRsRsRsRsRimmmmmmmmbRcRsLsmbLsRsLsLsLsL
smmmbLsRsLsLsmbLgRsbLsbLsRsbLsbLgbLibLjRsbLsbRsbRsbRsbLsbLsbLsLsLsmmbs
bLsRcb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 29; Drug: PCAP2 10 然 Apo 50 然
bRsLsLsmbsbLsLsLsLsLsLsLsLsLsmmmmmmmmbRsLsbLsLsLsmmbLsLsmbLsLsLsLgLgLs
mmbLsLsLsLsmmmbRjbRiRsmbRgRsmbLsRsRsRsmmbRsRsRhRimbRsRsRgRsRsRsRsRsRgR
smmmmmmmbRsRsRsRgRgRsRgmmmbsbRgRsmbRgbRsRsRsRsmmmbRhbRibRibLsRsRsRgmbR
sbRgRsRsRsRsRsRsRsRsRsRsRsRgmmmmmmmmmmmbsbsbsbRsRsmbRgbLjLhbLsbLsbLsbL
sbRibLsRsbRsRsmbRsbRsRsRsmmbRsbRsRsmbRsLsbRgbLsRsRsRsRjRgmmbLsLsmbRsbL
sbRsbRsRsRsmmbRgRsRsRsRsRsRsmmmmmmbRibRsRsRsmmbRcRsmbRsbLsLsLsmmbLgbLs
LsLsmmbLgRsbLsbLsbLsbReRsmbRsbRsbLebLsbLsbLibReRsmbRsbRsbRsRsmbRsbRsRs
RsmmbLsbRiRsmbLsbLsLsmbLsLsmbRcbLgbRibsbLjbLibRebRsbRgRsmbRcRsmbRsbRsR
sLsmbRcbsbLsbRcbRsRsRsRsRsRsRsmmmmmmbRgRsRsRsRimmmbRsRsRsmmbRsRsRsRsLs
RsmmmbRsRsmbRsRsmbRsRsmbRsbRsbRsbRsRsmbLsRsbsbsbRsbRsRsmbRgbRsRsmbRsRs
mbRsRsRsRsRsmmmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 30; Drug: PCAP2 10 然 Apo 50 然
bLsbLsbLsbLibLsRsLsbLsLsLsmmbLsbLgLsbLsbLsLsLsLsmmmbLsbsbLsbsbLgLsLiLs
bLgbRjbLibLsbRsbLsbRjbRsRoLsbLobRgRsmbRebRsbRcbLgbRcbRiRsmbRiRgbRhRsRs
RsmmmbRcbLebLcbLcbLcbRcRsmbRsbRcRsmbLsbRgbsbLeLsbsbRgRgbRsRsReRsRsmmmb
sbLsLsmbLoRsbRgbLjbRiRsmbRgRsRsmmbRgRsRimbsbRgRsRsRsmmmbRiRobLcbLsbRgR
smbLcbLoLsmbLgbLcbRsRjbRibRiRsRsRsRgmmmbLsbRsbRibRsRsLcmbLcRsRsmbLcLsR
sLsRsmbLobRcRsmbLsbRiRsmbLcLgLsbLcLsmbRibRebRgbLebRsbLibRsbLcbLgbRebRc
RsmbRcbLsbLgLsbRebLhbLcLsmbRsbRjbRebLgLsbLgLsbLibRibLsRsbLsLgbLgbLcbRg
bLgbLcbLoLsLcmbLhbLsbLcbRiRsmbReRsmbRiLsLsmbLsLsmbRjbRcbsbRcLsLsmbLsLs
mbLeLobLibLobRsLsbLgLsbLsbLibRobRiRsRsRsmmmbsbRcbLsLsmbLcbLgbRjbLcLsmb
RibLsbRebRgRibLcbLcbLcLsmbLibRiRsRsRgmmbRhbRcRsmbRiRoRsmbRsbRsRsmbLebL
oLsmbRibLhLsbLgLsbRgLgbLsLsmbLsbLgLsbLibLgRsbRebLcLsRsmbLcbRhLsbRhRgRo
bRgRsRsRsmmmbRiRsmbRibLjbRhRiRiRobLsbLgbLgbLebRhbRibRibRgRsmbLsbRibRsb
LgbRjbRhRsmbsbRsbRebRsbLebRsLsbRebLebLebLibRiLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 31; Drug: PCAP2 3 然 Apo 50 然
bLiLsLeLgLsbLsLsLsLimmbLiLsbLebRsbLebRsbRgbRsRsReRsmmbRsbLsRiRsRsRsRsR
sRsRsmmmmmmmbRgbLsRsRgRgRsRsmmbRibRibRgbRgbRgLsLsLgmbRibRgRgRsRsRsmmmb
RsRsmbRsbReRsmbLobRsLgbLsbRsRsLsmbLsLsLsLsLsmmmmbLsLsmbLgLsLgbRsLsbRsL
gbLsLsLsLsmmmbLsLsmbRsLsbLsbLsLsmbRsbRsLsLsmbLgLsLgLsbLgLgbLgLgbLsLsLs
LsmmmbLsbLsbLsbLgbLsLsmbLgLsLsmbLsLsLsmmbLsLsmbLgLgLgbLibLsbRsbLgLsRsb
RsLgLibLgbLgLsLsLgLgLeLsmbLgLsLsmbLibLgLsLgLsRsLsLgLsLsLsmmbLsLsLsmmbR
sLsRsLsbLsbRsRsmbLsLgLsLsmbLgLsbLgbLgLgLsbLgLsbLsLsmbLgLsbLgLsLsLgLsmb
LsLsmbRsRsLsLsmmbLsRsLsLsmbLsLgLgLsLsLsLsmmmbLgLsbLgbLgbRsLsLsmbLgLsLg
bLsLsLsmmbLibLgbLsRsLsbLiLsLgbLibLgbLsLsLsLsLgLsmmmbLsLsmbLsbLsLsmbLgb
LsbLgRsbLgLgbLiLsLsmbLsLsLsLsmmmbLsbLsbLgbLsbLsLsLsmmbLgLgbLsLgLsbLiLs
bLsbLgLsLsLgLsLiLsmbLgLsbLgbLibRsLsLiLsLsLsLsLgLsLsmmmmbLgLgbLgbLgbLgb
LgLsbLgbLsLsLsLsmmmbLsLsLsmmbLgLsbLgbLibLgbLsLsmbLsbRsLsLsLsmmbLsLsmbL
gLsbLgbsbLsLsLsLgmmbLiLsbLsLgLsLsmbLgbLgbRsLsLsLsmmbLsbLsLsmbLgLgbLgLs
bLsbLsLsmbLgbLgLgLsbLgLsRsbLgbLsLsmbLsLsmbLgbLsLsLsmmbLsbLsLsmbLsbLgLs
bLsRsbLsLsmbLgbLsbLgLsbLgRsbLgLsLsLsmmbLgbLiLsbLgbRsLsRsbLsbLsbLgRsbLg
LsLsmbLgLsLsmbRsLsbLsbRsLsbLsLgLsbLgbLgLsbLgbRsbLsbLgRsbLgbLsbLgbLsbLs
Lsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 32; Drug: PCAP2 3 然 Apo 50 然
bLsbsbLsLsLgLsLsmmbLibLgLsLsLgmbLsbLsbLsbLsRsLsbLgLsbLsbLsbLibLibLgbLs
bLgbLeLsbLgbLsbLiLgbLibLgbLgbRcbLsbLibLsLibLsLgLsbLibLgbLsbLsbLsbLsbLs
LsmbLibLgbLgbLsbLsLsLsLgLgmmbLsLsmbLsbLsLgbLsbLsbLibLgbLsbLsbLsbLgbLeb
LebLibLsbLsbLgbLsLiLcbLcb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 33; Drug: PCAP2 3 然 Apo 50 然
bLcbRcbLeLsLsmbLjbLebLcbsbsbsbLjbLjLcbRsbRcRsRimbLgLsbRhbLibLcLsmb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 34; Drug: PCAP2 3 然 Apo 50 然
bRjbLsbRsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 35; Drug: PCAP2 3 然 Apo 50 然
bRsRsmbRcbReReRsmbRsbRhbReRsRsRsmmmbLeLsLsmbLsbLcLsmbRsbLoLsmbLcLsmbLh
bLebLhbLhbLcbLsbLiLsbLsbLsbLibLsLsmbRgbRiLsbLsRibRiRsRsmmbRgRiRhRsmbRg
bRiRsmbRebRcRsmbRibLcbRsbRibRcbsbRebLsbsbRsbsbsbsbRiRsRgmbRsbRsLsbReRs
RembRcbRcbRibRiRsLsRsRsRgmmbsbsbRibRjReRsRsRemmbReRgRsmbRhbRiRsRsRsLsm
mmbRhRsRsmmbReRsmbLgbsbRsbLgLgLsbRjbsbRsbRgbsbRcRsLsmbRsLsbRcLsbRsRsRs
RsRsRsRsmmmmmmbRibRsbRhb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 36; Drug: PCAP2 3 然 Apo 50 然
bLgbsbLgLsbLgbLjbRgbRsRsmbRjbRcbLcLsmbLgbLsbLsLsRsmbLsbLsLsmbLsLgbLsbL
ibsbLsLsmbsbLsbLsbLsbLsbLsbRsbLsbLsbLibLgbLibLgbLgLebLgbRsLsbsbsbsbLeL
sbLcRsbLcbLsbRsLcbLiLgbLsLibLjbLsLgLsbLgbRsLgbLibLsbLibLsbLgbLsbLsbRib
RsbsbRibLsbsbRgRsRgRsRsmmmbRibRibRsbLsRsbRsbRiRsmbLsbLsbRgbLsbsbLsLsmb
RsRsmbLsbLsbRsbRsbRsbRgbRsbLsbLsbLsbRsbLsbLsbLsbLibLebLebLebLebLgbsbsb
sbsbLsbRsbRsbLsbLsbsbsbsbsbsbLsbsbLibLsLsLsLsLsmmmmbLsbLsbLsbLsbsbLsbL
sbLsbRsbLsbLsbLiLsLsmbLgbLgLsbsbLibLsLsmbLebLsLsmbLsbLibLebLebsbLgbLeb
LjbRsbRibLsbLjbLhbLjbRebRgbLsLsmbRsLgLsLibLgbLebsbRebRhRsRsmmbRgRgRsRg
mbRiRsmbRsRsRgRsRsRsmmmmbLsbLsbLsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 37; Drug: PCAP2 1 然 Apo 50 然
bLsLsmbLsbLgbLiLsbLcbLibRcbsbLeLsLsLsmmbsbLsLsmbsbLsbLiLsLsLsLsmmmbsbL
gLsLsLsLsmmmbLcbRcbRcbLiLsbLsLsLsLsmmmbLsRsbLsLsmbLgbLsLsLsLsLsmmmmbLg
bRjLsbRcRsmbsbRsRsRsRsmmmbRsRsRsRsRsRsRsmmmmmmbRsbRsLsLsmbRsbsbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 38; Drug: PCAP2 1 然 Apo 50 然
bRjRsmbRjbLiLsLsLgLsLsLsLsLsLsmmmmmmbLiLsLsLsLsLsLsLsLgLsLiLsLgLsLsLsL
sLsLsLsmmmmmmmmmmmmbLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLimmmmmmmmmmmm
mmmmmbLgLsLsLsLsLgLsLsmmmmbsbsbLsLsLsLsLsLsLsmmmmmmbLiLsLsLsLgLsLsLsLs
LsLsLsLimmmmmmmmbLeLsLgLsLsLsLsLsmmmmbLgLsLsLsLsLsLsLemmmmmbLsLsRsLsLs
LsmmmbLiLgLsbRjRgbRsRsRsRsmmmbRsRsRsmmbRsRsRsRsLsRsmmmbLsLsLsLsLsLsLgL
sLsLgLsLsLsLsLgLgmmmmmmmmmbLsbLsLsLsLsLsLsLsmmmmmmbLsLsLsLsLsLsLsLsLsL
smmmmmmmmmbLsLsmbLsLsLsLsLsLgLsLsLsLsLgmmmmmmmbLsLsLgLgLsLgLsLsLsLsLsL
sLimmmmmmbRsbLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLgLsLsLsmmmmmmm
mmmmmmmmmmmmmmmbLcbRsLsRsLsLsLsLsRsLsRsLsmmmbLsLsLsLsLsLsLsLgLgLsLgLsL
sLsLsLsLsmmmmmmmmmmmbLeLsbLsLsLsLsLsmmmmbLsLsLsLsmmmbLsLsLsLsLsLsLsLsL
sLsLsLsLgLgLsLsLsLsLsLgLsLsLgLsmmmmmmmmmmmmmmmmbLsLsmbLsLsLsLsLsLsLsLs
LsLsLsLgLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmmmmmmmmmbRjRsmbRgbLsbRsbsbLsbLs
LsLsLgLsLsLsLsLsLsLsLgLsLgmmmmmmmmbsbLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsL
sLsLsmmmmmmmmmmmmmmmmmmbLgRsbLeLsLsmbsbsbLsLgLiLgLsLsLsmmbLsLsLgLsLsLs
LgLsmmmbLiLgLgLsLsLgLsLsLhmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 39; Drug: PCAP2 1 然 Apo 50 然
bsbLjbsbLgRsbLoLsmbLeRsbLibLcbsbRjbRhbLobLcbRjbLcbRcbRobLhbsbRjbLhbLcb
LcLsmbLgbRjRebRsRcbRsLsbRsLsLsmbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 40; Drug: PCAP2 1 然 Apo 50 然
bLibLgbRibsbRobLsbLgbLibRibLeLsRsbsbRsbLsbLsbLsbRsLsLsLsmmbLgbRsbRsbLs
bLsbRsbLsLgRsbLobRsbRibLsbLsbLsbLsbLsbRsbRcbsb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 41; Drug: PCAP2 1 然 Apo 50 然
bRebRebsbRsbLsLsLsLsmmmbRjbRgbLsLsLsmmbRebRebRebReRsmbRebRebRebsbRebRe
bRebRebRebRebRebRebRebRebRebReRsLsmbRebRsRebReRsmbRebRebRebRibRcRsmbRe
RsmbRebRebRebRebReRsmbRebReRsmbRebRebRebRsbRebReLsbLsbRhbRibRebRebRebR
ebRebReRsRsmmbRgbsbRebsbRebsb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 42; Drug: PCAP2 1 然 Apo 50 然
bLsLsLsmmbRsLsLsLsLsLgLsmmmbLsLhLiLgLsbLsLsLsLsmmmbsbLeLsLsmbLiLiLiLgL
sbRcRsmbsbRsRgRsRsmmbRsRiRsRsmmbLcLsmbLoLsmbLhbRsbRjRgRsmbsbRibLsbRsbR
gRsRsRgmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 43; Drug: Control Apo 50 然
bLsRsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLsLgLsLgmmmmmmmmmmmmmmmmbLsLsLsLs
LsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmmmmmbLsbLsLsmbLsLsLsLsLsmmmmbLsLsLsLsL
sLsmmmmmbLsLsLsLsLsLsmmmmmbLgbLsRsbsbsbRsbLsLgLsLsLsLsLsLsLsLsLsLsmmmm
mmmmmbLsLsLsLsLsLsLsLsLsLiLsLsLsmmmmmmmmmmbRibRjbLsRsbsbLsbRsbRsRsLsmb
RsbsbLsb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 44; Drug: Control Apo 50 然
bLjLsmbRobLcbRsbLsbLibRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 45; Drug: Control Apo 50 然
bRgbRiRsmbRsRsRsReRsRsmmmmbRiRsRsmmbRsRsRsRsLsRsRsmmmmbRsbRgLsbRgRsRsR
sRsmmmmbRsbRsRsRsmmbRsbRsRsmbRcRsmbLibRsRsmbRsLsbRgbRebRgRsRgmbRsRcbLi
bRsRsmbRgbRsRsRsmmbRsRibRgLsRsRgbRgRsRgRsRsmmmbRsRgbRsRsmbRibReRsRsmmb
LibsbRgbRsbRgRsRsRsRsRhLsmmmmbRgbRsbLcbRcbLsbRcbLgbLgbLgbRgbRsRsRsmmbR
sRsRsRsRsRsmmmmmbRsbRsRgRsRsmmbRsRsmbRebsbLgbRgbRhRsmbRsRsRsRsRsRsRsmm
mmmmbRsRsRsRsmmmbRsbRsbRgRsRsmmbLsRsbLsRsRsRsLsmmbRsRsmbRgLsRsLsRsRsmb
RsRgbRiRsmbRhbRsRsRsLgmmbLgLsbReRsmbRibRgbReRsRsLsLgmmbLgbLgLsbLsbsbsb
sbLsbRsRsmbRsbsbsbsbsbsbsbsbLsbLsbsbsbsbRsb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 46; Drug: Control Apo 50 然
b

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 47; Drug: Control Apo 50 然
bLebsbRgbLsbLsLsmbLsbLsbLsRsbLebRobRebRibLsLjbRcRsmbRsRsmbsbsbLobRebLc
bLcbsbsbsbLeLsbRiRgbRsbRcbRobRcbRsRsRsRiRgmmbRsbsbsbLsLsLsLsLsLsLsLsLs
LsmmmmmmmmmbLsbLsLsRsLsmbRsRsRsRsRgRsRgRsRsRsmmmmmmmbLsRsLsbLsLsLsmmb

>ZF Recording 2016-04-15; tW: 300s; Start: 123042; End: 123543;
Recording: 13-1; Individual: 48; Drug: Control Apo 50 然
bLjbLgbLgbLsbLgbLsbRsLibLsbLgbRsbLsbRsbLsbRsbRsbLsbLsbLsbLsbLgbLsbLgbL
sbLsbLjbRsbLebLebLsbLsbLsbRsbLsbLgbsbLibLiLsbLiLsLsmbsb

